11.12.2012 Views

Meeting everyday needs of people everywhere - Unilever

Meeting everyday needs of people everywhere - Unilever

Meeting everyday needs of people everywhere - Unilever

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Unilever</strong> N.V. 1999<br />

Annual Report on Form 20-F<br />

Reverse for <strong>Unilever</strong> PLC Report<br />

<strong>Meeting</strong> <strong>everyday</strong> <strong>needs</strong> <strong>of</strong> <strong>people</strong> <strong>everywhere</strong><br />

U


A truly multi-local multinational<br />

<strong>Unilever</strong> is dedicated to meeting the <strong>everyday</strong> <strong>needs</strong> <strong>of</strong> <strong>people</strong> <strong>everywhere</strong>.<br />

Around the world our Foods and Home & Personal Care brands are chosen by<br />

many millions <strong>of</strong> individual consumers each day. Earning their trust, anticipating<br />

their aspirations and meeting their daily <strong>needs</strong> are the tasks <strong>of</strong> our local<br />

companies. They bring to the service <strong>of</strong> their consumers the best in brands<br />

and both our international and local expertise.<br />

<strong>Unilever</strong>’s Corporate Purpose<br />

Our purpose in <strong>Unilever</strong> is to meet the <strong>everyday</strong> <strong>needs</strong> <strong>of</strong> <strong>people</strong> <strong>everywhere</strong><br />

– to anticipate the aspirations <strong>of</strong> our consumers and customers and to<br />

respond creatively and competitively with branded products and services<br />

which raise the quality <strong>of</strong> life.<br />

Our deep roots in local cultures and markets around the world are our<br />

unparalleled inheritance and the foundation for our future growth. We will<br />

bring our wealth <strong>of</strong> knowledge and international expertise to the service <strong>of</strong><br />

local consumers – a truly multi-local multinational.<br />

Our long-term success requires a total commitment to exceptional standards<br />

<strong>of</strong> performance and productivity, to working together effectively and to a<br />

willingness to embrace new ideas and learn continuously.<br />

We believe that to succeed requires the highest standards <strong>of</strong> corporate<br />

behaviour towards our employees, consumers and the societies and<br />

world in which we live.<br />

This is <strong>Unilever</strong>’s road to sustainable, pr<strong>of</strong>itable growth for our business<br />

and long-term value creation for our shareholders and employees.


1 <strong>Unilever</strong> Annual Report on Form 20-F 1999<br />

Contents<br />

Cross reference to Form 20-F 2<br />

Report <strong>of</strong> the Directors<br />

Financial highlights 3<br />

Chairmen’s statement 4-5<br />

Selected financial data 6-10<br />

About <strong>Unilever</strong> 11-12<br />

Performance review 13<br />

1999/98 14-25<br />

1998/97 26-34<br />

Financial review 35-38<br />

Operating review 39-42<br />

Corporate governance 43-48<br />

Remuneration report 49-59<br />

Financial Statements<br />

<strong>Unilever</strong> N.V. (NV) is a public limited company registered in<br />

the Netherlands which has listings <strong>of</strong> shares or certificates<br />

(depositary receipts) <strong>of</strong> NV on the stock exchanges in<br />

Amsterdam, London and New York and in Belgium,<br />

France, Germany, Luxembourg and Switzerland.<br />

<strong>Unilever</strong> PLC (PLC) is a public limited company registered<br />

in England which has shares listed on the London Stock<br />

Exchange and, as American Depositary Receipts, on<br />

the New York Stock Exchange.<br />

The two parent companies, NV and PLC, operate as nearly<br />

as is practicable as a single entity, together referred to as<br />

the Group or the <strong>Unilever</strong> Group. NV and PLC and their<br />

group companies constitute a single group under<br />

Netherlands and United Kingdom legislation for the<br />

purposes <strong>of</strong> presenting consolidated accounts.<br />

Accordingly, the accounts <strong>of</strong> the <strong>Unilever</strong> Group are<br />

presented by both NV and PLC as their respective<br />

consolidated accounts.<br />

This report is the <strong>Unilever</strong> Annual Report on Form 20-F<br />

to the Securities and Exchange Commission in the United<br />

States <strong>of</strong> America for the year ended 31 December 1999.<br />

There are two versions, expressed in guilders for NV and<br />

pounds sterling for PLC.<br />

Statement <strong>of</strong> directors’ responsibilities 60<br />

Report <strong>of</strong> independent auditors 61<br />

Accounting information<br />

and policies 62-65<br />

Consolidated pr<strong>of</strong>it and loss account<br />

and Statement <strong>of</strong> total recognised<br />

gains and losses 66<br />

Consolidated balance sheet 67<br />

Consolidated cash flow statement 68<br />

Notes to the consolidated accounts 69-104<br />

Schedules – <strong>Unilever</strong> Group 105<br />

Key divergence statements from<br />

United States GAAP 106<br />

Differences from United States GAAP 107<br />

Principal group companies and fixed<br />

investments 108-110<br />

Company accounts 111-117<br />

Shareholder Information<br />

Control <strong>of</strong> <strong>Unilever</strong> 118-121<br />

Analysis <strong>of</strong> shareholding 122<br />

Information about exchange controls<br />

affecting security holders 122<br />

Nature <strong>of</strong> the trading market 123<br />

Taxation for US residents 124-125<br />

Dividends 126<br />

Signature 126<br />

Financial calendar and addresses 127<br />

Publications 128<br />

Web site 128<br />

The brand names shown in italics in this Form 20-F are<br />

trade marks owned by or licensed to companies within<br />

the <strong>Unilever</strong> Group.<br />

In addition, there is the <strong>Unilever</strong> Annual Report &<br />

Accounts for the year ended 31 December 1999, which<br />

is produced as two separate documents – the <strong>Unilever</strong><br />

Annual Review 1999 and the <strong>Unilever</strong> Annual Accounts<br />

1999. These documents comply with the Netherlands and<br />

the United Kingdom regulations. Both documents are<br />

made available to all shareholders but, unless they have<br />

elected to receive the full Annual Report & Accounts, only<br />

the Annual Review document is mailed to them.<br />

There are three versions <strong>of</strong> both these documents:<br />

– figures expressed in guilders, in Dutch;<br />

– figures expressed in pounds sterling, in English;<br />

– figures expressed in guilders, in English.<br />

The effect <strong>of</strong> exchange rate fluctuations over time may<br />

result in the trends shown in the guilder accounts differing<br />

significantly from those shown in the sterling accounts.


2 <strong>Unilever</strong> Annual Report on Form 20-F 1999<br />

Cross reference to Form 20-F<br />

Item page<br />

1 Description <strong>of</strong> the business<br />

Selected financial data 9-10<br />

About <strong>Unilever</strong> 11-12<br />

Recent acquisitions and disposals 15<br />

Operating review 39-42<br />

2 Description <strong>of</strong> property 42<br />

3 Legal proceedings 42<br />

4 Control <strong>of</strong> <strong>Unilever</strong> 118-121<br />

5 Nature <strong>of</strong> trading market 123<br />

6 Exchange controls and other limitations<br />

affecting security holdings 122<br />

7 Taxation 124-125<br />

8 Selected financial data<br />

Selected financial data 6-8<br />

Dividends 126<br />

9 Management’s discussion and analysis <strong>of</strong><br />

financial condition and results <strong>of</strong> operations<br />

Performance review 13-34<br />

Financial review 35-38<br />

9a Quantitative and qualitative disclosures about<br />

market risk<br />

Managing market risks 37-38<br />

10 Directors and other <strong>of</strong>ficers <strong>of</strong> Registrant<br />

Corporate governance 43-48<br />

11 Compensation <strong>of</strong> directors and <strong>of</strong>ficers<br />

Remuneration report 49-54<br />

12 Options to purchase securities from Registrant<br />

or subsidiaries<br />

Remuneration report – Share options 54-59<br />

13 Interest <strong>of</strong> management in certain transactions n/a<br />

14 Description <strong>of</strong> securities to be registered n/a<br />

15 Defaults upon senior securities n/a<br />

16 Changes in securities and changes in security for<br />

registered securities n/a<br />

17 Financial statements n/a<br />

18 Financial statements<br />

Report <strong>of</strong> independent auditors 61<br />

Accounting information and policies 62-65<br />

Consolidated pr<strong>of</strong>it and loss account 66<br />

Statement <strong>of</strong> total recognised gains and losses 66<br />

Consolidated balance sheet 67<br />

Consolidated cash flow statement 68<br />

Notes to the consolidated accounts 69-104<br />

Schedules – <strong>Unilever</strong> Group 105<br />

Key divergence statements from United States GAAP 106<br />

Differences from United States GAAP 107<br />

Principal group companies and fixed investments 108-110<br />

Cautionary Statement<br />

The Annual Report includes forward-looking statements within the meaning <strong>of</strong> section 27A <strong>of</strong> the US Securities Act <strong>of</strong> 1933, as<br />

amended, and section 21E <strong>of</strong> the US Securities and Exchange Act <strong>of</strong> 1934, as amended.<br />

We believe that the expectations reflected in these statements are reasonable. However, no assurance can be given that such<br />

expectations will prove to have been correct. Accordingly, results could differ materially from those set out in the forward-looking<br />

statements as a result <strong>of</strong>, among other factors, price fluctuations; currency fluctuations; loss <strong>of</strong> market; environmental risks; physical<br />

risks; and legislative, fiscal and regulatory developments.


Financial highlights<br />

• Excellent personal care results<br />

• Food pr<strong>of</strong>its* rise on slightly lower volumes<br />

• Home care volumes up but market investment reduces pr<strong>of</strong>it<br />

• Strong progress in Asia and Pacific as regional economies recover<br />

• Home & Personal Care pr<strong>of</strong>its* up in North America – Foods results lower<br />

• Good performance in Western Europe and Africa and Middle East<br />

*before exceptional items


Chairmen’s Statement – 1999 and the path to growth<br />

Operating margins before exceptional<br />

items rise to 11%<br />

Excellent progress in personal care<br />

Focus on 400 leading brands to<br />

accelerate top line growth<br />

We have made good progress pursuing our strategy<br />

<strong>of</strong> category focus and margin improvement against a<br />

challenging economic and competitive background.<br />

Our Home & Personal Care categories all grew strongly and<br />

we saw further improved margins in Foods. We are pleased<br />

with the developments in Western Europe and the recovery<br />

in South East Asia. Marketing investments in Latin America<br />

reduced pr<strong>of</strong>its.<br />

Margins before exceptional items further increased by<br />

half a percentage point to over 11%, a record.<br />

The fourth quarter saw the business achieve the highest<br />

level <strong>of</strong> underlying growth for two years. This included<br />

good performances from businesses which are already<br />

advanced in implementing our strategy <strong>of</strong> focusing on<br />

fewer brands. This is early evidence the strategy is working.<br />

However, sales growth <strong>of</strong> 2% at constant exchange rates<br />

and underlying volume growth <strong>of</strong> 1%<br />

for the full year were disappointing.<br />

In May 1999 our shareholders authorised a special dividend<br />

<strong>of</strong> Fl. 16 billion and a share consolidation which reduced<br />

the number <strong>of</strong> shares in issue. Earnings per share on the<br />

adjusted shareholdings rose by 9% before exceptional<br />

items.<br />

Our objective <strong>of</strong> delivering a total return to shareholders in<br />

the top third <strong>of</strong> a group <strong>of</strong> peer companies over a threeyear<br />

period was again achieved. However, our sector as a<br />

whole suffered as investor interest focused on high<br />

technology and internet stocks and there was an even<br />

sharper decline in the <strong>Unilever</strong> share price during the<br />

fourth quarter. This has been painful for everybody in<br />

<strong>Unilever</strong>. It was all the more disappointing given the<br />

significant appreciation in the preceding three years. As a<br />

result <strong>of</strong> this decline we were below the total shareholder<br />

return benchmark measured over a single year.<br />

We are pleased to report that the business passed the<br />

critical Year 2000 change without disruption.<br />

Categories<br />

Corporate Categories, which represent 86% <strong>of</strong> the total<br />

Comments refer to results before exceptional<br />

items and at constant rates <strong>of</strong> exchange.<br />

sales, continue to grow faster than the business as a<br />

whole. In 1999 they grew 3%, whereas turnover in other<br />

categories fell by 2%, largely due to disposals. We remain<br />

committed to improving the performance <strong>of</strong> these other<br />

businesses or exiting those that are not able to deliver<br />

sustained value.<br />

Our personal care businesses had another outstanding<br />

year. Turnover and pr<strong>of</strong>its grew strongly in all categories<br />

and regions with total sales up 7% and pr<strong>of</strong>its increasing<br />

by 24%. Home care and pr<strong>of</strong>essional cleaning also<br />

showed good sales growth but pr<strong>of</strong>its declined by 4% as<br />

higher expenditure to protect our strong market position<br />

in Latin America <strong>of</strong>fset increases in pr<strong>of</strong>its in Western<br />

Europe and Asia and Pacific.<br />

Foods pr<strong>of</strong>itability improved but overall foods sales<br />

declined partly due to disposals. Beverages pr<strong>of</strong>its were<br />

up, led by double digit volume growth in the ready-todrink<br />

sector. Oil and dairy based foods showed a good<br />

increase in pr<strong>of</strong>its but markets in Europe and North<br />

America continue to contract. Ice cream sales increased<br />

but pr<strong>of</strong>its overall were slightly below 1998.<br />

Regions<br />

The global reach <strong>of</strong> the Company was again an important<br />

factor. We were able to benefit from the good economic<br />

conditions in western markets. Sales and pr<strong>of</strong>its rose<br />

strongly in Asia and Pacific region as economies recovered<br />

from the crisis in late 1997 and 1998. In Western Europe<br />

pr<strong>of</strong>its and margins advanced well. In Central and Eastern<br />

Europe our business remained weak, with a slow recovery<br />

in Russia. There were notable increases in results for Africa<br />

and the Middle East. Sales and pr<strong>of</strong>its were affected in<br />

Latin America by difficult economic conditions in several<br />

countries coupled with a competitive challenge in our<br />

largest regional category, laundry.<br />

People<br />

The quality <strong>of</strong> our <strong>people</strong> was, as always, an important<br />

factor in our success during a demanding year. <strong>Unilever</strong><br />

employees bring to the business dedication, skill and<br />

special values. It is a particular privilege to lead this team<br />

in these changing times. They are responding to new<br />

challenges with great enthusiasm. Our thanks to one<br />

and all.<br />

The path to growth<br />

In February 2000 we announced a series <strong>of</strong> linked<br />

initiatives to align our entire organisation behind<br />

ambitious plans for accelerating growth and expanding<br />

margins. By 2004 we will increase annual top line growth<br />

to 5% and operating margins to 15%, underpinning our<br />

commitment to double digit earnings growth.


Chairmen’s Statement<br />

The principal components <strong>of</strong> the plans are:<br />

Brands We will concentrate product innovation and brand<br />

development on a focused portfolio <strong>of</strong> 400 leading<br />

brands. These have been chosen both on the basis <strong>of</strong> the<br />

strength <strong>of</strong> their current consumer appeal and their<br />

prospects for sustained growth. They include familiar<br />

brands such as Dove, Lux, Lipton, Magnum, and Calvin<br />

Klein fragrances. We will invest a total <strong>of</strong> €1.5 billion in<br />

additional marketing support over five years and by 2004,<br />

we expect this investment to have driven growth rates in<br />

the focused portfolio to at least 6% per annum.<br />

E-business E-business is directly relevant to our growth<br />

plans in the areas <strong>of</strong> brand communication and building<br />

direct relationships with consumers. The development <strong>of</strong><br />

online selling will be pioneered by the recently announced<br />

venture with iVillage. Alliances with AOL, Micros<strong>of</strong>t,<br />

Excite@Home and Wowgo are in place to support brand<br />

communication and build consumer understanding.<br />

E-business also <strong>of</strong>fers significant opportunities in<br />

business-to-business transactions throughout the supply<br />

chain and we will be rolling out a global e-procurement<br />

system over the next two years. We are intent on<br />

achieving a rapid expansion <strong>of</strong> e-business and have<br />

committed €200 million to these initiatives in 2000 and<br />

this will grow.<br />

Supply chain Our local businesses will be involved in<br />

developing plans to reorder our manufacturing activities<br />

into integrated regional networks in support <strong>of</strong> our<br />

brands. Our target is a world-class supply chain based on<br />

some 150 key sites plus a number producing principally<br />

for local markets. As a consequence we expect there will<br />

be a substantial reduction in the number <strong>of</strong><br />

manufacturing sites, probably by around 100.<br />

Simplification Concentrating on 400 brands will give us<br />

the opportunity to focus resources where they can be<br />

most effective, reduce overheads and streamline the<br />

Corporate Centre. Central to the plans will be revised<br />

knowledge and information systems to support our<br />

leading brands and the redesigned supply chain.<br />

Under-performing businesses The remaining businesses<br />

that do not meet performance standards, or which are<br />

no longer relevant to our strategy, will be restructured<br />

or divested.<br />

These initiatives are planned to deliver annualised savings<br />

<strong>of</strong> €1.5 billion by 2004. Of those savings, €1.15 billion<br />

will be allocated to margin improvement and €350 million<br />

to increasing resources behind the 400 leading brands.<br />

The programme is estimated to cost €5 billion in total,<br />

the majority <strong>of</strong> which is expected to be exceptional<br />

restructuring cost. It is likely to lead to a reduction <strong>of</strong><br />

around 25 000 jobs over the next five years, primarily in<br />

Europe and the Americas, representing 10% <strong>of</strong> <strong>Unilever</strong>’s<br />

total workforce. Provision for the costs and asset writedowns<br />

will be made as necessary consultations are<br />

completed and specific plans finalised.<br />

While these initiatives will lead to job losses over the fiveyear<br />

period, they are necessary for the long-term health <strong>of</strong><br />

the company. We will take the utmost care to implement<br />

these changes in close consultation with those affected to<br />

minimise the personal impact.<br />

Our strategic objectives and the imperative for change are<br />

clear. To translate strategy into action, we must now align<br />

the entire Company and all our employees behind our<br />

strategic aims.<br />

Therefore, during 2000, we will be making changes to our<br />

organisation and the way we reward <strong>people</strong> to put<br />

greater insistence on delivery. We are confident that such<br />

changes will energise the business and build the<br />

momentum for sustained outstanding performance.<br />

Antony Burgmans Niall FitzGerald<br />

Chairmen <strong>of</strong> <strong>Unilever</strong><br />

This statement accompanied the Annual Accounts which<br />

were signed on 7 March 2000.<br />

Subsequent to that date there have been the following<br />

notable developments:<br />

In April 2000 <strong>Unilever</strong> agreed to buy Slim•Fast Foods for<br />

Fl. 5.3 billion and the directors <strong>of</strong> Ben and Jerry’s<br />

Homemade Inc. approved <strong>Unilever</strong>’s <strong>of</strong>fer <strong>of</strong> Fl. 750<br />

million for all the outstanding shares <strong>of</strong> the company.<br />

On 2 May 2000 <strong>Unilever</strong> confirmed that it had made a<br />

non-public proposal to Bestfoods seeking to enter into<br />

negotiations to acquire all the outstanding stock <strong>of</strong><br />

Bestfoods for US $ 66 per share in cash, subject to certain<br />

conditions.


Selected financial data<br />

The financial data below shows key figures which are derived from our audited consolidated accounts <strong>of</strong> the <strong>Unilever</strong><br />

Group for the last five years and is qualified by reference to those accounts and notes.<br />

Consolidated pr<strong>of</strong>it and loss account<br />

00000000000000001111<br />

Fl. million<br />

00511100000<br />

1995 1996 1997 1998 1999<br />

0000000000 01111 01111 01111 01111<br />

Turnover 79 703 87 795 94 597 89 112 90 296<br />

11110 01111 01111 01111 01111<br />

Operating pr<strong>of</strong>it 6 382 7 518 7 563 9 718 9 482<br />

Exceptional items in operating pr<strong>of</strong>it (585) (620) (1 800) 276 (594)<br />

Operating pr<strong>of</strong>it before exceptional items<br />

– continuing businesses 6 129 7 518 8 849 9 442 10 076<br />

Non-operating exceptional items (a) — — 7 998 — —<br />

Income from fixed investments 120 89 85 82 114<br />

Interest (645) (657) (230) 344 (30)<br />

11110 01111 01111 01111 01111<br />

Pr<strong>of</strong>it on ordinary activities before taxation 5 857 6 950 15 416 10 144 9 566<br />

11110 01111 01111 01111 01111<br />

Pr<strong>of</strong>it on ordinary activities after taxation 3 882 4 419 11 231 6 806 6 549<br />

11110 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it 3 718 4 205 10 923 6 488 6 106<br />

11110 01111 01111 01111 01111<br />

Normal dividends on ordinary capital (1 578) (1 780) (2 277) (2 727) (2 743)<br />

Special dividends on ordinary capital (16 374)<br />

11110 01111 01111 01111 01111<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 2 125 2 410 8 631 (12 628) 3 319<br />

11110 01111 01111 01111 01111<br />

Combined earnings per shar e (b)(c)<br />

Guilders per Fl. 1.12 (1995-98: Fl. 1) <strong>of</strong> ordinary capital 3.32 3.76 9.78 5.80 5.80<br />

11110 01111 01111 01111 01111<br />

Ordinary dividends (b)<br />

NV – Guilders per Fl. 1.12 (1995-98: Fl. 1) <strong>of</strong> ordinary capital 1.55 1.75 2.23 2.51 2.79<br />

11110 01111 01111 01111 01111<br />

Special ordinary dividends<br />

NV – Guilders per Fl. 1 <strong>of</strong> ordinary capital 14.50<br />

Consolidated balance sheet<br />

00000000000000001111<br />

Fixed assets (d) 22 042 23 902 20 375 18 995 21 171<br />

Stocks 10 683 11 573 10 378 10 461 11 291<br />

Debtors 11 757 13 562 15 352 14 849 16 935<br />

Trade and other creditors (e) (16 675) (18 644) (20 039) (36 170) (22 428)<br />

11110 01111 01111 01111 01111<br />

27 807 30 393 26 066 8 135 26 969<br />

11110 01111 01111 01111 01111<br />

Net (funds)/debt (f) 4 703 5 014 (10 625) (12 735) (1 508)<br />

Provisions for liabilities and charges 8 220 9 014 10 918 9 507 10 097<br />

Minority interests 895 1 015 1 039 899 1 275<br />

Capital and reserves (e) 13 989 15 350 24 734 10 464 17 105<br />

11110 01111 01111 01111 01111<br />

27 807 30 393 26 066 8 135 26 969


Selected financial data<br />

Consolidated cash flow statement<br />

(g)<br />

00000000000000001111<br />

Fl. million<br />

00511100000<br />

1995 1996 1997 1998 1999<br />

0000000000 01111 01111 01111 01111<br />

Cash flow from operating activities 8 182 9 983 12 249 9 948 12 460<br />

Returns on investments and servicing <strong>of</strong> finance (756) (687) (750) 201 (283)<br />

Taxation (1 669) (1 877) (4 157) (2 779) (3 180)<br />

Capital expenditure and financial investment (2 953) (2 819) (2 774) (3 083) (3 307)<br />

Acquisitions and disposals (1 581) (2 275) 13 749 744 (799)<br />

Dividends paid on ordinary share capital (1 533) (1 786) (2 062) (2 365) (2 791)<br />

Special dividend (13 427)<br />

11110 01111 01111 01111 01111<br />

Cash flow before management <strong>of</strong><br />

liquid resources and financing (310) 539 16 255 2 666 (11 327)<br />

Management <strong>of</strong> liquid resources 651 (766) (14 122) (4 413) 12 509<br />

Financing (195) 770 (1 517) 92 (322)<br />

11110 01111 01111 01111 01111<br />

Increase/(decrease) in cash in the period 146 543 616 (1 655) 860<br />

Key ratios<br />

Return on shareholders’ equity (%) 26.4 29.4 49.8 24.6 42.3<br />

Return on capital employed (%) 14.2 15.2 28.5 16.0 22.3<br />

Operating margin (%) 8.0 8.6 8.0 10.9 10.5<br />

Net pr<strong>of</strong>it margin (%) (h) 4.7 4.8 11.6 7.3 6.8<br />

Net interest cover (times) 10.1 11.6 68.0 — 319.0<br />

Net gearing (%) 24.0 23.5 — — —<br />

Earnings: fixed charges 5.7 6.5 12.8 9.7 8.1<br />

Sterling/guilder exchange rates<br />

Annual average £1 = Fl. 2.53 2.62 3.18 3.29 3.35<br />

Year-end £1 = Fl. 2.49 2.96 3.34 3.12 3.55<br />

Selected financial data on a US GAAP basis<br />

Net pr<strong>of</strong>it 3 740 3 568 10 581 5 605 5 488<br />

Combined earnings per share<br />

Guilders per Fl. 1.12 (1995–98: Fl. 1) <strong>of</strong> ordinary capital 3.34 3.19 9.47 5.01 5.20<br />

Combined earnings per share excluding<br />

non-operating exceptional items<br />

Guilders per Fl. 1.12 (1995–98: Fl. 1) <strong>of</strong> ordinary capital 2.87 2.72 3.08 5.01 5.20<br />

Capital and reserves 27 402 31 388 42 441 42 515 33 883<br />

Earnings: fixed charges 6.1 5.9 12.3 8.4 7.5<br />

Net gearing (%) 14.3 13.4 — — —<br />

Net interest cover (times) 11.2 10.6 60.5 — 183.0<br />

Additional financial data<br />

Total assets 48 189 54 040 65 635 67 186 61 458<br />

Creditors due after more than one year 6 386 7 585 7 263 6 702 6 241


Selected financial data<br />

Definition <strong>of</strong> key ratios<br />

00000000000000001111<br />

Return on shareholders’ equity is net pr<strong>of</strong>it attributable to ordinary shareholders expressed as a percentage <strong>of</strong> the<br />

average capital and reserves attributable to ordinary shareholders during the year.<br />

Return on capital employed is the sum <strong>of</strong> pr<strong>of</strong>it on ordinary activities after taxation plus interest after taxation on<br />

borrowings due after more than one year, expressed as a percentage <strong>of</strong> the average capital employed during the year.<br />

Return on shareholders’ equity is substantially influenced by the Group’s policy prior to 1998, <strong>of</strong> writing <strong>of</strong>f purchased<br />

goodwill in the year <strong>of</strong> acquisition as a movement in pr<strong>of</strong>it retained. Return on capital employed and net gearing are<br />

also influenced but to a lesser extent.<br />

Operating margin is operating pr<strong>of</strong>it expressed as a percentage <strong>of</strong> turnover.<br />

Net pr<strong>of</strong>it margin is net pr<strong>of</strong>it expressed as a percentage <strong>of</strong> turnover.<br />

Net interest cover is pr<strong>of</strong>it on ordinary activities before net interest and taxation divided by net interest.<br />

Net gearing is net debt (borrowings less cash and current investments) expressed as a percentage <strong>of</strong> the sum <strong>of</strong> capital<br />

and reserves, minority interests and net debt.<br />

Earnings: fixed charges. Earnings consist <strong>of</strong> net pr<strong>of</strong>it (including the pr<strong>of</strong>it on the sale <strong>of</strong> the speciality chemicals<br />

businesses) increased by fixed charges and income taxes. Fixed charges consist <strong>of</strong> interest payable on debt and a portion<br />

<strong>of</strong> lease costs determined to be representative <strong>of</strong> interest. This ratio takes no account <strong>of</strong> interest receivable although<br />

<strong>Unilever</strong>’s treasury operations involve both borrowing and depositing funds.<br />

00000000000000001111<br />

Notes<br />

00000000000000001111<br />

(a) Non-operating exceptional items in 1997 includes Fl. 8 482 million pr<strong>of</strong>it on sale <strong>of</strong> speciality chemicals businesses.<br />

(b) Figures for earnings per share and dividends have been restated to reflect the four-for-one share split in<br />

October 1997.<br />

(c) For the basis <strong>of</strong> the calculations <strong>of</strong> combined earnings per share including the treatment <strong>of</strong> the 1999 share<br />

consolidation see note 30 on page 90.<br />

(d) Includes goodwill and intangibles purchased after 1 January 1998.<br />

(e) 1998 includes the special dividend <strong>of</strong> Fl. 16 014 million assuming all shareholders had taken the cash dividend.<br />

Capital and reserves in 1999 reflect the increase <strong>of</strong> Fl. 3 045 million as a result <strong>of</strong> the preference shares issued.<br />

(f) Net (funds)/debt comprises borrowings less cash and current investments.<br />

(g) The cash flow statement and the associated notes are presented in accordance with United Kingdom Financial<br />

Reporting Standard 1. Figures for 1995 have been restated on the same basis.<br />

(h) Net pr<strong>of</strong>it margin includes the pr<strong>of</strong>it on sale <strong>of</strong> the speciality chemicals businesses in 1997.<br />

00000000000000001111


Selected financial data<br />

By geographical area<br />

00000000000000001111<br />

Fl. million<br />

00511100000<br />

1995 1996 1997 1998 1999<br />

0000000000 01111 01111 01111 01111<br />

Turnover<br />

Europe 42 547 44 002 44 832 41 805 41 404<br />

North America 14 993 18 328 19 613 18 552 19 474<br />

Africa and Middle East 3 675 4 217 4 826 4 911 5 065<br />

Asia and Pacific 10 924 12 589 14 613 12 786 14 815<br />

Latin America 7 564 8 659 10 713 11 058 9 538<br />

11110 01111 01111 01111 01111<br />

79 703 87 795 94 597 89 112 90 296<br />

11110 01111 01111 01111 01111<br />

Operating pr<strong>of</strong>it<br />

Europe 3 241 3 593 3 868 5 068 4 775<br />

North America 1 109 1 628 1 112 2 077 1 866<br />

Africa and Middle East 400 436 450 490 585<br />

Asia and Pacific 951 1 033 1 228 1 005 1 415<br />

Latin America 681 828 905 1 078 841<br />

11110 01111 01111 01111 01111<br />

6 382 7 518 7 563 9 718 9 482<br />

11110 01111 01111 01111 01111<br />

Net operating assets<br />

Europe 10 601 11 305 6 782 7 187 7 572<br />

North America 5 067 6 121 3 693 3 831 4 399<br />

Africa and Middle East 1 428 1 624 1 705 1 542 1 794<br />

Asia and Pacific 2 876 3 289 3 153 2 825 3 304<br />

Latin America 2 178 2 258 2 999 3 019 3 350<br />

11110 01111 01111 01111 01111<br />

22 150 24 597 18 332 18 404 20 419


Selected financial data<br />

By operation<br />

00000000000000001111<br />

Fl. million<br />

00511100000<br />

1995 1996 1997 1998 1999<br />

0000000000 01111 01111 01111 01111<br />

Turnover<br />

Foods 41 690 43 841 47 216 46 385 45 183<br />

Home & Personal Care 28 937 34 583 41 152 41 393 43 588<br />

Other Operations 2 502 2 397 2 232 1 334 1 525<br />

Speciality Chemicals 6 574 6 974 3 997<br />

11110 01111 01111 01111 01111<br />

79 703 87 795 94 597 89 112 90 296<br />

11110 01111 01111 01111 01111<br />

Operating pr<strong>of</strong>it<br />

Foods 2 824 3 122 2 737 3 970 3 942<br />

Home & Personal Care 2 458 3 211 4 074 4 611 5 202<br />

Other Operations 225 195 238 1 137 338<br />

Speciality Chemicals 875 990 514<br />

11110 01111 01111 01111 01111<br />

6 382 7 518 7 563 9 718 9 482<br />

11110 01111 01111 01111 01111<br />

Net operating assets<br />

Foods 11 176 11 918 10 784 10 780 11 716<br />

Home & Personal Care 6 190 7 315 7 124 7 259 8 356<br />

Other Operations 839 853 424 365 347<br />

Speciality Chemicals 3 945 4 511<br />

11110 01111 01111 01111 01111<br />

22 150 24 597 18 332 18 404 20 419<br />

11110 01111 01111 01111 01111<br />

Capital expenditur e<br />

Foods 1 614 1 642 1 614 1 708 1 523<br />

Home & Personal Care 870 906 1 117 1 122 1 271<br />

Other Operations 73 83 70 98 81<br />

Speciality Chemicals 513 430 262<br />

11110 01111 01111 01111 01111<br />

3 070 3 061 3 063 2 928 2 875<br />

The principal speciality chemicals businesses were sold in July 1997. Continuing businesses previously reported as<br />

Speciality Chemicals have been reallocated to other segments.


About <strong>Unilever</strong><br />

History and structure <strong>of</strong> <strong>Unilever</strong><br />

NV and PLC are the two parent companies <strong>of</strong> the <strong>Unilever</strong><br />

Group <strong>of</strong> companies. NV was incorporated under the<br />

name Naamlooze Vennootschap Margarine Unie in<br />

the Netherlands in 1927. PLC was incorporated under the<br />

name Lever Brothers Limited in Great Britain in 1894.<br />

Since 1930 when the <strong>Unilever</strong> Group was formed, NV and<br />

PLC have operated, as nearly as is practicable, as a single<br />

entity. They have the same directors, adopt the same<br />

accounting principles, and are linked by a series <strong>of</strong><br />

agreements. The Equalisation Agreement, which regulates<br />

the mutual rights <strong>of</strong> the two sets <strong>of</strong> shareholders, is<br />

particularly important. It makes the position <strong>of</strong> the<br />

shareholders <strong>of</strong> both companies, as far as possible,<br />

the same as if they held shares in a single company.<br />

(See Control <strong>of</strong> <strong>Unilever</strong> on page 118)<br />

NV and PLC are both public companies, with separate stock<br />

exchange listings and different shareholders. You cannot<br />

convert or exchange the shares <strong>of</strong> one for shares <strong>of</strong> the<br />

other. There is no fixed relationship between the trading<br />

prices <strong>of</strong> their shares – the relative share prices on the<br />

various markets can, and do, fluctuate from day to day and<br />

hour to hour. This happens for various reasons, including<br />

changes in exchange rates. Over time the prices <strong>of</strong> NV<br />

and PLC shares do stay in close relation to each other,<br />

in particular because <strong>of</strong> our equalisation arrangements.<br />

(See Control <strong>of</strong> <strong>Unilever</strong> on page 118)<br />

NV and PLC are holding and service companies. Our<br />

businesses are carried out by our Group companies<br />

around the world. The holding companies have agreed<br />

to co-operate in all areas, to exchange all relevant business<br />

information and to ensure all group companies act<br />

accordingly. In most cases, shares in the group companies<br />

are held ultimately by NV or PLC. The main exception is<br />

that US companies are owned by both – 75% by NV and<br />

25% by PLC. This arrangement is designed to create a<br />

balance between the funds generated by the NV and PLC<br />

parts <strong>of</strong> the Group. (See Control <strong>of</strong> <strong>Unilever</strong> on page 118)<br />

Business structur e<br />

<strong>Unilever</strong> is organised, and its internal results are reported,<br />

on both a product and a regional basis.<br />

On a product basis, Category Directors are responsible for<br />

developing category strategies for implementation across<br />

<strong>Unilever</strong>’s operations and they work closely with Business<br />

Groups to develop regional strategies. They are also<br />

responsible for directing and managing the allocation <strong>of</strong><br />

corporate resources for research and development and the<br />

innovation network.<br />

On a regional basis, <strong>Unilever</strong>’s operations are organised into<br />

twelve Business Groups. These are regionally based with the<br />

exception <strong>of</strong> DiverseyLever, a worldwide grouping <strong>of</strong><br />

pr<strong>of</strong>essional cleaning products and services. Western<br />

Europe and North America are further sub-divided by Foods<br />

and Home & Personal Care product categories.<br />

The individual operating companies, which form the core<br />

building blocks <strong>of</strong> the <strong>Unilever</strong> organisation, come within<br />

the Business Groups. The President <strong>of</strong> each Business Group<br />

is accountable for the performance <strong>of</strong> the companies in<br />

his group. (See Business Group Presidents on page 45)<br />

Description <strong>of</strong> business<br />

<strong>Unilever</strong> is one <strong>of</strong> the world’s leading suppliers <strong>of</strong> fast<br />

moving consumer goods in foods, household care and<br />

personal product categories. It also has other operations,<br />

mainly plantations.<br />

Foods<br />

Oil and Dairy Based Foods and Bakery We are the market<br />

leader in margarine and related spreads in most countries<br />

in Europe and North America. We sell spreads, oils and<br />

cooking fats in more than 50 countries including<br />

Australia, Indonesia, South Africa and Turkey.<br />

In Western Europe and North America, consumer interest<br />

remains strong in spreads <strong>of</strong>fering qualities related to<br />

‘health’ and ‘taste’, although overall consumption in the<br />

sector is declining. Important brands in these markets are<br />

Becel (the Netherlands), Flora (UK), Fruit d’Or (France),<br />

Rama (Germany) and Country Crock and Take Control<br />

(USA). In many other countries, sales <strong>of</strong> spreads are<br />

growing as a result <strong>of</strong> changes in eating habits and<br />

increases in population and personal incomes. We sell<br />

olive oil in a number <strong>of</strong> European countries and North<br />

America under the Bertolli brand name and in France<br />

under the Puget brand.


About <strong>Unilever</strong><br />

Bakery products comprise speciality bakery fats, designed<br />

for end-applications such as bread, cakes, biscuits and<br />

pastry, as well as bread and confectionery ingredients.<br />

Frozen bakery products are supplied to bakeries.<br />

Ice cream and beverages We are the leading producer <strong>of</strong><br />

ice cream in most European countries, the United States<br />

and Latin America. We have ice cream sales in more than<br />

90 countries worldwide. Important household names are<br />

Wall’s, Langnese, Ola and Algida in Europe and Good<br />

Humor and Breyers in the United States. Ice cream<br />

products such as Magnum, Solero, Cornetto, Carte d’Or<br />

and Viennetta are brands sold internationally as part <strong>of</strong><br />

local or international house names.<br />

We have important positions in packet tea and tea-related<br />

drinks in many regions through our Lipton and Brooke<br />

Bond brands. Lipton is the world’s leading brand in tea<br />

and iced tea. Sales <strong>of</strong> ready-to-drink teas are growing<br />

throughout Europe, North America and East Asia. We<br />

have a joint venture with PepsiCo Inc. which markets<br />

ready-to-drink products in North America and Mexico.<br />

We also have extensive tea plantations in India and<br />

Kenya, supplying tea for our own brands and the market<br />

in general.<br />

Culinary and frozen foods We are the leading producer<br />

<strong>of</strong> frozen foods in Europe, under the Birds Eye brand in the<br />

United Kingdom and Iglo brand in most other European<br />

countries. We also market frozen seafood in the United<br />

States under the Gorton’s brand. A range <strong>of</strong> meal solutions,<br />

first launched in Italy under the brand Quattro Stelle, is<br />

being extended across Europe.<br />

We have a significant pasta sauce business under the<br />

Ragú and Five Brothers brands. We also sell bouillons and<br />

other cooking aids in Europe, North America, Australasia,<br />

Egypt and sub-Saharan Africa. In the United Kingdom,<br />

Colman’s is a significant brand in meal sauces and<br />

condiments and the announcement <strong>of</strong> the acquisition <strong>of</strong><br />

Amora Maille in France in 1999 will add an important<br />

brand covering condiments, mayonnaise and vinegar- b a s e d<br />

products with sales in a number <strong>of</strong> European countries.<br />

Salad dressings, spices and seasonings are marketed in<br />

the United States under the Lipton and Lawry’s brands.<br />

Instant soups are sold under the Cup-a-Soup, Recipe<br />

Soups and Lipton brands, particularly within Europe,<br />

the United States and Australasia.<br />

Home & Personal Car e<br />

Home care and pr<strong>of</strong>essional cleaning We are one <strong>of</strong> the<br />

two leading global suppliers <strong>of</strong> products for fabrics<br />

cleaning, surface care and hygiene in a domestic and<br />

a pr<strong>of</strong>essional setting. We have operations in some 60<br />

countries and we are market leader in many. The best<br />

known brands, some <strong>of</strong> which are limited to single<br />

countries or regions, are Wisk, all, Omo, Skip and Persil<br />

(UK and France) fabric cleaners, Comfort, Cajoline and<br />

Snuggle fabric conditioners, and Cif/Jif and Domestos<br />

surface cleaners and hygiene products.<br />

DiverseyLever is a leading provider <strong>of</strong> cleaning and<br />

hygiene products and services to institutional, laundry<br />

and food and beverage customers.<br />

Personal care We are the world leader in personal wash,<br />

deodorants and anti-perspirants. We have important market<br />

shares in toothpastes, skin care and hair care products in<br />

many countries.<br />

Our leading international brands include Lux, Dove and<br />

Lifebuoy in personal wash, Rexona, Impulse and Degree<br />

deodorants and anti-perspirants, and Axe male personal<br />

care range. In skincare, Pond’s, Vaseline and Fair & Lovely<br />

are international brands and Hazeline is an important<br />

brand in China for skin care and hair shampoos.<br />

Hair shampoos are sold internationally under the Organics<br />

and Timotei brands and in North America under the<br />

ThermaSilk, Salon Selectives and Finesse brands.<br />

Toothpastes are sold widely under the Signal, Close-Up<br />

and Mentadent brands and in China Zhonghua is the<br />

brand leader.<br />

We are one <strong>of</strong> the world’s largest producers <strong>of</strong> prestige<br />

fragrances. We sell a number <strong>of</strong> fragrances under the<br />

Calvin Klein house name, including Obsession, Eternity<br />

and Escape, which are classic brands, and cK be aimed at<br />

a youthful market. Elizabeth Arden sells an integrated<br />

range <strong>of</strong> cosmetics, skin care and fragrances and markets<br />

a number <strong>of</strong> fragrances under designer house names.<br />

Our Unipath business manufactures and markets<br />

diagnostic medical products, with a special focus on<br />

women’s reproductive health.<br />

Other Operations<br />

We own significant oil plantations in the Democratic<br />

Republic <strong>of</strong> Congo, Côte d’Ivoire, Ghana and Malaysia<br />

and tea plantations in India, Kenya and Tanzania. These<br />

are classified as Other Operations from 1999 onwards.<br />

Chemicals<br />

We sold our speciality chemicals businesses in July 1997.


13 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review<br />

This discussion, unless otherwise indicated, is based on<br />

the results <strong>of</strong> our Group’s continuing operations, which:<br />

•<br />

•<br />

includes acquisitions made each year;<br />

excludes from 1997 the speciality chemicals<br />

businesses that were sold in 1997 and the proceeds<br />

<strong>of</strong> that sale.<br />

Our accounting policies are based on United Kingdom<br />

generally accepted accounting principles (GAAP) and<br />

Dutch GAAP which differ significantly from United States<br />

G A A P. The principal diff e rences are described on page 1 0 7 .<br />

We have shown reconciliations to the approximate net<br />

income and capital and reserves under US GAAP on<br />

page 106.<br />

Euro reporting<br />

Following the introduction <strong>of</strong> the euro, we have<br />

published supplementary information in euros<br />

throughout 1999 and will replace the guilder and<br />

sterling with the euro for reporting purposes from the<br />

start <strong>of</strong> the year 2000.<br />

Effect <strong>of</strong> exchange rates on the way we<br />

present our financial statements<br />

We have published our accounts in two currencies,<br />

Dutch guilders and pounds sterling. The effect <strong>of</strong><br />

exchange rate fluctuations over time may result in<br />

the trends shown in the guilder accounts differing<br />

significantly from those shown in the sterling accounts.<br />

Foreign currency amounts are translated into the<br />

published currency using annual average exchange rates<br />

for results and cash flows. An exception to this was in<br />

1997, when the pr<strong>of</strong>it on disposal <strong>of</strong> the speciality<br />

chemicals businesses was translated at the rates<br />

prevailing on 8 July 1997, and the discontinued<br />

businesses’ results were translated at the average rates<br />

up to the date <strong>of</strong> disposal. Year-end exchange rates are<br />

used for the consolidated balance sheet, except for the<br />

ordinary capital <strong>of</strong> NV which is translated at the rate<br />

<strong>of</strong> £1 = Fl. 12 (see Control <strong>of</strong> <strong>Unilever</strong> on page 118).<br />

The exchange rates used for the last five years were:<br />

Fl. 1 to £1<br />

0005111<br />

Average rates Year-end rates<br />

00001105111 05111<br />

1995 Fl. 2.53 Fl. 2.49<br />

1996 Fl. 2.62 Fl. 2.96<br />

1997 Fl. 3.18 Fl. 3.34<br />

1998 Fl. 3.29 Fl. 3.12<br />

1999 Fl. 3.35 Fl. 3.55<br />

In the following discussion we have used annual average<br />

exchange rates to translate foreign currency amounts.<br />

To eliminate the effect <strong>of</strong> exchange rate fluctuations,<br />

we express our key year-on-year comparisons at<br />

constant rates <strong>of</strong> exchange. This means using the<br />

annual average rates for the previous year so that<br />

year-on-year comparisons are the same in both guilders<br />

and sterling.<br />

Our results in a particular reporting currency (guilders or<br />

sterling) are depressed in years in which the reporting<br />

currency strengthens in relation to other currencies and<br />

vice versa. The difference between the percentage<br />

change calculated for each <strong>of</strong> the reporting currencies in<br />

the table below and the percentage change at constant<br />

exchange rates reflects the extent to which the reporting<br />

currency has strengthened or weakened against the<br />

weighted average <strong>of</strong> the underlying currencies. The<br />

difference in the percentage change between the guilder<br />

accounts and the sterling accounts reflects the<br />

movement in the exchange rate between the two<br />

currencies. Figures in 1996/1997 and the trend in<br />

1997/1998 are impacted by the pr<strong>of</strong>it on disposal<br />

<strong>of</strong> the speciality chemicals businesses.<br />

The following table shows certain percentage increases/(decreases) in our Group results between years expressed in<br />

guilders and sterling, and at constant exchange rates.<br />

00000000000110000011<br />

1996-1997 1997-1998 1998-1999<br />

0000 0000 0000<br />

Results Const. Results Const. Results Const.<br />

Fl. £ Rates Fl. £ Rates Fl. £ Rates<br />

% % % % % % % % %<br />

0000011 1011 1011 011 1011 1011 011 1011 1011<br />

Turnover 8 (11) (1) (6) (9) (2) 1 — 2<br />

Operating pr<strong>of</strong>it 1 (17) (8) 28 24 34 (2) (4) (2)<br />

Net pr<strong>of</strong>it 159 107 141 (41) (41) (38) (6) (7) (5)<br />

00000000000110000011


14 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review<br />

The information in the following tables is based on<br />

exchange rates between pounds sterling and US dollars,<br />

and guilders and US dollars, based on the Noon Buying<br />

Rate in New York City for cable transfers in foreign<br />

c u r rencies as certified for customs purposes by the Federal<br />

Reserve Bank <strong>of</strong> New York (The Noon Buying Rate).<br />

US $ per £1<br />

Calendar period At 31 December Average rate High Low<br />

00005 0111 5111 5111<br />

1995 1.55 1.58 1.64 1.53<br />

1996 1.71 1.57 1.71 1.49<br />

1997 1.64 1.64 1.70 1.58<br />

1998 1.66 1.66 1.72 1.61<br />

1999 1.62 1.62 1.68 1.55<br />

On 28 April 2000 the Noon Buying Rate was US $ 1.56<br />

to £1.<br />

Fl. per US $ 1<br />

Calendar period At 31 December Average rate High Low<br />

00005 0111 5111 5111<br />

1995 1.60 1.60 1.75 1.52<br />

1996 1.73 1.69 1.76 1.61<br />

1997 2.03 1.95 2.12 1.73<br />

1998 1.88 1.97 2.09 1.81<br />

1999 2.19 2.07 2.20 1.87<br />

On 28 April 2000 the Noon Buying Rate was Fl. 2.00 to<br />

US $ 1.<br />

The exchange rates used for translating US dollars into<br />

pounds sterling and guildersin this report for the last five<br />

years were:<br />

US $ per £1 Fl. per US $ 1<br />

Average Year-end Average Year-end<br />

rates rates rates rates<br />

0050 0111 0111 0111<br />

1995 1.58 1.55 1.60 1.60<br />

1996 1.56 1.70 1.68 1.74<br />

1997 1.64 1.65 1.94 2.03<br />

1998 1.66 1.66 1.98 1.88<br />

1999 1.62 1.62 2.07 2.19<br />

The exchange rate on 28 April 2000 for €1 was £0.58,<br />

Fl. 2.20371 and US $ 0 . 9 1 .<br />

1999 results compared with 1998<br />

<strong>Unilever</strong> Group<br />

Overall turnover increased by 2% to Fl. 90 890 million and<br />

underlying volume growth <strong>of</strong> 1% was just over half that<br />

achieved in 1998. This reflected the challenging economic<br />

and competitive nature <strong>of</strong> some <strong>of</strong> our regional markets.<br />

Operating pr<strong>of</strong>it incre a s e d 7% to Fl. 10 082 million.<br />

Operating margins at 11% were at an historic high. There<br />

was good margin progress in almost all regions, notably in<br />

Europe and Asia and Pacific. Pr<strong>of</strong>it growth in personal care<br />

was particularly strong.<br />

Net pr<strong>of</strong>it was up 3%. This reflected lower interest<br />

income, due to the reduction in net funds following<br />

payment <strong>of</strong> the special dividend in mid-1999. Earnings per<br />

share taking account <strong>of</strong> the share consolidation, which<br />

reduced the number <strong>of</strong> shares, rose 9%.<br />

Exceptionals and restructuring<br />

Included in operating pr<strong>of</strong>it in 1999 was an exceptional<br />

charge <strong>of</strong> Fl. 594 million. This compared with a net<br />

benefit <strong>of</strong> Fl. 276 million in 1998, which included the<br />

Fl. 858 million pr<strong>of</strong>it on the disposal <strong>of</strong> Plant Breeding<br />

International, in Cambridge, United Kingdom.<br />

The 1999 exceptional charge includes a restructuring<br />

charge <strong>of</strong> Fl. 512 million (1998: Fl. 585 million). In 1999<br />

these charges were principally in respect <strong>of</strong> our Foods<br />

and Personal Care operations in North America, and in<br />

Western European Foods and Latin American businesses.<br />

In 1998 the restructuring projects were focused mainly in<br />

Foods in Europe and the businesses in Asia and Pacific.<br />

Details <strong>of</strong> movements in all restructuring provisions in<br />

1999 and 1998 are shown in current money in note 18<br />

on page 78 and the cash flows in note 26 on page 86.<br />

Under US GAAP, certain <strong>of</strong> the restructuring charges in<br />

each year would not have been recognised until certain<br />

additional criteria had been met, and would then have<br />

been included as a charge in subsequent years. Details<br />

<strong>of</strong> the US GAAP adjustments relating to the restructuring<br />

charges are given on page 106.<br />

The benefits arising from the 1998 restructuring plan are<br />

now being seen, although we expect further progress in<br />

the coming year.<br />

The 1997 restructuring plan is substantially implemented<br />

and the expected headcount reductions and levels <strong>of</strong><br />

savings are broadly in line with the original plan.<br />

On 22 February 2000 we announced a series <strong>of</strong> linked<br />

initiatives as part <strong>of</strong> a programme to accelerate growth<br />

and expand margins. These initiatives consist <strong>of</strong> focusing<br />

resources on 400 key brands, closing certain<br />

manufacturing sites and reorganising or divesting<br />

underperforming businesses. The programme is estimated<br />

to cost €5 billion in total, the majority <strong>of</strong> which is<br />

expected to be exceptional restructuring cost. It is likely to<br />

lead to the reduction <strong>of</strong> around 25 000 jobs over five<br />

years, primarily in Europe and the Americas, and to deliver<br />

annual savings <strong>of</strong> €1.5 billion by 2004.


15 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review – 1999<br />

Recent acquisition and disposals<br />

During the year we made 27 small acquisitions. The most<br />

important were:<br />

Varela SA – Home & Personal Care in Colombia<br />

Mountain Cream – Ice cream in China and Hong Kong<br />

Beijing Tea Processing Factory – Tea in China<br />

Sociedad Industrial Dominicana – Home & Personal Care<br />

and ice cream in the Dominican Republic<br />

Miro Aebe – Tomato products in Greece<br />

Rossell – Tea plantation in India<br />

Selecta Dairy Products Inc.– Ice cream in Philippines<br />

Slotts & Kockens – Culinary brands in Sweden<br />

At current exchange rates, Fl. 1 101 million was invested<br />

in acquisitions, which are expected to add approximately<br />

Fl. 529 million to sales in a full year.<br />

In addition to the above the following acquisitions are<br />

expected to be completed in May 2000.<br />

– agreement was reached in 1999 to acquire two<br />

leading French culinary brands, Amora and Maille, for<br />

Fl. 1 540 million.<br />

– in April 2000 <strong>Unilever</strong> agreed to buy Slim•Fast<br />

Foods Company, a leading US-based food business,<br />

best known for its nutritionally-balanced products, for<br />

Fl. 5.3 billion (US $ 2.3 billion) cash.<br />

– in April 2000 the Board <strong>of</strong> Directors <strong>of</strong> Ben & Jerry’s<br />

Homemade Inc. approved <strong>Unilever</strong>’s <strong>of</strong>fer <strong>of</strong><br />

Fl. 750 million (US $ 326 million) for all <strong>of</strong> the<br />

outstanding shares <strong>of</strong> the company on a fully<br />

diluted basis.<br />

In 1999, we disposed <strong>of</strong> 23 businesses, including<br />

Homann, a salad and dressing business in Germany,<br />

a beverage business in Dubai and various other small<br />

businesses. At current exchange rates, Fl. 294 million<br />

was received from these disposals, with a reduction <strong>of</strong><br />

approximately Fl. 766 million <strong>of</strong> sales in a full year.<br />

Performance review by region and category<br />

The segmental analysis which follows is based on<br />

operating results before exceptional items, at constant<br />

exchange rates, and includes the results <strong>of</strong> the speciality<br />

chemicals businesses up to 8 July 1997 but does not take<br />

account <strong>of</strong> US GAAP adjustments. Turkey, formerly<br />

reported under Africa and Middle East region, is reported<br />

within Europe from 1 January 1998. Figures for previous<br />

years have been restated on the same basis.


16 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Europe<br />

1999 1999 1998 Change<br />

at current at constant at constant<br />

Fl. million rates rates rates<br />

Turnover 41 404 41 346 41 805 (1)%<br />

Operating pr<strong>of</strong>it 4 775 4 767 5 068 (6)%<br />

Operating pr<strong>of</strong>it before exceptional items 4 988 4 977 4 670 7%<br />

Exceptional items (net) (213) (210) 398<br />

Operating margin 11.5% 11.5% 12.1%<br />

Operating margin before exceptional items 12.0% 12.0% 11.2%<br />

Western Europe Our results again improved. Strong<br />

improvements in operating pr<strong>of</strong>its and margins reflected<br />

the benefits <strong>of</strong> restructuring and supply chain efficiencies.<br />

Volumes increased but disposals and other portfolio<br />

rationalisation led to a slight fall in overall sales.<br />

We continued the move from a national to a Euro p e a n<br />

s t r u c t u re, in order to better manage our leading brands,<br />

reduce costs and improve eff i c i e n c y.<br />

Home & Personal Care continued to drive our success,<br />

with volume growth <strong>of</strong> more than 3% and market share<br />

advances in most categories. In personal care, our<br />

deodorants, personal wash and oral categories did<br />

especially well, with deodorants enjoying another year <strong>of</strong><br />

double digit growth. The continuing extension <strong>of</strong> Dove,<br />

the brand contributing most to the growth <strong>of</strong> our<br />

personal care portfolio, made a particular impact. Sales<br />

were lower in Calvin Klein and Elizabeth Arden prestige<br />

fragrance brands.<br />

In home care, we increased market share in laundry.<br />

Tablets maintained their sector leadership and we launched<br />

a double-layer variant. Fabric conditioners increased sales<br />

markedly on the back <strong>of</strong> a new ‘easy-ironing’ variant under<br />

the Comfort and Snuggle brands. Innovative brand<br />

extensions in household cleaning, including Domestos<br />

3-in-1, Domestos hygienic wipes and Cif Oxy-Gel,<br />

contributed to overall growth.<br />

In Foods, overall pr<strong>of</strong>its improved, but volumes were<br />

marginally down. Volumes rose in culinary, ice cream and<br />

tea, with Lipton ready-to-drink tea growing by more than<br />

13%. We maintained our market share in yellow fats in a<br />

contracting market. Frozen foods volumes declined,<br />

reflecting the continued focusing <strong>of</strong> our portfolio. In<br />

December 1999 we announced the acquisition <strong>of</strong> the major<br />

French culinary company Amora Maille, which will improve<br />

our culinary market position and geographical coverage.<br />

Central and Eastern Europe It was a challenging year<br />

in the region and our sales and pr<strong>of</strong>its were down.<br />

The economic recovery in Russia was much slower than<br />

predicted, with a knock-on effect throughout Central<br />

Europe. The Turkish economy was badly hit by the<br />

natural disasters <strong>of</strong> 1999 but our company continues to<br />

perform well.<br />

In response to these events we streamlined our operations<br />

to benefit from the eventual improvement in trading<br />

conditions. In Russia we significantly reduced the cost base<br />

<strong>of</strong> our operations and adapted our portfolio. We improved<br />

our competitive position in the market by producing packs<br />

locally and manufacturing Rama and Calvé onshore.<br />

Falls in tea and ice cream pr<strong>of</strong>its in the region were partly<br />

<strong>of</strong>fset by an improved performance in laundry, particularly<br />

in Turkey.<br />

In Europe as a whole, exceptional items in 1999 mainly<br />

related to the restructuring <strong>of</strong> our Foods business. In the<br />

previous year, they included the pr<strong>of</strong>it on the disposal <strong>of</strong><br />

Plant Breeding International.


17 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

North America<br />

1999 1999 1998 Change<br />

at current at constant at constant<br />

Fl. million rates rates rates<br />

Turnover 19 474 18 693 18 552 1%<br />

Operating pr<strong>of</strong>it 1 866 1 791 2 077 (14)%<br />

Operating pr<strong>of</strong>it before exceptional items 2 144 2 057 1 991 3%<br />

Exceptional items (net) (278) (266) 86<br />

Operating margin 9.6% 9.6% 11.2%<br />

Operating margin before exceptional items 11.0% 11.0% 10.7%<br />

We had a mixed year in North America: Home & Personal<br />

Care achieved excellent results, but our Foods business<br />

returned a weaker performance. Overall, pr<strong>of</strong>its rose by<br />

3% with sales and volumes climbing modestly.<br />

Our Home & Personal Care business achieved a 5%<br />

volume growth, well above 1998, with pr<strong>of</strong>its also ahead.<br />

Our key brands flourished, with market share increases in<br />

our three priority categories <strong>of</strong> deodorants, hair and<br />

personal wash. Led by the successful relaunch <strong>of</strong> Suave<br />

and the strong growth <strong>of</strong> ThermaSilk, we achieved daily<br />

hair care category leadership. In home care, laundry<br />

experienced 4% underlying volume growth, with liquid<br />

all making a particular contribution.<br />

The merger <strong>of</strong> the three mass market Home & Personal<br />

Care businesses was completed successfully, although<br />

there were short-term customer service difficulties. The<br />

size and scope <strong>of</strong> the new organisation have strengthened<br />

our position in the marketplace.<br />

Our prestige fragrance brands returned to modest<br />

growth in North America on the strength <strong>of</strong> the Elizabeth<br />

Arden launches <strong>of</strong> Green Tea and Cerruti Image.<br />

However, Elizabeth Arden cosmetics sales were less<br />

robust. We announced the launch <strong>of</strong> a new Calvin Klein<br />

cosmetics range.<br />

In DiverseyLever, our pr<strong>of</strong>essional cleaning business, pr<strong>of</strong>its<br />

were adversely impacted by a sales reorganisation and<br />

some account losses.<br />

We marked the first full year since the new Lipton was<br />

formed from the merger <strong>of</strong> Thomas J. Lipton and Van den<br />

Bergh Foods. After achieving strong growth in 1998,<br />

Foods volumes were 3% down with pr<strong>of</strong>its and margins<br />

also falling.<br />

In tea, we successfully trialled Lipton Cold Brew,<br />

cold infusion tea bags aimed at the huge iced tea market.<br />

Investment in innovation also helped maintain our market<br />

share in yellow fats. By the end <strong>of</strong> the year our new blood<br />

cholesterol-level lowering spread Take Control had taken<br />

leadership in this new sector.<br />

In culinary, Wishbone dressings and Ragú pasta sauce<br />

made excellent progress. However, our withdrawal from<br />

the industrial tomato business and supply chain difficulties<br />

contributed to a drop in overall culinary volumes.<br />

We invested strongly in ice cream cabinets and sold more<br />

impulse products. However, competitive pressure saw us<br />

lose some ground in packaged ice cream.<br />

Exceptional charges in 1999 relate to the restructuring <strong>of</strong><br />

our Foods and Home & Personal Care businesses.


18 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Africa and Middle East<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 5 065 5 291 4 911 8%<br />

Operating pr<strong>of</strong>it 585 610 490 24%<br />

Operating pr<strong>of</strong>it before exceptional items 553 578 493 17%<br />

Exceptional items (net) 32 32 (3)<br />

Operating margin 11.6% 11.5% 10.0%<br />

Operating margin before exceptional items 10.9% 10.9% 10.0%<br />

Our businesses in Africa and Middle East had another<br />

good year despite depressed oil prices in early 1999 and<br />

economic and political instability in parts <strong>of</strong> Africa.<br />

Volumes grew by more than 6% in our corporate<br />

categories, operating pr<strong>of</strong>its climbed by 17%, sales<br />

increased by 8% and margins also rose.<br />

In Africa, we attained excellent growth in Home &<br />

Personal Care – our largest business in the region.<br />

Laundry, oral and mass skin were strong. To increase the<br />

affordability <strong>of</strong> our brands, we launched sachet versions <strong>of</strong><br />

toothpaste and laundry products in most African markets.<br />

Our South African operations flourished, with share<br />

increases in priority categories. We introduced our ice<br />

cream brands to the South African townships for the first<br />

time, with smaller, more affordable products. Our<br />

businesses in Côte d’Ivoire and Ghana did well and we<br />

achieved volume growth in Nigeria.<br />

T h roughout Africa, we focused on strengthening our<br />

distribution network by developing exclusive regional<br />

agents, and on increasing the availability <strong>of</strong> our pro d u c t s<br />

with a more effective sales appro a c h .<br />

In the Middle East, our Egyptian Foods and Home &<br />

Personal Care companies were successfully merged. We<br />

developed our out-<strong>of</strong>-home tea portfolio by introducing<br />

Lipton branding into thousands <strong>of</strong> independent tea shops<br />

– creating new <strong>Unilever</strong> channels to consumers. Indicative<br />

<strong>of</strong> our ability to satisfy local tastes was the roll-out <strong>of</strong><br />

Tasbeeka, a ready-made version <strong>of</strong> a popular tomatobased<br />

culinary product.<br />

Arabia performed strongly, particularly in tea, where we<br />

increased market share by more than 3%. As part <strong>of</strong> our<br />

strategy <strong>of</strong> making our supply chain more efficient, we<br />

opened a new tea packing factory in Dubai.<br />

We made good progress in Morocco, where strong<br />

growth in laundry reinforced our position. We made<br />

strides in Israel and built on our successful presence in<br />

Lebanon by launching operations in Jordan and Syria.


19 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Asia and Pacific<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 14 815 14 014 12 786 10%<br />

Operating pr<strong>of</strong>it 1 415 1 333 1 005 33%<br />

Operating pr<strong>of</strong>it before exceptional items 1 455 1 373 1 120 23%<br />

Exceptional items (net) (40) (40) (115)<br />

Operating margin 9.6% 9.5% 7.9%<br />

Operating margin before exceptional items 9.8% 9.8% 8.8%<br />

Our Asia and Pacific business had a very good year across<br />

most countries in the region, benefiting from the recovery<br />

in South East Asia.<br />

Led by a strong showing in Home & Personal Care, we<br />

achieved excellent growth in volume and pr<strong>of</strong>its. Foods,<br />

however, performed less well and pr<strong>of</strong>its were marginally<br />

below 1998. Overall margins improved by a full<br />

percentage point and there was significantly increased<br />

investment in marketing.<br />

In India, we had another outstanding year in both volume<br />

and pr<strong>of</strong>it growth. Key to this growth was a powerful<br />

Home & Personal Care performance, with particularly<br />

good results in hair, laundry, mass skin and personal wash.<br />

We continued to meet consumer <strong>needs</strong> with innovation,<br />

for example, rolling out a resealable toothpaste sachet<br />

and a miniature Rexona deodorant stick for lower<br />

income consumers.<br />

Foods was less buoyant in India. The business was<br />

particularly affected by disappointing tea sales which only<br />

started to recover towards the end <strong>of</strong> the year following<br />

the withdrawal <strong>of</strong> the excise duty on packaged tea<br />

imposed in 1998. However, there was an enthusiastic<br />

reception from Indian consumers to the roll-out <strong>of</strong> our<br />

tea-based beverage Lipton Tiger.<br />

Our operations in China achieved double digit volume<br />

growth, largely due to the accelerating growth <strong>of</strong> the<br />

Hazeline range <strong>of</strong> hair products and the successful<br />

relaunch <strong>of</strong> the brand’s personal wash range. However,<br />

the business remained in loss, reflecting our continued<br />

investment. We streamlined the business, moving from<br />

joint venture based operations to a three company<br />

structure focused on the core areas <strong>of</strong> home and personal<br />

care, foods and beverages, and ice cream.<br />

Other activities included the launch <strong>of</strong> herbal based<br />

Zhonghua toothpaste, entry into the large green tea<br />

market through the purchase <strong>of</strong> Jinghua, a leading Beijing<br />

based brand, and the acquisition <strong>of</strong> Mountain Cream ice<br />

cream.<br />

In the face <strong>of</strong> last year’s economic crisis in South East Asia,<br />

the strategy <strong>of</strong> adapting our portfolio and reaching out to<br />

lower income consumers was successful, leaving us well<br />

placed to benefit from the economic recovery. In<br />

Indonesia, turnover grew by a third, and in the Philippines<br />

and Vietnam, where sales were also buoyant, we achieved<br />

double digit volume growth.<br />

We made further good progress in Japan, particularly in<br />

personal care, on the back <strong>of</strong> successful launches such as<br />

Dove bar and facial foam and the Mod’s Hair care range.<br />

In Australasia, our laundry range was simplified and<br />

relaunched, making products easier for consumers to use<br />

and enabling us to reinforce our strong position. In Foods,<br />

Flora pro.activ, our innovative blood cholesterol-level<br />

lowering spread, sold very well. In Japan and Australia<br />

tea pr<strong>of</strong>its grew.


20 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Latin America<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 9 538 11 546 11 058 4%<br />

Operating pr<strong>of</strong>it 841 993 1 078 (8)%<br />

Operating pr<strong>of</strong>it before exceptional items 936 1 097 1 168 (6)%<br />

Exceptional items (net) (95) (104) (90)<br />

Operating margin 8.8% 8.6% 9.8%<br />

Operating margin before exceptional items 9.8% 9.5% 10.6%<br />

Our Latin American business proved its resilience in a<br />

challenging year, adapting to regional recession and<br />

devaluation in Brazil and responding vigorously to<br />

competitive activity.<br />

Sales rose by 4%, at constant exchange rates; sales<br />

declined 14% at current rates. Volumes fell, but much less<br />

sharply than private consumption. Home care pr<strong>of</strong>its were<br />

a ffected by major investments behind our market leading<br />

position in laundry. This was mostly <strong>of</strong>fset by excellent<br />

results in personal care. Sales in Foods were generally<br />

l o w e r, but overall margins and pr<strong>of</strong>its incre a s e d ,<br />

particularly in Mexico. Overall pr<strong>of</strong>its declined by 6%.<br />

We responded swiftly to the increased laundry<br />

competition. We reformulated our leading brands, were<br />

first to introduce tablets in Argentina and Chile and took<br />

steps to ensure brand availability across all price ranges.<br />

We maintained leading positions in all our key markets.<br />

Elsewhere in home care, our new Cif floor cleaning range<br />

met with great success following its launch in Argentina.<br />

In personal care, innovation helped deodorants, hair and<br />

oral to another good year. Overall personal care sales were<br />

up and we increased our market leadership in several<br />

categories. In particular, excellent progress was achieved in<br />

Brazil. In Foods, volumes fell in ice cream – though market<br />

share improved – and in yellow fats.<br />

To counter the recession, we accelerated cost reduction<br />

plans, focused resources on leading brands and adapted<br />

our portfolio to <strong>of</strong>fer consumers more affordable<br />

products, such as a reformulated Ala soap. We advanced<br />

plans to rationalise Brazilian ice cream production and<br />

distribution and opened a low cost Mexican ice cream<br />

factory, replacing three local facilities. Across the region,<br />

cross-border sourcing became increasingly important.<br />

Joint ventures and acquisitions remained central to<br />

developing the business. In the Dominican Republic we<br />

acquired Sociedad Industrial Dominicana, an ice cream<br />

and home and personal care business with good<br />

coverage in several Caribbean countries. In Colombia we<br />

embarked on a joint venture with Varela, a leading home<br />

care company.<br />

Exceptional charges in 1999 relate mainly to restructuring<br />

in our regional Foods operations.


21 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Oil and dairy based foods and bakery<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 16 038 16 187 16 952 (5)%<br />

Operating pr<strong>of</strong>it 1 549 1 561 1 474 6%<br />

Operating pr<strong>of</strong>it before exceptional items 1 714 1 724 1 628 6%<br />

Exceptional items (net) (165) (163) (154)<br />

Operating margin 9.7% 9.7% 8.7%<br />

Operating margin before exceptional items 10.7% 10.6% 9.6%<br />

Oil and dairy based foods Consumers in more than 50<br />

countries use our spreads, oils and cooking fats and we<br />

are market leader in margarine and related spreads in<br />

most European countries and in North America.<br />

In 1999, operating pr<strong>of</strong>its from our oil and dairy based<br />

foods and bakery business grew by 6% and margins<br />

improved, mainly in Europe. This reflected lower input<br />

costs and the benefits <strong>of</strong> restructuring and supply chain<br />

efficiencies.<br />

Our yellow fats volumes fell in a declining market. In<br />

Western Europe and North America, we maintained share<br />

by continuing to stimulate consumer demand through<br />

innovative new products. In Central and Eastern Europe<br />

and Latin America volumes were down.<br />

We have strong market positions in brands promoting<br />

cardiovascular health. In 1999, we successfully added<br />

products proven to lower blood cholesterol levels under<br />

the Take Control and Flora and Becel pro.activ brands.<br />

They were launched in Australia, Switzerland, New<br />

Zealand and the United States, where Take Control<br />

became category market leader in its launch year. We will<br />

introduce these products in the European Union as soon<br />

as regulatory clearance is obtained.<br />

More and more consumers are choosing liquid oils for<br />

cooking. In North America and Northern Europe, olive oil,<br />

in particular, is becoming increasingly popular. <strong>Unilever</strong> is<br />

the world’s biggest marketer <strong>of</strong> branded olive oil. In 1999,<br />

our Bertolli and Puget olive oil brands performed well,<br />

despite increased raw material costs.<br />

Bakery Our bakery products business mainly provides<br />

speciality bakery fats, designed for pr<strong>of</strong>essional bread,<br />

cake and pastry-making, and frozen bakery products for<br />

bakeries. Our operating pr<strong>of</strong>its in bakery improved in<br />

1999, partly due to a programme <strong>of</strong> cost savings.<br />

The future <strong>of</strong> our European bakery business is under<br />

review; it is being restructured to improve performance<br />

significantly, or it will be divested by the end <strong>of</strong> 2000.


22 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Ice cream and beverages<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 14 625 14 657 14 593 0%<br />

Operating pr<strong>of</strong>it 1 196 1 193 1 144 4%<br />

Operating pr<strong>of</strong>it before exceptional items 1 307 1 311 1 312 0%<br />

Exceptional items (net) (111) (118) (168)<br />

Operating margin 8.2% 8.1% 7.8%<br />

Operating margin before exceptional items 8.9% 8.9% 9.0%<br />

Ice cream We are the world’s leading producer <strong>of</strong> ice<br />

cream, supplying consumers in more than 90 countries.<br />

Our strategy focuses on growing leading brands such as<br />

Magnum, Solero, Cornetto, Carte d’Or and Viennetta,<br />

which are sold as international brands, and also on<br />

developing locally relevant varieties and extending our<br />

business with new sales channels.<br />

In 1999, overall volumes were flat and operating pr<strong>of</strong>its<br />

were slightly below 1998. In Western Europe, where we<br />

benefited from a warmer summer, volumes rose by 2%<br />

and pr<strong>of</strong>its improved. Growth centred on demand for<br />

multi-packs and desserts, particularly Carte d’Or. Results<br />

fell in Central and Eastern Europe and Latin America due<br />

to economic instability and reduced consumption levels.<br />

In North America, impulse volumes rose but our packaged<br />

ice cream sales and pr<strong>of</strong>its fell due to increased price<br />

competition.<br />

We virtually completed the worldwide roll-out <strong>of</strong> our heart<br />

logo. This provides international recognition <strong>of</strong> our brands<br />

and enables us to further concentrate production and<br />

move products between different markets.<br />

In 1999, new variants <strong>of</strong> our leading brands – such as the<br />

Magnum Double – demonstrated innovation in action.<br />

We extended our ranges <strong>of</strong> multi-packs <strong>of</strong> impulse<br />

products for in-home consumption and strengthened our<br />

position in the growing scooping sector. We also reached<br />

out to lower income consumers with more affordable<br />

products, notably in China and South Africa.<br />

In the United Kingdom, the Competition Commission’s<br />

report into the ice cream industry recommended<br />

limitations on both our freezer cabinet and distribution<br />

arrangements. We are confident the strength <strong>of</strong> our<br />

brands will sustain our business. The more significant<br />

ruling <strong>of</strong> the European courts is expected in 2000.<br />

Beverages Brooke Bond, and our world leading brand<br />

Lipton, have earned us extremely strong international<br />

positions in packet tea and related drinks. We are also<br />

strong in ready-to-drink tea, which is growing throughout<br />

Europe, North America and East Asia, and have a joint<br />

venture with PepsiCo Inc. to market ready-to-drink<br />

products in North America.<br />

Operating pr<strong>of</strong>its were up 7%. Volume was on a par with<br />

1998, reflecting the temporary impact <strong>of</strong> excise duties<br />

on packaged tea in India. We enjoyed good growth in<br />

Western Europe, Africa and Middle East and saw a strong<br />

global volume increase <strong>of</strong> 14% in ready-to-drink tea.<br />

We brought a range <strong>of</strong> innovations to our product and<br />

sales channels. In Europe, we developed our portfolio with<br />

the launch <strong>of</strong> a new harmonised range <strong>of</strong> fruit flavoured<br />

teas, Lipton Sun Tea and the further roll-out <strong>of</strong> Tchaé<br />

green tea and pyramid tea bags. In the United Kingdom,<br />

Brooke Bond pyramid bags were established as the top<br />

brand. In North America, we successfully test-marketed<br />

our patent-protected cold infusion tea bags.


23 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Culinary and frozen foods<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 14 520 14 539 14 840 (2)%<br />

Operating pr<strong>of</strong>it 1 197 1 177 1 352 (13)%<br />

Operating pr<strong>of</strong>it before exceptional items 1 460 1 437 1 464 (2)%<br />

Exceptional items (net) (263) (260) (112)<br />

Operating margin 8.2% 8.1% 9.1%<br />

Operating margin before exceptional items 10.1% 9.9% 9.9%<br />

Culinary Our culinary category includes ranges <strong>of</strong><br />

cooking ingredients, sauces and soups. The acquisition<br />

<strong>of</strong> Amora Maille in France, announced in December 1999,<br />

will add two important brands with sales in a number <strong>of</strong><br />

European countries. During the year we also reported the<br />

acquisition <strong>of</strong> Scandinavian culinary company Slotts and<br />

Kockens. To raise global awareness <strong>of</strong> our brands and<br />

achieve supply chain efficiencies, we began branding<br />

selected items with a newly designed culinary<br />

masterbrand logo.<br />

In 1999, overall culinary volumes were down, although<br />

pr<strong>of</strong>its rose slightly. A lower sales figure reflects the<br />

disposal <strong>of</strong> our Homann salads business. We achieved 5%<br />

underlying volume growth in Western Europe but volumes<br />

were lower in the Americas.<br />

We used a raft <strong>of</strong> innovative approaches to bring flavour<br />

and convenience to familiar foods. In the United<br />

Kingdom, our ethnic two-step chicken sauce range, Sizzle<br />

& Stir, had a great year; in North America, new Lawry’s<br />

fruit juice-based marinades swiftly gained market<br />

leadership and in Russia we started local production<br />

<strong>of</strong> mayonnaise in a new, low cost pack format.<br />

Frozen foods We are the leading producer <strong>of</strong> frozen<br />

foods in Europe, under the Findus brand in Italy and the<br />

Birds Eye, Frudesa, Mora and Iglo brands in other<br />

countries. We are brand leader in frozen seafood in the<br />

United States, under the Gorton’s name.<br />

In 1999 the refocusing <strong>of</strong> our portfolio took overall frozen<br />

foods volumes and pr<strong>of</strong>its below last year. We continued<br />

to focus on our strongest lines, such as meal solutions,<br />

which are one <strong>of</strong> the areas targeted for strategic growth.<br />

In 1999, our premium ready meal range 4 Salti in Padella,<br />

first launched in Italy, continued its remarkable progress.<br />

We are now rolling it out throughout Europe. In the<br />

United States, we test-marketed innovative crispy stuffed<br />

and herb-flavoured fish fillets.


24 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Home care and pr<strong>of</strong>essional cleaning<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 20 065 20 555 19 422 6%<br />

Operating pr<strong>of</strong>it 1 804 1 825 1 848 (1)%<br />

Operating pr<strong>of</strong>it before exceptional items 1 880 1 897 1 983 (4)%<br />

Exceptional items (net) (76) (72) (135)<br />

Operating margin 9.0% 8.9% 9.5%<br />

Operating margin before exceptional items 9.4% 9.2% 10.2%<br />

We are one <strong>of</strong> the two leading global suppliers <strong>of</strong> pro d u c t s<br />

for fabric and surface cleaning and hygiene in a domestic<br />

and a pr<strong>of</strong>essional setting. DiverseyLever is a leading<br />

provider <strong>of</strong> cleaning and hygiene products and services to<br />

institutional, laundry and food and beverage customers.<br />

Home care Overall volumes climbed by 3% across our<br />

home care businesses. We enjoyed particular growth in<br />

Africa and Middle East and Asia and Pacific, with good<br />

progress in Western Europe and North America. Although<br />

we achieved improved results and margins in Western<br />

Europe and Asia and Pacific, operating pr<strong>of</strong>its declined<br />

globally by 4%. This reflected major investments behind<br />

our market leading positions in Latin America.<br />

In Europe, laundry volumes grew by almost 4% and<br />

supply chain savings boosted margins. A second<br />

generation, double-layer tablet formulation built on last<br />

year’s pioneering launch helped maintain our sector market<br />

leadership. The introduction <strong>of</strong> S u r f powder in the<br />

Philippines met with great success while in Brazil B r i l h i a n t e<br />

powder became the number two brand by combining the<br />

superior cleaning properties <strong>of</strong> bleach with kindness to<br />

clothes. The popularity <strong>of</strong> liquid a l l helped us to a 4% rise<br />

in laundry volumes in North America.<br />

Some innovations, like our new ‘easy-ironing’ fabric<br />

conditioner, created whole new segments in the market.<br />

Easy Iron, which will be rolled out throughout Western<br />

Europe under the Comfort and Snuggle brands, captured<br />

a 10% share <strong>of</strong> the United Kingdom market within<br />

six months.<br />

In Europe, in household care, we teamed up with a paper<br />

supplier to launch Domestos hygienic wipes. U s i n g<br />

patented technology we created new products under the<br />

Cif brand name: Cif Oxy-Gel, a general purpose cleaner<br />

which uses bubbles to shift grime, and the Cif floor<br />

cleaning range. Sunlight dishwash bar, another recent<br />

launch, flourished in Malaysia.<br />

Pr<strong>of</strong>essional cleaning DiverseyLever had another<br />

challenging year. Volumes were 1% ahead, with operating<br />

pr<strong>of</strong>its broadly in line with 1998.<br />

Europe, where the business is strongest, performed better<br />

than the previous year. In North America, sales grew but<br />

pr<strong>of</strong>its were adversely impacted by a reshaping <strong>of</strong> part <strong>of</strong><br />

the sales organisation. Latin America and Asia and Pacific<br />

achieved higher sales and pr<strong>of</strong>its, the latter region<br />

benefiting from improved economic conditions.<br />

In Europe, we began simplifying the product portfolio and<br />

focusing on key customer segments.


25 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1999<br />

Personal car e<br />

Fl. million 1999 1999 1998 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 23 523 23 423 21 971 7%<br />

Operating pr<strong>of</strong>it 3 398 3 401 2 763 23%<br />

Operating pr<strong>of</strong>it before exceptional items 3 479 3 477 2 812 24%<br />

Exceptional items (net) (81) (76) (49)<br />

Operating margin 14.4% 14.5% 12.6%<br />

Operating margin before exceptional items 14.8% 14.8% 12.8%<br />

We are the world leader in deodorants and skin, with<br />

important market positions in toothpaste and hair<br />

products in many countries. Our strategy focuses on<br />

growing leading brands such as Dove, Lux and Axe, while<br />

finding new ways to reach consumers and to make our<br />

brands affordable to those with lower incomes.<br />

Our personal care business had an exceptional year. We<br />

achieved a significant double digit rise in operating pro f i t s<br />

a c ross all regions, volume growth <strong>of</strong> almost 5% and a<br />

s t rong improvement in margins.<br />

Dove, the brand contributing most to the growth <strong>of</strong> our<br />

personal care portfolio, had another excellent year. As part<br />

<strong>of</strong> our strategy to ‘stretch’ the brand and get closer to<br />

consumers, many Dove users in North America were<br />

individually advised <strong>of</strong> new launches, such as Dove<br />

Nutrium. In Japan, Dove facial foam became market<br />

leader in its first year.<br />

Our hair business enjoyed another healthy year, growing<br />

by 9%. Consumer insight helped us develop variants that<br />

meet local <strong>needs</strong>. For example, in Latin America, where<br />

we are already market leaders, a formulation <strong>of</strong> Sedal<br />

specially designed for local hair types is proving very<br />

popular among Brazilian consumers. New variants <strong>of</strong> our<br />

premium product ThermaSilk and the enduringly popular<br />

Suave helped us to grow share in North America, taking<br />

market leadership.<br />

Deodorants grew in many major markets including North<br />

America, Latin America and Western Europe, where we<br />

made particular inroads in the United Kingdom. Dove<br />

deodorant has been launched in more than 20 countries.<br />

In India, a campaign to raise awareness <strong>of</strong> deodorants<br />

among lower income consumers was led by a miniature<br />

version <strong>of</strong> the Rexona stick.<br />

In oral care, the launch <strong>of</strong> successful new chewing gums,<br />

Signal in France and Mentadent Actigum in Italy, showed<br />

our ability to penetrate new areas and new outlets, such<br />

as confectioners.<br />

We are one <strong>of</strong> the world’s largest producers <strong>of</strong> prestige<br />

fragrances, which are sold under the names <strong>of</strong> Calvin<br />

Klein, Elizabeth Arden and other designers. Sales <strong>of</strong><br />

fragrance brands grew slightly during 1999. Recent<br />

Calvin Klein launches have been overshadowed by the<br />

phenomenal success <strong>of</strong> the earlier brands. However, our<br />

Calvin Klein business remains strong and pr<strong>of</strong>itable and<br />

we have announced the launch <strong>of</strong> a new cosmetics range.<br />

We will restructure Elizabeth Arden by the end <strong>of</strong> 2000,<br />

as part <strong>of</strong> our plans to create a fast growing international<br />

cosmetics and fragrance business.


26 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review – 1998<br />

1998 results compared with 1997<br />

<strong>Unilever</strong> Group<br />

In 1998 our net pr<strong>of</strong>its before all exceptional items<br />

increased by 16% at constant rates <strong>of</strong> exchange. The net<br />

pr<strong>of</strong>it margin on the same basis exceeded 7% <strong>of</strong> turnover,<br />

an all-time high. Our global reach and regional balance<br />

were significant factors in our performance in 1998. We<br />

have almost two thirds <strong>of</strong> our business in Western Europe<br />

and North America, which helped to maintain momentum<br />

when developing and emerging markets faltered.<br />

In We s t e rn Europe, underlying volume growth was flat but<br />

we had a further strong increase in operating margins.<br />

Turnover was down slightly due to continued reduction<br />

in non-core brands and disposals <strong>of</strong> businesses. In Central<br />

and Eastern Europe, the Russian economic crisis caused<br />

a sharp downturn in our business from August onwards.<br />

We will remain committed to Russia as a long-term<br />

opportunity, provided free market conditions continue.<br />

In North America our Foods business achieved underlying<br />

volume growth <strong>of</strong> 5%, the highest for several years.<br />

Volume growth in Home & Personal Care was lower at<br />

2%. Our pr<strong>of</strong>it margins increased significantly in both<br />

businesses. We completed the integration <strong>of</strong> our Foods<br />

businesses in the United States.<br />

Our businesses in Africa and the Middle East performed<br />

well. This region is consistently successful despite a volatile<br />

environment. In 1998 our volume, market share and<br />

pr<strong>of</strong>its again increased in the face <strong>of</strong> heightened<br />

international competition.<br />

The slowdown in economies in Latin America in the<br />

second half <strong>of</strong> 1998 meant that we had weaker volume<br />

growth than in 1997. Our pr<strong>of</strong>its still advanced strongly,<br />

despite higher marketing spend than in the previous year.<br />

Our performance in Asia and Pacific varied enormously.<br />

Yet again, our businesses in India produced outstanding<br />

results with Home & Personal Care being particularly<br />

successful. In those economies hit by the South East Asia<br />

crisis, our businesses performed well by shifting rapidly<br />

from a strategy <strong>of</strong> high growth to one <strong>of</strong> protecting<br />

market share, margins and cash flow. We continue to<br />

see attractive long-term growth potential in these<br />

countries, and also in China, where our performance<br />

in 1998 was disappointing.<br />

Economies around the world were delicately poised at<br />

the end <strong>of</strong> 1998. Looking ahead, it was unclear whether<br />

they would recover or move further into recession.<br />

Nevertheless, we believed that the improvement in<br />

underlying pr<strong>of</strong>itability <strong>of</strong> recent years was sustainable<br />

and further margin improvement could reasonably be<br />

expected as restructuring benefits continue to flow.<br />

We believed many <strong>of</strong> the challenges and opportunities<br />

the business experienced in 1998 would continue to be<br />

faced in 1999. In 1998 we concentrated on building and<br />

enhancing market shares in key categories and we were<br />

well placed to benefit from any improvement in general<br />

trading conditions.<br />

1998 was a critical year for the European Monetary Union.<br />

The introduction <strong>of</strong> the euro proceeded on time on<br />

1 January 1999. The Netherlands participated; the United<br />

Kingdom did not. As a consequence the euro will replace<br />

the Dutch guilder by 2002. As a result we published<br />

supplementary information in euros in 1999 and will<br />

replace the guilder with the euro for reporting purposes as<br />

from year 2000. We began to undertake euro contracts for<br />

foreign exchange contracts and deposits from January<br />

1999. We believe it is an important step in the<br />

development <strong>of</strong> the single market and will enhance<br />

competitiveness to the benefit <strong>of</strong> Europe’s citizens.<br />

Our turnover <strong>of</strong> Fl. 89 112 million (at current rates)<br />

decreased by 6% compared with 1997, which included<br />

the speciality chemicals businesses. At constant rates <strong>of</strong><br />

exchange, turnover decreased by 2%.<br />

In our continuing operations, (that is excluding the<br />

speciality chemicals businesses in 1997), turnover fell by<br />

2%; at constant rates <strong>of</strong> exchange turnover increased<br />

by 2% to Fl. 92 393 million. In our continuing business,<br />

underlying volume growth was little more than half the<br />

rate achieved in 1997. Productivity for our continuing<br />

operations, based on sales per employee, improved by<br />

6% in 1998.<br />

Exceptionals and restructuring<br />

Exceptional items in 1998 produced a net benefit <strong>of</strong><br />

Fl. 276 million in comparison with the charge <strong>of</strong><br />

Fl. 1 800 million in 1997. This Fl. 276 million includes<br />

restructuring costs <strong>of</strong> Fl. 585 million mainly focused in<br />

Europe, and Asia and Pacific which were more than <strong>of</strong>fset<br />

by pr<strong>of</strong>its on business disposals. Our significant projects<br />

included further restructuring <strong>of</strong> foods businesses in<br />

Europe (mainly Austria, France, Germany and Turkey),<br />

foods operations in India, ice cream and detergents in<br />

China and tomato products in Brazil.<br />

The pr<strong>of</strong>its on business disposals arose principally from the<br />

sale <strong>of</strong> Plant Breeding International in Europe. The cash


27 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review – 1998<br />

impact <strong>of</strong> these disposals was Fl. 1 460 million, all <strong>of</strong><br />

which we received in 1998.<br />

Restructuring under our 1998 plan was much lower than<br />

the Fl. 1 492 million in our 1997 plan, which included the<br />

acceleration <strong>of</strong> some projects.<br />

We focused our 1997 gross restructuring plan, mainly in<br />

E u rope (Fl. 862 million) and North America (Fl. 533 million).<br />

Our significant projects included continuing rationalisation<br />

<strong>of</strong> foods operations in Europe, merger <strong>of</strong> our mass<br />

personal care business in North America and closure <strong>of</strong><br />

our Lipton USA culinary factory. We were satisfied with<br />

progress in 1998; both the timescale for implementation<br />

<strong>of</strong> headcount reduction and the level <strong>of</strong> savings were<br />

broadly in line with our original plan.<br />

Savings from our 1996 restructuring plan, the total gross<br />

cost <strong>of</strong> which was Fl. 912 million, were in line with<br />

original expectations. By the end <strong>of</strong> 1998, the plan was<br />

substantially implemented with significant savings and<br />

headcount reductions already achieved.<br />

Under United States GAAP, a proportion <strong>of</strong> these costs<br />

w e re not recognised until 1999 and a proportion <strong>of</strong> the<br />

1997 costs were recognised in 1998 (see pages 106 and<br />

107). In addition, we charged a further Fl. 307 million<br />

<strong>of</strong> non-exceptional restructuring costs to operating pr<strong>of</strong>it<br />

in 1998.<br />

The movements in restructuring provisions are shown in<br />

note 18 on page 78 and the cash flows in note 26 on<br />

page 86.<br />

Acquisitions and disposals<br />

During 1998 we made 20 acquisitions. The most<br />

important were:<br />

Vegetaline – White fat in France<br />

Star – Margarine in Italy<br />

Arua – Margarine in Spain<br />

Moskovsky Margarinovy Zavod – Margarine in Russia<br />

AmeriClean – Pr<strong>of</strong>essional cleaning in the United States<br />

Huanan Laocai – Soy sauce in China<br />

Carrancedo – Bakery in Mexico<br />

At current exchange rates, Fl. 783 million was invested<br />

in acquisitions, which were expected to add approximately<br />

Fl. 651 million to sales in a full year.<br />

In 1998 we disposed <strong>of</strong> 24 businesses reflecting ongoing<br />

refocusing <strong>of</strong> the portfolio and reducing the non-core<br />

activities. This included PBI, the plant breeding business<br />

in the UK; Bushells, a c<strong>of</strong>fee business in Australia;<br />

Puritan, a meat business in Canada; Astra Calve’s seed<br />

oils business in France; the remaining Cutex nail polish<br />

remover businesses in various countries, mainly Latin<br />

America; and Harmony, a hair care brand in the UK.<br />

At current exchange rates, Fl. 1 460 million was received<br />

from disposals, with approximately Fl. 678 million <strong>of</strong><br />

sales in a full year.<br />

Performance review by region and category<br />

The segmental analysis which follows is based on<br />

operating results before exceptional items, at constant<br />

exchange rates, and includes the results <strong>of</strong> the speciality<br />

chemicals businesses up to 8 July 1997 but does not take<br />

account <strong>of</strong> US GAAP adjustments. Turkey, formerly<br />

reported under Africa and Middle East region, is reported<br />

within Europe from 1 January 1998. Figures for previous<br />

years have been restated on the same basis.


28 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Europe<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

Continuing business rates rates rates<br />

Turnover 41 805 41 477 43 274 (4)%<br />

Operating pr<strong>of</strong>it 5 068 5 016 3 617 39%<br />

Operating pr<strong>of</strong>it before exceptional items 4 670 4 631 4 467 4%<br />

Exceptional items (net) 398 385 (850)<br />

Operating margin 12.1% 12.1% 8.4%<br />

Operating margin before exceptional items 11.2% 11.2% 10.3%<br />

In Western Europe our operating pr<strong>of</strong>its were ahead <strong>of</strong><br />

1997, with our margins rising by almost 1% <strong>of</strong> turnover.<br />

This reflected the benefits <strong>of</strong> restructuring, our focus on<br />

corporate categories and further reduction in non-core<br />

brands. However, our underlying volume was flat due to<br />

the effect on ice cream <strong>of</strong> a poor summer in Northern<br />

Europe. We had lower sales because <strong>of</strong> the impact <strong>of</strong><br />

business disposals and reduction in non-core brands.<br />

In Home & Personal Care we had another very good year,<br />

with strong advances in sales, operating pr<strong>of</strong>its and<br />

margins. In Foods, despite a poor ice cream season, we<br />

maintained our strong position in the ice cream market.<br />

Our operating pr<strong>of</strong>its improved in tea, frozen foods<br />

and culinary. Overall margins in Foods were slightly<br />

ahead <strong>of</strong> 1997.<br />

Given the difficult circumstances caused by Russia’s<br />

economic crisis, our results in Central and Eastern Europe<br />

were creditable. Sales rose 4% and underlying volumes<br />

by 5%. Pr<strong>of</strong>its overall were slightly ahead <strong>of</strong> 1997 and<br />

we maintained operating margins. Growth in Central and<br />

Eastern Europe was mixed. The Czech business was very<br />

successful, but Poland was down on the previous year.<br />

We made good progress in restructuring our business in<br />

Turkey, which delivered a satisfactory underlying volume<br />

growth and much improved pr<strong>of</strong>itability. In Russia our<br />

business was far ahead <strong>of</strong> expectations at the end <strong>of</strong><br />

t h e first half <strong>of</strong> 1998. This progress was cut short by<br />

the economic crisis which intensified in August and<br />

we responded quickly to the new situation. Our overall<br />

results were well below 1997.<br />

In Europe as a whole, the net benefit <strong>of</strong> exceptional items<br />

in 1998 was Fl. 385 million, compared with a charge <strong>of</strong><br />

Fl. 850 million in 1997. Restructuring costs were focused<br />

primarily on our Foods business. They were more than<br />

o ffset by pro f i t sf rom the sale <strong>of</strong> Plant Bre e d i n g<br />

I n t e rn a t i o n a l .


29 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

North America<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

Continuing business rates rates rates<br />

Turnover 18 552 18 287 17 944 2%<br />

Operating pr<strong>of</strong>it 2 077 2 041 911 124%<br />

Operating pr<strong>of</strong>it before exceptional items 1 991 1 955 1 719 14%<br />

Exceptional items (net) 86 86 (808)<br />

Operating margin 11.2% 11.2% 5.1%<br />

Operating margin before exceptional items 10.7% 10.7% 9.6%<br />

Our business continued to benefit from high consumer<br />

confidence arising from the strength <strong>of</strong> the United States<br />

economy. Underlying volume growth was 3% and<br />

operating pr<strong>of</strong>its rose by 14%, after increased investment<br />

in marketing. In Foods, underlying volume growth was<br />

5%; Home & Personal Care recorded a 2% growth in<br />

volumes, with mass market gains balancing lower sales <strong>of</strong><br />

prestige products. Our overall margins improved by over<br />

1% <strong>of</strong> turnover, mainly due to reduction in non-core<br />

brands and savings from restructuring.<br />

Our home care business, with a slight increase in sales,<br />

saw good progress in operating pr<strong>of</strong>its, which continued<br />

to benefit from past restructuring. In personal care, we<br />

had notable growth in hair care, deodorants, mass skin<br />

products and personal wash. Our prestige business<br />

recorded lower pr<strong>of</strong>its in North America. Calvin Klein<br />

fragrance sales fell, although demand for the new<br />

Contradiction range did compensate in part for lower<br />

sales <strong>of</strong> cK be and cK one. Elizabeth Arden made progress<br />

with the launch <strong>of</strong> Splendor and the favourable<br />

performance <strong>of</strong> White Diamonds, and returned to pr<strong>of</strong>it,<br />

although still not at acceptable levels.<br />

During the year, we completed the merger <strong>of</strong> Thomas J.<br />

Lipton and Van den Bergh Foods to form our new Lipton<br />

food businesses. Exceptional items in 1998 reflect pr<strong>of</strong>its<br />

on minor business disposals: the significant charge d u r i n g<br />

the previous year related to the merger <strong>of</strong> the Home &<br />

Personal Care businesses, completed in 1999.<br />

Africa and Middle East<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

Continuing business rates rates rates<br />

Turnover 4 911 5 276 4 773 11%<br />

Operating pr<strong>of</strong>it 490 551 444 24%<br />

Operating pr<strong>of</strong>it before exceptional items 493 554 454 22%<br />

Exceptional items (net) (3) (3) (10)<br />

Operating margin 10.0% 10.4% 9.3%<br />

Operating margin before exceptional items 10.0% 10.5% 9.5%<br />

Our businesses in this region made good progress in<br />

operating pr<strong>of</strong>its and margins. Underlying volumes grew<br />

by 7%. We achieved these strong results in an increasingly<br />

competitive market and against a tough economic and<br />

political background.<br />

In South Africa, our pr<strong>of</strong>its and margins advanced<br />

strongly, due to an improved mix <strong>of</strong> products and good<br />

cost control. Home care results were particularly good.<br />

Operations in Côte d’Ivoire again did well, benefiting from<br />

favourable economic conditions. There were encouraging<br />

signs <strong>of</strong> recovery in our Kenyan business, and in Nigeria<br />

we made good progress in stabilising the business and<br />

implementing a restructuring programme. Despite no GDP<br />

growth in the Middle East, our businesses in Saudi Arabia<br />

and the Gulf increased underlying volumes, and improved<br />

pr<strong>of</strong>its and margins. Egypt did particularly well in tea and<br />

personal care. Our tea and oil palm estates made a useful<br />

contribution to the region’s results, mainly reflecting world<br />

commodity prices. We bought an oil palm estate in Ghana<br />

to support our core business there.


30 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Asia and Pacific<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

Continuing business rates rates rates<br />

Turnover 12 786 16 140 14 026 15%<br />

Operating pr<strong>of</strong>it 1 005 1 408 1 181 19%<br />

Operating pr<strong>of</strong>it before exceptional items 1 120 1 516 1 242 22%<br />

Exceptional items (net) (115) (108) (61)<br />

Operating margin 7.9% 8.7% 8.4%<br />

Operating margin before exceptional items 8.8% 9.4% 8.8%<br />

The region presented considerable challenges in 1998.<br />

We made good progress in strengthening our business,<br />

but our results were hit by the severe economic crisis in<br />

South East Asia. The currency devaluations in Indonesia,<br />

Malaysia, the Philippines, South Korea and Thailand<br />

mean that, at current rates, sales and operating pr<strong>of</strong>its<br />

for the region were down 9% and 10% respectively,<br />

although we maintained operating margins as a<br />

percentage <strong>of</strong> turnover, and already strong market<br />

positions further improved. In managing the economic<br />

downturn in South East Asia and handling the effect <strong>of</strong><br />

rapidly devaluing currencies, we determined that our<br />

ability to make less expensive products to meet the<br />

<strong>needs</strong> <strong>of</strong> consumers with reduced spending power<br />

was vital. This demanded creativity in the way we<br />

formulated, packaged and distributed our products.<br />

Speed in development was also critical.<br />

Our business in India once again delivered an outstanding<br />

performance. It achieved this in an economic enviro n m e n t<br />

that was more difficult than in 1997. Underlying volume<br />

g rowth rate was more than twice the country’s GDP gro w t h<br />

rate. Pr<strong>of</strong>its rose faster than sales, despite a significant<br />

i n c rease in marketing spend. There were further market<br />

s h a re advances in all categories. Personal care pro d u c t s<br />

w e re particularly successful. Our operations in Pakistan also<br />

i m p roved in 1998 with strong growth in sales and pro f i t s .<br />

Tea market shares and pr<strong>of</strong>its re c o v e red following a longawaited<br />

adjustment to the duty regime to address smuggling.<br />

We had a disappointing business performance in China,<br />

with lower sales and increased losses. However, we<br />

maintain a long-term commitment to this region. In 1998<br />

we made a start on simplifying the legal structure <strong>of</strong> the<br />

business and costs reduced. Sales in Japan were adversely<br />

affected by economic conditions in the country. We have<br />

made further good progress in Vietnam.<br />

In Australia, our results were lower than 1997, partly due<br />

to the disposal <strong>of</strong> c<strong>of</strong>fee operations.


31 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Latin America<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

Continuing business rates rates rates<br />

Turnover 11 058 11 213 10 583 6%<br />

Operating pr<strong>of</strong>it 1 078 1 106 896 23%<br />

Operating pr<strong>of</strong>it before exceptional items 1 168 1 192 967 23%<br />

Exceptional items (net) (90) (86) (71)<br />

Operating margin 9.8% 9.8% 8.5%<br />

Operating margin before exceptional items 10.6% 10.6% 9.1%<br />

Economies in the region started to falter around mid-year.<br />

This reduced consumption in many markets, particularly<br />

in the south, and slowed underlying volume growth.<br />

Nevertheless, the region again performed well. Pr<strong>of</strong>its and<br />

margins moved ahead strongly, most notably in personal<br />

care. A continuing strategy <strong>of</strong> focusing on key categories<br />

and countries was critical to our success here, which was<br />

underpinned by greater cost effectiveness and efficiency<br />

in the business operations. We increased marketing<br />

investment, improving market shares in important<br />

categories.<br />

In Brazil, our largest business in the region, ice cream and<br />

personal care products led a significant pr<strong>of</strong>it advance.<br />

Kibon, the ice cream company purchased towards the end<br />

<strong>of</strong> 1997, made an important contribution to pr<strong>of</strong>its and<br />

made us market leader in the region. In Foods, an<br />

important restructuring programme began to improve<br />

margins, whilst in laundry, higher investment in marketing<br />

reduced pr<strong>of</strong>its but increased market share. Chile and<br />

Colombia showed good sales growth and, together with<br />

Argentina, advanced pr<strong>of</strong>its strongly. We made continued<br />

progress in Mexico, where changes to our portfolio<br />

increased the focus on core operations. We made<br />

significant advances in pr<strong>of</strong>its, and underlying volumes<br />

grew with personal care performing particularly well.<br />

Oil and dairy based foods and bakery<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 16 952 17 196 17 687 (3)%<br />

Operating pr<strong>of</strong>it 1 474 1 498 977 53%<br />

Operating pr<strong>of</strong>it before exceptional items 1 628 1 648 1 702 (3)%<br />

Exceptional items (net) (154) (150) (725)<br />

Operating margin 8.7% 8.7% 5.5%<br />

Operating margin before exceptional items 9.6% 9.6% 9.6%<br />

Globally, turnover in this product area was down slightly,<br />

mainly due to business disposals, with underlying volume<br />

staying flat. However, in North America we increased our<br />

margarine market share via innovative products such as<br />

Brummel & Brown, a new low-fat yoghurt-based<br />

spread. We also made share gains in Western Europe,<br />

where the initial roll-out <strong>of</strong> Bertolli, an olive oil-based<br />

range, was successful. We have well-established<br />

health-focused brands, such as Flora and Becel, which<br />

remained strong.<br />

Through much <strong>of</strong> Central and Eastern Europe, our sales<br />

<strong>of</strong> margarine continued at the same levels as in 1997,<br />

despite regional economic difficulties. In Russia, however,<br />

we started the year extremely positively but sales fell<br />

sharply after the economic crisis intensified in August. In<br />

olive oil, Italy and France did well, but Spain experienced<br />

another difficult year due to the competitive market place.<br />

In bakery, to achieve greater focus in Europe, we<br />

integrated three businesses. Speciality products, such as<br />

Maison du Pain, are proving increasingly successful.


32 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Ice cream and beverages<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 14 593 14 987 14 198 6%<br />

Operating pr<strong>of</strong>it 1 144 1 171 1 092 7%<br />

Operating pr<strong>of</strong>it before exceptional items 1 312 1 340 1 340 0%<br />

Exceptional items (net) (168) (169) (248)<br />

Operating margin 7.8% 7.8% 7.7%<br />

Operating margin before exceptional items 9.0% 8.9% 9.4%<br />

Overall, underlying volume growth was flat in this product<br />

area. The progress we made in North America and Latin<br />

America was <strong>of</strong>fset by Europe, following the effect <strong>of</strong> the<br />

poor summer on ice cream sales. Pr<strong>of</strong>its were also flat.<br />

Ice cream turnover rose by 4% in 1998. This is explained<br />

partly by price increases, due to higher raw material costs<br />

in North America, and to the acquisition <strong>of</strong> Kibon in<br />

Brazil. Our pr<strong>of</strong>its were lower, mainly in Europe. We had<br />

a good year in North America, where innovation and<br />

increased marketing investment helped regain our<br />

leadership <strong>of</strong> take-home packaged ice cream and maintain<br />

our lead in the impulse-buy ice cream sector. In Northern<br />

Europe, the poor summer hit our sales and pr<strong>of</strong>its,<br />

emphasising the need for us to encourage <strong>people</strong> to eat<br />

ice cream all year round. We rolled-out Winner Taco, an<br />

any-time ice cream snack, throughout Western Europe.<br />

Our focus continued on developing global brands,<br />

including new variants <strong>of</strong> the Magnum brand. We<br />

launched a global logo for ice cream, the heart-shaped<br />

‘happiness’ design, as part <strong>of</strong> our strategy <strong>of</strong> increasing<br />

brand awareness among consumers around the world.<br />

The European Commission’s investigation into ice cream<br />

marketing in Ireland culminated in its decision declaring<br />

the practice <strong>of</strong> cabinet exclusivity contrary to Articles 85<br />

and 86 <strong>of</strong> the Treaty <strong>of</strong> Rome, at least in the specific<br />

context <strong>of</strong> the Irish market. This decision was<br />

subsequently suspended by the European Court and we<br />

are vigorously appealing it. Since the end <strong>of</strong> 1998, we<br />

have amended distribution agreements in the United<br />

Kingdom to accommodate observations made by the<br />

Monopolies and Mergers Commission.<br />

In beverages, our business continued to develop a global<br />

tea portfolio and achieved a 4% rise in underlying volume<br />

growth, mainly in Latin America, Europe, and Africa and<br />

Middle East. Our overall margins also improved. In the<br />

United Kingdom, we completed the roll-out <strong>of</strong> PG Tips<br />

Pyramid tea bags, increasing market share. We also<br />

achieved strong growth in new markets, particularly in<br />

Egypt and Poland. Fruit-flavoured teas, relaunched as<br />

Lipton Sun Tea, continued to grow and we have now<br />

introduced them in 18 countries. In ready-to-drink tea,<br />

Lipton Brisk iced tea increased our market lead in North<br />

America and, in Southern Europe, the very hot summer<br />

helped increase our sales. Conversely, in Northern Europe<br />

the bad weather held back growth.


33 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Culinary and frozen foods<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 14 840 14 885 15 331 (3)%<br />

Operating pr<strong>of</strong>it 1 352 1 349 668 102%<br />

Operating pr<strong>of</strong>it before exceptional items 1 464 1 454 1 133 28%<br />

Exceptional items (net) (112) (105) (465)<br />

Operating margin 9.1% 9.1% 4.4%<br />

Operating margin before exceptional items 9.9% 9.8% 7.4%<br />

Our underlying volume growth was higher than 1997,<br />

principally in culinary which grew by 4%. Operating<br />

pr<strong>of</strong>its and margins improved significantly and we had<br />

notable gains in Europe and North America. Overall, our<br />

turnover declined by 3% largely due to disposals <strong>of</strong><br />

businesses in Germany and the United Kingdom.<br />

In culinary, we had a good year with pasta sauces in<br />

North America, reflecting the continued success <strong>of</strong> our<br />

expanding Five Brothers and Ragú Cheese Creations!<br />

ranges. Tailoring mayonnaise to national or regional taste<br />

continued to prove successful. In France, Mayonnaise<br />

Gourmande sold well, with a place in the dairy cabinet<br />

reinforcing associations <strong>of</strong> freshness. In Italy, we<br />

relaunched Calvé yoghurt-based mayonnaise which<br />

proved particularly successful and has extended our<br />

market-leadership. Strong innovation enhanced the<br />

business’s stock and bouillon range. We launched a new<br />

liquid bouillon in Scandinavia under the Touch <strong>of</strong> Taste<br />

brand which was a particular success. In Latin America,<br />

restructuring <strong>of</strong> culinary operations continued and<br />

pr<strong>of</strong>its improved.<br />

In frozen foods, our overall volume was marginally below<br />

1997, due to our continued portfolio rationalisation.<br />

H o w e v e r, pr<strong>of</strong>its were higher in We s t e rn Europe, particularly<br />

in the United Kingdom. In 1998, we successfully continued<br />

the development <strong>of</strong> individual products for local markets.<br />

Home care and pr<strong>of</strong>essional cleaning<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 19 422 20 228 19 350 5%<br />

Operating pr<strong>of</strong>it 1 848 1 916 1 528 25%<br />

Operating pr<strong>of</strong>it before exceptional items 1 983 2 046 1 711 20%<br />

Exceptional items (net) (135) (130) (183)<br />

Operating margin 9.5% 9.5% 7.9%<br />

Operating margin before exceptional items 10.2% 10.1% 8.8%<br />

Our home care and pr<strong>of</strong>essional cleaning business made<br />

good progress overall, particularly in Western Europe and<br />

North America. We had both a better product mix and<br />

increased efficiencies meaning operating margins again<br />

rose, even after further marketing investment.<br />

Our laundry business achieved increases in both turnover<br />

and pr<strong>of</strong>its. In Europe, the convenience and quality <strong>of</strong> our<br />

new laundry tablets, backed by a substantial marketing<br />

programme, swiftly established our leadership in the<br />

European laundry tablets market. We also advanced our<br />

laundry market share in almost all developing and<br />

emerging markets. Household care maintained a trackrecord<br />

for labour-saving innovation with Domestos Active<br />

Toilet Gel, which we launched successfully in five<br />

European countries. We had other launches around the<br />

world, including Sunlight machine dish wash tablets in<br />

the United States and Cif/Jif extensions in Latin America<br />

and Europe.<br />

DiverseyLever‘s second full trading year since we merged<br />

Lever Industrial International with Diversey was somewhat<br />

disappointing with underlying volume flat in 1998. We<br />

had reasonable results in Southern Europe, the United<br />

Kingdom and North America, but we experienced<br />

difficulties in other parts <strong>of</strong> Western Europe and the Far<br />

East. In May 1998, we bought Michigan-based cleaning<br />

and hygiene business AmeriClean Systems, which became<br />

part <strong>of</strong> DiverseyLever.


34 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Performance review by region and category – 1998<br />

Personal car e<br />

Fl. million 1998 1998 1997 Change<br />

at current at constant at constant<br />

rates rates rates<br />

Turnover 21 971 23 617 21 802 8%<br />

Operating pr<strong>of</strong>it 2 763 3 039 2 546 19%<br />

Operating pr<strong>of</strong>it before exceptional items 2 812 3 087 2 723 13%<br />

Exceptional items (net) (49) (48) (177)<br />

Operating margin 12.6% 12.9% 11.7%<br />

Operating margin before exceptional items 12.8% 13.1% 12.5%<br />

Our personal care business had another excellent year,<br />

with strong underlying volume growth across most<br />

categories and regions. After we increased investment<br />

in marketing, we made very good progress in pr<strong>of</strong>its<br />

and margins. Our results were especially encouraging<br />

in Western Europe and Latin America.<br />

Personal wash did very well, assisted by the development<br />

<strong>of</strong> Dove. The Dove brand, which we originally launched<br />

as a personal wash bar, has now been extended into<br />

body-wash liquid and, in some countries, facial foam,<br />

body lotion and deodorants. Our new product launches<br />

were key to the significant growth in our skin care<br />

businesses in North America and Latin America.<br />

In hair care, our business advanced through innovation,<br />

such as the successful development and launch <strong>of</strong> the<br />

ThermaSilk range in the United States.<br />

We had varying success with oral care. In India, we gained<br />

market share with Pepsodent toothpaste, but in the<br />

United States, our sales <strong>of</strong> Mentadent toothpaste were hit<br />

by intense competition, although the brand’s toothbrushes<br />

continued to gain ground.<br />

We had another outstanding year in deodorants,<br />

particularly in North America and Europe, which both<br />

increased our market share.<br />

Our prestige business had a mixed year. Results were good<br />

in Europe but were hit by difficult trading conditions in<br />

North America. Elizabeth Arden re t u rned to pro f i t ,<br />

although not yet at acceptable levels. Calvin Klein<br />

fragrance sales were flat, as consumer enthusiasm for the<br />

new C o n t r a d i c t i o n range was <strong>of</strong>fset by reduced demand<br />

for cK p ro d u c t s .<br />

Plantations, plant science & trading operations<br />

Following our disposal <strong>of</strong> Univanich Thailand, Plant<br />

Breeding International and the Sulmac flower businesses,<br />

the remaining Plantations and Trading Operations were<br />

reclassified as ‘Other Operations’ in 1999.


Financial review<br />

The figures quoted in this review are in guilders, at current<br />

rates <strong>of</strong> exchange, unless otherwise stated. The pr<strong>of</strong>it and<br />

loss and cash flow information is translated at average<br />

rates <strong>of</strong> exchange for the relevant year and the balance<br />

sheet information at year-end rates <strong>of</strong> exchange.<br />

Results - 1999<br />

Turnover for the Group was 1% higher at<br />

Fl. 90 296 million. Underlying volume growth <strong>of</strong> 1%<br />

was partly <strong>of</strong>fset by the slight strengthening <strong>of</strong> the<br />

guilder against the basket <strong>of</strong> <strong>Unilever</strong> currencies.<br />

Operating pr<strong>of</strong>it befor e exceptional items increased<br />

by 7%, reflecting a further strengthening in underlying<br />

margin <strong>of</strong> 0.6 percentage points <strong>of</strong> turnover to 11.2%.<br />

Operating pr<strong>of</strong>it , however, fell by 2% after taking<br />

exceptional charges <strong>of</strong> Fl. 594 million, compared to<br />

net gains in 1998 <strong>of</strong> Fl. 276 million which included the<br />

pr<strong>of</strong>it on the disposal <strong>of</strong> Plant Breeding International,<br />

Cambridge, UK. The 1999 charge included Fl. 512 million<br />

for restructuring. Under US GAAP, the operating pr<strong>of</strong>it<br />

from continuing operations before and after exceptional<br />

items increased by approximately 6% and 2% respectively,<br />

reflecting different treatment <strong>of</strong> restructuring costs and<br />

goodwill (see pages 106 and 107).<br />

Income from fixed investments increased to<br />

Fl. 114 million (1998: Fl. 82 million), reflecting improved<br />

performance in our joint ventures in the US and Portugal,<br />

and the pr<strong>of</strong>it on a number <strong>of</strong> small disposals.<br />

Net interest costs were Fl. 30 million, compared with an<br />

interest income in 1998 <strong>of</strong> Fl. 344 million. The swing is<br />

due to a Fl. 11.2 billion reduction in net funds during the<br />

year, following payment <strong>of</strong> Fl. 13 billion for the cash<br />

element <strong>of</strong> the special dividend in June 1999. Net interest<br />

cover for the year was more than 300 times, and over 30<br />

times for the second half year.<br />

The Group’s effective tax rate reduced to 32% compared<br />

with 33% in 1998, mainly reflecting prior year tax credits.<br />

Minority interests increased to Fl. 443 million (1998:<br />

F l . 3 1 8 million) as a result <strong>of</strong> continued strong performance<br />

in India, and a return to pr<strong>of</strong>itability in Nigeria.<br />

Net pr<strong>of</strong>it after exceptional items fell by 6% (2% under<br />

US GAAP, see pages 106 and 107) as a result <strong>of</strong> the<br />

negative swing in exceptional items, and the impact on<br />

net interest <strong>of</strong> the special dividend. Combined earnings<br />

per shar e was unchanged at Fl. 5.80, as the reduction in<br />

net income was <strong>of</strong>fset by the reduction in the number <strong>of</strong><br />

shares following the share consolidation. Combined<br />

earnings per shar e befor e exceptional items rose<br />

by 9%.<br />

Retur n on capital employed increased to 22% from<br />

16% in 1998. This improvement is due to the more<br />

efficient capital structure resulting from the payment<br />

<strong>of</strong> the special dividend.<br />

The payment <strong>of</strong> the special dividend has been responsible<br />

for a reduction <strong>of</strong> the Weighted Average Cost <strong>of</strong> Capital<br />

(WACC) <strong>of</strong> some 0.5%. WACC is calculated as the real<br />

cost <strong>of</strong> equity multiplied by the market capitalisation, plus<br />

the real after taxation interest cost <strong>of</strong> debt multiplied by<br />

the market value <strong>of</strong> the net debt, divided by the sum <strong>of</strong><br />

the market values <strong>of</strong> debt and equity.<br />

Results - 1998<br />

Turnover for the Group at Fl. 89 112 million decreased<br />

by 6% compared with 1997 which included the speciality<br />

chemicals businesses disposed <strong>of</strong> during the year. In the<br />

continuing operations (ie excluding the speciality<br />

chemicals businesses in 1997), turnover fell by 2%, and<br />

underlying volume growth <strong>of</strong> almost 2% was little more<br />

than half the rate achieved in 1997. Productivity for the<br />

continuing operations, based on sales per employee,<br />

improved by 6% in 1998.<br />

Operating pr<strong>of</strong>it before exceptional items for the<br />

Group decreased by 7% in 1998 to Fl. 9 442 million.<br />

However, for the continuing operations this represented<br />

an increase <strong>of</strong> 7%. This increase reflected mainly a<br />

significant improvement in margins in both North America<br />

and Latin America.<br />

Operating pr<strong>of</strong>it in the continuing operations increased<br />

by 28% to Fl. 9 718 million. Exceptional items in 1998<br />

produced a net benefit <strong>of</strong> Fl. 276 million in comparison<br />

with a charge <strong>of</strong> Fl. 1 800 million in 1997. This<br />

F l . 2 7 6 million includes restructuring costs <strong>of</strong> Fl. 585 million<br />

mainly focused in Europe and Asia Pacific which were<br />

more than <strong>of</strong>fset by pr<strong>of</strong>its on business disposals which<br />

arose principally on the disposal <strong>of</strong> Plant Breeding<br />

International in Europe. Under US GAAP the increase in<br />

operating pr<strong>of</strong>it from continuing operations before and<br />

after exceptional items would have been approximately<br />

5% and 30% respectively, reflecting different treatment<br />

<strong>of</strong> restructuring cost, goodwill and pr<strong>of</strong>its on sale <strong>of</strong> the<br />

specialty chemicals businesses (see pages 106 and 107).<br />

Income from fixed investments in 1998 <strong>of</strong> Fl. 8 2 m i l l i o n<br />

was in line with last year (1997: Fl. 85 million).


Financial review<br />

Net interest income was Fl. 334 million compared to an<br />

interest cost in 1997 <strong>of</strong> Fl. 230 million. Average net funds<br />

for the year at constant rates were Fl. 11.0 billion.<br />

The Group’s effective tax rate reduced to 33% compared<br />

to 35% in 1997 when the impact <strong>of</strong> the disposal <strong>of</strong> the<br />

speciality chemicals businesses is excluded. The reduction<br />

is mainly due to one-<strong>of</strong>f items and the benefit <strong>of</strong> prior<br />

year tax credits.<br />

Minority interests <strong>of</strong> Fl. 318 million were in line with<br />

1997 with higher pr<strong>of</strong>its in India <strong>of</strong>fset by increased losses<br />

in China, and the impact in 1997 <strong>of</strong> the minority interests’<br />

share in the pr<strong>of</strong>it on disposal <strong>of</strong> the speciality chemicals<br />

businesses.<br />

Net pr<strong>of</strong>it after exceptional items decreased by 41%<br />

to Fl. 6 488 million (47% to Fl. 5 605 million under<br />

US GAAP, pages 106 and 107). Excluding the pr<strong>of</strong>it on<br />

the sale <strong>of</strong> the speciality chemicals businesses and loss<br />

on the disposal <strong>of</strong> fixed assets in 1997, net pr<strong>of</strong>it<br />

increased by 41%. The Fl. 2 076 million positive swing<br />

in operating exceptional items referred to previously made<br />

a significant contribution to this improvement; excluding<br />

exceptional items, net income was 13% ahead <strong>of</strong> 1997<br />

( a p p ro x i m a t e l y11% under US GAAP). Earnings per<br />

shar e decreased by 41% from Fl. 9.78 to Fl. 5.80 due to<br />

the speciality chemicals businesses disposal pr<strong>of</strong>it in 1997.<br />

Return on capital employed , before the impact <strong>of</strong> the<br />

special dividend (see below), decreased to 16% from 28%<br />

in 1997, entirely due to the impact <strong>of</strong> the pr<strong>of</strong>it on sale<br />

<strong>of</strong> speciality chemicals businesses in 1997. Average capital<br />

employed excludes goodwill on acquisitions made before<br />

1998, which are eliminated in reserves. As the special<br />

dividend is accounted for on 31 December 1998, its<br />

impact on average capital employed and the related<br />

return on capital employed is not material in 1998. In a<br />

full year the impact <strong>of</strong> the special dividend would increase<br />

return on capital employed to approximately 24%.<br />

Dividends and market capitalisation<br />

Ordinary dividends paid and proposed on the NV<br />

ordinary capital amount to Fl. 2.79 per Fl. 1.12 share<br />

(1998: Fl. 2.51 per Fl. 1 share), an increase <strong>of</strong> 11% per<br />

share. The ratio <strong>of</strong> dividends to pr<strong>of</strong>it attributable to<br />

ordinary shareholders increased to 45.2% (1998: 42.1%).<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained was Fl. 3 319 million (1998:<br />

Fl. 3 746 million before the special dividend).<br />

U n i l e v e r ’s combined m a r k e t c a p i t a l i s a t i o n at 31 D e c e m b e r<br />

1999 was Fl. 116.1 billion (1998: Fl. 1 7 1 . 3 b i l l i o n ) .<br />

Balance sheet<br />

The weakening <strong>of</strong> the guilder against the basket <strong>of</strong><br />

<strong>Unilever</strong> currencies between the two balance sheet dates<br />

resulted in a Fl. 774 million gain on retranslation <strong>of</strong> net<br />

assets. Pr<strong>of</strong>it retained, after accounting for dividends,<br />

currency retranslation <strong>of</strong> opening balances and <strong>of</strong><br />

movements, and goodwill adjustments on the disposal<br />

<strong>of</strong> businesses previously acquired, increased by<br />

Fl. 4 239 million to Fl. 14 420 million. Total capital<br />

and reserves increased to Fl. 17 105 million (1998:<br />

Fl. 10 464 million). The issue <strong>of</strong> new 10 cents NV<br />

p re f e rence shares, to NV shareholders who opted to take<br />

the special dividend in this form, contributed Fl. 3 045 m i l l i o n .<br />

Cash flow<br />

Cash flow from operations increased by Fl. 2 512 million<br />

to Fl. 12 460 million on the strength <strong>of</strong> lower working<br />

capital outflows and improved results (before acquisitions<br />

and disposals).<br />

Capital expenditur e was in line with last year; financial<br />

investments increased somewhat as a result <strong>of</strong> additional<br />

share purchases to meet employee share option plans.<br />

During the year 27 businesses were acquired for a cash<br />

consideration <strong>of</strong> Fl. 1 064 million and 23 businesses<br />

were disposed for cash proceeds <strong>of</strong> Fl. 270 million. In<br />

December 1999 <strong>Unilever</strong> agreed to purchase the French<br />

foods business Amora Maille for Fl. 1 540 million; this<br />

acquisition is expected to be completed in the first half<br />

<strong>of</strong> 2000.<br />

Net funds at the end <strong>of</strong> the year were Fl. 1 508 million,<br />

Fl. 11 227 million lower than at the end <strong>of</strong> 1998 with the<br />

decrease reflecting the Fl. 13 billion cash payment in<br />

respect <strong>of</strong> the special dividend. Gearing remained zero<br />

at the end <strong>of</strong> 1999.<br />

Finance and liquidity<br />

During 1999 <strong>Unilever</strong> paid a special dividend <strong>of</strong> some<br />

F l . 1 6 billion to ordinary shareholders, <strong>of</strong> which appro x i m a t e l y<br />

Fl. 3 billion was taken up by NV shareholders in the form<br />

<strong>of</strong> pre f e rence shares. After payment <strong>of</strong> the special dividend<br />

the balance sheet remains very strong, and <strong>Unilever</strong> re t a i n s<br />

its capability to raise funds in all major global debt markets<br />

at the lowest costs available to corporate borro w e r s .<br />

Group policy is to finance operating subsidiaries through<br />

the mix <strong>of</strong> retained earnings, third party borrowings and<br />

loans from parent and Group financing companies that<br />

is most appropriate for the particular country and<br />

business concerned.


Financial review<br />

Total borrowings at the end <strong>of</strong> 1999 totalled<br />

Fl. 10 553 million (1998: Fl. 10 146 million). More than<br />

one third <strong>of</strong> <strong>Unilever</strong>’s total borrowings are in euros,<br />

approximately one third in US dollars and the remainder<br />

spread over a large number <strong>of</strong> other currencies.<br />

Long-term debt fell by Fl. 939 million to Fl. 4 084 million.<br />

Debt totalling Fl. 1 464 million was reclassified to shortterm<br />

at the year end and there were no significant new<br />

long-term borrowings. The maturity pr<strong>of</strong>ile is spread over<br />

an eight year period to 2007. Some 85% <strong>of</strong> the long-term<br />

debt was repayable within five years at the end <strong>of</strong> 1999<br />

(1998: 60%).<br />

<strong>Unilever</strong> has commercial paper programmes in place in the<br />

United States and Europe for short-term finance purposes.<br />

In addition, operating subsidiaries fund part <strong>of</strong> their dayto-day<br />

<strong>needs</strong> through local bank borrowings. At the end<br />

<strong>of</strong> 1999 short-term borrowings were Fl. 6 469 million<br />

(1998: Fl. 5 123 million).<br />

Cash and current investments at the end <strong>of</strong> 1999 totalled<br />

Fl. 12 061 million (1998: Fl. 22 881 million); these funds<br />

a re held in euros (52%), US dollars (17%), sterling (12%)<br />

and other currencies (19%). The funds are mainly invested<br />

in short-term bank deposits and high-grade marketable<br />

securities.<br />

Assets held in foreign currencies are, to a considerable<br />

extent, financed by borrowings in the same currencies.<br />

Consequently, at the end <strong>of</strong> 1999 some 51% (1998: 57%<br />

before accounting for the special dividend) <strong>of</strong> <strong>Unilever</strong>’s<br />

total capital and reserves were denominated in the<br />

currencies <strong>of</strong> the two parent companies, euro and sterling.<br />

From an earnings perspective, some 43% <strong>of</strong> <strong>Unilever</strong>’s<br />

1999 net income was denominated in the euro, 14% in<br />

sterling and 15% in the US dollar.<br />

Treasury and hedging policies<br />

<strong>Unilever</strong>’s Treasury aims to be excellent in meeting the<br />

business requirements for finance and financial services,<br />

with its prime objective being to minimise the cost <strong>of</strong> debt<br />

and maintain <strong>Unilever</strong>’s financial strength. The Group<br />

Treasury function is governed by financial policies and<br />

plans agreed by the directors, and operates as a cost<br />

centre. In addition to policies, guidelines and exposure<br />

limits, a system <strong>of</strong> authorities and extensive independent<br />

reporting covers all major areas <strong>of</strong> activity.<br />

Performance is monitored closely. Independent reviews are<br />

undertaken by the corporate internal audit function.<br />

<strong>Unilever</strong> has an interest rate management policy aimed<br />

at optimising net interest and reducing volatility. This is<br />

achieved by modifying the underlying interest rate<br />

exposure <strong>of</strong> debt and cash positions through the use <strong>of</strong><br />

straightforward derivative instruments. The proportion <strong>of</strong><br />

fixed rate cash and fixed rate debt was reduced in 1999 in<br />

line with changes in the recommended fixing levels within<br />

this policy.<br />

Under the Group’s foreign exchange policy, trading and<br />

financial exposures are generally hedged, mainly through<br />

the use <strong>of</strong> forward foreign exchange contracts. Some<br />

flexibility is permitted within overall exposure limits.<br />

Managing market risks<br />

The Group is exposed to a variety <strong>of</strong> market risks,<br />

including the effects <strong>of</strong> changes in foreign currency<br />

exchange rates, interest rates and credit spreads. In the<br />

normal course <strong>of</strong> business, the Group also faces risks that<br />

are either non-financial or non-quantifiable, eg country<br />

and counterparty risk.<br />

Counterparty exposures are minimised by restricting<br />

dealing counterparties to a limited number <strong>of</strong> financial<br />

institutions that have secure credit ratings, by working<br />

within agreed counterparty limits and by setting limits on<br />

the maturity <strong>of</strong> investments. Counterparty credit ratings<br />

are closely monitored and concentration <strong>of</strong> credit risk with<br />

any single counterparty is avoided.<br />

The Group uses straightforward derivative financial<br />

instruments, eg interest rate swaps, forward rate<br />

agreements and forward exchange contracts, to manage<br />

the market risks associated with the underlying assets,<br />

liabilities and anticipated transactions. The Group uses<br />

these derivative financial instruments to reduce risk by<br />

creating <strong>of</strong>fsetting market exposures. The use <strong>of</strong> leveraged<br />

instruments is not permitted.<br />

The following discussion about our risk-management<br />

activities includes ‘forward-looking’ statements that<br />

involve risk and uncertainties. Our actual results could<br />

differ materially from those projected.


Financial review<br />

The analysis below presents the sensitivity <strong>of</strong> our fair<br />

value <strong>of</strong> the financial and derivative instruments our<br />

Group held at 31 December 1999, to the hypothetical<br />

changes described below.<br />

Interest rate risk<br />

The fair value <strong>of</strong> our debt, investments and related<br />

hedging instruments is affected by movements in<br />

interest rates. The analysis shows the sensitivity <strong>of</strong> the<br />

fair value <strong>of</strong> interest rate sensitive instruments to a<br />

hypothetical 10% change in the interest rates across<br />

all maturities as at 31 December 1999.<br />

Foreign exchange rate risk<br />

The fair value <strong>of</strong> our debt, investments and hedging<br />

instruments, denominated in currencies other than the<br />

functional currency <strong>of</strong> the entities holding them, are<br />

subject to exchange rate movements. The analysis shows<br />

the sensitivity <strong>of</strong> these fair values to a hypothetical 10%<br />

change in foreign exchange rates as at 31 December 1999.<br />

000000051111<br />

Sensitivity to a hypothetical<br />

10% adverse movement in<br />

rates as at 31 December<br />

(Fl. million)<br />

000000051111<br />

1999 1998<br />

000000 05111<br />

Interest rate risk 9 44<br />

Foreign exchange rate risk 35 31<br />

Further details on derivatives, foreign exchange exposures<br />

and other related information on financial instruments are<br />

given in note 29 on pages 88 to 90.<br />

Commodities contracts<br />

Some <strong>of</strong> our businesses, principally edible fats companies<br />

in Europe, may use forward contracts in a number <strong>of</strong> oils<br />

to hedge future requirements. We purchase forward<br />

contracts in bean, rape, sunflower, palm, coconut and<br />

p a l m k e rnel oils, almost always for physical delivery.<br />

Wemay also use futures contracts to hedge future price<br />

movements; however, the amounts are not material.<br />

The total value <strong>of</strong> open futures contracts at the end <strong>of</strong><br />

1999 was not material.<br />

In addition, our plantations’ businesses may use forward<br />

contracts for physical delivery <strong>of</strong> palm oil and tea under<br />

strictly controlled policies and exposure limits. We did<br />

not have any outstanding futures contracts at the end<br />

<strong>of</strong> 1999.<br />

Impact <strong>of</strong> price changes<br />

Information concerning the impact <strong>of</strong> price changes<br />

is restricted to tangible fixed assets and depreciation.<br />

See note 9 on page 74.<br />

Total shareholder return<br />

Total Shareholder Return (TSR) is a concept used to<br />

compare the performance <strong>of</strong> different companies’ stocks<br />

and shares over time. It combines share price appreciation<br />

and dividends paid to show the total return to the<br />

shareholder. The absolute size <strong>of</strong> the TSR will vary with<br />

stock markets, but the relative position is a reflection <strong>of</strong><br />

the market perception <strong>of</strong> overall performance.<br />

The Company calculates the TSR over a three-year rolling<br />

period. This period is sensitive enough to reflect changes<br />

but long enough to smooth out short-term volatility. The<br />

return is expressed in US dollars, based on the equivalent<br />

US dollar share price for NV and PLC. US dollars were<br />

chosen to facilitate comparison with companies in<br />

<strong>Unilever</strong>’s chosen reference group.<br />

<strong>Unilever</strong> has set itself a TSR target in the top third <strong>of</strong> a<br />

reference group <strong>of</strong> 21 international consumer goods<br />

companies. Together, these give a fair reflection <strong>of</strong> its<br />

category and regional spread.<br />

Our objective <strong>of</strong> delivering a total return to shareholders<br />

in the top third over a three year period was again<br />

achieved. However, in 1999 share prices in our sector<br />

as awhole suffered as investor interest focused on high<br />

technology and internet stocks and there was an even<br />

sharper decline in the <strong>Unilever</strong> share price during the<br />

fourth quarter. Consequently we would be below the<br />

benchmark if it were measured over a single year.


Operating review<br />

Year 2000<br />

We had no Y2K -related issues <strong>of</strong> any significance during<br />

the millennium change. Our Y2 K teams tested critical<br />

systems throughout the millennium weekend and<br />

confirmed within 48 hours that all our business systems<br />

around the world were operating normally.<br />

The seamless way our <strong>people</strong> worked together<br />

emphasised the strength and coherence <strong>of</strong> <strong>Unilever</strong>’s<br />

global organisation. All aspects <strong>of</strong> our three-year Y2K<br />

preparation programme were completed on schedule.<br />

This included checking and, where necessary, upgrading<br />

100 000 internal systems, verifying the millennium<br />

readiness <strong>of</strong> almost 100 000 business partners and<br />

infrastructure providers, and preparing detailed<br />

contingency plans to protect against possible failures.<br />

<strong>Unilever</strong>’s spend for the Y 2K programme amounted to<br />

Fl. 670 million. This included all external costs, associated<br />

depreciation on capital expenditure, and directly related<br />

internal costs from 1996 to the completion <strong>of</strong> the<br />

programme.<br />

Technology and innovation<br />

The popularity <strong>of</strong> iced tea continues to grow. Until now,<br />

the main way to make it has been to boil water and then<br />

allow it to cool. In 1999, our scientists found a way to<br />

make the key elements <strong>of</strong> tea more soluble, allowing it<br />

to be brewed with cold water straight from the tap. The<br />

result was Lipton Cold Brew tea bags – a breakthrough<br />

that saves the consumer time and effort when preparing<br />

iced tea.<br />

To develop Dove Nutrium skin nourishing body wash<br />

we combined our expert knowledge <strong>of</strong> the chemistry<br />

<strong>of</strong> product development and the physiology <strong>of</strong> skin.<br />

The product is sold in an innovative twin-chamber bottle<br />

which dispenses the cleansing and nourishing elements<br />

separately, improving the deposition <strong>of</strong> nutrients to<br />

the skin.<br />

These two examples demonstrate the way we combine<br />

world-class technology with deep consumer insight to<br />

produce revolutionary new products that make a real<br />

difference to <strong>people</strong>’s daily lives and set the agenda<br />

for our competitors.<br />

Based in six laboratories and over 70 innovation centres<br />

around the world, our technology and innovation<br />

capability is focused entirely on our business goals.<br />

In Brazil, for example, the São Paulo innovation centre<br />

worked with our European laboratories to reformulate<br />

Omo. An ingredient was identified and added, making<br />

this popular laundry brand more effective at removing oily<br />

stains. This helped retain our leading market position and<br />

attracted new consumers to the brand.<br />

Technology is also used to reduce supply chain costs and<br />

enhance performance. In India, ice cream distribution<br />

costs were halved through a number <strong>of</strong> improvements,<br />

including the development <strong>of</strong> insulated boxes for carriage<br />

in hire trucks. These removed the need for dedicated<br />

vehicle fleets which stay idle out <strong>of</strong> season.<br />

In 1999, we invested further in extending the reach <strong>of</strong><br />

our international laboratories. For example, we expanded<br />

the key technology teams in our new Indian facility in<br />

Bangalore, completed a new Home & Personal Care<br />

laboratory in China and began upgrading our food<br />

science and nutrition facilities in Vlaardingen, in<br />

the Netherlands.<br />

Collaboration with external agencies is an integral part<br />

<strong>of</strong> our research. In 1999, work started on the <strong>Unilever</strong><br />

Centre, a UK research facility which we are building in<br />

partnership with the University <strong>of</strong> Cambridge. The Centre<br />

is due to open in 2000.<br />

In 1999 <strong>Unilever</strong> spent Fl. 2 060 million on technology<br />

and innovation: 2.3% <strong>of</strong> our turnover. We filed 466<br />

patent applications, an increase <strong>of</strong> more than a third<br />

on last year.<br />

Information technology<br />

Hollywood hairstyle secrets were shared with our<br />

consumers via the internet, courtesy <strong>of</strong> a ground-breaking<br />

<strong>Unilever</strong> promotion.<br />

Our Salon Selectives brand sponsored part <strong>of</strong> the hair and<br />

beauty section <strong>of</strong> the America Online (AOL) Oscars night<br />

web site. Tens <strong>of</strong> thousands <strong>of</strong> <strong>people</strong> logged on and<br />

chose to register their details in a bid to win a Hollywoodstyle<br />

beauty makeover. The result: consumers felt Salon<br />

Selectives could relate to, and meet, their hair care <strong>needs</strong>,<br />

the brand pr<strong>of</strong>ile was raised and our online marketing<br />

database was boosted significantly.<br />

This initiative, co-ordinated by our New York Interactive<br />

Brand Centre, is a prime example <strong>of</strong> how we are using<br />

internet technology to get closer to consumers. In 2000<br />

we announced a joint venture with iVillage, the leading<br />

American online women’s site, to create an interactive<br />

personal care business. We announced a similar<br />

partnership with Wowgo, the new European online<br />

company for teenage girls.


Operating review<br />

In 1999, we doubled our spending on online advertising.<br />

Integral to this expansion has been the development <strong>of</strong><br />

our marketing alliances with leading internet companies<br />

AOL and Micros<strong>of</strong>t and the forging <strong>of</strong> a similar<br />

relationship with broad band internet provider<br />

Excite@Home.<br />

<strong>Unilever</strong> has established a global reach <strong>of</strong> internet<br />

expertise, with interactive brand centres in key locations<br />

around the world. One <strong>of</strong> our first steps to developing<br />

direct internet channels enabled American consumers to<br />

buy Unipath’s new fertility monitors online as well as<br />

through conventional retailers. The internet proves a<br />

perfect channel for selling items such as these which<br />

require detailed product information.<br />

We are increasingly using IT to support customer – as well<br />

as consumer – relationships. During the year, we laid the<br />

ground for internet-enabled sales with our customers by<br />

conducting web-based tests with a limited number <strong>of</strong><br />

retailers. In the UK, we worked with leading retailer Tesco<br />

to develop a shared information resource which will<br />

support effective promotion via the more efficient transfer<br />

<strong>of</strong> up to the minute information. By 2001 we expect to be<br />

working collaboratively via the internet with some <strong>of</strong> our<br />

major customers.<br />

The internet is also a powerful tool for exploiting our<br />

scale in purchasing. In 2000, we announced that we<br />

would be working with Ariba, a leading business-tobusiness<br />

e-commerce system provider, to build a global<br />

online procurement platform. By 2001, we aim to use<br />

e-commerce and web-enabled systems for a significant<br />

part <strong>of</strong> our purchasing spend – saving time and money.<br />

All our computer hardware is already bought via the<br />

internet and intranet and we have successfully piloted<br />

the purchase <strong>of</strong> packaging supplies and ingredients<br />

using ‘electronic auctions’.<br />

Leveraging <strong>Unilever</strong>’s knowledge and making it easily<br />

accessible to our <strong>people</strong> is the great challenge. Our<br />

extensive IT networks are now making this possible.<br />

Environmental responsibility<br />

<strong>Unilever</strong>’s Viso factory in Vietnam produces detergent<br />

powders and shampoos for this important market in<br />

South East Asia. Since 1996, it has reduced rates <strong>of</strong> water<br />

pollution loading by 84%, emissions by 70% and energy<br />

use by 46%. This is just one example <strong>of</strong> our dedication to<br />

the responsible environmental management we see as an<br />

integral part <strong>of</strong> our business processes.<br />

Environmental management We have completed<br />

environmental audits at 90% <strong>of</strong> our factories and will<br />

have audited all sites by the end <strong>of</strong> 2000. Progress<br />

continues on certifying operations to the international<br />

environmental management system standard ISO 14001.<br />

To date we have 44 certified factories.<br />

Eco-efficiency We are reducing our impact on the<br />

environment by making energy and raw material use<br />

more efficient and systematically cutting factory waste.<br />

Since 1996, our Tortuguitas personal products factory<br />

in Buenos Aires has cut pollution loading by 65%, waste<br />

by 45% and energy use by 25%. In Ghana, the national<br />

Environmental Protection Agency recognised <strong>Unilever</strong><br />

Ghana as the leader in environmental management<br />

practices in the manufacturing industry.<br />

<strong>Unilever</strong> is working to ensure packaging does its job with<br />

minimum environmental impact. Our European ice cream<br />

operations are exceeding waste reduction demands with<br />

lighter weight ice cream wrappers, and by using more<br />

recycled materials and reduced-weight secondary<br />

packaging.<br />

We are helping consumers to optimise product use.<br />

For instance, laundry tablets, which we have launched<br />

in Chile, Argentina and many countries in Europe, enable<br />

exact dosing which has reduced the average weight <strong>of</strong><br />

detergent per wash.<br />

Sustainability The Marine Stewardship Council, now a<br />

fully independent non-pr<strong>of</strong>it organisation, will launch the<br />

first products from certified, sustainable fisheries in 2000.<br />

In 1999, we completed a screening programme <strong>of</strong> our<br />

fishery suppliers and continue to progress towards<br />

sourcing all fish from sustainable fisheries by 2005.<br />

Clean water is essential for the consumption <strong>of</strong> <strong>Unilever</strong><br />

products. We support more than 20 water stewardship<br />

projects: in the Philippines we received the 1999 Mother<br />

Nature Award from the Pollution Control Association<br />

for our factory water treatment and contribution to<br />

remediation <strong>of</strong> the Pasig River. In the UK, we are backing<br />

SWIM (Sustainable Water – Integrated Catchment<br />

Management), an inclusive, multi-disciplinary approach<br />

to improving access to and management <strong>of</strong> water<br />

resources. During 1999 we made preparations to take<br />

a leading role at the spring 2000 World Water Forum<br />

in the Netherlands.<br />

As part <strong>of</strong> our sustainable agriculture initiative, Brooke<br />

Bond Tea estates in Kericho, Kenya, have been working<br />

with farmers, environmentalists and agronomists to test


Operating review<br />

sustainability indicators in tea production. Similar pilots<br />

are under way in palm oil, spinach, peas and tomatoes<br />

in eight other countries.<br />

<strong>Unilever</strong>’s commitment to sustainability was recognised<br />

in 1999 with our inclusion in the Dow Jones Sustainability<br />

Group Index. This index uses a systematic methodology to<br />

identify companies that lead the way in taking a strategic<br />

approach towards sustainable business development.<br />

Responsible corporate behaviour<br />

<strong>Unilever</strong> is committed to the highest standards <strong>of</strong><br />

corporate behaviour towards its employees, consumers<br />

and the societies in which we operate.<br />

This commitment is at the heart <strong>of</strong> the <strong>Unilever</strong><br />

Corporate Purpose, and is reflected in the Company’s<br />

Code <strong>of</strong> Business Principles. This code sets the framework<br />

for worldwide operational standards, covering issues<br />

such as employee health and safety, product quality<br />

and environmental impact. All Company chairmen are<br />

required to give positive assurance that these policies<br />

and principles are adhered to, and compliance is audited<br />

on a regular basis.<br />

To succeed as a ‘multi-local multinational’, it is essential<br />

that <strong>Unilever</strong>’s operating companies stay close to<br />

and understand evolving consumer <strong>needs</strong> and values.<br />

<strong>Unilever</strong>’s long-term commitment means that not only are<br />

our branded products and services instrumental in raising<br />

living standards, but our policies <strong>of</strong> developing employees<br />

and business partners also contribute to economic<br />

development locally.<br />

As well as pursuing high standards in our business<br />

practices, we also recognise <strong>Unilever</strong>’s responsibility to<br />

wider society. We are committed to working directly and<br />

in partnership with public authorities and a range <strong>of</strong><br />

different organisations to address important social,<br />

economic and environmental challenges. Around the<br />

world <strong>Unilever</strong> companies are active in projects that<br />

contribute to sustainable development and in initiatives<br />

to raise standards <strong>of</strong> education and health both among<br />

employees and in local communities.<br />

In 1999 our companies spent around Fl. 85 million on<br />

community involvement and almost Fl. 10 million w a s<br />

contributed to disaster relief projects in countries as far<br />

apart as Turkey, Taiwan and Colombia.<br />

How companies interact with society is attracting<br />

increasing attention. We believe corporate social<br />

responsibility should be managed as pr<strong>of</strong>essionally as any<br />

other business discipline. In the year 2000, several<br />

<strong>Unilever</strong> companies in different parts <strong>of</strong> the world are<br />

testing a framework to evaluate our performance in this<br />

area. The outcome <strong>of</strong> the project will help us to develop<br />

a consistent <strong>Unilever</strong> approach to managing corporate<br />

social responsibility in diverse cultures. It will also enable<br />

us to share good practice which will strengthen our local<br />

contribution around the world.<br />

Conducting our business with respect for the communities<br />

where we operate is not only responsible corporate<br />

behaviour, it also makes good business sense. We will<br />

continue to strive to meet the highest standards and<br />

to enhance <strong>Unilever</strong>’s reputation as a company that<br />

recognises its wider corporate responsibilities.<br />

Competition<br />

We have a wide and diverse set <strong>of</strong> competitors in our<br />

consumer goods businesses. Many <strong>of</strong> our competitors<br />

also operate on an international scale, but others have<br />

a narrower regional or local focus.<br />

Competition is intense and challenging. We aim to<br />

c o m p e t e and give value to our consumers and customers<br />

i n t h ree ways:<br />

•<br />

•<br />

•<br />

by continually developing new and improved products;<br />

by sharing our innovations and concepts with our<br />

businesses all around the world; and<br />

by striving to lower the cost <strong>of</strong> our sourcing,<br />

manufacturing and distribution processes whilst still<br />

maintaining, and improving, the quality <strong>of</strong> our<br />

products.<br />

We support efforts to create a more open competitive<br />

environment through the liberalisation <strong>of</strong> international<br />

trade. We also support the fuller implementation <strong>of</strong> the<br />

Single European Market and inclusion <strong>of</strong> other European<br />

countries in the European Union.<br />

Exports<br />

We sell our products in nearly all countries throughout<br />

the world and manufacture in many <strong>of</strong> them. Inside the<br />

European Union we make many <strong>of</strong> our products in only<br />

a few countries, for sale in all <strong>of</strong> them.<br />

We also export a wide range <strong>of</strong> products to countries<br />

where we do not make them. We <strong>of</strong>ten use this export<br />

trade to develop new markets before building local<br />

manufacturing facilities, usually through our facilities<br />

in neighbouring countries.


Operating review<br />

People<br />

year end in thousands 95 96 97 98 99<br />

Europe 102 101 84 82 76<br />

North America 27 31 23 23 22<br />

Africa &Middle East 72 64 58 57 48<br />

Asia &Pacific 76 78 74 72 71<br />

Latin America 30 30 30 31 29<br />

Included in the table above are 50 000 <strong>people</strong> employed<br />

in our plantations businesses worldwide. The average<br />

number <strong>of</strong> employees during the year is shown in note 3<br />

on page 72.<br />

A brand manager at Elida Fabergé UK was one <strong>of</strong> 400<br />

graduate recruits from all over the world who went out to<br />

meet consumers in their own homes. Such training aims<br />

to bring our employees even closer to consumers and<br />

provide insights that will help us build powerful, relevant<br />

brands and channels.<br />

The initiative is part <strong>of</strong> <strong>Unilever</strong>’s Foundation programme,<br />

co-ordinated by our Marketing Academy, which was<br />

established in 1999 to further develop the skills <strong>of</strong> our<br />

marketers and to foster a spirit <strong>of</strong> enterprise. Similar<br />

academies are at work in other parts <strong>of</strong> our business.<br />

In 1999 we also introduced career ‘road maps’ for<br />

young managers. These help <strong>people</strong> to plan, and take<br />

more control <strong>of</strong>, their career development. They assist<br />

individuals to build experience and expertise in a logical<br />

sequence.<br />

Growth is driven by leaders with certain characteristics,<br />

such as the relentless passion for winning. To assess<br />

and improve individual strengths, we have developed a<br />

‘Leadership Pr<strong>of</strong>ile for Accelerated Growth’ for our senior<br />

managers. To help them reach peak potential, they have<br />

been given their own personal development coaches and<br />

are being challenged to set themselves tougher targets<br />

directly linked to delivering superior performance.<br />

To position the business behind our strategy for growth,<br />

in 2000 we will be making changes to the organisation<br />

and to the way we reward <strong>people</strong>. These changes<br />

will reinforce 1999 initiatives that aligned reward<br />

more closely to both Company performance and to<br />

developing the capability <strong>of</strong> the organisation to sustain<br />

strong growth.<br />

The initiatives announced in February 2000 to accelerate<br />

top line growth and margin improvement are likely to lead<br />

to a reduction <strong>of</strong> around 25 000 jobs over the next five<br />

years. These are necessary for the long-term health <strong>of</strong> the<br />

Company; we will, however, take the utmost care to<br />

implement these changes in close consultation to<br />

minimise the personal impact.<br />

Related party transactions<br />

Transactions with related parties are conducted in<br />

accordance with the pricing policies described on<br />

page 65 and consist primarily <strong>of</strong> sales to joint<br />

ventures.The amounts involved are not material<br />

to the turnover or pr<strong>of</strong>its <strong>of</strong> the Group.<br />

Intellectual property<br />

We have a number <strong>of</strong> patents, and we conduct some<br />

<strong>of</strong> our operations under licences which are based on<br />

patents or trademarks owned or controlled by others.<br />

We are not dependent on any one patent or group <strong>of</strong><br />

patents. We protect our brands and technology in every<br />

available way.<br />

Description <strong>of</strong> our properties<br />

We have interests in properties in most <strong>of</strong> the countries<br />

where there are <strong>Unilever</strong> operations. We use our<br />

properties predominantly to house production and<br />

distribution activities, rather than for resale. For the list<br />

<strong>of</strong> principal group companies and fixed investments as<br />

at 31 December 1999, see pages 108 to 110.<br />

We own properties and operate throughout the world,<br />

so we are subject to the changing laws and regulations<br />

<strong>of</strong> various countries. Future changes in these laws could<br />

affect our property ownership, currency control, taxation<br />

and trade regulation, and could also restrict our ability<br />

to pay dividends or repay capital.<br />

Legal proceedings<br />

We are not involved in any legal proceedings and<br />

do not have any obligations under environmental<br />

legislation which we expect to lead to a material loss.<br />

None <strong>of</strong> our directors or <strong>of</strong>ficers are involved, in any<br />

way, in any material legal proceedings against us.


Corporate governance<br />

Directors<br />

The Chairmen <strong>of</strong> NV and PLC are the principal executive<br />

<strong>of</strong>ficers <strong>of</strong> <strong>Unilever</strong>. Our nine directors are each full-time<br />

executives and directors <strong>of</strong> both NV and PLC. As well as<br />

holding specific management responsibilities, they are<br />

responsible – as directors <strong>of</strong> NV and PLC – for the conduct<br />

<strong>of</strong> the business as a whole.<br />

Our operations worldwide are organised into 12 Business<br />

Groups, each with a Business Group President. For details<br />

<strong>of</strong> the Business Group Presidents see page 45.<br />

The directors have set out a number <strong>of</strong> areas for which<br />

the Boards have direct responsibility for decision-making.<br />

They meet to consider the following corporate events<br />

and actions:<br />

•<br />

•<br />

•<br />

•<br />

•<br />

•<br />

Agreement <strong>of</strong> quarterly results announcements<br />

Approval <strong>of</strong> the Annual Report and Accounts<br />

Declaration <strong>of</strong> dividends<br />

Convening <strong>of</strong> shareholders’ meetings<br />

Approval <strong>of</strong> corporate strategy<br />

Authorisation <strong>of</strong> major transactions<br />

All other matters are delegated to committees whose<br />

actions are reported to and monitored by the Boards.<br />

Board meetings are held in London and Rotterdam and<br />

chaired by the Chairmen <strong>of</strong> NV and PLC. The Chairmen<br />

are assisted by the Joint Secretaries, who ensure the<br />

Boards are supplied with all the information necessary for<br />

their deliberations. Information is normally supplied a<br />

week prior to each meeting.<br />

Directors are elected by shareholders at the Annual<br />

General <strong>Meeting</strong>s <strong>of</strong> NV and PLC, to hold <strong>of</strong>fice until<br />

the end <strong>of</strong> the next AGM. For details <strong>of</strong> the nomination<br />

procedure for directors, see Control <strong>of</strong> <strong>Unilever</strong> on<br />

page 118. All directors submit themselves for re-election<br />

each year and retire at the latest by the age <strong>of</strong> 62. They<br />

are executive <strong>of</strong>ficers, and cease to hold executive <strong>of</strong>fice<br />

on ceasing to be directors. We appoint our other<br />

executive <strong>of</strong>ficers for an indefinite period. None <strong>of</strong> our<br />

directors or executive <strong>of</strong>ficers are elected under any<br />

arrangement or understanding.<br />

All <strong>of</strong> our directors have been with <strong>Unilever</strong> full time for<br />

at least five years, and in most cases for most <strong>of</strong> their<br />

business careers. For details see pages 44 to 46.<br />

There are no family relationships between any <strong>of</strong> our<br />

directors or executive <strong>of</strong>ficers.<br />

Advisory Directors<br />

The Advisory Directors are the principal external presence<br />

in the governance <strong>of</strong> <strong>Unilever</strong>. The role <strong>of</strong> an Advisory<br />

Director involves giving advice to the Boards in general,<br />

and to the Executive Committee in particular, on business,<br />

social and economic issues. One <strong>of</strong> their key roles is to<br />

assure the Boards that our corporate governance<br />

provisions are adequate and reflect, as far as possible, best<br />

practice. They serve on certain key Board committees, the<br />

roles and membership <strong>of</strong> which are described below.<br />

The appointment <strong>of</strong> Advisory Directors is provided for in<br />

the Articles <strong>of</strong> Association <strong>of</strong> both parent companies,<br />

although they are not formally members <strong>of</strong> the Boards.<br />

They are therefore not entitled to vote at meetings <strong>of</strong> t h e<br />

B o a rds and bear no legal responsibility for the Board s ’<br />

a c t i o n s . Their terms <strong>of</strong> appointment, role and powers are<br />

enshrined in resolutions <strong>of</strong> the Boards. As well as their<br />

own committee meetings, they attend the quarterly<br />

directors’ meetings, other directors’ and Executive<br />

Committee members’ conferences, and other meetings<br />

with the Chairmen. In addition, the Advisory Directors<br />

may meet as a body, at their discretion, and appoint a<br />

senior member as their spokesman.<br />

Our Advisory Directors are chosen for their broad<br />

experience, international outlook and independence.<br />

They are appointed by resolutions <strong>of</strong> the Boards, normally<br />

for an initial term <strong>of</strong> three to four years and thereafter for<br />

terms <strong>of</strong> three years. They are usually appointed for a<br />

maximum <strong>of</strong> three consecutive terms and retire at 70.<br />

Their remuneration is determined by the Boards. All<br />

appointments and re-appointments are based on the<br />

recommendations <strong>of</strong> the Nomination Committee.<br />

Board Committees<br />

The directors have established the following committees:<br />

Executive Committee The Executive Committee comprises<br />

the Chairmen <strong>of</strong> NV and PLC and normally five other<br />

members: the two Category Directors for Foods and<br />

for Home & Personal Care; the Strategy & Technology<br />

Director; the Financial Director; and the Personnel Director.<br />

For details <strong>of</strong> the members <strong>of</strong> the Executive Committee<br />

see pages 44 and 45. Members <strong>of</strong> the Executive<br />

Committee are appointed by all the directors for one year<br />

at a time. It is responsible for agreeing priorities and<br />

allocating resources, setting overall corporate targets,<br />

agreeing and monitoring Business Group strategies and<br />

plans, identifying and exploiting opportunities created by<br />

<strong>Unilever</strong>’s scale and scope, managing external relations at<br />

the corporate level and developing future leaders.


Corporate governance<br />

It generally meets formally every two or three weeks and<br />

is chaired, alternately, by the Chairmen <strong>of</strong> NV and PLC. It<br />

also meets with specific Business Groups and Corporate<br />

Centre departments. The Committee is supplied with<br />

information by the Executive Committee Secretariat.<br />

Audit Committee The Audit Committee normally<br />

comprises three Advisory Directors and meets at least<br />

twice a year. Since 4 May 1999 it has been chaired by<br />

Hilmar Kopper, and its other members have been Claudio<br />

X Gonzalez and Onno Ruding. It reviews financial<br />

statements before publication and oversees financial<br />

reporting and control arrangements. The head <strong>of</strong> our<br />

internal audit function and our external auditors attend<br />

the Committee’s meetings and have direct access to its<br />

Chairman. The Chief Auditor ensures that the Committee<br />

is supplied with necessary information.<br />

External Affairs and Corporate Relations Committee<br />

The External Affairs and Corporate Relations Committee<br />

usually comprises three Advisory Directors and normally<br />

meets four times a year. Since 4 May 1999 it has been<br />

chaired by Lady Chalker, and its other members have been<br />

Oscar Fanjul and Senator George Mitchell. It advises on<br />

external matters <strong>of</strong> relevance to the business – including<br />

issues <strong>of</strong> corporate social responsibility – and reviews our<br />

corporate relations strategy. The Committee is supplied<br />

with necessary information by the Head <strong>of</strong> the Corporate<br />

Relations Department.<br />

Nomination Committee The Nomination Committee<br />

comprises three Advisory Directors and the Chairmen <strong>of</strong><br />

NV and PLC and meets at least once a year. Since 4 May<br />

1999 it has been chaired by Frits Fentener van Vlissingen<br />

and its other members have been Sir Derek Birkin,<br />

Bertrand Collomb, Antony Burgmans and Niall FitzGerald.<br />

It recommends to the Boards candidates for the positions<br />

<strong>of</strong> Director, Advisory Director and Executive Committee<br />

member. The Committee is supplied with information by<br />

the Joint Secretaries.<br />

Remuneration Committee The Remuneration Committee<br />

normally comprises three Advisory Directors and meets at<br />

least twice a year. Since 4 May 1999 it has been chaired<br />

by Frits Fentener van Vlissingen, and its other members<br />

have been Sir Derek Birkin and Bertrand Collomb. It<br />

reviews our executive remuneration and is responsible for<br />

the Executive Share Option Scheme. The Committee<br />

determines specific remuneration packages for each <strong>of</strong> the<br />

directors. The Committee is supplied with information by<br />

the Head <strong>of</strong> the Private Administration Department.<br />

Routine business committees Committees are set up to<br />

conduct routine business as and when they are necessary.<br />

They comprise any two <strong>of</strong> the directors and certain senior<br />

executives. They administer certain matters previously<br />

agreed by the Boards or the Executive Committee.<br />

The Joint Secretaries are responsible for the operation<br />

<strong>of</strong> these committees.<br />

All committees are formally set up by Board resolution<br />

with carefully defined remits. They report regularly and<br />

are responsible to the Boards <strong>of</strong> NV and PLC.<br />

Executive Committee <strong>of</strong> the Boar d<br />

Antony Burgmans*<br />

Chairman, <strong>Unilever</strong> N.V.<br />

Aged 53. Chairman <strong>of</strong> <strong>Unilever</strong> N.V. and Vice-Chairman<br />

<strong>of</strong> <strong>Unilever</strong> PLC since 4 May 1999. Joined <strong>Unilever</strong> 1972.<br />

Appointed director 8 May 1991. Previous posts include:<br />

Personal Products Co-ordinator 91/94. Responsible for South<br />

European Foods business 94/96. Business Group President, Ice<br />

Cream & Frozen Foods – Europe and Chairman <strong>of</strong> <strong>Unilever</strong><br />

Europe Committee 96/98. Vice-Chairman <strong>of</strong> <strong>Unilever</strong> N.V.<br />

1998. Member, Supervisory Board <strong>of</strong> ABN AMRO Bank N.V.<br />

Niall FitzGerald*<br />

Chairman, <strong>Unilever</strong> PLC<br />

Aged 54. Chairman <strong>of</strong> <strong>Unilever</strong> PLC and Vice-Chairman <strong>of</strong><br />

<strong>Unilever</strong> N.V. since 7 May 1996. Joined <strong>Unilever</strong> 1967. Appointed<br />

director 20 May 1987. Previous posts include: Financial Director<br />

87/89. Edible Fats & Dairy Co-ordinator 89/90. Member, Foods<br />

Executive 89/91. Detergents Co-ordinator 91/95. Member<br />

<strong>of</strong> Special Committee 1996.<br />

Clive Butler*<br />

Category Director, Home & Personal Care<br />

Aged 53. Category Director, Home & Personal Care since 1996.<br />

Joined <strong>Unilever</strong> 1970. Appointed director 6 May 1992. Previous<br />

posts include: Corporate Development Director 1992. Personnel<br />

Director 93/96. Non-executive director <strong>of</strong> Lloyds TSB Group plc.<br />

Patrick Cescau*<br />

Financial Director<br />

Aged 51. Financial Director since 1999. Joined <strong>Unilever</strong> 1973.<br />

Appointed director 4 May 1999. Previous posts include:<br />

Chairman, Indonesia 91/95. President, Van den Bergh Foods, USA<br />

95/97. President, Lipton, USA 97/98. Controller and Deputy<br />

Financial Director 98/99.<br />

Alexander Kemner*<br />

Category Director, Foods<br />

Aged 60. Category Director, Foods since 1996. Joined <strong>Unilever</strong><br />

1966. Appointed director 3 May 1989. Previous posts include:<br />

Food & Drinks Co-ordinator 89/90. Member, Foods Executive<br />

89/92. Regional Director, East Asia & Pacific 93/96.<br />

Rudy Markham*<br />

Strategy & Technology Director<br />

Aged 53. Strategy & Technology Director since 1998. Joined<br />

<strong>Unilever</strong> 1968. Appointed director 6 May 1998. Previous posts<br />

include: Business Group President, North East Asia 96/98.


Corporate governance<br />

Jan Peelen*<br />

Personnel Director<br />

Aged 60. Personnel Director since 1996. Joined <strong>Unilever</strong> 1966.<br />

Appointed director 20 May 1987. Retiring 2000. Previous posts<br />

include: Regional Director, East Asia & Pacific 87/92. Chairman,<br />

Foods Executive 93/96. Chairman, Supervisory Board <strong>of</strong> VVAA<br />

Groep B.V. and Member, Supervisory Board <strong>of</strong> Buhrmann N.V.<br />

since 1999.<br />

Business Group Presidents<br />

Roy Brown*<br />

Food & Beverages – Europe<br />

Aged 53. Joined <strong>Unilever</strong> 1974. Appointed director 6 May 1992.<br />

Appointed Business Group President 1996. Chairman <strong>of</strong> <strong>Unilever</strong><br />

Europe Committee since 1998. Previous position: Regional<br />

Director, Africa & Middle East and Central & Eastern Europe<br />

and responsible for Plantations and Plant Science Group.<br />

Non-executive director <strong>of</strong> GKN plc.<br />

Robert Polet<br />

Ice Cream & Frozen Foods – Europe<br />

Aged 44. Joined <strong>Unilever</strong> 1978. Appointed Business Group President<br />

1998. Previous position: Executive Vice-President for Ice Cream &<br />

Frozen Foods – Europe.<br />

Richard Goldstein<br />

Foods – North America<br />

Aged 58. Joined <strong>Unilever</strong> 1975. Appointed Business Group President<br />

1996. Previous position: President & CEO, <strong>Unilever</strong> United States<br />

(in which position he continues) and Chairman & CEO, <strong>Unilever</strong><br />

Canada Ltd. Mr Goldstein will be resigning from <strong>Unilever</strong> on<br />

1 June 2000.<br />

John Sharpe<br />

Home & Personal Care – Europe<br />

Aged 58. Joined <strong>Unilever</strong> 1963. Appointed Business Group President<br />

1996. Previous position: CEO, Lever Europe.<br />

Charles Strauss<br />

Home & Personal Care – North America<br />

Aged 57. Joined <strong>Unilever</strong> 1986 upon <strong>Unilever</strong>’s acquisition <strong>of</strong><br />

Ragú Foods. Appointed Business Group President 1996. Previous<br />

position: Business Group President, Latin America 96/99.<br />

Çetin Yüceulu g˘<br />

DiverseyLever<br />

Aged 54. Joined <strong>Unilever</strong> 1973. Appointed Business Group Pre s i d e n t<br />

1996. Previous position: CEO, Lever Industrial International.<br />

Manfred Stach<br />

Africa<br />

Aged 57. Joined <strong>Unilever</strong> 1970. Appointed Business Group President<br />

1998. Previous position: Chairman, Union Deutsche<br />

Lebensmittelwerke GmbH and National Manager, Germany.<br />

Jeff Fraser<br />

Central Asia & Middle East<br />

Aged 56. Joined <strong>Unilever</strong> 1967. Appointed Business Group President<br />

1996. Previous position: Operations Member, Latin America<br />

& Central Asia.<br />

Jean Martin<br />

Central & Eastern Europe<br />

Aged 55. Joined <strong>Unilever</strong> 1968. Appointed Business Group President<br />

1996. Previous position: CEO, Personal Products in Europe.<br />

Bruno Lemagne<br />

China<br />

Aged 53. Joined <strong>Unilever</strong> 1972. Appointed Business Group President<br />

1998. Previous position: Chairman, <strong>Unilever</strong> (China) Limited.<br />

André van Heemstra<br />

East Asia Pacific<br />

Aged 54. Joined <strong>Unilever</strong> 1970. Appointed Business Group President<br />

1996. Previous position: Chairman, Langnese-Iglo GmbH.<br />

Ralph Kugler<br />

Latin America<br />

Aged 44. Joined <strong>Unilever</strong> 1979. Appointed Business Group President<br />

1999. Previous position: Executive Vice-President, Latin America.<br />

Robert Phillips*<br />

Prestige Personal Products<br />

Aged 61. Joined <strong>Unilever</strong> 1986 upon <strong>Unilever</strong>’s acquisition <strong>of</strong><br />

Chesebrough-Pond’s. Appointed director 3 May 1995. Appointed<br />

Business Group President 1996. Chairman <strong>of</strong> <strong>Unilever</strong> North<br />

America Committee since 1996. Retiring 2000. Previous position:<br />

Business Group President, Home & Personal Care – North<br />

America 96/99.<br />

* <strong>Unilever</strong> Board member<br />

Advisory Directors<br />

Sir Derek Birkin TD<br />

Aged 70. Appointed 1993. Retiring 2000. Chairman, Tunnel<br />

Holdings 75/82. Director, RTZ Corporation 82/96, CEO 85/91 and<br />

Chairman 91/96. Director, Merchants Trust 86/99. Director,<br />

Carlton Communications Plc and Merck & Co. Inc. since 1992.<br />

Baroness Chalker <strong>of</strong> Wallasey<br />

Aged 57. Appointed 1998. Member <strong>of</strong> Parliament for Wallasey<br />

74/92. Created a life peer in 1992. Minister <strong>of</strong> State at the<br />

Foreign and Commonwealth Office 86/97. Director, Freeplay<br />

Energy Ltd and Capital Shopping Centres PLCsince 1997 and<br />

Landell Mills Ltd since 1999.<br />

Bertrand Collomb<br />

Aged 57. Appointed 1994. French government administrator<br />

66/75. Lafarge Group since 1975. Chairman and CEO, Lafarge<br />

since 1989. Member, European Round Table <strong>of</strong> Industrialists.<br />

Chairman, Institut de l’Entreprise. Director, Elf Aquitaine since<br />

1994. Member, Supervisory Board, Allianz AG since 1998.<br />

Oscar Fanjul<br />

Aged 50. Appointed 1996. Secretary General and Under<br />

Secretary, Spanish Ministry <strong>of</strong> Industry and Energy 83/85.<br />

Chairman, Instituto Nacional de Hidrocarburos 85/95. Chairman<br />

and CEO Repsol 86/96 and Honorary Chairman since 1996.<br />

Director <strong>of</strong> Ericsson, S.A. since 1996, Tecnicas Reunidas, S.A. and<br />

Chairman, C<strong>of</strong>ir, S.A. 97/99. Member <strong>of</strong> the International<br />

Advisory Boards <strong>of</strong> the Chubb Corporation and Marsh McLennan.<br />

Frits Fentener van Vlissingen<br />

Aged 66. Appointed 1990. Member, Executive Board, SHV<br />

Holdings N.V. 67/75, and Chairman, 75/84. Managing Director,<br />

Flint Holding N.V. since 1984. Member, Supervisory Board,<br />

Amsterdam-Rotterdam Bank 74/91, ABN AMRO Bank N.V. since<br />

1991 and Akzo Nobel N.V. since 1984.


Corporate governance<br />

Claudio X Gonzalez<br />

Aged 65. Appointed 1998. Special Advisor to the President <strong>of</strong><br />

Mexico 88/94. Chairman and CEO Kimberly-Clark de Mexico since<br />

1973. Dire c t o r, Kimberly-Clark Corp. since 1976, Kellogg Company<br />

since 1989 and General Electric Company (USA) since 1993.<br />

Hilmar Kopper<br />

Aged 64. Appointed 1998. Director, Deutsche Bank 77/97, CEO<br />

89/97 and Chairman, Supervisory Board, since 1997. Member,<br />

Supervisory Board, Bayer AG since 1988, Akzo Nobel N.V. since<br />

1990 and DaimlerChrysler AG (Chairman) since 1998. Director<br />

<strong>of</strong> Xerox Corp. since 1999.<br />

Senator George J Mitchell<br />

Aged 66. Appointed 1998. Member <strong>of</strong> the US Senate 80/95 and<br />

Senate Majority Leader 88/95. Member <strong>of</strong> the law firm Verner,<br />

Liipfert, Bernhard, McPherson and Hand since 1995. Chairman <strong>of</strong><br />

the Northern Ireland Peace Initiative 95/99. Director, Walt Disney<br />

Company, Federal Express Corp., Xerox Corp. and UNUM<br />

Insurance Corp. since 1995 and Staples, Inc. since 1998.<br />

Onno Ruding<br />

Aged 60. Appointed 1990. Member <strong>of</strong> Board, Amsterdam-<br />

Rotterdam Bank 81/82. Minister <strong>of</strong> Finance, the Netherlands<br />

82/89. Chairman, Netherlands Christian Federation <strong>of</strong> Employers<br />

90/92. Vice-Chairman and Director, Citibank since 1992. Director<br />

<strong>of</strong> Corning Inc. since 1999.<br />

Honorary Advisory Director<br />

The Rt Hon The Viscount Leverhulme KG TD<br />

Aged 84. Grandson <strong>of</strong> William Lever, the founder <strong>of</strong> Lever<br />

Brothers. Appointed Honorary Advisory Director <strong>of</strong> PLC for life<br />

on his retirement as an Advisory Director in 1985.<br />

Corporate Officers<br />

Jos Westerburgen<br />

Joint Secretary<br />

Aged 57. Appointed 4 May 1988.<br />

Years <strong>of</strong> service on 31 December 1999: 16.<br />

Stephen Williams<br />

Joint Secretary<br />

Aged 52. Appointed 1 December 1986.<br />

Years <strong>of</strong> service on 31 December 1999: 13.<br />

Jeffrey Allgrove<br />

Controller<br />

Aged 47. Appointed 4 May 1999.<br />

Years <strong>of</strong> service on 31 December 1999: 22.<br />

Jan Haars<br />

Treasurer<br />

Aged 48. Appointed 1 August 1997.<br />

Years <strong>of</strong> service on 31 December 1999: 2.<br />

Board changes<br />

Mr Jan Peelen and Mr Bob Phillips retired in May 2000<br />

and their colleagues wish to record their appreciation <strong>of</strong><br />

their contributions to <strong>Unilever</strong>.<br />

Mr Jan Peelen has served <strong>Unilever</strong> for 33 years, 12 <strong>of</strong><br />

them as a director. After a period as Chairman <strong>of</strong> the<br />

Foods Executive, he has been Personnel Director. Mr Bob<br />

Phillips joined <strong>Unilever</strong> in 1986 upon the acquisition <strong>of</strong><br />

Chesebrough-Pond’s, was appointed a director in 1995,<br />

and has spent most <strong>of</strong> his <strong>Unilever</strong> career concerned with<br />

Personal Products, mainly in North America.<br />

All existing directors retired from <strong>of</strong>fice, in accordance<br />

with the Articles <strong>of</strong> Association <strong>of</strong> NV and PLC, at the<br />

Annual General <strong>Meeting</strong>s on 3 May 2000 and, with the<br />

exceptions <strong>of</strong> Mr Jan Peelen and Mr Bob Phillips, <strong>of</strong>fered<br />

themselves for re-election and were duly re-elected.<br />

As already announced, Mr Keki Dadiseth, Mr André van<br />

Heemstra and Mr Charles Strauss <strong>of</strong>fered themselves for<br />

election at the Annual General <strong>Meeting</strong>s on 3 May 2000.<br />

They were duly elected. Mr Dadiseth and Mr van<br />

Heemstra become members <strong>of</strong> the Executive Committee;<br />

Mr Dadiseth to undertake a review <strong>of</strong> the top organisation<br />

<strong>of</strong> <strong>Unilever</strong> and Mr van Heemstra to succeed Mr Jan<br />

Peelen as Personnel Director. Mr Strauss succeeds Mr Bob<br />

Phillips as Chairman <strong>of</strong> the North America Committee,<br />

while continuing as President <strong>of</strong> the Home & Personal<br />

Care North America Business Group.<br />

Mr Keki Dadiseth is aged 54 and joined the <strong>Unilever</strong><br />

Group in 1973. He became Chairman <strong>of</strong> Hindustan Lever<br />

Limited in 1993; having previously worked for the<br />

Overseas Committee in London and then been responsible<br />

in India at various times for personnel, personal products,<br />

mergers and acquisitions, and detergents.<br />

Brief biographies <strong>of</strong> Mr van Heemstra and Mr Strauss can<br />

be found in ‘Business Group Presidents’ on page 45.<br />

At the Annual General <strong>Meeting</strong>s on 4 May 1999,<br />

Mr Patrick Cescau was elected a director and became<br />

Financial Director and a member <strong>of</strong> the Executive<br />

Committee. Mr J Allgrove succeeded him as Controller.<br />

Mr Morris Tabaksblat and Mr Hans Eggerstedt duly retired<br />

as directors at those meetings and Mr Antony Burgmans<br />

became Chairman <strong>of</strong> NV and Vice-Chairman <strong>of</strong> PLC.<br />

Advisory Directors’ changes<br />

Sir Derek Birkin retired as an Advisory Director with effect<br />

from the Annual General <strong>Meeting</strong>s in 2000. The directors<br />

wish to record their appreciation <strong>of</strong> his substantial


Corporate governance<br />

contribution during the past seven years, particularly while<br />

a member <strong>of</strong> the Nomination and Remuneration<br />

Committees.<br />

The Rt Hon The Lord Brittan <strong>of</strong> Spennithorne QC<br />

was appointed as an Advisory Director with effect from<br />

1 May 2000 until the Annual General <strong>Meeting</strong>s in 2003.<br />

Lord Brittan was a member <strong>of</strong> the UK Government, as<br />

Home Secretary and as Secretary <strong>of</strong> State for Trade and<br />

Industry, and, between 1989 and 1999, <strong>of</strong> the European<br />

Commission, where he became a Vice-President,<br />

his responsibilities having included competition and<br />

trade policy.<br />

The Boards have resolved to re-appoint Mr Bertrand<br />

Collomb as an Advisory Director, also until the Annual<br />

General <strong>Meeting</strong>s in 2003.<br />

Sir Brian Hayes and Lord Wright <strong>of</strong> Richmond retired<br />

at the Annual General <strong>Meeting</strong>s on 4 May 1999.<br />

Requirements in the Netherlands and the UK<br />

A vital factor in the arrangements between NV and PLC<br />

is their having the same directors. As the concept <strong>of</strong> the<br />

non-executive director, as recognised in the United<br />

Kingdom, is not a feature <strong>of</strong> corporate governance in the<br />

Netherlands, and the Supervisory Board, as recognised in<br />

the Netherlands, is unknown in the United Kingdom, it is<br />

not practicable to appoint supervisory or non-executive<br />

directors who could serve on both Boards. However, a<br />

strong independent element has long been provided by<br />

<strong>Unilever</strong>’s Advisory Directors, who perform many <strong>of</strong> the<br />

functions <strong>of</strong> supervisory and non-executive directors.<br />

The Audit, External Affairs and Corporate Relations and<br />

Remuneration Committees consist exclusively <strong>of</strong> Advisory<br />

Directors and the majority <strong>of</strong> the members <strong>of</strong> the<br />

Nomination Committee are Advisory Directors. See page<br />

44 for details.<br />

The Committee on Corporate Governance in the<br />

Netherlands issued its report ‘Recommendations on<br />

Corporate Governance in the Netherlands’ in 1997.<br />

NV applies the Committee’s recommendations for<br />

supervisory directors to its Advisory Directors in so far<br />

as these are in line with their specific role within <strong>Unilever</strong>.<br />

NV complies with all other recommendations <strong>of</strong> the<br />

Committee, except that the Board <strong>of</strong> Directors takes the<br />

view that requests for an item to be placed on the agenda<br />

for a shareholders’ meeting must be supported by more<br />

than an insignificant proportion <strong>of</strong> the shareholders and<br />

will therefore only accept requests from a shareholder or<br />

group <strong>of</strong> shareholders holding at least 1% <strong>of</strong> the voting<br />

rights attaching to the issued share capital <strong>of</strong> NV. Requests<br />

must be submitted, at the latest, 60 days prior to the date<br />

<strong>of</strong> the meeting.<br />

PLC is required, as a company that is incorporated in the<br />

United Kingdom and listed on the London Stock<br />

Exchange, to state how it has applied the principles and<br />

how far it has complied with the provisions set out in<br />

Section 1 <strong>of</strong> the Combined Code (‘the Code’) appended<br />

to the Listing Rules <strong>of</strong> the London Stock Exchange.<br />

As already explained, the Boards control the Company<br />

through the Executive Committee. Responsibilities are<br />

s h a red by the Chairmen <strong>of</strong> NV and PLC, while the Advisory<br />

D i rectors perform many <strong>of</strong> the functions <strong>of</strong> the supervisory<br />

board members or non-executive directors, although they<br />

are not formally members <strong>of</strong> the Boards. For the purposes<br />

<strong>of</strong> the Code, the Boards have not appointed a senior<br />

independent director, on the basis that issues for the<br />

Boards can be raised with whichever Advisory Director is<br />

the Chairman <strong>of</strong> the relevant Board Committee and the<br />

Advisory Directors are entitled to meet as a body and<br />

appoint a senior member as their spokesman.<br />

<strong>Unilever</strong>’s remuneration policy is contained within the<br />

report by the Boards on the directors’ remuneration and<br />

interests on pages 49 to 59. This also deals with any noncompliance<br />

with the Code in this area. Members <strong>of</strong> the<br />

Audit, Remuneration and Nomination Committees will be<br />

available to answer questions at the Annual General<br />

<strong>Meeting</strong>s <strong>of</strong> both NV and PLC. The members attending<br />

each meeting will not necessarily include the Chairman <strong>of</strong><br />

the Committee, since these meetings take place at about<br />

the same time in Rotterdam and London respectively.<br />

A description <strong>of</strong> <strong>Unilever</strong>’s compliance with ‘Internal<br />

Control – Guidance for Directors on the Combined Code’<br />

is given on page 60.<br />

<strong>Unilever</strong> has, since its inception, adopted the principle that<br />

it is good practice that the most senior roles in NV and<br />

P L C are shared and not concentrated in one person.<br />

As a consequence it is a principal tenet <strong>of</strong> its governance<br />

philosophy, which finds expression in two <strong>people</strong> who<br />

each combine the roles <strong>of</strong> Chairman and Chief Executive<br />

and who meet regularly for joint decision making. This<br />

carefully balanced arrangement has served <strong>Unilever</strong>’s<br />

unique constitutional arrangements very well for many<br />

years and the Boards believe that to separate these roles<br />

would only introduce undesirable and unnecessary<br />

complexity. Since the Advisory Directors are not formally<br />

members <strong>of</strong> the Boards, it would be inappropriate for one<br />

<strong>of</strong> them to act as Chairman. In all other respects, PLC has<br />

complied with the Code throughout 1999.


Corporate governance<br />

Shareholder relations<br />

We believe it is important to both explain the business<br />

developments and financial results to shareholders and<br />

to understand the objectives <strong>of</strong> investors. Within the<br />

Executive Committee, the Financial Director has lead<br />

responsibility for investor relations, with the active<br />

involvement <strong>of</strong> the Chairmen. They are supported by<br />

an Investor Relations Department which organises<br />

presentations for analysts and institutional investors,<br />

mainly held in Europe and North America.<br />

Both NV and PLC communicate with their shareholders<br />

through the Annual General <strong>Meeting</strong>s. At the AGMs,<br />

both Chairmen give a full account <strong>of</strong> the progress <strong>of</strong> the<br />

business over the last year and a review <strong>of</strong> the current<br />

issues. A summary <strong>of</strong> their addresses is published on our<br />

web site and released to stock exchanges and media.<br />

Copies are freely available on request.<br />

Our Chairmen, both in communications about the Annual<br />

General <strong>Meeting</strong>s and at the actual meetings, encourage<br />

shareholders to attend and to ask questions. Question and<br />

answer sessions form an important part <strong>of</strong> the meetings in<br />

both the Netherlands and the United Kingdom. We are<br />

committed to efforts to establish more effective ways <strong>of</strong><br />

shareholder communication. We actively participate in the<br />

Shareholders Communication Channel which has been set<br />

up by a group <strong>of</strong> Dutch companies in order to facilitate<br />

direct communications with shareholders who are<br />

otherwise unknown to them. The Shareholders<br />

Communication Channel will also be used to facilitate<br />

proxy voting in the Netherlands.<br />

Reporting to shareholders<br />

The directors’ responsibilities are set out formally on<br />

page 60. These cover Annual accounts, Going concern<br />

and Internal control. The report to shareholders on<br />

directors’ remuneration and interests is set out on<br />

pages 49 to 59.<br />

The responsibility <strong>of</strong> the auditors to report on these<br />

matters is set out on page 61.


49 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Remuneration <strong>of</strong> Directors and Executive Officers<br />

The aggregate amount <strong>of</strong> remuneration paid by the<br />

<strong>Unilever</strong> Group to all directors and executive <strong>of</strong>ficers for<br />

services in all capacities during 1999 was Fl. 28 198 932.<br />

The aggregate amount set aside by the <strong>Unilever</strong> Group<br />

during 1999 to provide pension, retirement or similar<br />

benefits for directors and executive <strong>of</strong>ficers was<br />

Fl. 6 701 246.<br />

Policy: directors’ emoluments<br />

The objective <strong>of</strong> <strong>Unilever</strong>’s remuneration policy for<br />

directors is to motivate and retain top class business<br />

<strong>people</strong> able to direct and lead a large global company,<br />

and to reward them accordingly.<br />

The Remuneration Committee believes that the level <strong>of</strong><br />

remuneration <strong>of</strong> Dutch or British directors resident in their<br />

home countries should be in line with that <strong>of</strong> executive<br />

directors <strong>of</strong> major international industrial companies based<br />

in the Netherlands and the United Kingdom respectively,<br />

who have similar responsibilities to a <strong>Unilever</strong> director<br />

whilst recognising <strong>Unilever</strong>’s size and special features. The<br />

levels <strong>of</strong> remuneration <strong>of</strong> the Chairmen and the members<br />

<strong>of</strong> the Executive Committee take into account their special<br />

responsibilities and provide differentials comparable to<br />

those found in other major international industrial<br />

companies. A director who is not resident in his home<br />

country is paid at the level <strong>of</strong> remuneration appropriate<br />

to his place <strong>of</strong> residence if this is higher than that in his<br />

home country. Directors not <strong>of</strong> Dutch or British nationality<br />

are, in principle, to be no worse <strong>of</strong>f than they would be<br />

if based in their home country in a job <strong>of</strong> comparable<br />

importance.<br />

Levels <strong>of</strong> remuneration are reviewed annually by the<br />

Remuneration Committee in the light <strong>of</strong> external expert<br />

advice which assesses competitive levels <strong>of</strong> remuneration<br />

in the largest companies relevant to the residence <strong>of</strong> the<br />

group <strong>of</strong> <strong>Unilever</strong> directors concerned. Comparison is<br />

also made with the remuneration <strong>of</strong> other employees<br />

within <strong>Unilever</strong>.<br />

The Remuneration Committee’s policy is to seek to link<br />

reward closely to performance by using merit pay<br />

increases and bonuses based on both corporate and<br />

personal performance.<br />

NV and PLC and their group companies constitute a single<br />

group. It is therefore the practice for directors to receive<br />

emoluments from both NV and PLC because they serve<br />

both companies. Emoluments, wherever stated, include<br />

payments from both NV and PLC. All emoluments and<br />

fees earned by directors from outside directorships and<br />

like sources are required to be paid to and are retained<br />

by <strong>Unilever</strong>.<br />

All directors’ emoluments, including those <strong>of</strong> the<br />

Chairmen, are made up <strong>of</strong> the following elements:<br />

(i) Salary:<br />

Salaries are fixed by the Remuneration Committee.<br />

They are usually fixed in the currency appropriate to the<br />

location, the Netherlands, United Kingdom or United<br />

States, where the director is based. On the same basis<br />

as other employees, directors receive an additional<br />

month’s salary in the year they complete 25 years’ service<br />

with <strong>Unilever</strong>.<br />

(ii) Allowances and value <strong>of</strong> benefits in kind:<br />

In appropriate cases, and usually in accordance with the<br />

same rules as apply to all qualifying employees, dire c t o r s<br />

receive allowances to help them meet expenses incurre d<br />

by virtue <strong>of</strong> their employment, for example, in re s p e c t<br />

o f relocation and consequential disturbance and<br />

education expenses. Certain <strong>of</strong> the London based<br />

d i rectors receive an allowance to take account <strong>of</strong> the<br />

f a c t that part <strong>of</strong> their remuneration is paid in the<br />

Netherlands. Benefits in kind are items such as a<br />

company car and medical insurance.<br />

(iii) Performance related payments:<br />

These arise primarily under an annual bonus scheme.<br />

Bonuses are set by the Remuneration Committee.<br />

The maximum cash bonus for directors is 40% <strong>of</strong> salary.<br />

Bonuses are based on achievement <strong>of</strong> a target or target<br />

range which may involve two measures <strong>of</strong> performance:<br />

(a)a corporate target; and<br />

(b)individual targets.<br />

The corporate target is based on the average <strong>of</strong> the<br />

increase in earnings per share expressed in guilders and<br />

in pounds sterling. The individual targets are based on<br />

previously agreed key objectives.<br />

Directors are given the opportunity to use 25% <strong>of</strong> their<br />

cash bonuses, during the year <strong>of</strong> payment, to purchase<br />

shares in NV and PLC and to be awarded shares <strong>of</strong><br />

equivalent value, upon condition that all the shares are<br />

retained for at least five years.


50 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Policy: directors’ pensions<br />

The aim <strong>of</strong> the Remuneration Committee is that pension<br />

and other related benefits should be in line with good<br />

practice by major companies in the Netherlands and the<br />

United Kingdom, bearing in mind the need to establish<br />

reasonable comparability between the conditions for the<br />

various nationalities <strong>of</strong> directors.<br />

All directors are members <strong>of</strong> the normal <strong>Unilever</strong> pension<br />

schemes. Because directors are paid by both NV and PLC,<br />

they participate in both the NV and PLC normal pension<br />

schemes. The NV scheme has been on a contribution<br />

holiday since 1990. The PLC scheme has been on a<br />

contribution holiday since January 1997.<br />

All directors are also members <strong>of</strong> their respective early<br />

retirement scheme, which provides an overall pension<br />

coverage inclusive <strong>of</strong> benefits under other <strong>Unilever</strong><br />

schemes. The current arrangements are that directors<br />

belong to either the NV or PLC scheme, depending on<br />

their contractual arrangements. NV finances the NV<br />

scheme and PLC finances the PLC scheme. Also, under<br />

the current arrangements, in order to equalise benefits<br />

amongst the directors, those directors who are members<br />

<strong>of</strong> the NV scheme and retire at normal retirement date,<br />

receive an additional lump sum amount equal to one<br />

year’s final pensionable pay. The benefits received by<br />

directors under these early retirement schemes are, in<br />

most other respects, the same as those generally provided<br />

for senior management.<br />

Under both the early retirement schemes, final<br />

pensionable pay takes into account the bonuses paid<br />

in the last three years prior to termination <strong>of</strong> service,<br />

subject to a maximum <strong>of</strong> 20% <strong>of</strong> pensionable pay.<br />

The Remuneration Committee believes that the policy <strong>of</strong><br />

allocating a significant part <strong>of</strong> directors’ emoluments to<br />

performance related payments instead <strong>of</strong> salary, whilst<br />

retaining control over the overall package <strong>of</strong> emoluments,<br />

should not affect the directors’ reasonable expectations <strong>of</strong><br />

a pension at a level that is in line with that provided by<br />

major companies in the Netherlands and the United<br />

Kingdom. The Committee does not agree with the<br />

recommendations <strong>of</strong> the Combined Code in this respect<br />

but continues to keep the development <strong>of</strong> best practice<br />

in respect <strong>of</strong> the pensionability <strong>of</strong> bonuses under review.<br />

Directors’ pensions: further information<br />

It is expected that the directors’ pensions will be regularly<br />

increased in payment and in deferment in line with the<br />

increase in the consumer price index in the country,<br />

the Netherlands or United Kingdom, to which the scheme<br />

in which they participate relates. These pension increases<br />

a re awarded at the discretion <strong>of</strong> NV or PLC, as appro p r i a t e ,<br />

although the schemes in the United Kingdom guarantee<br />

increases in line with retail price inflation, up to a<br />

maximum <strong>of</strong> 5% per annum.<br />

For directors in the NV early retirement scheme who are<br />

aged 55 or more, the immediate early retirement pension<br />

is shown. For the NV director who has not attained age<br />

55 by the year end, the pension payable under the normal<br />

NV scheme is shown payable from the age at which it is<br />

most valuable, while that payable under the normal PLC<br />

scheme is payable unreduced (partly discretionary and<br />

partly by right) from age 60, and subject to a 5% per<br />

annum reduction for each year that retirement precedes<br />

age 60.<br />

For directors in the PLC early retirement scheme, early<br />

retirement is possible from age 50 (or age 55 for PLC<br />

directors appointed after 1 January 1999), in which case<br />

the total accrued pension is reduced by 5% per annum<br />

for each year <strong>of</strong> early retirement prior to age 60.<br />

Dependants’ and children’s pensions are payable under<br />

the normal and early retirement schemes in each country.<br />

Under the NV normal and early retirement scheme, the<br />

spouse’s pension is 70% <strong>of</strong> the member’s pension, while<br />

under the PLC early retirement scheme, the spouse’s<br />

pension is 66.7% <strong>of</strong> the member’s retirement pension.<br />

Under the normal PLC scheme, the spouse’s pension is<br />

50% <strong>of</strong> the member’s pension.<br />

Where, for directors in the NV early retirement scheme,<br />

the early retirement pension is shown, this amount will be<br />

reduced at age 65 by an allowance, currently Fl. 25 801,<br />

corresponding to the State benefits payable. The pension<br />

may also be subject to minor adjustments to equalise<br />

social security benefits.<br />

Members may pay additional voluntary contributions.<br />

Neither the contributions nor the resulting benefits are<br />

included in the table <strong>of</strong> pension entitlements.


51 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Directors’ pensions<br />

The pension entitlements <strong>of</strong> directors are shown separately for those in the NV and PLC early retirement schemes.<br />

NV scheme (1)<br />

01111000000000000000<br />

Increase Total<br />

Age, at 31 Normal Contributions in accrued accrued<br />

December Retirement paid by pension pension at<br />

1999 Age (2) director during 31 December<br />

during 1999 1999 (3)(4) 1999 (4)<br />

yrs mths yrs mths Fl. Fl. Fl.<br />

011110000000 511§ 1111§ 511§ 1111§ 01111 01111 01111<br />

M Tabaksblat (5) 62 3 60 0 0 1 128 1 595 748<br />

A Burgmans (6) 52 11 60 0 0 117 369 765 256<br />

H Eggerstedt (7) 61 10 60 0 0 43 328 1 244 856<br />

A Kemner 60 3 60 0 0 156 562 1 033 251<br />

J Peelen 59 10 60 0 0 163 713 1 026 669<br />

01111000000000000000<br />

PLC scheme<br />

01111000000000000000<br />

Increase Total<br />

Age, at 31 Normal Contributions in accrued accrued<br />

December Retirement paid by pension pension at<br />

1999 Age (2) director during 31 December<br />

during 1999 1999 (3)(8) 1999 (8)<br />

yrs mths yrs mths £ £ £<br />

011110000000 511§ 1111§ 511§ 1111§ 01111 01111 01111<br />

N W A FitzGerald 54 4 60 9 0 56 979 510 474<br />

R D Brown 53 1 60 0 0 15 787 228 292<br />

A C Butler 53 6 60 0 0 21 948 260 272<br />

P J Cescau (9) 51 3 60 0 0 149 751 192 240<br />

R H P Markham 53 10 60 0 0 44 414 251 351<br />

R M Phillips (10) 61 6 60 0 0 42 392 556 723<br />

01111000000000000000<br />

(1) The NV early retirement scheme operates on the basis <strong>of</strong> a justifiable expectation and does not provide a vested deferred entitlement. Directors<br />

leaving before age 55 are not entitled to any benefit, while those terminating service at age 55 or older can expect to receive an immediate pension<br />

under the expectations <strong>of</strong> the scheme.<br />

(2) Normal Retirement Age is that established for the purposes <strong>of</strong> the respective early retirement scheme for the director, and generally does not<br />

coincide with the termination date <strong>of</strong> his employment under the terms <strong>of</strong> his service contracts (see ‘Service contracts’ on page 54).<br />

(3) The increase in accrued pension during the year excludes any increase for inflation over the year, and is shown on a consistent basis with the<br />

accrued pension at the end <strong>of</strong> the year. For directors retiring during the year, the accrued pension and its increase are based on the position when<br />

the director retired. For directors appointed during the year, the increase is based on the difference between the accrued pension at the end <strong>of</strong> the<br />

year and the accrued pension immediately prior to the appointment.<br />

(4) For directors in the NV early retirement scheme aged 55 and over, the accrued pension is the immediate annual pension payable under all <strong>Unilever</strong><br />

schemes. For the NV director under age 55, no pension is included in respect <strong>of</strong> the NV early retirement scheme and the accrued pension is that<br />

payable in total, under the normal <strong>Unilever</strong> schemes, ignoring any future inflationary increases. The accrued pension under the normal PLC scheme<br />

is payable from age 65, while the accrued pension under the normal NV scheme is shown payable from age 62, which is the age at which the most<br />

valuable retirement terms are provided, and includes temporary pensions converted to lifetime equivalent pensions. The additional lump sum <strong>of</strong> one<br />

year’s final pensionable pay, payable on normal retirement is excluded from these pensionable amounts. Amounts paid are disclosed separately in<br />

the year <strong>of</strong> retirement.<br />

(5) Retired during the year. In addition to the pension benefit shown, a lump sum amount <strong>of</strong> Fl. 2 640 000 was paid on retirement.<br />

(6) 88% <strong>of</strong> the total accrued pension at 31 December 1999 and 82% <strong>of</strong> the increase in accrued pension correspond to the normal NV scheme.<br />

(7) Retired during the year. In addition to the pension benefit shown, a lump sum amount <strong>of</strong> Fl. 2 058 000 was paid on retirement.<br />

(8) For the PLC scheme, the accrued pension shown is that which would be paid annually from Normal Retirement Age, based on service to<br />

31 December 1999, and includes benefits from all <strong>Unilever</strong> schemes. It does not include allowance for any future inflationary increases.<br />

(9) Elected on 4 May 1999. The accrued pension includes benefits (actuarially converted for consistency) under all <strong>Unilever</strong> Schemes and those earned,<br />

prior to appointment, under social security schemes.<br />

(10) The pension will be converted to US dollars upon retirement and will be increased in future to maintain US purchasing power.


52 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Directors’ emoluments<br />

The aggregate emoluments <strong>of</strong> the directors were as follows:<br />

01111000000000000000<br />

Fl. £<br />

111111111005 111111111005<br />

1999 1998 1999 1998<br />

01111000000011111111111011111 11011111 1011111 11011111<br />

Salary 15 878 902 15 819 554 4 747 056 4 809 837<br />

Allowances and value <strong>of</strong> benefits in kind 2 401 242 2 416 405 717 860 734 693<br />

Performance related payments 5 278 724 7 797 962 1 578 094 2 370 922<br />

1011111 11011111 1011111 11011111<br />

Total 23 558 868 26 033 921 7 043 010 7 915 452<br />

1011111 11011111 1011111 11011111<br />

Gains on exercise <strong>of</strong> share options (1) 2 585 849 8 008 505 773 049 2 434 936<br />

01111000000000000000<br />

The emoluments <strong>of</strong> the individual directors were as follows:<br />

01111000000000000000<br />

Allowances<br />

and value <strong>of</strong> Performance<br />

Salary<br />

benefits in<br />

kind<br />

related<br />

payments<br />

Total Total<br />

(1)<br />

Equivalent totals (10)<br />

1011111111011111<br />

1999 1998 1999 1998<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

Paid in guilders: Fl. Fl. Fl. Fl. Fl. £ £<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

M Tabaksblat (2) 916 667 87 280 264 642 1 268 589 3 272 891 379 249 995 102<br />

A Burgmans (3) 1 533 333 41 507 558 483 (9) 2 133 323 1 909 962 637 765 580 712<br />

A Kemner 1 420 000 35 838 495 617 (9) 1 951 455 1 858 548 583 395 565 080<br />

J Peelen 1 420 000 286 353 409 954 2 116 307 2 151 582 632 678 654 175<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

Paid in pounds sterling: £ £ £ £ £ Fl. Fl.<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

N W A FitzGerald (4) 750 000 118 550 284 525 (9) 1 153 075 1 116 333 3 857 037 3 671 620<br />

R D Brown 398 965 (7) 163 623 119 757 682 345 648 196 2 282 444 2 131 915<br />

A C Butler 400 000 41 191 153 230 (9) 594 421 839 497 1 988 338 2 761 106<br />

P J Cescau (5) 233 333 93 057 104 545 430 935 0 1 441 479 0<br />

H Eggerstedt (6) 228 750 6 872 66 040 301 662 702 795 1 009 059 2 311 491<br />

R H P Markham 375 000 42 158 139 713 (9) 556 871 363 972 1 862 733 1 197 104<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

Paid in US dollars: $ $ $ $ $ Fl. Fl.<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

R M Phillips 1 260 521 (8) 190 139 312 863 1 763 523 1 720 180 3 648 104 3 414 408<br />

00111111111111111111111011111 1011111 1011111 1011111 1011111 1011111 1011111<br />

£ £<br />

1011111 1011111<br />

1 090 614 1 038 129<br />

01111000000000000000<br />

(1) See pages 58 and 59.<br />

(2) Chairman <strong>of</strong> NV, retired on 31 May 1999.<br />

(3) Chairman <strong>of</strong> NV.<br />

(4) Chairman <strong>of</strong> PLC.<br />

(5) Elected on 4 May 1999.<br />

(6) Retired on 31 May 1999.<br />

(7) Includes 25 year service award <strong>of</strong> £33 965.<br />

(8) Includes 25 year service award <strong>of</strong> US $ 135 521.<br />

(9) Includes value <strong>of</strong> shares awarded under bonus scheme (see page 49).<br />

(10) Based on average rates for the year <strong>of</strong> £1 = Fl. 3.345, £1 = US $ 1.617, US $ 1 = Fl. 2.069 (1998: £1 = Fl. 3.289, £1 = US $ 1.657,<br />

US $ 1 = Fl. 1.985).<br />

For the years up to and including 1997, NV lent the amount <strong>of</strong> taxation charged on the grant <strong>of</strong> options under Dutch<br />

fiscal legislation to the recipients. Amounts are repaid when the options are exercised. At 31 December 1999 a total <strong>of</strong><br />

Fl. 1.0 million (1998: Fl. 1.1 million) was lent to the directors.<br />

No compensation for loss <strong>of</strong> <strong>of</strong>fice, payments for loss <strong>of</strong> <strong>of</strong>fice or other termination payments were paid to directors<br />

in 1999.


53 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Directors’ interests: share capital<br />

The interest in the share capitals <strong>of</strong> NV and PLC and their group companies <strong>of</strong> those who were directors at the end <strong>of</strong><br />

1999 and <strong>of</strong> their families were as shown in the tables below:<br />

01111000000000000000<br />

1 January 31 December<br />

11111001111110111100000005111111111101111 111011111<br />

NV (ordinary shares) Fl. 1 Fl. 1.12<br />

A Burgmans 856 6 920<br />

N W A FitzGerald 5 504 6 175<br />

A C Butler — 625<br />

A Kemner 870 1 454<br />

R H P Markham — 582<br />

J Peelen 894 798<br />

R M Phillips 8 694 7 762<br />

NV (preference shares) Fl. 0.10<br />

A Burgmans — 7 750<br />

A Kemner — 1 628<br />

J Peelen — 894<br />

PLC (ordinary shares) 1.25p 1.4p<br />

N W A FitzGerald 33 140 40 357<br />

175 632 840 (a) 156 815 034 (a)<br />

A Burgmans 17 894 20 627<br />

A C Butler 24 828 27 243<br />

A Kemner 14 684 18 605<br />

R H P Markham 43 140 43 246<br />

J Peelen 9 342 8 340<br />

R M Phillips 10 572 9 439<br />

Margarine Union (1930) Limited (shares)<br />

N W A FitzGerald 600 (a) 600 (a)<br />

01111000000000000000<br />

(a) Held jointly as a trustee <strong>of</strong> the Leverhulme Trust and the Leverhulme Trade Charities Trust with no beneficial interest.<br />

On 10 May 1999, <strong>Unilever</strong>’s share capital was consolidated on the basis <strong>of</strong> 100 new shares <strong>of</strong> Fl. 1.12 each for every<br />

112 existing NV shares <strong>of</strong> Fl. 1 each and 100 new shares <strong>of</strong> 1.4p each for every 112 existing PLC shares <strong>of</strong> 1.25p each.<br />

The directors, in common with other employees <strong>of</strong> PLC and its United Kingdom subsidiaries, have beneficial interests in<br />

the undermentioned NV and PLC ordinary shares acquired for the purpose <strong>of</strong> satisfying options granted under the PLC<br />

1985 Executive Share Option and Sharesave Schemes and the <strong>Unilever</strong> PLC International 1997 Executive Share Option<br />

Scheme.<br />

01111000000000000000<br />

1 January 31 December<br />

Fl. 1/1.25p Fl. 1.12/1.4p<br />

11111001111110111100000005111111111101111 111011111<br />

All directors – NV ordinary shares 551 802 —<br />

– PLC ordinary shares 39 623 389 42 492 210<br />

On election <strong>of</strong> P J Cescau as a director on 4 M a y 1999 the trusts held 42 129 131 PLC 1.25p shares and 1 099 623 NV Fl. 1 share s .<br />

01111000000000000000<br />

Further information, including details <strong>of</strong> the NV and PLC ordinary shares acquired by certain group companies in<br />

connection with other share option schemes, is given in note 20 on page 81.<br />

The only changes in the interests <strong>of</strong> the directors and their families in NV ordinary shares between 31 D e c e m b e r 1 9 9 9<br />

and 28 April 2000 were that:<br />

(i) A Burgmans acquired 1 050 NV ordinary shares pursuant to the annual bonus scheme;<br />

(ii) A C Butler acquired 962 NV ordinary shares pursuant to the annual bonus scheme;<br />

(iii) P J Cescau acquired 842 NV ordinary shares pursuant to the annual bonus scheme;<br />

(iv) N W A FitzGerald acquired 1 744 NV ordinary shares pursuant to the annual bonus scheme;<br />

(v) R H P Markham acquired 872 NV ordinary shares pursuant to the annual bonus scheme;<br />

(vi) J Peelen acquired and sold 37 396 NV shares through the exercise <strong>of</strong> options granted under the NV Executive Share<br />

Option Scheme.


54 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

The only changes in the interests <strong>of</strong> the directors and <strong>of</strong> their families in PLC ordinary shares between 31 December<br />

1999 and 28 April 2000 were that:<br />

(i) A Burgmans acquired 8 294 PLC ordinary shares pursuant to the annual bonus scheme;<br />

(ii) A C Butler acquired 7 604 PLC ordinary shares pursuant to the annual bonus scheme;<br />

(iii) P J Cescau acquired 6 654 PLC ordinary shares pursuant to the annual bonus scheme;<br />

(iv) N W A FitzGerald acquired 13 782 PLC ordinary shares pursuant to the annual bonus scheme;<br />

(v) N W A FitzGerald acquired 30 PLC ordinary shares;<br />

(vi) R H P Markham acquired 6 890 PLC ordinary shares pursuant to the annual bonus scheme;<br />

(vii) the holding <strong>of</strong> the <strong>Unilever</strong> Employee Share Trusts has reduced to 41 969 815 PLC ordinary shares.<br />

Service contracts<br />

NV and PLC’s Articles <strong>of</strong> Association require that at every<br />

Annual General <strong>Meeting</strong>, all the directors shall retire from<br />

<strong>of</strong>fice. All directors’ contracts <strong>of</strong> service with the <strong>Unilever</strong><br />

Group are generally terminated not later than the end <strong>of</strong><br />

the month in which the Annual General <strong>Meeting</strong> next<br />

before or after the director’s 62nd birthday occurs.<br />

Contracts are currently determinable by the employer at<br />

not less than two years’ notice. Formerly, contracts were<br />

determinable by the employer at not less than three years’<br />

notice. The Remuneration Committee believes that this<br />

change for existing directors has brought their service<br />

contracts into line with the arrangements for the existing<br />

directors <strong>of</strong> many peer group companies. The Committee<br />

has noted the recommendation in the Combined Code<br />

in favour <strong>of</strong> one year contracts but continues to be<br />

concerned to have regard to best practice, as well as legal<br />

entitlements upon termination, in both the Netherlands<br />

and the United Kingdom. Developments in both countries<br />

are kept under regular review with respect to existing<br />

directors and new appointments.<br />

The compensation payable to a director upon the<br />

termination <strong>of</strong> his service contract will be calculated in<br />

accordance with the law applicable. The directors have<br />

service contracts with both NV and PLC. The Remuneration<br />

Committee’s aim is always to deal fairly with cases <strong>of</strong><br />

termination whilst taking a robust line in minimising any<br />

such compensation. The Remuneration Committee has<br />

given due consideration to the re c o m m e n d a t i o n s<br />

c o n t a i n e d in the Combined Code regarding the merits <strong>of</strong><br />

providing explicitly in the directors’ contracts <strong>of</strong> service<br />

provisions relating to compensation commitments in the<br />

event <strong>of</strong> early termination. However, the companies have<br />

to take account <strong>of</strong> the law in the Netherlands that<br />

provides that, irrespective <strong>of</strong> what the service contract<br />

may say, the termination <strong>of</strong> employment for a reason<br />

other than misconduct or negligence entitles a long<br />

serving employee to compensation comparable to at least<br />

two years’ remuneration. The Committee will continue to<br />

keep its current practice under review.<br />

In 1999 three directors served for only part <strong>of</strong> the year.<br />

In 1998 two directors served for only part <strong>of</strong> the year.<br />

Advisory Directors<br />

The Advisory Directors are not formally members <strong>of</strong> the<br />

Boards <strong>of</strong> NV and PLC and are therefore excluded when<br />

reference is made to directors in the preceding text.<br />

The remuneration <strong>of</strong> the Advisory Directors is decided<br />

by the Boards. Advisory Directors receive an annual fee<br />

and are reimbursed expenses incurred in attending<br />

meetings. They do not receive any performance related<br />

bonuses, pension provisions, share options or other<br />

f o r m s <strong>of</strong> benefit.<br />

The annual fee paid in 1999 to each <strong>of</strong> B Collomb, O F a n j u l ,<br />

F H Fentener van Vlissingen, H Kopper and H O C R R u d i n g<br />

was Fl. 8 0 000 and to each <strong>of</strong> Sir D e re kBirkin, Lady Chalker<br />

<strong>of</strong> Wa l l a s e y, C X Gonzalez and Senator G J Mitchell was<br />

£ 2 7 500. Sir B r i a n Hayes and Lord Wright <strong>of</strong> Richmond<br />

re t i red during the year and each received fees <strong>of</strong> £9 424.<br />

At the end <strong>of</strong> 1999 the aggregate interest <strong>of</strong> the Advisory<br />

Directors in the share capital <strong>of</strong> NV and PLC were<br />

8 479 (1998: 8 375) ordinary shares <strong>of</strong> NV and 1 785<br />

(1998: 4 000) ordinary shares <strong>of</strong> PLC.<br />

Share options<br />

<strong>Unilever</strong> introduced share options for directors and other<br />

senior managers during 1985 in the United Kingdom and<br />

the Netherlands and for key employees in North America<br />

during 1992. Types <strong>of</strong> share options for employees<br />

generally were introduced during 1985 in the United<br />

Kingdom, 1991 in the Republic <strong>of</strong> Ireland and 1995 in<br />

the Netherlands and North America.


55 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Directors are generally entitled to share options on<br />

the same basis as other employees. They participate in<br />

the NV Employee Share Option Scheme and the PLC<br />

1985 Sharesave Scheme, which are all-employee<br />

schemes, and in the International 1997 Executive Share<br />

Option Scheme.<br />

The NV Employee Share Option Scheme was introduced<br />

in 1995 and is open to all employees in the Netherlands.<br />

The PLC 1985 Sharesave Scheme is open to all employees<br />

who work a minimum number <strong>of</strong> hours in the United<br />

Kingdom. The North American Employee Stock Purchase<br />

Plan was also introduced in 1995 and is open to all<br />

employees in the United States and Canada.<br />

Grants <strong>of</strong> share options to directors and other senior<br />

executives in 1999 were made under the International<br />

1997 Executive Share Option Scheme (the ‘International<br />

Scheme’) which was established after taking into account<br />

the guidelines and views <strong>of</strong> institutional investor<br />

committees. The International Scheme comprises the<br />

NV Executive Share Option Scheme, the <strong>Unilever</strong> PLC<br />

International 1997 Executive Share Option Scheme, the<br />

<strong>Unilever</strong> PLC 1985 Executive Share Option Scheme and<br />

the North American Executive Stock Option Plan. The<br />

Boards granted options to acquire a number <strong>of</strong> ordinary<br />

shares in NV and a number <strong>of</strong> ordinary shares in PLC <strong>of</strong><br />

approximately equal market value.<br />

The Boards have established benchmark grant levels (the<br />

‘normal allocation’) to assist in determining actual grant<br />

levels under the International Scheme. In accordance with<br />

the undertaking made at the time the International<br />

Scheme was introduced, the Remuneration Committee<br />

has reviewed these normal allocations and has determined<br />

that they continue to be in line with those awarded by<br />

companies in <strong>Unilever</strong>’s peer group. The actual level <strong>of</strong><br />

grant made to each individual, which is decided by the<br />

Boards, who are advised by the Remuneration Committee,<br />

is dependent on certain performance criteria, group and<br />

individual, which are set annually by the Boards and the<br />

Remuneration Committee. These criteria must be satisfied<br />

before an individual can be granted an option.<br />

The Group criterion for 1999 was that the Group’s<br />

earnings per share over the three financial years preceding<br />

the date <strong>of</strong> grant <strong>of</strong> any option should have cumulatively<br />

risen by at least 6% more than the rate <strong>of</strong> inflation. If it<br />

had not, no grants would have been made.<br />

Once the Group criterion had been met, each individual’s<br />

option grant varied according to the percentage increase,<br />

above the rate <strong>of</strong> inflation, <strong>of</strong> the Group’s earnings per<br />

share over the financial year preceding the date <strong>of</strong> grant.<br />

The level <strong>of</strong> grant would vary according to the amount<br />

<strong>of</strong> the percentage rise. The Remuneration Committee<br />

decided that for 1999 the targets and levels <strong>of</strong> grant<br />

would be:<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

Level <strong>of</strong> grant as percentage<br />

EPS achieved in prior year <strong>of</strong> normal allocation<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 10 0 0 1 1 1 1 1 1<br />

Inflation + less than 4% 0%<br />

Inflation + 4% 50%<br />

Inflation + 5% 75%<br />

Inflation + 6% 100%<br />

Inflation + 7% 125%<br />

Inflation + 8% or more 150%<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

The normal allocations in 1999 to which the percentages<br />

above would be applied were:<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

NV shares PLC shares<br />

111101111110111111111111011111 111111011111<br />

Chairmen 12 000 80 000<br />

Other directors 6 000 – 7 500 40 000 – 50 000<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

The price payable for each ordinary share under an option<br />

is not less than the closing price on the Stock Exchange<br />

Daily Official List on the date <strong>of</strong> grant. In normal<br />

circumstances, an option granted under the International<br />

Scheme may not be exercised earlier than three years after<br />

the date <strong>of</strong> grant.<br />

Participants are further incentivised by the grant <strong>of</strong><br />

‘premium options’. These are options granted to reward<br />

commitment and good performance over a five year<br />

period. The first premium options will be granted in 2002.<br />

To qualify for the grant <strong>of</strong> a premium option the Group<br />

must have performed well over the preceding five years<br />

and each individual must not have realised free cash from<br />

the exercise <strong>of</strong> options granted in the previous five years<br />

and must have received on average at least 100% <strong>of</strong> his<br />

normal allocation over the preceding five years. Premium<br />

options will be granted over 20% <strong>of</strong> the number <strong>of</strong><br />

shares subject to the individual’s initial grant <strong>of</strong> options<br />

under the scheme.<br />

Prior to 1997, options under the NV and PLC Executive<br />

Share Option Schemes were only granted if the<br />

Remuneration Committee was satisfied that there had<br />

been a sufficient improvement in the performance <strong>of</strong> the<br />

Group over the two to three years preceding the grant.<br />

The grant <strong>of</strong> options was discretionary. It was dependent<br />

on the Chairmen being satisfied that the grant was<br />

merited by the individual in the light <strong>of</strong> personal<br />

performance and potential for future contribution to the<br />

business. For the Boards, the Remuneration Committee<br />

had to be so satisfied. Options were phased in evenly over


56 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

a three year period. The maximum number <strong>of</strong> options<br />

depended on seniority. The maximum aggregate value <strong>of</strong><br />

the exercise prices <strong>of</strong> options that could be held at any<br />

one time was four times appropriate salary.<br />

Under the terms <strong>of</strong> options to acquire ordinary shares in<br />

NV, some individuals may be or have been granted the<br />

right to elect to receive the equivalent cash value instead<br />

<strong>of</strong> receiving shares on the exercise <strong>of</strong> their options.<br />

This right is rescindable by the company (NV or a wholly<br />

owned subsidiary <strong>of</strong> NV) which granted such options,<br />

while they remain unexercised. It is the general intention<br />

<strong>of</strong> the company that this right will remain extended where<br />

it may be unduly disadvantageous to an individual not to<br />

have such a right.<br />

Under the terms <strong>of</strong> the PLC Unapproved Share Option<br />

Scheme (formerly the PLC Expatriate Share Option<br />

Scheme), PLC has the right to substitute the equivalent<br />

cash value for any individual’s right to acquire shares on<br />

the exercise <strong>of</strong> their options. It is not PLC’s intention to<br />

exercise this right except in circumstances where it may<br />

be unduly disadvantageous to an individual were it not<br />

to do so. Accordingly, no amount has been charged<br />

as a compensation expense during the year ended<br />

31 December 1999 in respect <strong>of</strong> this scheme.<br />

The PLC Sharesave Scheme covers all directors <strong>of</strong> PLC and<br />

employees <strong>of</strong> its United Kingdom subsidiaries meeting<br />

minimum service and United Kingdom taxation residence<br />

requirements. Participants to whom options have been<br />

granted make monthly contributions to a savings scheme<br />

approved by the United Kingdom Treasury for this<br />

purpose. At the end <strong>of</strong> five years the proceeds from the<br />

savings scheme may be applied to obtain ordinary shares<br />

<strong>of</strong> PLC at a price which is not less than 90% <strong>of</strong> the<br />

market value <strong>of</strong> the shares on a specified date within<br />

a thirty day period ending with the date on which the<br />

options were granted.<br />

The <strong>Unilever</strong> Savings Related Share Option Scheme<br />

(Ireland) operated in a similar manner to the PLC<br />

Sharesave Scheme for employees <strong>of</strong> Group companies<br />

in the Republic <strong>of</strong> Ireland. Following a change in the law,<br />

options are no longer granted under this scheme.<br />

All directors <strong>of</strong> NV and all employees <strong>of</strong> <strong>Unilever</strong><br />

Nederland B.V. may participate in the share option scheme<br />

for employees in the Netherlands if they are on the payroll<br />

at the moment <strong>of</strong> grant. In respect <strong>of</strong> grants made in<br />

1995, 1996 and 1997 an employee also had to be a<br />

participant in the Save-As-You-Earn Scheme. For grants<br />

made in 1998 and subsequent years there was no<br />

requirement for employees to participate in the Save-As-<br />

You-Earn Scheme. The grant <strong>of</strong> share options takes place<br />

after a resolution to such effect has been adopted by the<br />

Board <strong>of</strong> <strong>Unilever</strong> Nederland B.V. The share options are<br />

granted at 100% <strong>of</strong> the market price at the moment <strong>of</strong><br />

the grant. Options granted prior to 1998 can be exercised<br />

during a period <strong>of</strong> five years from the date <strong>of</strong> grant.<br />

Options granted in 1998 and subsequent years can only<br />

be exercised on the fifth anniversary <strong>of</strong> the grant date.<br />

In 1998 and 1999 each participant was granted an option<br />

to acquire 50 NV share s .<br />

Under the <strong>Unilever</strong> North America 1999 Employee Stock<br />

Purchase Plans, employees meeting minimum service<br />

requirements are granted options to purchase shares <strong>of</strong><br />

NV at a special price, which is some 90% <strong>of</strong> the market<br />

price at the grant date, through a payroll deduction<br />

programme over a two year period.<br />

NV intends to meet the obligations under the NV options<br />

by transferring previously purchased shares to directors<br />

and employees as the options are exercised. Any excess <strong>of</strong><br />

cost over option price in respect <strong>of</strong> shares acquired for this<br />

purpose, together with any movement in the market value<br />

above option price in respect <strong>of</strong> shares not yet acquired<br />

for this purpose, is charged against the results over the<br />

vesting period. During the year ended 31 December 1999<br />

the maximum amount <strong>of</strong> this charge which could be<br />

regarded as compensatory, should all individuals with a<br />

right to receive cash as an alternative to shares exercise<br />

such a right, was less than Fl. 15 million.<br />

De D<strong>of</strong>fer B.V., a wholly owned subsidiary <strong>of</strong> NV, has<br />

acquired such number <strong>of</strong> NV shares as will be sufficient<br />

to satisfy the obligations <strong>Unilever</strong> United States, Inc. has<br />

incurred so far under the <strong>Unilever</strong> North America 1992<br />

Stock Option Plan and the <strong>Unilever</strong> North American 1999<br />

Employee Stock Purchase Plan. The excess <strong>of</strong> cost over the<br />

option price with respect to the shares acquired for this<br />

purpose is charged against results for the period.<br />

In 1990, the <strong>Unilever</strong> Employee Share Trust was<br />

established to purchase and hold ordinary shares <strong>of</strong> PLC<br />

to satisfy options granted under the PLC 1985 Sharesave<br />

Scheme and the PLC 1985 Executive Share Option<br />

Schemes. In 1995 the <strong>Unilever</strong> Employee Share Trust<br />

(Jersey) was established for the same purpose, and in<br />

1997 the powers <strong>of</strong> this trust were extended to enable<br />

it to purchase and hold shares <strong>of</strong> NV to satisfy options<br />

granted under the <strong>Unilever</strong> PLC International 1997<br />

Executive Share Option Scheme.


57 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

At 31 December 1999, the Trusts together held 42 492<br />

210 ordinary shares.<br />

In March 1998 the <strong>Unilever</strong> Qualifying Employee Share<br />

Ownership Trust was established to purchase and hold<br />

ordinary shares <strong>of</strong> PLC to satisfy options granted under<br />

the PLC 1985 Sharesave Scheme.<br />

Options held by directors and employees to acquire<br />

ordinary shares <strong>of</strong> NV and PLC at 31 December 1999 are<br />

shown in note 20 on page 81.<br />

For convenience and ease <strong>of</strong> presentation, the information<br />

on the directors’ share options and notional options is<br />

presented together on the next page.<br />

Options to purchase securities from Registrant <strong>of</strong> subsidiaries<br />

Options over the following number <strong>of</strong> shares were granted, exercised, forfeited or expired between 31 December 1999<br />

and 28 April 2000.<br />

0005111011110000000000011<br />

Granted Exercised, forfeited or expired<br />

10001111111 10011101111<br />

Shares <strong>of</strong> 1.4p Shares <strong>of</strong> Fl. 1.12 Shares <strong>of</strong> 1.4p Shares <strong>of</strong> Fl. 1.12<br />

00000000111111101111111 1101111111 101111111 1111101111<br />

PLC Sharesave Plan – n/a 2 687 922 n/a<br />

PLC Option Plans 3 235 100 495 050 169 613 1 250<br />

NV Option Plans 6 569 800 1 008 850 – 121 836<br />

NV Sharesave Plan n/a – n/a 9 856<br />

0005111011110000000000011<br />

Granted Exercised, forfeited or expired<br />

0000000011111110111111111110111111 10111111111111101111<br />

Shares <strong>of</strong> 1.4p Shares <strong>of</strong> 1.4p<br />

in the form <strong>of</strong> in the form <strong>of</strong><br />

American Shares <strong>of</strong> Fl. 1.12 American Shares <strong>of</strong> Fl. 1.12<br />

Depositary <strong>of</strong> the New York Depositary <strong>of</strong> the New York<br />

Receipts Registry Receipts Registry<br />

00000000111111101111111 1101111111 101111111 1111101111<br />

NA Option Plan 1 741 516 259 725 63 004 17 868<br />

NA Purchase Plan n/a – n/a 61 712<br />

0005111011110000000000011<br />

As at 28 April 2000 the directors and <strong>of</strong>ficers as a group held options to purchase the following ordinary shares:<br />

3 461 440 shares <strong>of</strong> 1.4p<br />

455 188 shares <strong>of</strong> Fl. 1.12<br />

194 828 shares <strong>of</strong> 1.4p in the form <strong>of</strong> American Depositary Receipts<br />

133 134 shares <strong>of</strong> Fl. 1.12 <strong>of</strong> the New York Registry


58 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

Options to acquire NV ordinary shares <strong>of</strong> Fl. 1.12 each and options to acquire PLC ordinary shares <strong>of</strong> 1.4p each were<br />

granted, exercised and held during 1999 as follows:<br />

0005111011110000000000011<br />

Options outstanding below Options outstanding above<br />

market price at end <strong>of</strong> year market price at end <strong>of</strong> year<br />

011111101111 0111111101111<br />

1 January 31 December Weighted Weighted<br />

Name Fl. 1/1.25p Granted (g) Exercised Fl. 1.12/1.4p Number average price Number average price<br />

000511101111 01111 11110 01111 01111 01111 011111 01111<br />

A Burgmans (a) 61 512 18 000 (2) 6 252 (6) 73 260 46 260 Fl. 64.42 27 000 Fl. 144.21<br />

(b) 122 50 (3) 0 172 72 Fl. 66.58 100 Fl. 133.64<br />

(c) 120 000 120 000 (4) 0 240 000 60 000 407p 180 000 593p<br />

(d) 2 904 0 0 2 904 0 0 2 904 594p<br />

N W A FitzGerald (a) 42 932 18 000 (2) 0 60 932 24 932 Fl. 84.37 36 000 Fl. 146.34<br />

(b) 50 50 (3) 0 100 0 0 100 Fl. 133.64<br />

(c) 635 392 120 000 (4) 0 755 392 515 392 315p 240 000 611p<br />

(d) 5 025 0 0 5 025 3 864 268p 1 161 594p<br />

R D Brown (a) 18 636 9 000 (2) 0 27 636 9 636 Fl. 91.95 18 000 Fl. 146.34<br />

(c) 166 180 60 000 (4) 0 226 180 106 180 364p 120 000 611p<br />

(d) 1 240 0 0 1 240 1 240 278p 0 0<br />

A C Butler (a) 25 450 11 250 (2) 0 36 700 14 200 Fl. 85.79 22 500 Fl. 146.34<br />

(b) 0 50 (3) 0 50 0 0 50 Fl. 140.27<br />

(c) 388 212 75 000 (4) 0 463 212 313 212 330p 150 000 611p<br />

(d) 4 652 0 0 4 652 4 652 371p 0 0<br />

P J Cescau (a) 20 250 (1) 0 0 20 250 0 0 20 250 Fl. 145.62<br />

(c) 135 000 (1) 0 0 135 000 0 0 135 000 605p<br />

(e) 45 000 (1) 0 0 45 000 45 000 US $ 38.84 0 0<br />

(f) 100 192 (1) 0 0 100 192 100 192 US $ 6.72 0 0<br />

A Kemner (a) 47 966 11 250 (2) 11 524 (7) 47 692 25 192 Fl. 73.54 22 500 Fl. 146.34<br />

(b) 122 50 (3) 0 172 72 Fl. 66.58 100 Fl. 133.64<br />

(c) 150 000 75 000 (4) 0 225 000 75 000 407p 150 000 611p<br />

(d) 6 440 0 0 6 440 6 440 268p 0 0<br />

R H P Markham (a) 51 082 11 250 (2) 0 62 332 39 832 Fl. 61.42 22 500 Fl. 146.34<br />

(b) 50 50 (3) 0 100 0 0 100 Fl. 133.64<br />

(c) 167 292 75 000 (4) 0 242 292 92 292 384p 150 000 611p<br />

(d) 0 3 283 (5) 0 3 283 0 0 3 283 514p<br />

J Peelen (a) 70 858 0 10 960 (8) 59 898 48 648 Fl. 66.80 11 250 Fl. 152.70<br />

(b) 122 50 (3) 0 172 72 Fl. 66.58 100 Fl. 133.64<br />

(c) 150 000 0 0 150 000 75 000 407p 75 000 668p<br />

(d) 5 025 0 0 5 025 3 864 268p 1 161 594p<br />

R M Phillips (a) 18 000 0 0 18 000 9 000 Fl. 94.30 9 000 Fl. 152.70<br />

(c) 457 928 0 0 457 928 397 928 315p 60 000 668p<br />

(e) 71 800 0 0 71 800 71 800 US $ 26.05 0 0<br />

000511101111 01111 11110 01111 01111 01111 011111 01111<br />

M Tabaksblat (a) 86 120 0 0 86 120 (9) 86 120 Fl. 63.96 0 0<br />

(c) 120 000 0 0 120 000 (9) 120 000 407p 0 0<br />

H Eggerstedt (a) 50 300 0 0 50 300 (9) 50 300 Fl. 62.53 0 0<br />

(c) 75 000 0 0 75 000 (9) 75 000 407p 0 0<br />

(d) 3 864 0 0 3 864 (9) 3 864 268p 0 0<br />

0005111011110000000000011<br />

(a) Number <strong>of</strong> NV shares the subject <strong>of</strong> options under the International Scheme.<br />

(b) NV Employee Share Option Scheme.<br />

(c) Number <strong>of</strong> PLC shares the subject <strong>of</strong> options under the International Scheme.<br />

(d) PLC 1985 Sharesave Scheme.<br />

(e) Number <strong>of</strong> NV New York shares the subject <strong>of</strong> options under the International Scheme.<br />

(f) Number <strong>of</strong> PLC shares the subject <strong>of</strong> options in the form <strong>of</strong> American Depositary Receipts under the International Scheme.<br />

(g) Granted in the year on the basis <strong>of</strong> earnings per share in the prior year.<br />

See also notes on page 59.


59 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Report <strong>of</strong> the Directors<br />

Remuneration report<br />

All share options are exercisable at a range <strong>of</strong> dates between 2000 and 2009 (see note 20 on page 81). No options<br />

lapsed unexercised during the year. The market price <strong>of</strong> the ordinary shares at the end <strong>of</strong> the year was for NV Fl. 120.78<br />

and US $ 54.44 and for PLC 456p and US $ 7.56, and the range during the year was between Fl. 107.98 and<br />

Fl. 163.07 and US $ 49.50 and US $ 88.25, and between 401p and 695p and US $ 6.45 and US $ 11.67 respectively.<br />

Options outstanding above and below the market prices at 31 December 1999 are set out in the table on page 58.<br />

Notes:<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

Number Market price<br />

<strong>of</strong> Exercise at date <strong>of</strong><br />

Note shares price exercise<br />

0111 111011 11100 11100<br />

(1) On election as a director<br />

(2) all Fl. 139.95<br />

(3) all Fl. 140.27<br />

(4) all 555p<br />

(5) all 514p<br />

(6) 6 252 Fl. 48.00 Fl. 138.37<br />

(7) 1 876 Fl. 48.00 Fl. 138.35<br />

9 648 Fl. 48.70 Fl. 138.35<br />

(8) 1 876 Fl. 48.00 Fl. 138.35<br />

4 312 Fl. 48.70 Fl. 138.35<br />

4 772 Fl. 50.30 Fl. 140.49<br />

(9) On date <strong>of</strong> retirement<br />

1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 0<br />

The exercise <strong>of</strong> all options under the NV Executive Share Option Scheme and North American Executive Stock Option<br />

Plan have always been satisfied by the transfer <strong>of</strong> shares purchased in the market at the time <strong>of</strong> the grant and held until<br />

exercise. The same practice has been adopted in respect <strong>of</strong> the PLC 1985 Sharesave and Executive Share Option<br />

Schemes for grants made from 1990 onwards and in respect <strong>of</strong> the NV Employee Share Option Scheme and the North<br />

American Employee Stock Purchase Plan from their inceptions during 1995. The Board has continued the same practice<br />

with the <strong>Unilever</strong> PLC International 1997 Executive Share Option Scheme. During 1999, 2 803 641 NV shares and 17<br />

732 079 PLC shares were purchased in the market in respect <strong>of</strong> options granted under these schemes, and 782 480 NV<br />

shares and 6 558 181 PLC shares to bring the number <strong>of</strong> shares back to the level before the share consolidation.


60 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

Statements <strong>of</strong> directors’ responsibilities<br />

Annual accounts<br />

The directors are required by Book 2 <strong>of</strong> the Civil Code in<br />

the Netherlands and the United Kingdom Companies Act<br />

1985 to prepare accounts for each financial year which<br />

give a true and fair view <strong>of</strong> the state <strong>of</strong> affairs <strong>of</strong> the<br />

<strong>Unilever</strong> Group, NV and PLC as at the end <strong>of</strong> the financial<br />

year and <strong>of</strong> the pr<strong>of</strong>it or loss for that year.<br />

The directors consider that in preparing the accounts the<br />

Group, NV and PLC have used appropriate accounting<br />

policies, consistently applied and supported by reasonable<br />

and prudent judgements and estimates, and that all<br />

accounting standards which they consider to be applicable<br />

have been followed, except as noted under ‘Accounting<br />

standards’ on page 62.<br />

The directors have responsibility for ensuring that NV<br />

and PLC keep accounting records which disclose with<br />

reasonable accuracy their financial position and which<br />

enable the directors to ensure that the accounts comply<br />

with the relevant legislation. They also have a general<br />

responsibility for taking such steps as are reasonably<br />

open to them to safeguard the assets <strong>of</strong> the Group<br />

and to prevent and detect fraud and other irregularities.<br />

This statement, which should be read in conjunction with<br />

the ‘Report <strong>of</strong> independent auditors’ set out on page 61,<br />

is made with a view to distinguishing for shareholders the<br />

respective responsibilities <strong>of</strong> the directors and <strong>of</strong> the<br />

auditors in relation to the accounts.<br />

Going concer n<br />

The directors continue to adopt the going concern basis<br />

in preparing the accounts. This is because the directors,<br />

after making enquiries and following a review <strong>of</strong> the<br />

Group’s budget for 2000 and 2001, including cash flows<br />

and borrowing facilities, consider that the Group has<br />

adequate resources to continue in operation for the<br />

foreseeable future.<br />

Internal control<br />

<strong>Unilever</strong> has a well established control environment,<br />

which is well documented and regularly reviewed.<br />

This incorporates internal control procedures which<br />

are designed to provide reasonable, but not absolute,<br />

assurance that assets are safeguarded and the risks facing<br />

the business are being controlled. The Boards <strong>of</strong> NV and<br />

PLC have also established a clear organisation structure,<br />

including delegation <strong>of</strong> appropriate authorities. The<br />

Group’s control environment is supported through a<br />

Code <strong>of</strong> Business Principles, which sets standards <strong>of</strong><br />

pr<strong>of</strong>essionalism and integrity for its operations worldwide.<br />

The Boards have overall responsibility for establishing key<br />

procedures designed to achieve a system <strong>of</strong> internal<br />

control and for reviewing its effectiveness. The day to day<br />

responsibility for implementation <strong>of</strong> these procedures and<br />

ongoing monitoring <strong>of</strong> risk and the effectiveness <strong>of</strong> these<br />

controls rests with the Group’s senior management at<br />

individual operating company and Business Group level.<br />

Business Groups, each <strong>of</strong> which have their own Risk<br />

Committees, review, on an ongoing basis, the risks<br />

faced by their group and the related internal control<br />

arrangements and provide written reports to the<br />

Corporate Risk Committee. This is comprised mainly <strong>of</strong><br />

Board members and chaired by the Financial Director. The<br />

Corporate Risk Committee maintains oversight, on behalf<br />

<strong>of</strong> the Boards, <strong>of</strong> the controls in place to identify, evaluate<br />

and manage risk. It reports regularly to the Boards, which<br />

retain ultimate responsibility.<br />

<strong>Unilever</strong>’s corporate internal audit function plays a key role<br />

in providing an objective view and continuing assessment<br />

<strong>of</strong> the effectiveness <strong>of</strong> the internal control systems<br />

throughout <strong>Unilever</strong> to both operating management<br />

and the Boards. The Group has an independent Audit<br />

Committee, entirely comprised <strong>of</strong> Advisory Directors.<br />

This Committee meets regularly with corporate internal<br />

audit and the external auditors.<br />

<strong>Unilever</strong> has a comprehensive budgeting system with an<br />

annual budget approved by the Boards, which is regularly<br />

reviewed and updated. Performance is monitored against<br />

budget and the previous year through monthly and<br />

quarterly reporting routines. The Group reports to<br />

shareholders quarterly.<br />

<strong>Unilever</strong>’s system <strong>of</strong> internal control has been in place<br />

throughout 1999 and up to the date <strong>of</strong> this report, and<br />

complies with the recommendations <strong>of</strong> ‘Internal Control<br />

– Guidance for Directors on the Combined Code’,<br />

published by the Internal Control Working Party <strong>of</strong> the<br />

Institute <strong>of</strong> Chartered Accountants in England & Wales<br />

in September 1999.


61 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

Report <strong>of</strong> independent auditors<br />

Report <strong>of</strong> the auditors to the members <strong>of</strong> <strong>Unilever</strong><br />

N.V. and <strong>Unilever</strong> PLC<br />

In our opinion the accounts and related schedule <strong>of</strong> the<br />

<strong>Unilever</strong> Group set out on pages 62 to 107, present fairly,<br />

in all material respects, the financial position <strong>of</strong> the<br />

<strong>Unilever</strong> Group at 31 December 1999 and 1998, and the<br />

results <strong>of</strong> its operations, total recognised gains and its<br />

cash flows for each <strong>of</strong> the three years in the period ended<br />

31 December 1999, in accordance with the general<br />

information on Accounting Standards and the accounting<br />

policies on pages 62 to 65. These accounts and related<br />

schedule are the responsibility <strong>of</strong> the Company’s<br />

management. Our responsibility is to express an opinion<br />

on these accounts and related schedule based on our<br />

audits. We conducted our audits in accordance with<br />

auditing standards generally accepted in the United<br />

Kingdom and the Netherlands, which are substantially the<br />

same as auditing standards generally accepted in the<br />

United States. These standards require that we plan and<br />

perform our audit to obtain reasonable assurance about<br />

whether the accounts are free <strong>of</strong> material misstatement.<br />

An audit includes examining on a test basis evidence<br />

supporting the amounts and disclosures in the accounts,<br />

assessing the accounting principles used and significant<br />

estimates made by management, and evaluating<br />

the presentation <strong>of</strong> the accounts. We believe that our<br />

audits provide a reasonable basis for the opinion<br />

expressed above.<br />

The accounting principles applied vary in certain<br />

significant respects from accounting principles generally<br />

accepted in the United States. The approximate effect<br />

<strong>of</strong> the major differences in the determination <strong>of</strong> net pr<strong>of</strong>it<br />

and capital and reserves are shown on page 106.<br />

PricewaterhouseCoopers N.V. PricewaterhouseCoopers<br />

Registeraccountants Chartered Accountants<br />

Rotterdam, The Netherlands and Registered Auditors<br />

London, England<br />

As auditors <strong>of</strong> <strong>Unilever</strong> N.V. As auditors <strong>of</strong> <strong>Unilever</strong> PLC<br />

7 March 2000<br />

A separate report on the accounts <strong>of</strong> the <strong>Unilever</strong> Group<br />

expressed in sterling is included in <strong>Unilever</strong> PLC’s Annual<br />

Report on Form 20-F for 1999.


62 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

Accounting information and policies<br />

<strong>Unilever</strong> Group<br />

<strong>Unilever</strong><br />

The two parent companies, NV and PLC, operate as nearly<br />

as is practicable as a single entity (the <strong>Unilever</strong> Group, also<br />

referred to as <strong>Unilever</strong> or the Group). NV and PLC have<br />

the same directors and are linked by a series <strong>of</strong><br />

agreements, including an Equalisation Agreement, which<br />

is designed so that the position <strong>of</strong> the shareholders <strong>of</strong><br />

both companies is as nearly as possible the same as if they<br />

held shares in a single company.<br />

The Equalisation Agreement provides for both companies<br />

to adopt the same accounting principles and requires as<br />

a general rule the dividends and other rights and benefits<br />

(including rights on liquidation) attaching to each Fl. 12<br />

nominal <strong>of</strong> ordinary capital <strong>of</strong> NV to be equal in value at<br />

the relevant rate <strong>of</strong> exchange to the dividends and other<br />

rights and benefits attaching to each £1 nominal <strong>of</strong><br />

ordinary share capital <strong>of</strong> PLC, as if each such unit <strong>of</strong><br />

capital formed part <strong>of</strong> the ordinary capital <strong>of</strong> one and<br />

the same company.<br />

Basis <strong>of</strong> consolidation<br />

By reason <strong>of</strong> the operational and contractual arrangements<br />

re f e r red to above and the internal participating interests set<br />

out in note 20 on page 80, NV and PLC and their group<br />

companies constitute a single group under Netherlands<br />

and United Kingdom legislation for the purposes <strong>of</strong><br />

presenting consolidated accounts. Accordingly, the<br />

accounts <strong>of</strong> the <strong>Unilever</strong> Group are presented by both NV<br />

and PLC as their respective consolidated accounts. These<br />

accounts are supplemented in notes 21 and 22 on page<br />

84 and note 34 on page 103 by additional information for<br />

the NV and PLC parts <strong>of</strong> the Group in which group<br />

companies are consolidated according to respective<br />

ownership.<br />

Companies legislation<br />

The consolidated accounts <strong>of</strong> the <strong>Unilever</strong> Group comply<br />

with Book 2 <strong>of</strong> the Civil Code in the Netherlands and the<br />

United Kingdom Companies Act 1985. The Company<br />

accounts, the notes to those accounts and the further<br />

statutory information given for each <strong>of</strong> NV and PLC<br />

comply with legislation in the Netherlands and the<br />

United Kingdom respectively. As explained under ‘Group<br />

companies’ on page 63, in order to give a true and fair<br />

view, the presentation <strong>of</strong> the consolidated capital and<br />

reserves differs from that specified by the United Kingdom<br />

Companies Act 1985.<br />

OECD Guidelines<br />

In preparing its annual accounts <strong>Unilever</strong> adheres to the<br />

disclosure recommendations <strong>of</strong> the OECD Guidelines for<br />

Multinational Enterprises.<br />

Accounting standards<br />

The accounts are prepared under the historical cost<br />

convention and comply in all material respects with<br />

applicable accounting principles in the Netherlands and<br />

with United Kingdom Accounting Standards.<br />

The accounting policies <strong>of</strong> the <strong>Unilever</strong> Group are set out<br />

on pages 63 to 65. Material variations from United States<br />

generally accepted accounting principles are set out on<br />

pages 106 and 107.<br />

United Kingdom Statement <strong>of</strong> Standard Accounting<br />

Practice Number 15 (SSAP 15) requires that no provision<br />

should be made for deferred taxation where it is probable,<br />

based on reasonable assumptions, that a liability will not<br />

crystallise. In this respect, SSAP 15 is not in agreement<br />

with Dutch law as currently applied. For this reason,<br />

and because <strong>of</strong> the Equalisation Agreement, full provision<br />

continues to be made for deferred taxation. The effects<br />

<strong>of</strong> this departure from SSAP 15 are shown in note 6 on<br />

page 73, note 18 on page 78 and note 30 on pages 90<br />

and 91.<br />

United Kingdom Urgent Issues Task Force Abstract 13<br />

(UITF 13) requires that NV or PLC shares held by employee<br />

trusts to satisfy options should be classified by the<br />

sponsoring company as fixed assets. Dutch law requires<br />

such shares to be accounted for within capital and<br />

reserves. In order to comply with Dutch law and the<br />

Equalisation Agreement, the requirements <strong>of</strong> UITF 13<br />

have not been followed. All shares held internally are<br />

accounted for in accordance with Dutch GAAP. The effects<br />

<strong>of</strong> this departure are shown in note 22 on page 84.<br />

United Kingdom Financial Reporting Standard 12<br />

‘Provisions, Contingent Liabilities and Contingent Assets’<br />

became mandatory for all UK companies with accounting<br />

periods ending on or after 23 March 1999. The only<br />

material impact <strong>of</strong> the adoption <strong>of</strong> this standard was the<br />

reallocation <strong>of</strong> fixed asset write down provisions to<br />

depreciation as disclosed in note 9 on page 75.<br />

The Group has also adopted United Kingdom Financial<br />

Reporting Standard 13 ‘Derivatives and Other Financial<br />

Instruments: Disclosures’ and this has resulted in<br />

additional disclosure in notes 14 and 15 on pages 76<br />

and 77.<br />

United Kingdom Financial Reporting Standard 15<br />

‘Measurement <strong>of</strong> Tangible Fixed Assets’ was issued in<br />

1999. The adoption <strong>of</strong> this standard did not result in a<br />

material change.


63 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

<strong>Unilever</strong> Group Accounting information and policies<br />

The Group has decided not to adopt the fair value<br />

provisions <strong>of</strong> SFAS 123 ‘Accounting for Stock-Based<br />

Compensation’. The disclosure requirements <strong>of</strong> this<br />

standard are given in note 33 on pages 94 to 102.<br />

SFAS 133 ‘Accounting for Derivative Instruments and<br />

Hedging Activities’ as amended by SFAS 137 is effective<br />

for fiscal years beginning after 15 June 2000. The<br />

statement requires that an entity recognise all derivatives<br />

as either assets or liabilities in the statement <strong>of</strong> financial<br />

position and measure those instruments at fair value.<br />

It is not possible to quantify the impact <strong>of</strong> this standard<br />

on <strong>Unilever</strong>’s financial position or results <strong>of</strong> operations<br />

in advance.<br />

SOP 98-1 ‘Accounting for the Costs <strong>of</strong> Computer<br />

S<strong>of</strong>tware Developed and Obtained for Internal Use’ is<br />

effective for fiscal years beginning after 15 December<br />

1998. The SOP provides authoritative guidance on<br />

accounting for the costs <strong>of</strong> computer s<strong>of</strong>tware developed<br />

or obtained for internal use and requires costs incurred in<br />

the application development stage to be capitalised and<br />

amortised over their expected useful lives. The adoption <strong>of</strong><br />

SOP 98-1 did not have a material effect on <strong>Unilever</strong>’s<br />

financial position or results <strong>of</strong> operations.<br />

SOP 98-5 ‘Reporting on the costs <strong>of</strong> start up activities’,<br />

requires that costs for start up activities and organisation<br />

costs be expensed as incurred and is applicable to all<br />

financial statements for fiscal years beginning after<br />

15 December 1998. The adoption <strong>of</strong> SOP 98-5 did not<br />

have a material effect on <strong>Unilever</strong>’s financial position or<br />

results <strong>of</strong> operations.<br />

Group companies<br />

Group companies are those companies in whose share<br />

capital NV or PLC holds an interest directly or indirectly,<br />

and whose consolidation is required for the accounts to<br />

give a true and fair view.<br />

In order that the consolidated accounts should present<br />

a true and fair view, it is necessary to differ from the<br />

presentational requirements <strong>of</strong> the United Kingdom<br />

Companies Act 1985 by including amounts attributable<br />

to both NV and PLC shareholders in the capital and<br />

reserves shown in the balance sheet. The Companies Act<br />

would require presentation <strong>of</strong> the capital and reserves<br />

attributable to NV and PLC shareholders as minority<br />

interests in the respective consolidated accounts <strong>of</strong> NV<br />

and PLC. This presentation would not give a true and<br />

fair view <strong>of</strong> the effect <strong>of</strong> the Equalisation Agreement,<br />

under which the position <strong>of</strong> all shareholders is as nearly<br />

as possible the same as if they held shares in a<br />

single company.<br />

Net pr<strong>of</strong>it and pr<strong>of</strong>it <strong>of</strong> the year retained are presented<br />

on a combined basis on page 66, with the net pr<strong>of</strong>it<br />

attributable to NV and PLC shareholders shown separately.<br />

Movements in pr<strong>of</strong>it retained are analysed between those<br />

attributable to NV and PLC shareholders in note 21 on<br />

page 84.<br />

Foreign currencies<br />

Exchange differences arising in the accounts <strong>of</strong> individual<br />

companies are dealt with in their respective pr<strong>of</strong>it and loss<br />

accounts. Those arising on trading transactions are taken<br />

to operating pr<strong>of</strong>it; those arising on cash, current<br />

investments and borrowings are classified as interest.<br />

In preparing the consolidated accounts, the pr<strong>of</strong>it and loss<br />

account, the cash flow statement and all movements in<br />

assets and liabilities are translated at annual average rates<br />

<strong>of</strong> exchange. The balance sheet, other than the ordinary<br />

share capital <strong>of</strong> NV and PLC, is translated at year-end rates<br />

<strong>of</strong> exchange. In the case <strong>of</strong> hyper-inflationary economies,<br />

the accounts are adjusted to remove the influences <strong>of</strong><br />

inflation before being translated.<br />

The ordinary share capital <strong>of</strong> NV and PLC is translated at<br />

the rate <strong>of</strong> £1 = Fl.12 contained in the Equalisation<br />

Agreement. The difference between this and the value<br />

derived by applying the year-end rate <strong>of</strong> exchange is taken<br />

to other reserves (see note 22 on page 84).<br />

The effects <strong>of</strong> exchange rate changes during the year on<br />

net assets at the beginning <strong>of</strong> the year are recorded as a<br />

movement in pr<strong>of</strong>it retained, as is the difference between<br />

pr<strong>of</strong>it <strong>of</strong> the year retained at average rates <strong>of</strong> exchange<br />

and at year-end rates <strong>of</strong> exchange.<br />

Goodwill and intangible assets<br />

No value is attributable to internally generated intangible<br />

assets. Goodwill (being the difference between the<br />

consideration paid for new interests in group companies,<br />

joint ventures and associated companies and the fair value<br />

<strong>of</strong> the Group’s share <strong>of</strong> their net assets at the date <strong>of</strong><br />

acquisition) and identifiable intangible assets purchased<br />

after 1 January 1998 are capitalised and amortised in<br />

operating pr<strong>of</strong>it over the period <strong>of</strong> their expected useful<br />

life, up to a maximum <strong>of</strong> 20 years. Periods in excess <strong>of</strong><br />

five years are used only where the directors are satisfied<br />

that the life <strong>of</strong> these assets will clearly exceed that period.<br />

Goodwill and intangible assets purchased prior to<br />

1 January 1998 were written <strong>of</strong>f in the year <strong>of</strong> acquisition<br />

as a movement in pr<strong>of</strong>its retained.


64 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

<strong>Unilever</strong> Group Accounting information and policies<br />

On disposal <strong>of</strong> a business acquired prior to 1 January<br />

1998, purchased goodwill written <strong>of</strong>f on acquisition is<br />

reinstated in arriving at the pr<strong>of</strong>it or loss on disposal.<br />

Tangible fixed assets<br />

Tangible fixed assets are stated at cost less depreciation.<br />

Depreciation is provided on a straight-line basis at<br />

percentages <strong>of</strong> cost based on the expected average useful<br />

lives <strong>of</strong> the assets. Estimated useful lives by major class <strong>of</strong><br />

assets are as follows:<br />

Freehold buildings 33-40 years<br />

(no depreciation on freehold land)<br />

Leasehold land and buildings *33-40 years<br />

Plant and equipment 3-20 years<br />

Motor vehicles 3-6 years<br />

*or life <strong>of</strong> lease if less than 33 years<br />

Current cost information is given in note 9 on page 74.<br />

Fixed investments<br />

Joint ventures are undertakings in which the Group has<br />

a long-term participating interest and which are jointly<br />

controlled by the Group and one or more other parties.<br />

Associated companies are undertakings in which the<br />

Group has a participating interest and is able to exercise<br />

significant influence.<br />

Interests in joint ventures and associated companies are<br />

stated in the consolidated balance sheet at the Group’s<br />

share <strong>of</strong> their underlying net assets.<br />

Other fixed investments are stated at cost less any<br />

amounts written <strong>of</strong>f to reflect a permanent diminution<br />

in value.<br />

Current assets<br />

Stocks are valued at the lower <strong>of</strong> cost and estimated<br />

net realisable value. Cost is mainly average cost, and<br />

comprises direct costs and, where appropriate, a<br />

proportion <strong>of</strong> production overheads.<br />

Debtors are stated after deducting adequate provision for<br />

doubtful debts.<br />

Current investments are liquid funds temporarily invested<br />

and are stated at their realisable value. The difference<br />

between this and their original cost is taken to interest in<br />

the pr<strong>of</strong>it and loss account.<br />

Retirement benefits<br />

The expected costs <strong>of</strong> providing retirement pensions under<br />

defined benefit plans, as well as the costs <strong>of</strong> other postretirement<br />

benefits, are charged to the pr<strong>of</strong>it and loss<br />

account over the periods benefiting from the employees’<br />

services. Variations from expected cost are normally<br />

spread over the average remaining service lives <strong>of</strong><br />

current employees.<br />

Contributions to defined contribution pension plans are<br />

charged to the pr<strong>of</strong>it and loss account as incurred.<br />

Liabilities arising under defined benefit plans are either<br />

externally funded or provided for in the consolidated<br />

balance sheet. Any difference between the charge to the<br />

pr<strong>of</strong>it and loss account in respect <strong>of</strong> funded plans and the<br />

contributions payable to each plan is recorded in the<br />

balance sheet as a prepayment or provision.<br />

Deferred taxation<br />

Full provision is made for deferred taxation, at the rates<br />

<strong>of</strong> tax prevailing at the year-end unless future rates have<br />

been enacted, on all significant timing differences arising<br />

from the recognition <strong>of</strong> items for taxation purposes in<br />

different periods to those in which they are included in<br />

the Group accounts.<br />

Provision is not made for taxation which would become<br />

payable if retained pr<strong>of</strong>its <strong>of</strong> group companies and joint<br />

ventures were distributed to the parent companies, as it<br />

is not the intention to distribute more than the dividends,<br />

the tax on which is included in the accounts.<br />

Derivative financial instruments<br />

The types <strong>of</strong> derivative financial instruments used by<br />

<strong>Unilever</strong> are described in note 29 on page 88 and in the<br />

Financial review on page 37.<br />

Changes in the value <strong>of</strong> forward foreign exchange<br />

contracts are recognised in the results in the same period<br />

as changes in the values <strong>of</strong> the assets and liabilities they<br />

are intended to hedge. Interest payments and receipts<br />

arising from interest rate derivatives such as swaps and<br />

forward rate agreements are matched to those arising<br />

from underlying debt and investment positions.<br />

Payments made or received in respect <strong>of</strong> the early<br />

termination <strong>of</strong> derivative financial instruments are spread<br />

over the original life <strong>of</strong> the instrument so long as the<br />

underlying exposure continues to exist.


65 <strong>Unilever</strong> Annual Report on Form 20-F 1999 Financial Statements<br />

<strong>Unilever</strong> Group Accounting information and policies<br />

Research and development<br />

Expenditure on research and development is charged<br />

against the pr<strong>of</strong>it <strong>of</strong> the year in which it is incurred.<br />

Turnover<br />

Group turnover comprises sales <strong>of</strong> goods and services<br />

after deduction <strong>of</strong> discounts and sales taxes. It includes<br />

sales to joint ventures and associated companies but does<br />

not include sales by joint ventures and associated<br />

companies or sales between group companies.<br />

Transfer pricing<br />

The preferred method for determining transfer prices for<br />

own manufactured goods is to take the market price.<br />

Where there is no market price, the companies concerned<br />

follow established transfer pricing guidelines, where<br />

available, or else engage in arm’s length negotiations.<br />

Trademarks owned by the parent companies and used by<br />

operating companies are, where appropriate, licensed in<br />

return for royalties or a fee.<br />

General services provided by central advisory departments,<br />

Business Groups and research laboratories are charged to<br />

operating companies on the basis <strong>of</strong> fees.<br />

Leases<br />

Lease payments, which are principally in respect <strong>of</strong><br />

operating leases, are charged to the pr<strong>of</strong>it and loss<br />

account on a straight-line basis over the lease term, or<br />

over the period between rent reviews where these exist.<br />

Shares held by employee share trusts<br />

The assets and liabilities <strong>of</strong> certain PLC trusts, NV and<br />

group companies which purchase and hold NV and PLC<br />

shares to satisfy options granted are included in the Group<br />

accounts. The book value <strong>of</strong> shares held is deducted from<br />

capital and reserves, and trust borrowings are included in<br />

the Group’s borrowings. The costs <strong>of</strong> the trusts are<br />

included in the results <strong>of</strong> the Group. These shares are<br />

excluded from the basic earnings per share calculation.


Consolidated pr<strong>of</strong>it and loss account and<br />

Statement <strong>of</strong> total recognised gains and losses<br />

<strong>Unilever</strong> Group<br />

Consolidated pr<strong>of</strong>it and loss account for the year ended 31 December<br />

00000000000000001111<br />

Fl. million<br />

111500000<br />

1999 1998 1997<br />

00000000005111150 11150 11150<br />

Turnover 1 90 296 89 112 94 597<br />

Continuing operations 89 996 89 112 90 600<br />

Acquisitions 300<br />

Discontinued operations 3 997<br />

Operating costs 2 (80 814) (79 394) (87 034)<br />

11150 11150 11150<br />

Operating pr<strong>of</strong>it 1 9 482 9 718 7 563<br />

Continuing operations 9 495 9 718 7 049<br />

Acquisitions (13)<br />

Discontinued operations 514<br />

Operating pr<strong>of</strong>it before exceptional items – continuing businesses 10 076 9 442 8 849<br />

Pr<strong>of</strong>it on sale <strong>of</strong> discontinued speciality chemicals businesses 8 482<br />

Loss on disposal <strong>of</strong> fixed assets in continuing businesses (484)<br />

Income from fixed investments 10 114 82 85<br />

Interest 5 (30) 344 (230)<br />

11150 11150 11150<br />

Pr<strong>of</strong>it on ordinary activities before taxation 9 566 10 144 15 416<br />

Taxation on pr<strong>of</strong>it on ordinary activities 6 (3 017) (3 338) (4 185)<br />

11150 11150 11150<br />

Pr<strong>of</strong>it on ordinary activities after taxation 6 549 6 806 11 231<br />

Minority interests (443) (318) (308)<br />

11150 11150 11150<br />

Net pr<strong>of</strong>it 6 106 6 488 10 923<br />

Attributable to: NV 21 3 882 3 655 7 649<br />

PLC 21 2 224 2 833 3 274<br />

Dividends (2 787) (19 116) (2 292)<br />

Preference dividends (44) (15) (15)<br />

Dividends on ordinary capital 7 (2 743) (2 727) (2 277)<br />

Special dividend 7 (16 374)<br />

11150 11150 11150<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 3 319 (12 628) 8 631<br />

00000000000000001111<br />

Combined earnings per shar e 30<br />

Guilders per Fl. 1.12 (1997-98: Fl. 1) <strong>of</strong> ordinary capital 5.80 5.80 9.78<br />

Pence per 1.4p (1997-98: 1.25p) <strong>of</strong> ordinary capital 26.01 26.45 44.74<br />

On a diluted basis the figures would be:<br />

Guilders per Fl. 1.12 (1997-98: Fl. 1) <strong>of</strong> ordinary capital 5.66 5.66 9.55<br />

Pence per 1.4p (1997-98: 1.25p) <strong>of</strong> ordinary capital 25.36 25.80 43.68<br />

00000000000000001111<br />

See note 30 on page 90 for an explanation <strong>of</strong> the impact <strong>of</strong> the share consolidation on earnings per share.<br />

Statement <strong>of</strong> total recognised gains and losses for the year ended 31 December<br />

00000000000000001111<br />

Net pr<strong>of</strong>it 6 106 6 488 10 923<br />

Currency retranslation 837 (1 356) 728<br />

11150 11150 11150<br />

Total recognised gains since last annual accounts 6 943 5 132 11 651<br />

00000000000000001111<br />

The notes on pages 62 to 65, 69 to 104, 106 and 107 form part <strong>of</strong> these accounts.<br />

References relate to notes on pages 69 to 75, 84, 90 and 91.<br />

Accounting policies <strong>of</strong> the <strong>Unilever</strong> Group are set out on pages 62 to 65.<br />

Variations from United States generally accepted accounting principles and Regulation S-X are outlined on pages 106 and 107.


Consolidated balance sheet as at 31 December<br />

<strong>Unilever</strong> Group<br />

00000000000000001111<br />

Fl. million<br />

1115000<br />

1999 1998<br />

000000000051111150111150 11150<br />

Fixed assets 21 171 18 995<br />

Goodwill and intangible assets 8 1 418 626<br />

Tangible fixed assets 9 19 440 18 045<br />

Fixed investments 10 313 324<br />

Current assets<br />

Stocks 11 11 291 10 461<br />

Debtors 12 16 935 14 849<br />

Debtors due within one year 12 12 653 11 297<br />

Debtors due after more than one year 12 4 282 3 552<br />

Current investments 13 3 254 10 870<br />

Cash at bank and in hand 14 8 807 12 011<br />

11150 11150<br />

Total current assets 40 287 48 191<br />

Creditors due within one year (26 740) (39 614)<br />

Borrowings 15 (6 469) (5 123)<br />

Trade and other creditors 16 (20 271) (18 477)<br />

Special dividend (16 014)<br />

Net current assets 13 547 8 577<br />

11150 11150<br />

Total assets less current liabilities 34 718 27 572<br />

00000000000000001111<br />

Creditors due after more than one year 6 241 6 702<br />

Borrowings 15 4 084 5 023<br />

Trade and other creditors 16 2 157 1 679<br />

Provisions for liabilities and charges 10 097 9 507<br />

Pensions and similar obligations 17 7 296 6 509<br />

Deferred taxation and other provisions 18 2 801 2 998<br />

Minority interests 1 275 899<br />

Capital and reserves 19 17 105 10 464<br />

Attributable to: NV: Called up share capital 20 926 905<br />

Share premium account 3 076 52<br />

Other reserves 22 (802) (498)<br />

Pr<strong>of</strong>it retained 21 10 292 7 355<br />

150 11150<br />

13 492 7 814<br />

150 11150<br />

PLC: Called up share capital 20 489 489<br />

Share premium account 333 293<br />

Other reserves 22 (1 337) (958)<br />

Pr<strong>of</strong>it retained 21 4 128 2 826<br />

150 11150<br />

3 613 2 650<br />

Total capital employed 34 718 27 572<br />

00000000000000001111<br />

Capital and reserves include amounts relating to preference shares in NV which under United Kingdom Financial<br />

Reporting Standard 4 are classified as non-equity. Minority interests in group companies are substantially all equity<br />

interests.<br />

The notes on pages 62 to 65, 69 to 104, 106 and 107 form part <strong>of</strong> these accounts.<br />

References relate to notes on pages 74 to 84.<br />

Commitments and contingent liabilities are shown in notes 23 and 24 on pages 84 and 85.<br />

Accounting policies <strong>of</strong> the <strong>Unilever</strong> Group are set out on pages 62 to 65.<br />

Variations from United States generally accepted accounting principles and Regulation S-X are outlined on pages 106 and 107.


Consolidated cash flow statement for the year ended 31 December<br />

<strong>Unilever</strong> Group<br />

00000000000000001111<br />

Fl. million<br />

1115011111501111150<br />

1999 1998 1997<br />

00000000005111150 11150 11150<br />

Cash flow from operating activities 26 12 460 9 948 12 249<br />

Continuing businesses 12 460 9 948 11 693<br />

Discontinued operations — — 556<br />

Dividends from joint ventures 61 53 58<br />

Returns on investments and servicing <strong>of</strong> finance 27 (344) 148 (808)<br />

Taxation (3 180) (2 779) (4 157)<br />

Capital expenditure and financial investment 27 (3 307) (3 083) (2 774)<br />

Acquisitions and disposals 27 (799) 744 13 749<br />

Dividends paid on ordinary share capital (2 791) (2 365) (2 062)<br />

Special dividend (13 427)<br />

11150 11150 11150<br />

Cash flow before management <strong>of</strong> liquid resources and financing (11 327) 2 666 16 255<br />

Management <strong>of</strong> liquid resources 27 12 509 (4 413) (14 122)<br />

Financing 27 (322) 92 (1 517)<br />

11150 11150 11150<br />

Increase/(decrease) in cash in the period 860 (1 655) 616<br />

00000000000000001111<br />

Reconciliation <strong>of</strong> cash flow to movement in net funds/(debt)<br />

00000000000000001111<br />

Net funds/(debt) at 1 January 28 12 735 10 625 (5 014)<br />

Increase/(decrease) in cash in the period 860 (1 655) 616<br />

Cash flow from decrease/(increase) in borrowings 332 (55) 1 612<br />

Cash flow from (decrease)/increase in liquid resources (12 509) 4 413 14 122<br />

11150 11150 11150<br />

Change in net funds resulting from cash flows (11 317) 2 703 16 350<br />

Borrowings within group companies acquired (63) (37) (63)<br />

Borrowings within group companies sold 10 7 292<br />

Liquid resources within group companies acquired 6 — 1<br />

Liquid resources within group companies sold — (4) (10)<br />

Non cash movements (465) (22) 72<br />

Currency retranslation 602 (537) (1 003)<br />

11150 11150 11150<br />

(Decrease)/increase in net funds in the period (11 227) 2 110 15 639<br />

11150 11150 11150<br />

Net funds/(debt) at 31 December 28 1 508 12 735 10 625<br />

00000000000000001111<br />

The notes on pages 62 to 65, 69 to 104, 106 and 107 form part <strong>of</strong> these accounts.<br />

References relate to notes on pages 86 to 88.<br />

Accounting policies <strong>of</strong> the <strong>Unilever</strong> Group are set out on pages 62 to 65.<br />

Variations from United States generally accepted accounting principles and Regulation S-X are outlined on pages 106 and 107.


Notes to the consolidated accounts<br />

<strong>Unilever</strong> Group<br />

1 Segmental information<br />

000000000000000§01111<br />

Fl. million<br />

5010000000511<br />

1999 1998 1997<br />

110111101110 110 11011101110<br />

Continuing Continuing Discontinued<br />

operations Acquisitions Total Total operations operations (c) Total<br />

0000151101110110 1110 110 110 110 110 110<br />

Turnover (a)(b)(e)<br />

By geographical area:<br />

Europe 41 308 96 41 404 41 805 43 274 1 558 44 832<br />

North America 19 473 1 19 474 18 552 17 944 1 669 19 613<br />

Africa and Middle East 5 065 — 5 065 4 911 4 773 53 4 826<br />

Asia and Pacific 14 668 147 14 815 12 786 14 026 587 14 613<br />

Latin America 9 482 56 9 538 11 058 10 583 130 10 713<br />

110 1110 110 110 110 110 110<br />

89 996 300 90 296 89 112 90 600 3 997 94 597<br />

110 1110 110 110 110 110 110<br />

By operation: (c)<br />

Foods – Oil & dairy based foods and bakery 16 038 — 16 038 16 952 17 687 17 687<br />

– Ice cream and beverages 14 464 161 14 625 14 593 14 198 14 198<br />

– Culinary and frozen foods 14 437 83 14 520 14 840 15 331 15 331<br />

Home care and pr<strong>of</strong>essional cleaning 20 018 47 20 065 19 422 19 350 19 350<br />

Personal care 23 514 9 23 523 21 971 21 802 21 802<br />

Other Operations 1 525 — 1 525 1 334 2 232 2 232<br />

Speciality Chemicals 3 997 3 997<br />

110 1110 110 110 110 110 110<br />

89 996 300 90 296 89 112 90 600 3 997 94 597<br />

110 1110 110 110 110 110 110<br />

Operating pr<strong>of</strong>it (a)(e)<br />

By geographical area before exceptional items:<br />

Europe 4 980 8 4 988 4 670 4 467 251 4 718<br />

North America 2 144 — 2 144 1 991 1 719 201 1 920<br />

Africa and Middle East 553 — 553 493 454 6 460<br />

Asia and Pacific 1 472 (17) 1 455 1 120 1 242 47 1 289<br />

Latin America 940 (4) 936 1 168 967 9 976<br />

110 1110 110 110 110 110 110<br />

Operating pr<strong>of</strong>it before exceptional items 10 089 (13) 10 076 9 442 8 849 514 9 363<br />

Exceptional items 4 (f) (594) — (594) 276 (1 800) — (1 800)<br />

110 1110 110 110 110 110 110<br />

Operating pr<strong>of</strong>it 9 495 (13) 9 482 9 718 7 049 514 7 563<br />

110 1110 110 110 110 110 110<br />

By operation before exceptional items: (c)<br />

Foods – Oil & dairy based foods and bakery 1 715 (1) 1 714 1 628 1 702 1 702<br />

– Ice cream and beverages 1 327 (20) 1 307 1 312 1 340 1 340<br />

– Culinary and frozen foods 1 449 11 1 460 1 464 1 133 1 133<br />

Home care and pr<strong>of</strong>essional cleaning 1 883 (3) 1 880 1 983 1 711 1 711<br />

Personal care 3 479 — 3 479 2 812 2 723 2 723<br />

Other Operations 236 — 236 243 240 240<br />

Speciality Chemicals 514 514<br />

110 1110 110 110 110 110 110<br />

Operating pr<strong>of</strong>it before exceptional items 10 089 (13) 10 076 9 442 8 849 514 9 363<br />

Exceptional items 4 (f) (594) — (594) 276 (1 800) — (1 800)<br />

110 1110 110 110 110 110 110<br />

Operating pr<strong>of</strong>it 9 495 (13) 9 482 9 718 7 049 514 7 563<br />

110000000001<br />

(a) The analysis <strong>of</strong> turnover by geographical area is stated on the basis <strong>of</strong> origin. Turnover on a destination basis would not be materially different.<br />

Inter-segment sales between operational segments and between geographical areas are not material. For the United Kingdom and the Netherlands,<br />

the combined turnover was Fl. 10 996 million (1998: Fl. 10 846million, 1997: Fl. 12 557 million) and the combined operating pr<strong>of</strong>it was<br />

Fl. 1 589 million (1998: Fl. 2 916 million, 1997: Fl. 2 209 million).<br />

(b) Group share <strong>of</strong> the turnover <strong>of</strong> joint ventures was Fl. 628 million (1998: Fl. 445million, 1997: Fl. 381million) <strong>of</strong> which Fl. 200million<br />

(1998: Fl. 192 million, 1997: Fl. 87million) was in Europe. These figures are not included in the analysis above.<br />

(c) In July 1997 <strong>Unilever</strong> sold its international speciality chemicals businesses – National Starch and Chemical Company, Quest International, Unichema<br />

International and Crosfield. These operations were reported as discontinued in 1997. No other business disposal qualifies to be treated as<br />

‘Discontinued operations’ in these accounts.<br />

(d) Net operating assets are goodwill and intangible assets purchased after 1 January 1998, tangible fixed assets, stocks and debtors less trade and<br />

other creditors (excluding taxation and dividends) and less provisions for liabilities and charges other than deferred taxation, deferred purchase<br />

consideration and certain balances arising as a result <strong>of</strong> the sale <strong>of</strong> the speciality chemicals businesses. 1998 has been restated to include goodwill<br />

and intangible assets.<br />

(e) The results for Turkey, formerly reported under Africa and Middle East region, are reported within Europe from 1 January 1998. Results for 1997<br />

have been restated on the same basis.<br />

(f) 1998 included the pr<strong>of</strong>it on disposal <strong>of</strong> Plant Breeding International.


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

1 Segmental information (continued)<br />

0000000000000§0001111<br />

Fl. million<br />

5110511<br />

1999 1998<br />

0000000000000010 10<br />

Net operating assets (d)(e)<br />

By geographical area:<br />

Europe 7 572 7 187<br />

North America 4 399 3 831<br />

Africa and Middle East 1 794 1 542<br />

Asia and Pacific 3 304 2 825<br />

Latin America 3 350 3 019<br />

10 10<br />

20 419 18 404<br />

10 10<br />

By operation: (c)(d)<br />

Foods – Oil & dairy based foods and bakery 2 786 2 854<br />

– Ice cream and beverages 5 516 4 935<br />

– Culinary and frozen foods 3 414 2 991<br />

Home care and pr<strong>of</strong>essional cleaning 4 715 4 046<br />

Personal care 3 641 3 213<br />

Other Operations 347 365<br />

10 10<br />

20 419 18 404<br />

0000000000000§0001111<br />

Additional segmental information as required by SFAS 131<br />

<strong>Unilever</strong> is organised as a matrix; accordingly segmental information is provided in accordance with SFAS 131 on the basis <strong>of</strong> product<br />

categories. For management reporting purposes <strong>Unilever</strong> uses a number <strong>of</strong> measures <strong>of</strong> segment performance at constant average<br />

rates <strong>of</strong> exchange (that is, the same rates as in the preceding year). The internal management measure <strong>of</strong> pr<strong>of</strong>it which is most<br />

consistent with operating pr<strong>of</strong>it reported in the accounts is ‘Trading Result’. This measure differs from operating pr<strong>of</strong>it, mainly because<br />

it includes depreciation on the basis <strong>of</strong> replacement cost, and a number <strong>of</strong> other adjustments, including the application <strong>of</strong> an inflation<br />

charge on working capital which is added back to arrive at operating pr<strong>of</strong>it, and certain other statistical items. Fixed assets are<br />

measured at depreciated replacement cost for management reporting purposes.<br />

0000000000000§0001111<br />

Fl. million<br />

00000000000511<br />

1999 1998 1997<br />

00001511011101110 11011101110 11011101110<br />

Exchange Exchange Exchange<br />

At constant rates At current At constant rates At current At constant rates At current<br />

1998 ratesadjustments 1999 rates 1997 rates adjustments 1998 rates 1996 rates adjustments 1997 rates<br />

000015110 110 110 110 110 110 110 110 110<br />

Turnover<br />

By operation:<br />

Foods – Oil & dairy based foods<br />

and bakery 16 187 (149) 16 038 17 196 (244) 16 952 16 614 1 073 17 687<br />

– Ice cream and beverages 14 657 (32) 14 625 14 987 (394) 14 593 13 134 1 064 14 198<br />

– Culinary and frozen foods 14 539 (19) 14 520 14 885 (45) 14 840 14 151 1 180 15 331<br />

Home care and pr<strong>of</strong>essional cleaning 20 555 (490) 20 065 20 228 (806) 19 422 17 606 1 744 19 350<br />

Personal care 23 423 100 23 523 23 617 (1 646) 21 971 19 756 2 046 21 802<br />

Other Operations 1 529 (4) 1 525 1 480 (146) 1 334 1 932 300 2 232<br />

Speciality Chemicals 3 677 320 3 997<br />

110 110 110 110 110 110 110 110 110<br />

Total 90 890 (594) 90 296 92 393 (3 281) 89 112 86 870 7 727 94 597<br />

110 110 110 110 110 110 110 110 110<br />

Trading result<br />

By operation:<br />

Foods – Oil & dairy based foods<br />

and bakery 1 442 (12) 1 430 1 435 (31) 1 404 822 24 846<br />

– Ice cream and beverages 1 229 14 1 243 1 168 3 1 171 1 003 85 1 088<br />

– Culinary and frozen foods 1 115 21 1 136 1 286 — 1 286 574 79 652<br />

Home care and pr<strong>of</strong>essional cleaning 1 791 (16) 1 775 1 890 (42) 1 848 1 320 125 1 445<br />

Personal care 3 338 2 3 340 2 997 (224) 2 773 2 271 205 2 476<br />

Other Operations 169 2 171 964 69 1 033 126 8 134<br />

Speciality Chemicals 398 35 433<br />

110 110 110 110 110 110 110 110 110<br />

Total trading result 9 084 11 9 095 9 740 (225) 9 515 6 513 560 7 074<br />

110 110 110 110 110 110<br />

Other adjustments 387 203 489<br />

110 110 110<br />

Total operating pr<strong>of</strong>it 9 482 9 718 7 563<br />

110 110 110


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

1 Segmental information (continued)<br />

000000000000000§01111<br />

Fl. million<br />

00000000000511<br />

1999 1998 1997<br />

1011101110 11011101110 11011101110<br />

Exchange Exchange Exchange<br />

At constant rates At current At constant rates At current At constant rates At current<br />

1998 rates adjustments 1999 rates 1997 rates adjustments 1998 rates 1996 rates adjustments 1997 rates<br />

000015110 110 110 110 110 110 110 110 110<br />

Depreciation and amortisation charge<br />

By operation:<br />

Foods – Oil & dairy based foods<br />

and bakery 582 (4) 578 496 (6) 490 487 22 509<br />

– Ice cream and beverages 769 (2) 767 652 (24) 628 629 45 674<br />

– Culinary and frozen foods 441 2 443 446 (2) 444 419 39 458<br />

Home care and pr<strong>of</strong>essional cleaning 621 (2) 619 595 (17) 578 532 69 601<br />

Personal care 541 4 545 468 (21) 447 419 55 474<br />

Other Operations 145 — 145 45 1 46 42 2 44<br />

Speciality Chemicals 191 15 206<br />

10 110 110 110 110 110 110 110 110<br />

Total 3 099 (2) 3 097 2 702 (69) 2 633 2 719 247 2 966<br />

10 110 110 110 110 110<br />

Other adjustments (568) (565) (630)<br />

110 110 110<br />

Depreciation and amortisation charged to<br />

pr<strong>of</strong>it and loss account 2 529 2 068 2 336<br />

110 110 110<br />

Total assets<br />

By operation:<br />

Foods – Oil & dairy based foods<br />

and bakery 7 417 8 226<br />

– Ice cream and beverages 9 098 9 325<br />

– Culinary and frozen foods 7 200 8 233<br />

Home care and pr<strong>of</strong>essional cleaning 10 625 10 003<br />

Personal care 9 522 9 041<br />

Other Operations 7 323 1 218<br />

110 110<br />

Total 51 185 46 046<br />

Corporate 14 599 24 350<br />

Other adjustments (4 326) (3 210)<br />

110 110<br />

Total assets 61 458 67 186<br />

110 110<br />

Capital expenditur e<br />

By operation:<br />

Foods – Oil & dairy based foods<br />

and bakery 408 (2) 406 464 11 475 409 14 423<br />

– Ice cream and beverages 811 (37) 774 907 (45) 862 762 48 810<br />

– Culinary and frozen foods 360 (17) 343 372 (1) 371 356 25 381<br />

Home care and pr<strong>of</strong>essional cleaning 685 (4) 681 665 (40) 625 579 38 617<br />

Personal care 595 (5) 590 525 (28) 497 456 44 500<br />

Other Operations 80 1 81 99 (1) 98 65 5 70<br />

Speciality Chemicals 230 32 262<br />

10 110 110 110 110 110 110 110 110<br />

Total 2 939 (64) 2 875 3 032 (104) 2 928 2 857 206 3 063<br />

10 110 110 110 110 110 110 110 110<br />

Geographic analysis<br />

Turnover:<br />

United Kingdom and Netherlands 10 864 132 10 996 10 602 244 10 846 10 987 1 570 12 557<br />

United States 16 906 713 17 619 16 464 348 16 812 15 360 2 337 17 697<br />

Other 63 120 (1 439) 61 681 65 327 (3 873) 61 454 60 523 3 820 64 343<br />

10 110 110 110 110 110 110 110 110<br />

Total 90 890 (594) 90 296 92 393 (3 281) 89 112 86 870 7 727 94 597<br />

10 110 110 110 110 110 110 110 110<br />

Fixed assets:<br />

United Kingdom and Netherlands 3 281 3 545<br />

United States 3 673 3 311<br />

Other 14 217 12 139<br />

110 110<br />

Total 21 171 18 995<br />

0000000000000§0001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

2 Operating costs<br />

000000§00<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Cost <strong>of</strong> sales (49 010) (49 167) (52 358)<br />

Continuing operations (48 806) (49 167) (49 898)<br />

Acquisitions (204)<br />

Discontinued operations (2 460)<br />

Distribution and selling costs (22 312) (21 752) (22 300)<br />

Continuing operations (22 250) (21 752) (21 835)<br />

Acquisitions (62)<br />

Discontinued operations (465)<br />

Administrative expenses (9 492) (8 475) (12 376)<br />

Continuing operations (9 445) (8 475) (11 818)<br />

Acquisitions (47)<br />

Discontinued operations (558)<br />

1110 1110 1110<br />

(80 814) (79 394) (87 034)<br />

1110 1110 1110<br />

Operating costs include:<br />

Staff costs 3 (12 842) (13 370) (14 091)<br />

Raw materials and packaging<br />

Amortisation <strong>of</strong> goodwill and<br />

(38 634) (39 008) (41 519)<br />

intangibles<br />

Depreciation <strong>of</strong> tangible<br />

(50) (17) —<br />

fixed assets (2 479) (2 051) (2 336)<br />

Advertising and promotions (11 779) (11 432) (11 545)<br />

Research and development<br />

*Lease rentals:<br />

(2 060) (1 828) (1 734)<br />

Plant and machinery (241) (280) (280)<br />

Other<br />

Remuneration <strong>of</strong> auditors:<br />

(819) (678) (663)<br />

Audit fees<br />

Payments to<br />

PricewaterhouseCoopers<br />

(27) (23) (23)<br />

for non-audit services (a) (77) (66) (46)<br />

(a)<br />

1110 1110 1110<br />

Non-audit services include due diligence work in respect <strong>of</strong><br />

acquisitions and disposals Fl. 7 million (1998: Fl. 7 million, 1997:<br />

Fl. 5 million); tax compliance and advisory services Fl. 30 million<br />

(1998: Fl. 10 million, 1997: Fl. 8 million) and other general<br />

consultancy Fl. 40 million (1998: Fl. 49 million, 1997:<br />

Fl. 30million). Coopers & Lybrand were paid Fl. 19 million in 1997<br />

for services in connection with the sale <strong>of</strong> the speciality chemicals<br />

businesses. This amount was charged against the pr<strong>of</strong>it on disposal.<br />

*Lease rentals:<br />

Minimum lease payments (1 056) (967) (950)<br />

Contingent lease payments (25) (8) (9)<br />

1110 1110 1110<br />

(1 081) (975) (959)<br />

Less: Sub-lease income 21 17 16<br />

1110 1110 1110<br />

(1 060) (958) (943)<br />

00000000<br />

3 Staff costs and employees<br />

0§0000000<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Staff costs:<br />

Remuneration <strong>of</strong> employees (10 794) (11 251) (11 771)<br />

Emoluments <strong>of</strong> directors<br />

as managers (24) (26) (26)<br />

Pension costs:<br />

Defined benefit schemes:<br />

Regular cost (651) (650) (733)<br />

Other (245) (245) (285)<br />

Amortisation <strong>of</strong><br />

surpluses/deficits 32 534 626 651<br />

Defined contribution<br />

schemes (10) (35) (80)<br />

Post-retirement health benefits (129) (154) (111)<br />

Social security costs (1 523) (1 635) (1 727)<br />

Superannuation <strong>of</strong> former<br />

directors — — (9)<br />

1110 1110 1110<br />

Total staff costs (12 842) (13 370) (14 091)<br />

1110 1110 1110<br />

Details <strong>of</strong> the remuneration <strong>of</strong> directors which form part <strong>of</strong> these<br />

accounts are given in the following sections <strong>of</strong> the Remuneration<br />

report: ‘Directors’ pensions’ on pages 50 and 51; ‘Directors’<br />

emoluments’ on page 52; ‘Share options’ on pages 54 to 59 and<br />

‘Advisory Directors’ on page 54.<br />

The average number <strong>of</strong> employees<br />

during the year was, in thousands:<br />

Europe 79 83 93<br />

North America 22 23 27<br />

Africa and Middle East 52 58 61<br />

Asia and Pacific 72 73 76<br />

Latin America 30 30 30<br />

1110 1110 1110<br />

255 267 287<br />

00000§000<br />

4 Exceptional items<br />

00000§000<br />

Included in operating pr<strong>of</strong>it<br />

Restructuring (512) (585) (1 492)<br />

Other including business<br />

disposals (82) 861 (308)<br />

1110 1110 1110<br />

(594) 276 (1 800)<br />

1110 1110 1110<br />

By geographical area:<br />

Europe (213) 398 (850)<br />

North America (278) 86 (808)<br />

Africa and Middle East 32 (3) (10)<br />

Asia and Pacific (40) (115) (61)<br />

Latin America (95) (90) (71)<br />

1110 1110 1110<br />

(594) 276 (1 800)<br />

1110 1110 1110<br />

By operation:<br />

Foods – Oil & dairy based<br />

foods and bakery (165) (154) (725)<br />

– Ice cream and<br />

beverages (111) (168) (248)<br />

– Culinary and<br />

frozen foods (263) (112) (465)<br />

Home care and<br />

pr<strong>of</strong>essional cleaning (76) (135) (183)<br />

Personal care (81) (49) (177)<br />

Other Operations 102 894 —<br />

Speciality Chemicals — — (2)<br />

1110 1110 1110<br />

(594) 276 (1 800)<br />

1110 1110 1110<br />

These amounts are mainly included in administrative expenses.<br />

5110001110111110111110


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

4 Exceptional items (continued)<br />

0000000§0<br />

Exceptional items are those items within ordinary activities which,<br />

because <strong>of</strong> their size or nature, are disclosed to give a proper<br />

understanding <strong>of</strong> the underlying result for the period. These<br />

include restructuring charges associated with reorganising<br />

businesses (comprising impairment <strong>of</strong> fixed assets, costs <strong>of</strong><br />

severance, and other costs directly attributable to the<br />

restructuring), and pr<strong>of</strong>its and losses on disposal <strong>of</strong> businesses.<br />

Provisions for impairment <strong>of</strong> fixed assets are recognised<br />

immediately the decision to reorganise is taken; provisions for<br />

other costs are taken when the obligation arises – normally on<br />

announcement; consequential costs within restructuring which<br />

arise in the ongoing business eg training, relocation and<br />

information technology, are recognised as they arise and are not<br />

normally treated as exceptional.<br />

On 22 February 2000, the Group announced a series <strong>of</strong> linked<br />

initiatives to align the organisation behind plans for accelerating<br />

growth and expanding margins. These initiatives are estimated to<br />

cost Fl. 11.0 billion over five years, most <strong>of</strong> which is expected to<br />

be exceptional restructuring costs. Provisions for these costs and<br />

asset write downs will be made as necessary consultations are<br />

completed and plans finalised.<br />

5110001110111110111110<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Non-operating exceptional items<br />

Pr<strong>of</strong>it on sale <strong>of</strong> speciality<br />

chemicals businesses — — 8 482<br />

Loss on disposal <strong>of</strong> fixed assets — — (484)<br />

1110 1110 1110<br />

— — 7 998<br />

Of the above pr<strong>of</strong>it on sale <strong>of</strong> the speciality chemicals businesses<br />

Fl. 53 million is attributable to minority interests and is reported<br />

under this heading in the pr<strong>of</strong>it and loss account.<br />

00000000§<br />

5 Interest<br />

00000000§<br />

Interest payable and similar charges:<br />

Bank loans and overdrafts (350) (424) (306)<br />

Bonds and other loans (638) (424) (686)<br />

Interest receivable and<br />

similar income 929 1 187 857<br />

Exchange differences 29 5 (95)<br />

1110 1110 1110<br />

(30) 344 (230)<br />

000000§00<br />

6 Taxation on pr<strong>of</strong>it on ordinary activities<br />

000000§00<br />

Parent and group companies (a) (3 005) (3 333) (4 177)<br />

Joint ventures (12) (5) (8)<br />

1110 1110 1110<br />

(3 017) (3 338) (4 185)<br />

1110 1110 1110<br />

Of which:<br />

Tax on non-operating<br />

exceptional items — — (1 613)<br />

Tax on pr<strong>of</strong>it on sale <strong>of</strong><br />

discontinued speciality<br />

chemicals businesses — — (1 771)<br />

Tax on loss on disposal <strong>of</strong><br />

fixed assets in continuing<br />

businesses — — 158<br />

Adjustments to previous years 291 146 17<br />

6 Taxation on pr<strong>of</strong>it on ordinary activities (continued)<br />

0000000§0<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

(a) United Kingdom<br />

Corporation Tax at 30.0%<br />

(1998: 31.0%, 1997: 31.5%) (981) (803) (648)<br />

less: double tax relief 531 172 182<br />

plus: non-United Kingdom<br />

taxes (2 555) (2 702) (3 711)<br />

1110 1110 1110<br />

(3 005) (3 333) (4 177)<br />

1110 1110 1110<br />

Deferred taxation has been<br />

included on a full provision<br />

basis for:<br />

Accelerated depreciation 187 177 298<br />

Other 184 (125) 383<br />

1110 1110 1110<br />

371 52 681<br />

1110 1110 1110<br />

On a SSAP 15 basis the<br />

credit/(charge) for deferred<br />

taxation would be: 307 (87) 30<br />

Pr<strong>of</strong>it on ordinary activities after<br />

taxation on a SSAP 15 basis<br />

would be: 6 485 6 667 10 580<br />

1110 1110 1110<br />

Europe is <strong>Unilever</strong>’s domestic tax base. The reconciliation between<br />

the computed rate <strong>of</strong> income tax expense which is generally<br />

applicable to <strong>Unilever</strong>’s European companies and the actual rate<br />

<strong>of</strong> taxation charged, expressed in percentages <strong>of</strong> the pr<strong>of</strong>it <strong>of</strong><br />

ordinary activities before taxation, excluding both the pr<strong>of</strong>it and<br />

the tax on the pr<strong>of</strong>it on non-operating exceptional items, is<br />

as follows:<br />

5110001110111110111110<br />

%<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Computed rate <strong>of</strong> tax<br />

(see below) 32 32 31<br />

Differences due to:<br />

Other rates applicable to<br />

non-European countries 2 1 2<br />

Incentive tax credits (2) (1) (1)<br />

Withholding tax on dividends 2 1 1<br />

Adjustments to previous years (3) (1) —<br />

Other 1 1 2<br />

1110 1110 1110<br />

Actual rate <strong>of</strong> tax 32 33 35<br />

1110 1110 1110<br />

In the above reconciliation, the computed rate <strong>of</strong> tax is the<br />

average <strong>of</strong> the standard rate <strong>of</strong> tax applicable in the European<br />

countries in which <strong>Unilever</strong> operates, weighted by the amount <strong>of</strong><br />

pr<strong>of</strong>it on ordinary activities before taxation generated in each <strong>of</strong><br />

those countries.


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

6 Taxation on pr<strong>of</strong>it on ordinary activities (continued)<br />

0000000§0<br />

Analyses <strong>of</strong> European and non-European pr<strong>of</strong>it on ordinary<br />

activities before taxation, and <strong>of</strong> the actual taxation charge<br />

thereon, are as follows:<br />

5110001110111110111110<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Pr<strong>of</strong>it on ordinary activities<br />

before taxation<br />

Europe:<br />

Parent and group companies 5 173 5 845 7 212<br />

Joint ventures 27 12 24<br />

1110 1110 1110<br />

5 200 5 857 7 236<br />

1110 1110 1110<br />

Outside Europe:<br />

Group companies 4 312 4 230 8 146<br />

Joint ventures 54 57 34<br />

1110 1110 1110<br />

4 366 4 287 8 180<br />

1110 1110 1110<br />

Total 9 566 10 144 15 416<br />

1110 1110 1110<br />

Taxation on pr<strong>of</strong>it on<br />

ordinary activities<br />

Europe:<br />

Parent and group companies<br />

Taxes payable (1 675) (2 402) (1 972)<br />

Deferred taxation 283 237 300<br />

<strong>of</strong> which:<br />

Accelerated depreciation 209 262 90<br />

Other 74 (25) 210<br />

Joint ventures (10) (4) (5)<br />

1110 1110 1110<br />

(1 402) (2 169) (1 677)<br />

1110 1110 1110<br />

Outside Europe:<br />

Group companies<br />

Taxes payable (1 701) (983) (2 888)<br />

Deferred taxation 88 (185) 383<br />

<strong>of</strong> which:<br />

Accelerated depreciation (22) (85) 207<br />

Other 110 (100) 176<br />

Joint ventures (2) (1) (3)<br />

1110 1110 1110<br />

(1 615) (1 169) (2 508)<br />

1110 1110 1110<br />

Total (3 017) (3 338) (4 185)<br />

0000§0000<br />

7 Dividends on ordinary capital<br />

0000§0000<br />

Dividends on ordinary capital<br />

Interim (857) (831) (756)<br />

Normal final (1 886) (1 896) (1 521)<br />

Special final (a) (16 374)<br />

(a) Assuming all shareholders had elected to take the cash dividend,<br />

further details are set out in note 19 on page 79 and note 20 on<br />

page 80.<br />

0000§0000<br />

8 Goodwill and intangible assets (a)<br />

00000§000<br />

Fl. million<br />

11111050<br />

1999<br />

5110001110111110<br />

Cost<br />

1 January 641<br />

Acquisitions/disposals 731<br />

Currency retranslation 115<br />

1110<br />

31 December (b) 1 487<br />

1110<br />

Amortisation<br />

1 January 15<br />

Charged to pr<strong>of</strong>it and loss account 50<br />

Currency retranslation 4<br />

1110<br />

31 December 69<br />

1110<br />

Net book value 31 December (b) 1 418<br />

1110<br />

(a) Arising on businesses purchased after 1 January 1998.<br />

(b) Of which identifiable intangibles have a net book value <strong>of</strong><br />

Fl. 205 million and a cost <strong>of</strong> Fl. 220 million.<br />

§00000000<br />

9 Tangible fixed assets<br />

00§000000<br />

1999 1998<br />

5110001110111110 1110<br />

At cost less depreciation:<br />

Land and buildings (a) 6 019 5 631<br />

Plant and machinery 13 421 12 414<br />

1110 1110<br />

19 440 18 045<br />

1110 1110<br />

(a) includes: freehold land 722 675<br />

leasehold land<br />

(mainly long-term leases) 205 168<br />

1110 1110<br />

Approximate current replacement cost<br />

<strong>of</strong> tangible fixed asssets net <strong>of</strong><br />

accumulated current cost depreciation 22 559 21 255<br />

1110 1110<br />

On current replacement cost basis the<br />

depreciation charge to the pr<strong>of</strong>it and<br />

loss account would have been<br />

increased by (559) (565)<br />

1110 1110<br />

Commitments for capital expenditure<br />

at 31 December 547 627<br />

1110 1110


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

9 Tangible fixed assets (continued)<br />

00§000000<br />

Fl. million<br />

111011111050<br />

Movements during 1999 Land and Plant and<br />

buildings machinery<br />

5110001110111110 1110<br />

Cost<br />

1 January 8 145 25 228<br />

Currency retranslation 623 1 742<br />

Capital expenditure 374 2 501<br />

Disposals (413) (2 355)<br />

Acquisition/disposal <strong>of</strong><br />

group companies (101) (123)<br />

Other adjustments 20 (27)<br />

1110 1110<br />

31 December 8 648 26 966<br />

1110 1110<br />

Depreciation<br />

1 January 2 514 12 814<br />

Currency retranslation 169 809<br />

Disposals (283) (1 991)<br />

Acquisition/disposal <strong>of</strong><br />

group companies (38) (289)<br />

Charged to pr<strong>of</strong>it and loss account (b) 259 2 220<br />

Other adjustments 8 (18)<br />

1110 1110<br />

31 December 2 629 13 545<br />

1110 1110<br />

Net book value 31 December 6 019 13 421<br />

1110 1110<br />

Includes payments on account and<br />

assets in course <strong>of</strong> construction 178 881<br />

1110 1110<br />

(b) Including a charge <strong>of</strong> Fl. 385million in respect <strong>of</strong> certain fixed assets<br />

written down to net realisable value in connection with restructuring<br />

projects.<br />

00§000000<br />

10 Fixed investments<br />

00§000000<br />

Fl. million<br />

111011111050<br />

1999 1998<br />

5110001110 1110<br />

Share <strong>of</strong> joint ventures:<br />

Assets 147 166<br />

Liabilities (72) (99)<br />

1110 1110<br />

Net assets 75 67<br />

Other fixed investments 238 257<br />

1110 1110<br />

313 324<br />

1110 1110<br />

Investments listed on a<br />

recognised stock exchange 51 25<br />

Unlisted investments 262 299<br />

1110 1110<br />

313 324<br />

1110 1110<br />

Market value <strong>of</strong> listed<br />

investments 82 62<br />

1110 1110<br />

Movements during the year:<br />

1 January 324<br />

Acquisitions/disposals —<br />

Currency retranslation 15<br />

Additions/reductions (40)<br />

Share <strong>of</strong> pr<strong>of</strong>its <strong>of</strong><br />

joint ventures 14<br />

1110<br />

31 December 313<br />

1110<br />

10 Fixed investments (continued)<br />

00§000000<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Income from fixed investments<br />

Share <strong>of</strong> joint ventures<br />

operating pr<strong>of</strong>it 93 67 50<br />

Share <strong>of</strong> interest and<br />

other income (12) — 7<br />

1110 1110 1110<br />

Share <strong>of</strong> joint ventures<br />

pr<strong>of</strong>it before taxation 81 67 57<br />

Income from other<br />

fixed investments 21 15 26<br />

Pr<strong>of</strong>it on disposal 12 — 2<br />

1110 1110 1110<br />

114 82 85<br />

00§000000<br />

11 Stocks<br />

00§000000<br />

Raw materials<br />

and consumables 4 619 4 508<br />

Finished goods and goods<br />

for resale 6 672 5 953<br />

1110 1110<br />

11 291 10 461<br />

00§000000<br />

12 Debtors<br />

00§000000<br />

Due within one year:<br />

Trade debtors 9 287 8 204<br />

Prepayments and accrued<br />

income 863 795<br />

Other debtors 2 503 2 298<br />

1110 1110<br />

12 653 11 297<br />

1110 1110<br />

Due after more than one year:<br />

Prepayments to funded<br />

pension schemes 17 1 350 1 258<br />

Deferred taxation 18 2 596 1 939<br />

Other debtors 336 355<br />

1110 1110<br />

4 282 3 552<br />

1110 1110<br />

Total debtors 16 935 14 849<br />

00§000000<br />

13 Current investments<br />

00§000000<br />

Listed 2 946 10 711<br />

Unlisted 308 159<br />

1110 1110<br />

3 254 10 870<br />

1110 1110<br />

Current investments includes short-term deposits, government<br />

securities and A- or higher rated money and capital market<br />

instruments.<br />

00§000000


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

14 Cash at bank and in hand<br />

Fl. million<br />

111050<br />

1999 1998<br />

5 1 1 0 0 0 1 1 1 0 0 0 0 0 § 0 0 0 1 1 0 1 111§1110 1110<br />

On call and in hand 3 032 2 047<br />

Repayment notice required 5 775 9 964<br />

1110 1110<br />

8 807 12 011<br />

1110 1110<br />

Interest rate pr<strong>of</strong>ile and currency analysis <strong>of</strong> financial assets<br />

Taking into account the various interest rate swaps, forward rate agreements and forward foreign currency contracts entered into by<br />

the Group, the table below sets out the interest rate pr<strong>of</strong>ile <strong>of</strong> the Group’s financial assets analysed by principal currency:<br />

00000000000000001111<br />

15 Borrowings<br />

00000000<br />

Fl. million<br />

111050<br />

1999 1998<br />

5110001110111110 1110<br />

Bank loans and overdrafts 4 551 4 064<br />

Bonds and other loans 6 002 6 082<br />

1110 1110<br />

10 553 10 146<br />

1110 1110<br />

The repayments fall due as follows:<br />

Within 1 year:<br />

Bank loans and overdrafts 4 063 3 686<br />

Bonds and other loans 2 406 1 437<br />

1110 1110<br />

Total due within one year 6 469 5 123<br />

1110 1110<br />

After 1 year but within 2 years 1 777 1 317<br />

After 2 years but within 3 years 105 1 648<br />

After 3 years but within 4 years 57 15<br />

After 4 years but within 5 years 1 535 14<br />

After 5 years: By instalments 8 7<br />

Not by instalments 602 2 022<br />

1110 1110<br />

Total due after more than one year 4 084 5 023<br />

1110 1110<br />

Total amount repayable by instalments<br />

any <strong>of</strong> which are payable after five years 54 53<br />

1110 1110<br />

Secured borrowings – mainly<br />

bank loans and overdrafts 113 286<br />

1110 1110<br />

Of which secured against<br />

tangible fixed assets 61 99<br />

1110 1110<br />

Fixed rate Floating rate Total<br />

000511100 11150 11150<br />

Weighted Weighted<br />

average average<br />

Fl. million interest rate fixing period Fl. million Fl. million<br />

00000011111111150 11150 11150 11150 11150<br />

1999<br />

Sterling 177 5.3% 0.1 years 1 305 1 482<br />

USDollar — — — 2 042 2 042<br />

Euro 2 428 4.8% 1.0 years 3 829 6 257<br />

Other — — — 2 280 2 280<br />

11150 11150 11150 11150 11150<br />

Total 2 605 9 456 12 061<br />

11150 11150 11150<br />

1998<br />

Sterling 1 202 6.6% 1.1 years 3 256 4 458<br />

USDollar — — — 4 973 4 973<br />

Euro 6 547 5.1% 0.9 years 5 342 11 889<br />

Other — — — 1 561 1 561<br />

11150 11150 11150 11150 11150<br />

Total 7 749 15 132 22 881<br />

11150 11150 11150<br />

Interest on substantially all <strong>of</strong> the floating rate financial assets above is determined principally by reference to the 3 months LIBOR.<br />

In addition to the above, the Group has other fixed investments <strong>of</strong> Fl. 238 million (1998: Fl. 257 million) which are non-interest bearing<br />

and have no fixed repayment date.<br />

00000000000000001111<br />

15 Borrowings (continued)<br />

00000000<br />

Fl. million<br />

111050<br />

1999 1998<br />

5110001110111110 1110<br />

Bonds and other loans<br />

NV<br />

8% Notes 1999 (US $) — 375<br />

9% Bonds 2000 (NLG) (a) 486 485<br />

3 1 ⁄2% Bonds 2001 (Swiss Frs.) (b) 411 414<br />

5 1 ⁄8% Notes 2001 (Deutschmarks) (c) 337 338<br />

6% Notes 2001 (US $) (d) 440 375<br />

6 5 ⁄8% Notes 2001 (US $) (d) 550 469<br />

6 1 ⁄2% Bonds 2004 (NLG) (a) 351 350<br />

7 1 ⁄8% Bonds 2004 (French Frs.) (e) 503 504<br />

7 1 ⁄4% Bonds 2004 (US $) (d) 550 469<br />

6 5 ⁄8% Notes 2005 (US $) (d) 440 375<br />

Other 912 879<br />

1110 1110<br />

Total NV 4 980 5 033<br />

1110 1110


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

15 Borrowings (continued)<br />

0000§0000000000001111<br />

Fl. million<br />

111050<br />

1999 1998<br />

5 1 1 0 0 0 1 1 1 0 0 0 0 0 § 0 0 0 1 1 0 1 111§1110 1110<br />

Other group companies:<br />

United States<br />

9 1 ⁄4% Notes 2000 (d) 878 749<br />

Other 16 6<br />

Other loans 128 294<br />

1110 1110<br />

Total other group companies 1 022 1 049<br />

1110 1110<br />

Total bonds and other loans 6 002 6 082<br />

1110 1110<br />

Swapped into:<br />

(a) floating rate guilders (range 2.9%-3.2% at 31 December 1999)<br />

(b) floating rate guilders (3.1% at 31 December 1999) and United States dollars (5.8% at 31 December 1999)<br />

(c) floating rate Deutschmarks (3.0% at 31 December 1999) and fixed rate Canadian dollars (6.7%)<br />

(d) floating rate United States dollars (range 5.8%-7.5% at 31December 1999)<br />

(e) floating rate French francs (7.9% at 31 December 1999)<br />

Derivative financial instruments are used to swap portions <strong>of</strong> the fixed rate debt described above into floating rate debt. Further details<br />

are set out in note 29 on page 88.<br />

The average interest rate on short-term borrowings in 1999 was 9% (1998: 8%).<br />

The day to day financing <strong>needs</strong> <strong>of</strong> <strong>Unilever</strong>’s operating companies are met using short-term overdraft facilities, substantially all <strong>of</strong><br />

which are uncommitted. In addition, at 31 December 1999 <strong>Unilever</strong> had committed borrowing facilities <strong>of</strong> Fl. 611 million, all <strong>of</strong> which<br />

mature within one year.<br />

Interest rate pr<strong>of</strong>ile and currency analysis <strong>of</strong> financial liabilities<br />

Taking into account the various interest rate swaps, forward rate agreements and forward foreign currency contracts entered into by<br />

the Group, the table below sets out the interest rate pr<strong>of</strong>ile <strong>of</strong> the Group’s financial liabilities analysed by principal currency:<br />

00000000000000001111<br />

Fixed rate Floating rate Total<br />

000511100 11150 11150<br />

Weighted Weighted<br />

average average<br />

Fl. million interest rate fixing period Fl. million Fl. million<br />

00000011111111150 11150 11150 11150 11150<br />

1999<br />

US Dollar — — — 3 325 3 325<br />

Euro 106 6.6% 5.5 years 4 523 4 629<br />

Sterling — — — 269 269<br />

Other 529 6.6% 3.0 years 1 801 2 330<br />

11150 11150 11150 11150 11150<br />

Total 635 9 918 10 553<br />

11150 11150 11150<br />

1998<br />

US Dollar 2 063 6.9% 3.5 years 1 861 3 924<br />

Euro 677 7.2% 5.5 years 3 191 3 868<br />

Sterling — — — 66 66<br />

Other 621 7.0% 2.5 years 1 667 2 288<br />

11150 11150 11150 11150 11150<br />

Total 3 361 6 785 10 146<br />

11150 11150 11150<br />

Interest on substantially all <strong>of</strong> the floating rate financial liabilities above is determined principally by reference to LIBOR.<br />

In addition to the above, the Group has preference shares denominated in guilders, which have no fixed repayment date. Details <strong>of</strong> the<br />

dividends payable on these preference shares are given in note 20 on page 80.<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

16 Trade and other creditors<br />

0000§0000<br />

Fl. million<br />

111050<br />

1999 1998<br />

5110001110111110 1110<br />

Due within one year:<br />

Trade creditors 8 933 7 688<br />

Social security and sundry taxes 924 869<br />

Accruals and deferred income 4 618 4 040<br />

Taxation on pr<strong>of</strong>its 1 405 1 422<br />

Dividends (a) 1 970 1 872<br />

Others 2 421 2 586<br />

1110 1110<br />

20 271 18 477<br />

1110 1110<br />

Due after more than one year:<br />

Accruals and deferred income 301 272<br />

Taxation on pr<strong>of</strong>its 1 459 1 147<br />

Others 397 260<br />

1110 1110<br />

2 157 1 679<br />

1110 1110<br />

Total creditors 22 428 20 156<br />

1110 1110<br />

(a) Excludes the special dividend.<br />

0000§0000<br />

17 Pensions and similar obligations<br />

0000§0000<br />

These are predominantly long-term liabilities:<br />

Unfunded pension plans 4 829 4 681<br />

Funded pension plans (680) (990)<br />

Post-retirement health benefits 1 797 1 560<br />

1110 1110<br />

5 946 5 251<br />

Add asset balances reclassified as debtors<br />

after more than one year 12 1 350 1 258<br />

1110 1110<br />

7 296 6 509<br />

1110 1110<br />

Movements during the year:<br />

1 January 5 251<br />

Currency retranslation 196<br />

Pr<strong>of</strong>it and loss account 501<br />

Payments (a) (70)<br />

Acquisitions/disposals (15)<br />

Other adjustments 83<br />

1110<br />

31 December 5 946<br />

1110<br />

(a) Net <strong>of</strong> refunds received from pension funds totalling Fl. 587million.<br />

Further details <strong>of</strong> <strong>Unilever</strong>’s pension and post-retirement benefits<br />

are given in note 32 on pages 91 to 93.<br />

0000§0000<br />

18 Deferred taxation and other provisions<br />

0000§0000<br />

Fl. million<br />

111050<br />

1999 1998<br />

5110001110111110 1110<br />

Deferred taxation on:<br />

Accelerated depreciation 2 527 2 547<br />

Stock reliefs 153 126<br />

Pension and similar provisions (1 226) (1 016)<br />

Short-term and other timing differences (2 430) (2 305)<br />

1110 1110<br />

(976) (648)<br />

Less asset balances reclassified as debtors<br />

due after more than one year 12 2 596 1 939<br />

1110 1110<br />

1 620 1 291<br />

Restructuring provisions 800 1 216<br />

Other provisions 381 491<br />

1110 1110<br />

2 801 2 998<br />

1110 1110<br />

Movements in deferred taxation:<br />

1 January (648)<br />

Currency retranslation 45<br />

Acquisition/disposal <strong>of</strong> group companies (2)<br />

Pr<strong>of</strong>it and loss account (371)<br />

1110<br />

31 December (976)<br />

1110<br />

On a SSAP 15 basis provision for<br />

deferred taxation would be: (404) (148)<br />

1110 1110<br />

Movements in restructuring provisions:<br />

1 January 1 216<br />

Currency retranslation 18<br />

Pr<strong>of</strong>it and loss account:<br />

new charges 438<br />

releases (130)<br />

Utilisation (742)<br />

1110<br />

31 December 800<br />

1110<br />

Restructuring provisions include primarily<br />

provisions for severance costs in connection<br />

with business reorganisations which have<br />

been announced.<br />

Movements in other provisions:<br />

1 January 491<br />

Currency retranslation 35<br />

Acquisition/disposal <strong>of</strong> group companies (1)<br />

Pr<strong>of</strong>it and loss account (34)<br />

Utilisation (110)<br />

1110<br />

31 December 381<br />

0000§0000


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

19 Capital and reserves<br />

0000§0000<br />

Fl. million<br />

111011111050<br />

1999 1998 1997<br />

5110001110 1110 1110<br />

Movements during the year:<br />

1 January 10 464 24 734 15 350<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 3 319 (12 628) 8 631<br />

Goodwill written back on<br />

the sale <strong>of</strong> speciality<br />

chemicals businesses — — 1 729<br />

Other goodwill movements 83 6 (1 606)<br />

Currency retranslation 774 (1 329) 701<br />

Change <strong>of</strong> book value <strong>of</strong><br />

shares or certificates held<br />

in connection with share<br />

options (582) (319) (72)<br />

Issue <strong>of</strong> new shares under<br />

PLC share option schemes 2 — 1<br />

Issue <strong>of</strong> new NV preference<br />

shares 3 045<br />

1110 1110 1110<br />

31 December 17 105 10 464 24 734<br />

1110 1110 1110<br />

As required by United Kingdom<br />

Financial Reporting Standard 4<br />

capital and reserves can be<br />

analysed as follows:<br />

Equity:<br />

Ordinary capital 13 795 10 199<br />

Non-equity:<br />

7% Cumulative Preference 29 29<br />

6% Cumulative Preference 161 161<br />

4% Cumulative Preference 75 75<br />

10 cents Cumulative Preference 3 045<br />

1110 1110<br />

Total non-equity 3 310 265<br />

1110 1110<br />

17 105 10 464<br />

1110 1110<br />

Share capital and share premium<br />

On 9 June 1999 NV issued 211 473 785 cumulative preference<br />

shares to those shareholders who elected to receive shares<br />

instead <strong>of</strong> the special dividend. The 10 cents cumulative<br />

preference shares were issued at a notional value <strong>of</strong> Fl. 14.50 per<br />

share, which is equal to the amount <strong>of</strong> the special dividend, <strong>of</strong><br />

which Fl. 14.40 was credited to the share premium account.<br />

Further details are set out in note 20 on page 80 and in the share<br />

premium account note on page 112.<br />

The issued share capital <strong>of</strong> NV increased by Fl. 21 million as a<br />

result <strong>of</strong> the issue <strong>of</strong> the 10 cents cumulative preference shares.<br />

NV share premium account increased by Fl. 3 024 million after<br />

charging issue costs <strong>of</strong> Fl. 21 million.<br />

A small number <strong>of</strong> PLC shares were allotted during the year<br />

under the PLC 1985 Executive Share Option Schemes.<br />

0000§0000


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

20 Called up share capital<br />

0000§0000000000001111<br />

Nominal Number Allotted,<br />

value <strong>of</strong> shares called up and<br />

Authorised per share allotted fully paid<br />

00111111111 000000051111 11 1111105 0051111<br />

1999 1998 1999 1998<br />

01111 0111 10111 0111<br />

Preferential share capital<br />

Fl. million NV Fl. million<br />

11110111110 11110111110<br />

75 75 7% Cumulative Preference Fl. 1 000 29 000 (a) 29 29<br />

200 200 6% Cumulative Preference Fl. 1 000 161 060 (a) 161 161<br />

75 75 4% Cumulative Preference Fl. 100 750 000 (a) 75 75<br />

65 10 cents Cumulative Preference Fl. 0.10 211 473 785 21<br />

01111 0111 10111 0111<br />

415 350 286 265<br />

01111 0111 10111 0111<br />

Ordinary share capital<br />

Fl. million NV Fl. million<br />

11110111110 11110111110<br />

1 120 Ordinary: (1999) Fl. 1.12 571 575 900 640<br />

1 000 (1998) Fl. 1 640 165 000 (a) 640<br />

2 2 Ordinary (Shares numbered<br />

1 to 2 400 – ‘Special Shares’) Fl. 1 000 2 400 (a) 2 2<br />

— — Internal holdings eliminated in consolidation (Fl. 1 000 shares) (2) (2)<br />

01111 0111 10111 0111<br />

1 122 1 002 640 640<br />

01111 0111 10111 0111<br />

Total NV share capital 926 905<br />

10111 0111<br />

£ million PLC £ million<br />

11110111110 11110111110<br />

136.2 Ordinary: (1999) 1.4p 2 911 458 580 40.8<br />

136.2 (1998) 1.25p 3 260 695 640 (b) 40.8<br />

(1997) 1.25p 3 260 613 800 (b)<br />

(1996) 1.25p 3 260 395 172 (b)<br />

0.1 0.1 Deferred £1 stock 100 000 (a) 0.1 0.1<br />

— — Internal holdings eliminated in consolidation (£1 stock) (0.1) (0.1)<br />

01111 0111 10111 0111<br />

136.3 136.3 Total PLC share capital 40.8 40.8<br />

01111 0111 10111 0111<br />

Guilder equivalent in millions (at Fl. 12 = £1) 489 489<br />

(a) The number <strong>of</strong> these shares in issue was the same for each <strong>of</strong> the years 1995 to 1998.<br />

(b) The increase in PLC ordinary shares and share premium account is due to the issue <strong>of</strong> shares under the PLC 1985 Executive Share Option Schemes.<br />

0000§0000000000001111<br />

The 7%, 6% and 4% preference shares <strong>of</strong> NV are entitled to dividends at the rates indicated. The 10 cents preference shares <strong>of</strong> NV<br />

are entitled to a dividend <strong>of</strong> 65% <strong>of</strong> the six months Euribor interest rate on their notional value <strong>of</strong> Fl. 14.50 each. A nominal dividend<br />

<strong>of</strong> 1 ⁄4% is paid on the deferred stock <strong>of</strong> PLC.<br />

The 4% cumulative preference capital <strong>of</strong> NV is redeemable at par at the Company‘s option either wholly or in part. The company has<br />

agreed that it will not buy back the 10 cents cumulative preference share capital <strong>of</strong> NV before 9 June 2004. At any time after this<br />

date, at the Company’s option, Fl. 14.40 <strong>of</strong> the notional value <strong>of</strong> the preference shares is convertible into ordinary NV shares and the<br />

remaining notional value is then redeemable. The Company expects to exercise the conversion right if any preference shares remain<br />

outstanding after 1 December 2004. The other classes <strong>of</strong> preferential share capital <strong>of</strong> NV and the deferred stock <strong>of</strong> PLC are not<br />

redeemable.<br />

Each shareholder <strong>of</strong> NV has one vote for each Fl. 0.10 <strong>of</strong> capital held <strong>of</strong> whatever class. Each shareholder <strong>of</strong> PLC has one vote for each<br />

1.4p <strong>of</strong> capital held. N.V. Elma and United Holdings Limited (see ‘Internal holdings’ on page 81) may not, by law, exercise any votes in<br />

general meetings <strong>of</strong> shareholders <strong>of</strong> NV, and United Holdings Limited may not exercise any votes in general meetings <strong>of</strong> PLC.<br />

In accordance with the Equalisation Agreement and the Articles <strong>of</strong> Association <strong>of</strong> NV and PLC, if either or both companies go into<br />

liquidation, the amounts available for distribution amongst shareholders are applied firstly to the repayment <strong>of</strong> preferential capital and<br />

arrears <strong>of</strong> dividends on preferential capital, and secondly to the distribution to ordinary shareholders <strong>of</strong> any reserves that have arisen<br />

under the Equalisation Agreement. Any remaining surplus is then pooled and distributed amongst the holders <strong>of</strong> ordinary shares <strong>of</strong><br />

both companies such that the amount payable on each Fl. 12 nominal <strong>of</strong> ordinary capital <strong>of</strong> NV is equal at the relevant rate <strong>of</strong><br />

exchange to the amount payable on each £1 nominal <strong>of</strong> ordinary capital <strong>of</strong> PLC. The holders <strong>of</strong> PLC‘s deferred stock are only entitled<br />

to repayment <strong>of</strong> capital.<br />

The reduction in the number <strong>of</strong> NV and PLC ordinary shares in issue during the year, and the change in the nominal values <strong>of</strong> the<br />

shares, arises from the consolidation <strong>of</strong> the ordinary share capitals, which together with the payment <strong>of</strong> a special dividend, was<br />

approved at the Annual General <strong>Meeting</strong> <strong>of</strong> each company on 4 May 1999. The consolidation <strong>of</strong> the NV ordinary shares was on the<br />

basis <strong>of</strong> 100 new shares <strong>of</strong> Fl. 1.12 each for every 112 existing shares <strong>of</strong> Fl. 1 each, and the consolidation <strong>of</strong> the PLC shares was on<br />

the basis <strong>of</strong> 100 new shares <strong>of</strong> 1.4p each for every 112 existing shares <strong>of</strong> 1.25p each.<br />

Under the arrangements for the variation <strong>of</strong> the Leverhulme Trust, shares in a group company have been issued which are convertible<br />

at the end <strong>of</strong> the year 2038 into a maximum <strong>of</strong> 207 500 000 ordinary shares <strong>of</strong> PLC.


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

20 Called up share capital (continued)<br />

0000§0000000000001111<br />

Internal holdings<br />

The ordinary shares numbered 1 to 2 400 (inclusive) in NV and deferred stock <strong>of</strong> PLC are held as to one half <strong>of</strong> each class by N.V. Elma<br />

– a subsidiary <strong>of</strong> NV – and one half by United Holdings Limited – a subsidiary <strong>of</strong> PLC. This capital is eliminated in consolidation. It<br />

carries the right to nominate persons for election as directors at general meetings <strong>of</strong> shareholders. The above mentioned subsidiaries<br />

have waived their rights to dividends on their ordinary shares in NV.<br />

The directors <strong>of</strong> N.V. Elma are NV and PLC, who with Mr A Burgmans and Mr N W A FitzGerald, are also directors <strong>of</strong> United Holdings<br />

Limited.<br />

Share options<br />

Options granted to directors and employees to acquire ordinary shares <strong>of</strong> NV and PLC and still outstanding at 31 December 1999 were<br />

as set out in the following table. The number <strong>of</strong> share options outstanding did not change as a result <strong>of</strong> the share consolidation.<br />

000000000000111111111501111150<br />

Number Range <strong>of</strong> option Date normally<br />

<strong>of</strong> shares prices per share exercisable<br />

0000000001111 000111 000111<br />

NV Executive Share Option Scheme 303 152 €22.82–€25.69 2000<br />

(Shares <strong>of</strong> Fl. 1.12) 477 716 €26.55–€32.49 2000–2001<br />

336 448 €42.79 2000–2002<br />

530 026 €64.98–€69.29 2000–2003<br />

1 131 315 €63.50 2000–2009<br />

(Shares <strong>of</strong> 1.4p) 2 224 588 £4.07 2000–2002<br />

3 490 157 £6.09–£6.68 2000–2003<br />

7 378 275 £5.55 2000–2009<br />

0000000001111 000111 000111<br />

North American Executive Stock Option Plan 43 000 US $ 25.69 2000–2002<br />

(Shares <strong>of</strong> Fl. 1.12 <strong>of</strong> the New York Registry) 117 236 US $ 26.81 2000–2003<br />

225 398 US $ 25.67 2000–2004<br />

293 366 US $ 31.60–US $ 31.95 2000–2005<br />

413 140 US $ 33.89 2000–2006<br />

317 420 US $ 48.74 2000–2007<br />

260 023 US $ 76.69 2000–2008<br />

293 888 US $ 69.19 2000–2009<br />

(Shares <strong>of</strong> 1.4p in the form <strong>of</strong> American Depositary Receipts) 2 122 188 US $ 6.72 2000–2007<br />

1 740 116 US $ 10.85 2000–2008<br />

1 968 176 US $ 9.30 2000–2009<br />

0000000001111 000111 000111<br />

PLC 1985 Executive Share Option Schemes 29 264 £1.84 2000<br />

(Shares <strong>of</strong> 1.4p) 254 840 £2.07–£2.27 2000–2001<br />

324 316 £2.54–£2.62 2000–2002<br />

991 355 £2.54–£2.83 2000–2003<br />

1 568 052 £2.83–£2.98 2000–2004<br />

2 149 600 £3.07–£3.08 2000–2005<br />

749 460 £3.43–£4.07 2000–2006<br />

6 620 £4.53 2000–2007<br />

282 976 £6.68–£6.79 2001–2007<br />

550 506 £5.55 2002–2009<br />

0000000001111 000111 000111<br />

PLC International 1997 Executive Share Option Scheme 209 276 €42.79 2000–2006<br />

(Shares <strong>of</strong> Fl. 1.12) 1 436 €49.63 2000–2007<br />

325 916 €69.29–€73.97 2001–2007<br />

541 373 €63.50 2002–2009<br />

(Shares <strong>of</strong> 1.4p) 1 347 964 £4.07 2000–2006<br />

2 656 £4.53 2000–2007<br />

1 853 054 £6.68–£6.79 2001–2007<br />

3 017 619 £5.55 2002–2009<br />

0000000001111 000111 000111<br />

NV Employee Share Option Scheme 43 970 €23.08 2000<br />

(Shares <strong>of</strong> Fl. 1.12) 56 753 €31.19 2000–2001<br />

58 766 €42.99 2000–2002<br />

259 199 €57.63 2003<br />

272 150 €63.65 2004<br />

0000000001111 000111 000111<br />

North American Employee Stock Purchase Plan<br />

(Shares <strong>of</strong> Fl. 1.12 <strong>of</strong> the New York Registry) 633 913 US $ 52.43 2000–2001<br />

0000000001111 000111 000111<br />

PLC 1985 Sharesave Scheme 127 864 £2.29 2000<br />

(Shares <strong>of</strong> 1.4p) 5 286 263 £2.68 2000–2001<br />

5 883 004 £2.78 2001–2002<br />

8 325 975 £3.71 2002–2003<br />

5 107 309 £5.94 2003–2004<br />

6 046 903 £5.14 2004–2005<br />

0000000001111 000111 000111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

20 Called up share capital (continued)<br />

0000§0000000000001111<br />

Options granted to directors and employees to acquire ordinary shares <strong>of</strong> NV and PLC which were exercised during the years ended<br />

31 December 1997, 1998 and 1999 were as follows:<br />

0000§0000000000001111<br />

Exercised Exercised Exercised<br />

In 1997 in 1998 in 1999<br />

51110 51110 51110<br />

Date Option price Number <strong>of</strong> Number <strong>of</strong> Number <strong>of</strong><br />

granted per share shares shares shares<br />

000000115511000 51110 51110 51110<br />

NV Executive Share Option Scheme 1992 Fl. 46.25 90 728 — —<br />

(Shares <strong>of</strong> Fl. 1.12) 1992 Fl. 46.80 59 068 — —<br />

1993 Fl. 49.28 167 944 65 300 —<br />

1993 Fl. 55.35 38 796 8 632 —<br />

1994 Fl. 48.00 268 804 118 160 91 884<br />

1994 Fl. 48.70 31 508 48 072 23 528<br />

1994 Fl. 51.27 33 356 — 8 120<br />

1995 Fl. 50.30 30 656 161 740 51 148<br />

1995 Fl. 56.63 27 140 63 060 49 360<br />

1996 Fl. 58.52 8 228 11 908 108 628<br />

1996 Fl. 71.62 3 040 13 172 2 208<br />

1997 Fl. 94.30 — 200 8 776<br />

(Shares <strong>of</strong> 1.4p) 1997 £4.07 — 1 320 58 352<br />

000000115511000 51110 51110 51110<br />

North American Executive Stock Option Plan 1992 US $ 25.69 77 400 33 000 5 800<br />

(Shares <strong>of</strong> Fl. 1.12 <strong>of</strong> the New York Registry) 1993 US $ 26.81 125 916 61 892 5 300<br />

1994 US $ 25.67 186 872 76 308 3 718<br />

1995 US $ 31.95 161 585 92 337 3 516<br />

1996 US $ 33.89 133 660 22 200 4 800<br />

1997 US $ 48.74 — 6 065 799<br />

(Shares <strong>of</strong> 1.4p in the form <strong>of</strong><br />

American Depositary Receipts) 1997 US $ 6.72 — 40 552 5 356<br />

000000115511000 51110 51110 51110<br />

PLC 1985 Executive Share Options Schemes 1988 £1.09 114 832 — —<br />

(Shares <strong>of</strong> 1.4p) 1989 £1.34 35 376 43 140 —<br />

1990 £1.62 68 420 38 700 81 348<br />

1990 £1.66 — — 46 840<br />

1991 £1.84 233 848 58 896 57 336<br />

1991 £1.83 214 612 15 368 20 840<br />

1991 £2.07 125 748 — 33 612<br />

1992 £2.27 829 128 182 112 103 072<br />

1992 £2.62 163 420 47 596 15 236<br />

1993 £2.54 502 620 134 856 154 496<br />

1993 £2.78 85 404 20 092 —<br />

1994 £2.83 113 944 113 164 171 780<br />

1994 £2.54 1 038 684 247 552 111 693<br />

1994 £2.83 61 184 140 984 —<br />

1995 £2.98 2 752 347 944 126 492<br />

1995 £3.07 10 812 153 424 —<br />

1996 £3.08 — 115 420 123 324<br />

1996 £3.43 — 66 148 —<br />

000000115511000 51110 51110 51110<br />

PLC International 1997 Executive 1997 Fl. 94.30 — 2 400 6 140<br />

Share Option Scheme 1998 Fl. 152.70 — — 160<br />

(Share <strong>of</strong> Fl. 1.12) 1999 Fl. 139.94 — — 4 900<br />

(Shares <strong>of</strong> 1.4p) 1997 £4.07 — 16 000 40 600<br />

000000115511000 51110 51110 51110<br />

NV Employee Share Option Scheme 1995 Fl. 50.87 47 414 9 760 17 296<br />

(Shares <strong>of</strong> Fl. 1.12) 1996 Fl. 68.75 49 022 12 282 12 311<br />

1997 Fl. 94.75 7 080 15 261 9 629<br />

1998 Fl. 127.00 — 1 892 9 763<br />

1999 Fl. 140.27 — — 4 601<br />

000000115511000 51110 51110 51110<br />

PLC 1985 Sharesave Scheme 1991 £1.46 789 884 — —<br />

(Shares <strong>of</strong> 1.4p) 1992 £1.82 11 912 048 487 891 —<br />

1993 £2.28 636 079 5 160 748 190 561<br />

1994 £2.29 380 839 586 407 3 556 228<br />

1995 £2.68 484 543 590 956 383 370<br />

1996 £2.78 399 239 317 218 187 593<br />

1997 £3.71 1 552 49 281 176 932<br />

1998 £5.94 — 35 26 634<br />

000000115511000 51110 51110 51110


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

20 Called up share capital (continued)<br />

0000§0000000000001111<br />

Exercised Exercised Exercised<br />

In 1997 in 1998 in 1999<br />

51110 51110 51110<br />

Date Option price Number <strong>of</strong> Number <strong>of</strong> Number <strong>of</strong><br />

granted per share shares shares shares<br />

000000115511000 51110 51110 51110<br />

<strong>Unilever</strong> Savings Related Share Option<br />

Scheme (Ireland) (Shares <strong>of</strong> 1.4p) 1991 Ir£2.19 432 192 — —<br />

000000115511000 51110 51110 51110<br />

North American Employee Stock Purchase Plan<br />

(Shares <strong>of</strong> Fl. 1.12 <strong>of</strong> the New York Registry) 1995 US $ 28.89 969 724 — —<br />

1997 US $ 47.83 — — 701 897<br />

000000115511000 51110 51110 51110<br />

All numbers <strong>of</strong> shares, and their option prices, have been adjusted to reflect the sub-division <strong>of</strong> each share into four shares, on<br />

13 October 1997, each option having an option price one fourth <strong>of</strong> the previous option price.<br />

To satisfy options granted under NV share option schemes and under North American stock option/purchase plans, certain group<br />

companies hold certificates or depositary receipts <strong>of</strong> ordinary shares <strong>of</strong> NV and <strong>of</strong> PLC. At 31 December 1999 there were options<br />

outstanding to purchase 6 066 879 Fl. 1.12 ordinary NVshares (1998: 9 670 233 Fl. 1 ordinary NV shares), and 18 923 500 1.4p<br />

ordinary PLC shares (1998: 4 949 657 1.25p ordinary PLC shares) in respect <strong>of</strong> these schemes and plans.<br />

To satisfy options granted under the share option schemes in the United Kingdom, trusts in Jersey and the United Kingdom purchase<br />

and hold PLC shares. The book value <strong>of</strong> these shares, together with the borrowings <strong>of</strong> the trusts, is taken up in the entity accounts <strong>of</strong><br />

PLC, as required by UITF Abstract 13. The trustees <strong>of</strong> these trusts have agreed, until further notice, to waive dividends on these shares,<br />

save for the nominal sum <strong>of</strong> 0.01p per 1.4p ordinary share. At 31 December 1999 there were options outstanding to purchase<br />

1 078 001 Fl. 1.12 ordinary NV shares (1998: 546 328 Fl. 1 ordinary NV shares), and 43 905 600 1.4p ordinary PLC shares<br />

(1998: 42 720 873 1.25p ordinary PLC shares) in respect <strong>of</strong> these schemes.<br />

At 31 December 1998 the Jersey trust held ordinary shares <strong>of</strong> NV for the purposes <strong>of</strong> share option schemes in the United Kingdom.<br />

During 1999 its holding <strong>of</strong> NV shares was sold to NV, subject to an agreement to reacquire the shares at book value when needed to<br />

satisfy the exercise <strong>of</strong> the options. As a result the shares became NV ‘treasury’ shares, on which no dividend is payable.<br />

The book value <strong>of</strong> all shares held in respect <strong>of</strong> stock option schemes is eliminated on consolidation by deduction from other reserves<br />

(see note 22 on page 84).<br />

By PLC trusts By NV/Group companies<br />

51110111511110 511101511110<br />

1999 1998 1999 1998<br />

0000000011111511110 51110 51110 51110<br />

Number <strong>of</strong> ordinary PLC shares held (1999: 1.4p, 1998: 1.25p) 42 492 210 39 623 389 19 031 246 9 750 637<br />

Number <strong>of</strong> ordinary NV shares held (1999: Fl. 1.12, 1998: Fl. 1) — 551 802 7 225 674 5 152 836<br />

Book value <strong>of</strong> shares held Fl. million 638 537 1 196 593<br />

Market value <strong>of</strong> shares held Fl. million 605 859 1 144 1 032<br />

5111110 51110 51110 51110<br />

At 31 December 1999 the exercise price <strong>of</strong> 31 435 091 PLC options and 4 247 803 NV options was above market price. These shares<br />

are accounted for in accordance with Dutch law. Any difference between the book value <strong>of</strong> the shares and the proceeds received<br />

when the shares are sold will be dealt with in reserves. Any difference between the cost <strong>of</strong> the shares and the exercise price <strong>of</strong> the<br />

related options is charged to the pr<strong>of</strong>it and loss account.<br />

Movements during 1998 and 1999 in the options granted to directors and employees were as follows:<br />

Outstanding Outstanding<br />

1 January Granted Exercised Forfeited 31 December<br />

5111105111105111105111105111 51110 51110 51110 51110<br />

1998<br />

NV Shares <strong>of</strong> Fl. 1 5 063 995 1 412 328 823 641 156 697 5 495 985<br />

PLC Shares <strong>of</strong> 1.25p 52 225 599 13 830 163 8 975 804 4 688 852 52 391 106<br />

5111105111105111105111105111 51110 51110 51110 51110<br />

1999<br />

NV Shares <strong>of</strong> Fl. 1.12 5 495 985 2 886 190 1 134 282 103 013 7 144 880<br />

PLC Shares <strong>of</strong> 1.4p 52 391 106 19 193 476 5 671 715 3 083 767 62 829 100<br />

5111105111105111105111105111 51110 51110 51110 51110<br />

No options expired during 1998 or 1999.<br />

0000§0000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

21 Pr<strong>of</strong>it retained<br />

0000§0000000000001111<br />

Fl. million<br />

00111500111115011111150<br />

NV PLC<br />

1110111110111110 11110111110111110<br />

1999 1998 1997 1999 1998 1997<br />

000000005111 0111 0111 10111 0111 0111<br />

Net pr<strong>of</strong>it 3 882 3 655 7 649 2 224 2 833 3 274<br />

Preference dividends (44) (15) (15) — — —<br />

Normal dividends on ordinary capital (1 562) (1 594) (1 415) (1 181) (1 133) (862)<br />

Special dividend (9 282) (7 092)<br />

0111 0111 0111 10111 0111 0111<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 2 276 (7 236) 6 219 1 043 (5 392) 2 412<br />

Goodwill written back on sale <strong>of</strong> speciality<br />

chemicals businesses 1 318 411<br />

Other goodwill movements 54 (181) (1 571) 29 187 (35)<br />

Currency retranslation 607 (747) 563 230 (609) 165<br />

0111 0111 0111 10111 0111 0111<br />

Net movement during the year 2 937 (8 164) 6 529 1 302 (5 814) 2 953<br />

Pr<strong>of</strong>it retained – 1 January 7 355 15 519 8 990 2 826 8 640 5 687<br />

0111 0111 0111 10111 0111 0111<br />

Pr<strong>of</strong>it retained – 31 December 10 292 7 355 15 519 4 128 2 826 8 640<br />

0111 0111 0111 10111 0111 0111<br />

Of which retained by:<br />

Parent companies 4 782 2 388 6 118 3 208 1 929 2 989<br />

Other group companies 5 495 4 965 9 418 918 893 5 650<br />

Joint ventures 15 2 (17) 2 4 1<br />

0111 0111 0111 10111 0111 0111<br />

10 292 7 355 15 519 4 128 2 826 8 640<br />

0111 0111 0111 10111 0111 0111<br />

Cumulative goodwill written <strong>of</strong>f (14 467) (14 521) (14 340) (6 075) (6 104) (6 291)<br />

0000§0000000000001111<br />

22 Other reserves<br />

0000§0000000000001111<br />

Adjustment on translation <strong>of</strong> PLC‘s ordinary capital at<br />

£1 = Fl. 12 — — — (345) (362) (353)<br />

Capital redemption reserve — — — 40 36 38<br />

Book value <strong>of</strong> shares or certificates held in connection<br />

with share options (a) (802) (498) (378) (1 032) (632) (490)<br />

110111 0111 0111 10111 0111 0111<br />

(802) (498) (378) (1 337) (958) (805)<br />

110111 0111 0111 10111 0111 0111<br />

(a) Under UITF 13 these shares would be classified as fixed assets.<br />

00000000000000001111<br />

23 Commitments<br />

0000§0000000000001111<br />

1999 1998 1997<br />

0000000000001111511111 0111 0111<br />

Long-term lease commitments under operating leases in respect <strong>of</strong>:<br />

Land and buildings 2 704 2 661 2 584<br />

Other tangibles fixed assets 969 943 1 177<br />

10111 0111 0111<br />

3 673 3 604 3 761<br />

10111 0111 0111<br />

The commitments fall due as follows:<br />

Within 1 year 729 708 712<br />

After 1 year but within 2 years 586 603 603<br />

After 2 years but within 3 years 482 479 504<br />

After 3 years but within 4 years 411 410 419<br />

After 4 years but within 5 years 382 364 347<br />

After 5 years 1 083 1 040 1 176<br />

10111 0111 0111<br />

3 673 3 604 3 761<br />

10111 0111 0111<br />

Other commitments 563 553 346<br />

Of which payable within one year 153 187 246<br />

0000§0000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

24 Contingent liabilities<br />

0000§0000000000001111<br />

Contingent liabilities amounting to Fl. 399 million (1998: Fl. 450 million) arise from guarantees. These guarantees are not expected to<br />

give rise to any material loss. Guarantees given by parent or group companies relating to liabilities included in the consolidated accounts<br />

are not included.<br />

Other contingent liabilities arise in respect <strong>of</strong> litigation against companies in the Group, investigations by competition authorities and<br />

obligations under environmental legislation in various countries. These are not expected to give rise to any material loss.<br />

0000§0000000000001111<br />

25 Acquisition and disposal <strong>of</strong> group companies<br />

0000§0000000000001111<br />

The net assets and results <strong>of</strong> acquired businesses are included in the consolidated accounts from their respective dates <strong>of</strong> acquisition.<br />

The following table sets out the effect <strong>of</strong> acquisitions <strong>of</strong> group companies in 1999 on the consolidated balance sheet. Acquisition<br />

accounting has been applied in all cases.<br />

0000§0000000000001111<br />

Fl. million<br />

111111111500111115011111150<br />

Balance sheets Adjustments to Fair values<br />

<strong>of</strong> acquired align accounting at date <strong>of</strong><br />

businesses policies Revaluations acquisition<br />

00000000001111 011115 011115 011115<br />

Acquisitions<br />

Intangible assets 40 (12) — 28<br />

Fixed assets 206 (5) 16 217<br />

Current assets 180 — (3) 177<br />

Creditors (41) (2) — (43)<br />

Provisions for liabilities and charges:<br />

Pensions and similar obligations (1) (1) — (2)<br />

Deferred taxation 1 1 (5) (3)<br />

Other provisions (2) — 2 —<br />

Minority interests — 22 (2) 20<br />

05 011115 011115 011115<br />

Total net assets acquired 383 3 8 394<br />

05 011115 011115 011115<br />

Fl. million<br />

5011111501111150<br />

1999 1998 1997<br />

0000000000001111 11150 11150<br />

Acquisitions<br />

Net assets acquired 394 109 1 048<br />

Goodwill arising 707 493 —<br />

Goodwill written <strong>of</strong>f (a) — 181 2 000<br />

05 11150 11150<br />

Consideration 1 101 783 3 048<br />

05 11150 11150<br />

Of which:<br />

Cash 27 1 064 747 2 941<br />

Cash balances <strong>of</strong> businesses acquired 27 (43) (35) (65)<br />

Current investments, cash deposits and borrowings <strong>of</strong> businesses acquired 57 38 62<br />

Non cash and deferred consideration 23 33 110<br />

05 11150 11150<br />

(a) Adjustments to goodwill on acquisitions made before 1 January 1998.<br />

0000§0000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

25 Acquisition and disposal <strong>of</strong> group companies (continued)<br />

0000§0000000000001111<br />

Fl. million<br />

00000000051<br />

1999 1998 1997<br />

05111 01115 511111115115111111151105111<br />

Speciality<br />

chemicals<br />

Total Total businesses Other Total<br />

000000511101115 01115 0115 5111111115 015111<br />

Disposals<br />

Intangible assets 4 — — — —<br />

Fixed assets 114 161 3 951 591 4 542<br />

Current assets 101 102 3 069 792 3 861<br />

Creditors (45) (46) (1 141) (384) (1 525)<br />

Provisions for liabilities and charges:<br />

Pensions and similar obligations (17) (3) (365) (145) (510)<br />

Deferred taxation (5) (3) (432) 3 (429)<br />

Other provisions (1) 16 214 63 277<br />

Minority interests 20 (33) 27 (1) 26<br />

01115 01115 511111115 5111111115 051111<br />

Net assets sold 171 194 5 323 919 6 242<br />

Attributable goodwill 83 187 1 730 394 2 124<br />

Pr<strong>of</strong>it on sale attributable to <strong>Unilever</strong> 40 1 079 8 419 (95) 8 324<br />

01115 01115 0115 5111111115 51111111115<br />

Consideration 294 1 460 15 472 1 218 16 690<br />

01115 01115 0115 5111111115 105111<br />

Of which:<br />

Cash 27 270 1 460 15 257 1 126 16 383<br />

Cash balances <strong>of</strong> businesses sold 27 7 4 (77) 93 16<br />

Current investments, cash deposits and borrowings <strong>of</strong><br />

businesses sold 10 (4) 292 (1) 291<br />

Non cash and deferred consideration 7 — — — —<br />

0000§0000000000001111<br />

26 Reconciliation <strong>of</strong> operating pr<strong>of</strong>it to operating cash flows<br />

0000§0000000000001111<br />

Fl. million<br />

000000051<br />

1999 1998 1997<br />

05111 0511 000511<br />

Continuing Discontinued<br />

Total Total businesses operations<br />

0000005111011151101115 0115 01115 01115<br />

Operating pr<strong>of</strong>it 9 482 9 718 7 049 514<br />

Depreciation and amortisation 2 529 2 068 2 188 148<br />

Changes in working capital:<br />

Stocks 41 (940) 259 (8)<br />

Debtors (373) (493) (331) (151)<br />

Creditors 587 386 901 (29)<br />

Pensions and similar provisions less payments 400 116 (7) 17<br />

Restructuring and other provisions less payments (417) (101) 1 258 57<br />

Other adjustments 211 (806) 376 8<br />

01115 0115 01115 05111<br />

Cash flow from operating activities 12 460 9 948 11 693 556<br />

01115 0115 01115 05111<br />

In 1999 a charge <strong>of</strong> Fl. 594 million was booked in operating pr<strong>of</strong>it for exceptional items <strong>of</strong> which Fl. 512 million was charged for<br />

restructuring projects, and a net Fl. 7 million for losses on disposal <strong>of</strong> businesses. Other exceptional items comprised primarily legal and<br />

insurance settlements and amounted to Fl. 75 million.<br />

The cash inflow relating to exceptional disposals and other items was Fl. 167,million all <strong>of</strong> which was received in 1999.<br />

The net cash outflow in respect <strong>of</strong> the restructuring costs is estimated at Fl. 308 million. This comprises Fl. 248 million in respect<br />

<strong>of</strong> employee compensation costs and Fl. 80 million <strong>of</strong> other related costs less proceeds <strong>of</strong> disposal <strong>of</strong> fixed assets <strong>of</strong> Fl. 20 million.<br />

Of these cash flows, Fl. 238 million arose in 1999 and Fl. 70 million is expected in 2000 and later years.<br />

0000§0000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

27 Analysis <strong>of</strong> cash flows for headings netted in the cash flow statement<br />

00000000000000001111<br />

Fl. million<br />

000005111<br />

1999 1998 1997<br />

00000000005105111 05111 05111<br />

Returns on investments and servicing <strong>of</strong> finance<br />

Dividends from other fixed investments 21 15 27<br />

Interest received 706 1 521 730<br />

Interest paid (832) (1 098) (1 160)<br />

Preference dividend paid (31) (15) (15)<br />

Dividends and other payments to minority shareholders (208) (275) (390)<br />

05111 05111 05111<br />

(344) 148 (808)<br />

05111 05111 05111<br />

Capital expenditure and financial investment<br />

Purchase <strong>of</strong> tangible fixed assets (2 894) (2 934) (3 038)<br />

Disposal <strong>of</strong> tangible fixed assets 143 172 309<br />

Acquisition/disposal <strong>of</strong> fixed investments 26 (2) 27<br />

Purchase <strong>of</strong> own shares (employee share schemes) (582) (319) (72)<br />

05111 05111 05111<br />

(3 307) (3 083) (2 774)<br />

05111 05111 05111<br />

In 1997 discontinued speciality chemicals businesses accounted for Fl. 249 million <strong>of</strong> net capital expenditure and Fl. 117 million <strong>of</strong><br />

taxation. In addition, payments <strong>of</strong> approximately Fl. 1 300 million were made during 1997 in respect <strong>of</strong> taxation on the pr<strong>of</strong>it on<br />

disposal <strong>of</strong> these businesses.<br />

Acquisitions and disposals<br />

Acquisition <strong>of</strong> group companies 25 (1 064) (747) (2 941)<br />

Cash balances <strong>of</strong> businesses acquired 25 43 35 65<br />

Consideration paid in respect <strong>of</strong> acquisitions made in previous years (55) — —<br />

Disposal <strong>of</strong> group companies 25 270 1 460 16 383<br />

Speciality chemicals businesses — — 15 257<br />

Other disposals 270 1 460 1 126<br />

Cash balances <strong>of</strong> businesses sold 25 7 (4) 16<br />

Speciality chemicals businesses — — (77)<br />

Other disposals 7 (4) 93<br />

Consideration received in respect <strong>of</strong> disposals made in previous years — — 226<br />

05111 05111 05111<br />

(799) 744 13 749<br />

05111 05111 05111<br />

Management <strong>of</strong> liquid resources<br />

Purchase <strong>of</strong> current investments (985) (3 618) (7 177)<br />

Sale <strong>of</strong> current investments 8 860 640 38<br />

(Increase)/decrease in cash on deposit 4 634 (1 435) (6 983)<br />

05111 05111 05111<br />

12 509 (4 413) (14 122)<br />

05111 05111 05111<br />

Financing<br />

Issue <strong>of</strong> ordinary share capital (employee share schemes) — — 1<br />

Issue <strong>of</strong> shares by group companies to minority shareholders 10 37 94<br />

Debt due within one year:<br />

Increases 419 1 129 1 584<br />

Repayments (861) (1 102) (3 199)<br />

Debt after one year:<br />

Increases 136 79 188<br />

Repayments (26) (51) (185)<br />

05111 05111 05111<br />

(322) 92 (1 517)<br />

05111 05111 05111<br />

Included as liquid resources are term deposits <strong>of</strong> less than one year, government securities and A- or higher rated money and capital<br />

market instruments.<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

28 Analysis <strong>of</strong> net funds/(debt)<br />

00000000000000001111<br />

Fl. million<br />

100000000000511<br />

Acquisitions/<br />

Disposals Other<br />

1 January Cash (excl. cash & non cash Currency 31 December<br />

1999 Flow overdrafts) changes movements 1999<br />

0000001111 05111 05111 05111 05111 05111<br />

Cash on call and in hand 2 047 786 199 3 032<br />

Overdrafts (2 404) 74 (57) (2 387)<br />

51115111<br />

860<br />

Borrowings due within one year (2 719) 442 (44) (1 492) (269) (4 082)<br />

Borrowings due after one year (5 023) (110) (9) 1 158 (100) (4 084)<br />

51115111<br />

332<br />

Current investments 10 870 (7 875) 6 (131) 384 3 254<br />

Cash on deposit 9 964 (4 634) — — 445 5 775<br />

51115111<br />

(12 509)<br />

05111 05111 05111 05111 05111 05111<br />

Net funds/(debt) 12 735 (11 317) (47) (465) 602 1 508<br />

05111 05111 05111 05111 05111 05111<br />

Other non cash changes include pr<strong>of</strong>its and losses on disposal and adjustments to realisable value <strong>of</strong> current investments; exchange<br />

gains and losses on borrowings; and the reclassification <strong>of</strong> long-term borrowings falling due within one year at the balance sheet date.<br />

00000000000000001111<br />

29 Financial instruments<br />

00000000000000001111<br />

The Group has comprehensive policies in place, approved by the directors, covering the use <strong>of</strong> straightforward derivative financial<br />

instruments. These instruments are used only for hedging purposes. Established controls are in place covering all financial instruments<br />

and include policies, guidelines, exposure limits, a system <strong>of</strong> authorities and independent reporting. Performance is closely monitored<br />

with independent reviews undertaken by internal audit. The accounting policies governing these instruments are in line with generally<br />

accepted practice and follow hedge accounting principles described in the accounting policies on page 64. The use <strong>of</strong> leveraged<br />

instruments is not permitted. Details <strong>of</strong> the instruments used for interest rate and foreign exchange exposure management, together<br />

with information on related exposures, are given below.<br />

Except for the description <strong>of</strong> <strong>Unilever</strong>’s currency exposures, all debtors and trade and other creditors have been excluded from the<br />

analysis below and from the interest rate and currency pr<strong>of</strong>iles in notes 14 and 15 on pages 76 and 77 either due to the exclusion <strong>of</strong><br />

short-term items, as permitted by United Kingdom Financial Reporting Standard 13, or because the amounts are not material.<br />

The reduction in the portion <strong>of</strong> fixed investments and fixed rate debt during 1999 and the position at the year end is in line with<br />

<strong>Unilever</strong>’s interest rate management policy. <strong>Unilever</strong> operates an interest rate management policy aimed at optimising net interest and<br />

reducing volatility. In general, cash is invested short-term, at floating interest rates. The interest payable on debt is in general also<br />

floating, but depending on the Group’s financial position, part may be fixed up to five years. This is achieved by using fixed rate longterm<br />

debt issues and derivative financial instruments such as interest rate swaps and forward rate agreements.<br />

At the end <strong>of</strong> 1999 interest rates were fixed on approximately 22% <strong>of</strong> the projected debt for 2000 and 21% for 2001 (compared to<br />

72% for 1999 and 50% for 2000 at the end <strong>of</strong> 1998). Interest receivable was fixed on approximately 34% <strong>of</strong> projected funds for<br />

2000 and 15% for 2001 (compared to 31% for 1999 and 16% for 2000 at the end <strong>of</strong> 1998).<br />

Nominal values <strong>of</strong> interest rate derivative instruments are shown in the table below. These nominal values when compared to the<br />

nominal value <strong>of</strong> the underlying debt and investments do not reflect the actual level <strong>of</strong> use <strong>of</strong> financial instruments. This is because<br />

certain financial instruments have consecutive strike and maturity dates on the same underlying investments in different periods.<br />

Derivatives are primarily used to swap fixed interest long-term debt into floating rate debt or to swap floating rate investments into<br />

fixed rate investments. Whilst the nominal amounts reflect the volume <strong>of</strong> activity, they do not therefore properly reflect the amount <strong>of</strong><br />

credit risk to which the Group is exposed. The market value <strong>of</strong> these interest rate instruments at the end <strong>of</strong> 1999 represented an<br />

unrealised and unrecognised loss <strong>of</strong> Fl. 60 million (1998: gain <strong>of</strong> Fl. 243 million). In 1998 losses <strong>of</strong> Fl. 47 million were deferred on the<br />

balance sheet. 44% (1998: 50%) <strong>of</strong> these derivative financial instruments will mature within one year, 92% (1998: 93%) within five<br />

years and the balance within ten years.<br />

00000000000000001111<br />

Fl. million<br />

0100511<br />

Nominal amounts at 31 December<br />

051111105111<br />

1999 1998<br />

00000011111105111110511105111111105111 05111<br />

Interest rate swaps 8 278 11 280<br />

Forward rate agreements 2 641 —<br />

05111 11051<br />

Total 10 919 11 280<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

29 Financial instruments (continued)<br />

00000000000000001111<br />

Under the Group’s foreign exchange policy, exposures with a maximum <strong>of</strong> one year maturity are generally hedged; this is achieved<br />

through the use <strong>of</strong> forward foreign exchange contracts. The market value <strong>of</strong> these instruments at the end <strong>of</strong> 1999 represented a<br />

recognised unrealised loss <strong>of</strong> Fl. 284 million (1998: Fl. 190 million) which was largely <strong>of</strong>fset by recognised unrealised gains on the<br />

underlying assets and liabilities.<br />

00000000000000001111<br />

Fl. million<br />

0100511<br />

Nominal amounts at 31 December<br />

051111105111<br />

1999 1998<br />

00000011111105111110511105111111105111 05111<br />

Foreign exchange contracts – buy 3 889 9 872<br />

– sell 7 849 17 642<br />

05111 11051<br />

Total 11 738 27 514<br />

00000000000000001111<br />

Assets held in foreign currencies are, to a large extent, financed by borrowings in the same currencies. Consequently, at the end <strong>of</strong><br />

1999 some 51% (1998: 57% before accounting for the special dividend) <strong>of</strong> <strong>Unilever</strong>’s total capital and reserves was denominated in<br />

the currencies <strong>of</strong> the two parent companies, euro and sterling. From an earnings perspective some 43% <strong>of</strong> <strong>Unilever</strong>’s 1999 net income<br />

was denominated in the euro, 14% in sterling and 15% in the US dollar.<br />

To ensure maximum flexibility in meeting changing business <strong>needs</strong>, investment management policy is to concentrate <strong>Unilever</strong>’s<br />

substantial liquid funds centrally in the parent and finance companies. These funds, mainly in dollars, guilders and sterling, are invested<br />

in short-term bank deposits and marketable securities, or on-lent to subsidiaries.<br />

Credit risk exposures are minimised by dealing only with a limited range <strong>of</strong> financial institutions with secure credit ratings, and by<br />

working within agreed counterparty limits. Counterparty credit ratings are regularly monitored and there is no significant concentration<br />

<strong>of</strong> credit risk with any single counterparty.<br />

Master netting agreements are in place for the majority <strong>of</strong> interest rate derivative instruments. The risk in the event <strong>of</strong> default by a<br />

counterparty is determined by the extent to which market prices have moved since the contracts were made. The Group believes that<br />

the risk <strong>of</strong> incurring such losses is remote.<br />

The undernoted table summarises the fair values and carrying amounts <strong>of</strong> the various classes <strong>of</strong> financial instruments as at<br />

31 December:<br />

0000000011111110511111051111051111105111<br />

Fl. million<br />

000010100511<br />

Fair value Carrying amount<br />

1051111105111 051111105111<br />

1999 1998 1999 1998<br />

0000000011111110511 10511 05111 05111<br />

Financial assets:<br />

Other fixed investments 269 294 238 257<br />

Current investments 3 254 10 870 3 254 10 870<br />

Cash 8 807 12 011 8 807 12 011<br />

05111 10511 05111 11051<br />

12 330 23 175 12 299 23 138<br />

Financial liabilities:<br />

Bonds and other loans (6 083) (6 422) (6 002) (6 082)<br />

Bank loans and overdrafts (4 551) (4 064) (4 551) (4 064)<br />

05111 10511 05111 11051<br />

(10 634) (10 486) (10 553) (10 146)<br />

Derivatives:<br />

Interest rate swaps – assets 71 362 — —<br />

– liabilities (131) (119) 3 (44)<br />

Forward rate agreements – liabilities — — (3) (3)<br />

Foreign exchange contracts – assets 92 66 (284) (190)<br />

– liabilities (376) (256) — —<br />

0000000011111110511111051111051111105111<br />

The fair values <strong>of</strong> fixed investments are based on their market values. The fair values <strong>of</strong> unlisted fixed investments are not materially<br />

different from their carrying amounts. Current investments, cash, bank loans and overdrafts have fair values which approximate to<br />

their carrying amounts because <strong>of</strong> their short-term nature. The fair values <strong>of</strong> forward foreign exchange contracts represent the<br />

unrealised gain or loss on revaluation <strong>of</strong> the contracts to year-end rates <strong>of</strong> exchange. The fair values <strong>of</strong> bonds and other loans, interest<br />

rate swaps and forward rate agreements are based on the net present value <strong>of</strong> the discounted anticipated future cash flows associated<br />

with these instruments.


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

29 Financial instruments (continued)<br />

00000000000000001111<br />

Currency exposures<br />

Group treasury manages the foreign exchange exposures that arise from the Group’s financing and investing activities in accordance<br />

with Group policies.<br />

The objectives <strong>of</strong> <strong>Unilever</strong>’s foreign exchange policies are to allow operating companies to manage foreign exchange exposures that<br />

arise from trading activities effectively within a framework <strong>of</strong> control that does not expose the Group to unnecessary foreign exchange<br />

risks. Operating companies are required to cover substantially all foreign exchange exposures arising from trading activities and each<br />

company operates within a specified maximum exposure limit. Business Groups monitor compliance with these policies. Compliance<br />

with the Group’s policies means that the net amount <strong>of</strong> monetary assets and liabilities at 31 December 1999 that are exposed to<br />

currency fluctuations is not material.<br />

00000000000000001111<br />

30 Combined earnings per shar e<br />

00000000000000001111<br />

Fl. million £ million<br />

01111101111101111 01111101111101111<br />

Fl. 1.12 Fl. 1 Fl. 1 1.4p 1.25p 1.25p<br />

01111 01111 01111 01111 01111 01111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Basic earnings per share Fl. 5.80 Fl. 5.80 Fl. 9.78 26.01p 26.45p 44.74p<br />

Basic earnings per share before exceptional items Fl. 6.19 Fl. 5.69 Fl. 5.06 27.76p 25.97p 23.86p<br />

Diluted earnings per share Fl. 5.66 Fl. 5.66 Fl. 9.55 25.36p 25.80p 43.68p<br />

Earnings per share on a SSAP 15 basis Fl. 5.74 Fl. 5.67 Fl. 9.20 25.73p 25.88p 41.99p<br />

Basis <strong>of</strong> calculation:<br />

The calculations <strong>of</strong> combined earnings per share are based on the net pr<strong>of</strong>it attributable to ordinary capital divided by the average<br />

number <strong>of</strong> share units representing the combined ordinary capital <strong>of</strong> NV and PLC in issue during the year, after deducting shares held<br />

to meet <strong>Unilever</strong> employee share options which are not yet vested. For the calculation <strong>of</strong> combined ordinary capital the exchange rate<br />

<strong>of</strong> £1 = Fl. 12 has been used, in accordance with the Equalisation Agreement. On 10 May 1999 the 1.25p ordinary shares <strong>of</strong> PLC were<br />

consolidated, so that every 112 1.25p ordinary shares were replaced by 100 1.4p ordinary shares. The Fl. 1 ordinary shares <strong>of</strong> NV were<br />

consolidated, so that 100 Fl. 1.12 ordinary shares replaced every 112 Fl. 1 ordinary shares. This consolidation was associated with the<br />

payment on 9 June 1999 <strong>of</strong> a special dividend, so that the economic impact was that <strong>of</strong> a share buy back at fair value at that date and<br />

therefore, in accordance with United Kingdom Financial Reporting Standard 14, earnings per share for prior years have not been<br />

restated.<br />

Earnings per share before exceptional items is provided because the directors believe it better explains the ongoing trends in the Group’s<br />

performance.<br />

The calculations <strong>of</strong> diluted earnings per share are based on (a) conversion into PLC ordinary shares <strong>of</strong> the shares in a group company<br />

which are convertible in the year 2038 as described in note 20 on page 80, and (b) the exercise <strong>of</strong> share options, details <strong>of</strong> which are<br />

set out in note 20 on pages 82 and 83.<br />

Calculation <strong>of</strong> average number <strong>of</strong> share units:<br />

000000111111051111105111110511111051111105111<br />

Thousands <strong>of</strong> share units Thousands <strong>of</strong> share units<br />

01111101111101111 01111101111101111<br />

Fl. 1.12 Fl. 1 Fl. 1 1.4p 1.25p 1.25p<br />

01111 01111 01111 01111 01111 01111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Average ordinary capital: NV 601 725 640 165 640 165 4 011 500 4 267 767 4 267 767<br />

PLC 459 745 489 099 489 080 3 064 967 3 260 662 3 260 536<br />

less shares held by employee share trusts and companies (16 287) (13 100) (13 913) (108 583) (87 331) (92 754)<br />

01111 01111 01111 01111 01111 01111<br />

Combined average number <strong>of</strong> share units for all bases<br />

except diluted earnings per share 1 045 183 1 116 164 1 115 332 6 967 884 7 441 098 7 435 549<br />

add shares issuable in 2038 23 625 23 625 23 625 157 500 157 500 157 500<br />

add shares under option 14 264 11 898 10 782 95 094 79 317 71 881<br />

less shares issuable at fair value (11 361) (7 528) (7 338) (75 735) (50 187) (48 920)<br />

01111 01111 01111 01111 01111 01111<br />

Adjusted combined average number <strong>of</strong> share units for<br />

diluted earnings per share basis 1 071 711 1 144 159 1 142 401 7 144 743 7 627 728 7 616 010<br />

01111 01111 01111 01111 01111 01111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

30 Combined earnings per shar e (continued)<br />

00000000000000001111<br />

Calculation <strong>of</strong> net pr<strong>of</strong>it:<br />

000000111111051111105111110511111051111105111<br />

Fl. million £ million<br />

01111101111101111 01111101111101111<br />

Fl. 1.12 Fl. 1 Fl. 1 1.4p 1.25p 1.25p<br />

01111 01111 01111 01111 01111 01111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it 6 106 6 488 10 923 1 825 1 973 3 331<br />

less preference dividends (44) (15) (15) (13) (4) (5)<br />

01111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it attributable to ordinary capital for basic and diluted<br />

earnings per share bases 6 062 6 473 10 908 1 812 1 969 3 326<br />

add exceptional items net <strong>of</strong> tax 408 (115) (5 268) 122 (36) (1 552)<br />

01111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it before exceptional items for basic earnings per share<br />

before exceptional items 6 470 6 358 5 640 1 934 1 933 1 774<br />

01111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it attributable to ordinary capital before adjustment 6 062 6 473 10 908 1 812 1 969 3 326<br />

SSAP 15 tax adjustment (64) (139) (651) (19) (42) (205)<br />

01111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it attributable to ordinary capital on SSAP 15 basis 5 998 6 334 10 257 1 793 1 927 3 121<br />

00000000000000001111<br />

31 Dividends per shar e<br />

00000000000000001111<br />

NV PLC<br />

01111101111101111 01111101111101111<br />

Guilders per Fl. 1.12 (1997-1998: Fl. 1) Pence per 1.4p (1997-1998: 1.25p)<br />

<strong>of</strong> ordinary capital <strong>of</strong> ordinary capital<br />

01111101111101111 01111101111101111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Interim 0.88 0.81 0.74 3.93 2.95 2.80<br />

Normal final 1.91 1.70 1.49 8.57 7.75 5.62<br />

Special final 14.50 66.13<br />

01111 01111 01111 01111 01111 01111<br />

Total 2.79 17.01 2.23 12.50 76.83 8.42<br />

00000000000000001111<br />

32 Pension and other benefit plans<br />

00000000000000001111<br />

UK GAAP accounting:<br />

In the majority <strong>of</strong> countries in which the Group operates, employees’ retirement arrangements are provided by defined benefit plans<br />

based on employee pensionable remuneration and length <strong>of</strong> service. These are either externally funded, with the assets <strong>of</strong> the plan<br />

held separately from those <strong>of</strong> the Group in independently administered funds, or are unfunded but with provisions maintained in the<br />

Group balance sheet. All are subject to regular actuarial review. Actuarial advice is provided by both external consultants and actuaries<br />

employed by the <strong>Unilever</strong> Group.<br />

Valuations are carried out annually for the largest plans and at least every three years for other plans using the projected unit method,<br />

with the aim <strong>of</strong> ensuring that as far as possible current and future regular pension charges remain a stable percentage <strong>of</strong> pensionable<br />

payroll. The actuarial assumptions used to calculate the benefit obligation vary according to the economic conditions <strong>of</strong> the country in<br />

which the plan is situated. It is usually assumed that, over the long term, the annual rate <strong>of</strong> return on investments will be higher than<br />

the annual increase in pensionable remuneration and in present and future pensions in payment. For the key factors influencing the<br />

actuarial valuations, the average assumptions for the principal plans, weighted by market value, at their most recent valuation were:<br />

interest rate 7.2% p.a.; salary increases 4.6% p.a.; pension increases 3.2% p.a. Assets are generally valued at a smoothed market<br />

value by spreading gains and losses relative to the actuarial basis over a three to five year period.<br />

At 31 December 1999 the market value <strong>of</strong> the assets <strong>of</strong> externally funded defined benefit plans was Fl. 36 046 million (1998:<br />

Fl. 29 175 million), and net provisions in the accounts amounted to Fl. 4 149 million (1998: Fl. 3 691 million). The level <strong>of</strong> funding<br />

<strong>of</strong> all defined benefit plans at the dates <strong>of</strong> the last valuations, in aggregate, was 124% (1998: 127%). The levels <strong>of</strong> funding represent<br />

the actuarial value <strong>of</strong> fund assets and the provisions held in the consolidated accounts at the dates <strong>of</strong> the most recent valuations<br />

expressed as a percentage <strong>of</strong> the value <strong>of</strong> benefits that had accrued to members at those dates, after allowing for expected future<br />

increases in pensionable remuneration and pensions in the course <strong>of</strong> payment.<br />

Pension costs and company contributions to defined benefit plans (as shown in note 3 on page 72) have been reduced in recent years<br />

principally by the amortisation <strong>of</strong> surpluses in the Group’s two biggest funds, which have been amortised using the ‘mortgage<br />

method’. The net amount <strong>of</strong> surplus recognised in the pr<strong>of</strong>it and loss account in 1999 was Fl. 534 million (1998: Fl. 626 million). It is<br />

expected that pension costs will continue to benefit from the amortisation <strong>of</strong> fund surpluses for a number <strong>of</strong> years.


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

32 Pension and other benefit plans (continued)<br />

00000000000000001111<br />

In 1999 the Group received a gross cash refund <strong>of</strong> Fl. 350 million from a Netherlands fund in a surplus position, and Fl. 237 million<br />

from a Finnish fund in surplus. These cash refunds do not directly impact the pension charge for 1999 as the surplus is amortised in<br />

accordance with the Group’s accounting policies. Further refunds from these funds may occur in 2000.<br />

The Group also operates a number <strong>of</strong> defined contribution plans. The assets <strong>of</strong> all the Group’s defined contribution plans are held in<br />

independently administered funds. The pension costs charged to the pr<strong>of</strong>it and loss account represent contributions payable by the<br />

Group to the funds. The market value <strong>of</strong> the assets <strong>of</strong> externally funded defined contribution plans as at 31 December 1999 was<br />

Fl. 3 931 million (1998: Fl. 3 378 million).<br />

Group companies provide other post-retirement benefits (mainly post-retirement medical benefit plans) to a number <strong>of</strong> retired<br />

employees in certain countries, principally the United States, under several different plans which are predominantly unfunded.<br />

The post-retirement, other than pension, plans operated by the Group are accounted for in accordance with SFAS 106.<br />

US GAAP accounting:<br />

The following tables summarises the balance sheet impact, as well as the benefit obligations, assets, funded status and economic<br />

assumptions associated with the key defined benefit pension plans and the other benefit plans as computed in accordance with<br />

SFAS 87 and SFAS 106. At 31 December 1999 these pension plans represented approximately 79% (1998: 76%; 1997: 71%) <strong>of</strong> all<br />

pension plans while 100% <strong>of</strong> the other benefit plans are represented (1998: 100%; 1997: 100%), based on the market value <strong>of</strong> the<br />

funds plus the provisions held in the Group’s accounts.<br />

Fl. million<br />

11100000511<br />

Pension plans Other benefits plans<br />

£ 01111101111 01111101111<br />

1999 1998 1999 1998<br />

0000000000111101111 01111 01111 01111<br />

Change in benefit obligation<br />

Benefit obligations beginning <strong>of</strong> year 20 446 16 964 1 573 1 458<br />

Extension <strong>of</strong> coverage (a) — 1 011 — —<br />

Service cost 478 398 30 30<br />

Interest cost 1 141 1 207 100 95<br />

Plan member contributions — — — —<br />

Amendments — 3 — 7<br />

Plan mergers — — — —<br />

Actuarial (gains)/losses (702) 3 138 157 122<br />

Acquisition/disposals — 76 — 30<br />

Settlements/curtailments (37) (250) 3 1<br />

Special Termination benefits 37 72 — —<br />

Benefits paid (1 341) (1 164) (110) (63)<br />

Currency retranslations 1 922 (1 009) 215 (106)<br />

0111 01111 01111 01111<br />

Benefit obligations end <strong>of</strong> year 21 944 20 446 1 968 1 574<br />

01111 01111 01111 01111<br />

Change in plan assets<br />

Fair value <strong>of</strong> plan assets at beginning <strong>of</strong> year 23 549 22 094 6 —<br />

Extension <strong>of</strong> coverage (a) — 1 608 — —<br />

Actual return on plan assets 6 151 2 447 — —<br />

Acquisition/(disposals) — 69 — —<br />

Settlements (40) (250) — —<br />

Employer contribution/surplus refunds (151) (59) 110 66<br />

Plan member contributions — — — 3<br />

Benefits paid (1 341) (1 164) (110) (63)<br />

Currency retranslations 2 326 (1 196) 1 —<br />

01111 01111 01111 01111<br />

Fair value <strong>of</strong> plan assets at end <strong>of</strong> year 30 494 23 549 7 6<br />

01111 01111 01111 01111<br />

Funded status at end <strong>of</strong> year 8 551 3 103 (1 641) (1 567)<br />

Unrecognised net transition liability/(asset) (826) (809) — —<br />

Unrecognised net actuarial loss/(gain) (8 774) (3 166) (135) 32<br />

Unrecognised prior service cost 397 335 7 (1)<br />

Other (FAS 112 liabilities) n/a n/a (28) (25)<br />

01111 01111 01111 01111<br />

Net amount recognised at end <strong>of</strong> year (652) (537) (1 797) (1 561)<br />

01111 01111 01111 01111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

32 Pension and other benefit plans (continued)<br />

00000000000000001111<br />

Fl. million<br />

11100000511<br />

Pension plans Other benefits plans<br />

£ 01111101111 01111101111<br />

1999 1998 1999 1998<br />

0000000000111101111 01111 01111 01111<br />

Amount recognised in the statement <strong>of</strong> financial position consists <strong>of</strong>:<br />

Prepaid benefit cost 1 159 1 193 — —<br />

Accrued benefit liability (1 815) (1 730) (1 801) (1 561)<br />

Additional minimum liability (28) (12) — —<br />

Intangible asset 18 9 — —<br />

Accumulated other comprehensive income 14 3 4 —<br />

01111 01111 01111 01111<br />

Net amount recognised at end <strong>of</strong> year (652) (537) (1 797) (1 561)<br />

01111 01111 01111 01111<br />

(a) From 1998, two additional plans were included in the pension exercise and one additional plan in the other benefit plans.<br />

00000000001111011111011111101111101111<br />

Pension plans Other benefits plans<br />

% %<br />

01111101111101111 01111101111101111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Weighted-average assumptions as <strong>of</strong> 31 December<br />

Discount rate 6.25 5.50 6.75 7.50 6.00 6.50<br />

Expected return on plan assets 7.25 6.75 7.25 n/a n/a n/a<br />

Rate <strong>of</strong> salary increases 3.75 3.50 4.00 4.50 4.50 5.00<br />

Cost <strong>of</strong> living increases 2.50 2.25 2.50 n/a n/a n/a<br />

00000001111011111011111011111101111101111101111<br />

The valuations <strong>of</strong> other benefit plans typically assume that medical cost inflation will fall from its current level <strong>of</strong> approximately 8.5%<br />

over the next few years and reach a constant level <strong>of</strong> approximately 5% by the year 2006.<br />

00000000001111011111011111101111101111<br />

Fl. million<br />

11100000000511<br />

Pension plans Other benefits plans<br />

01111101111101111 01111101111101111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Components <strong>of</strong> net periodic benefit cost<br />

Service cost 478 398 420 30 30 22<br />

Interest cost 1 141 1 207 1 232 99 95 89<br />

Expected return on plan assets (1 505) (1 539) (1 502) — — —<br />

Employee contributions — — — — (3) —<br />

Amortisation <strong>of</strong> prior service cost 54 53 48 — — —<br />

Amortisation <strong>of</strong> transition (asset) (140) (142) (143) — — —<br />

Amortisation <strong>of</strong> actuarial loss/(gain) (10) (122) (10) — 3 —<br />

01111 01111 01111 0111 01111 01111<br />

Total before FAS 88 events 18 (145) 45 129 125 111<br />

Adjustments for FAS 88 events 47 115 (366) — 30 (159)<br />

01111 01111 01111 01111 01111 01111<br />

Net periodic benefit cost 65 (30) (321) 129 155 (48)<br />

00000001111011111011111011111101111101111101111<br />

The projected benefit obligation, accumulated benefit obligation, and fair value <strong>of</strong> plan assets for the pension plans with accumulated<br />

benefit obligations in excess <strong>of</strong> plan assets were Fl. 1 914 million, Fl. 1 666 million, and Fl. 78 million respectively, as <strong>of</strong> 31 December<br />

1999 and Fl. 2 089 million, Fl. 1 814 million, and Fl. 81 million respectively, as <strong>of</strong> 31 December 1998.<br />

The Group also maintains a number <strong>of</strong> smaller defined benefit plans. Approximately Fl. 3 095 million (1998: Fl. 2 660 million) is<br />

provided for on their behalf in the Group balance sheet. In 1999 Fl. 287 million (1998: Fl. 191 million; 1997: Fl. 312 million) was<br />

charged in the accounts. These amounts, mainly in connection with unfunded plans, would not have been materially different under<br />

SFAS 87.<br />

In addition to the special terminations benefits mentioned in the table above, during 1999, the Group also charged Fl. 64 million<br />

(1998: Fl. 92 million; 1997: Fl. 111 million) in respect <strong>of</strong> pension or similar obligations arising on terminations <strong>of</strong> employment.<br />

Post-retirement health care benefits<br />

Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plans. A one-percentagepoint<br />

change in assumed health care cost trend rates would have the following effects:<br />

1% point 1% point<br />

increase decrease<br />

0000000000005105111 05111<br />

Effect on total <strong>of</strong> service and interest cost components 3 (2)<br />

Effect on post-retirement benefit obligation 30 (28)<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans<br />

00000000000000001111<br />

As at 31 December 1999, the Group had nine equity based compensation plans. These were the <strong>Unilever</strong> PLC 1985 Share Save Plan<br />

(the ‘PLC Sharesave Plan’), the <strong>Unilever</strong> PLC 1985 Executive Share Option Plan and the <strong>Unilever</strong> PLC 1985 Unapproved Executive Share<br />

Option Plan and the <strong>Unilever</strong> PLC International 1997 Executive Share Option Plan (together the ‘PLC Option Plans’), the <strong>Unilever</strong><br />

Savings Related Share Option Plan (Ireland) (the ‘Ireland Sharesave Plan’), the <strong>Unilever</strong> NV Executive Share Option Plan (the ‘NV Option<br />

Plan’), the <strong>Unilever</strong> NV Employee Share Option Plan (the ‘NV Sharesave Plan’), the <strong>Unilever</strong> North America Executive Stock Option Plan<br />

(the ‘NA Option Plan’) and the <strong>Unilever</strong> North America Employee Stock Purchase Plan (the ‘NA Purchase Plan’), which are all described<br />

below. Grants <strong>of</strong> share options to directors and other senior executives in 1997 and subsequent years are made under the International<br />

1997 Executive Share Option Plan (the ‘International Plan’). The International Plan comprises the NV Executive Option Plan, the<br />

<strong>Unilever</strong> PLC 1985 Executive Share Option Plan, the <strong>Unilever</strong> PLC International 1997 Executive Share Option Plan and the North<br />

American Executive Stock Option Plan.<br />

On 13 October 1997 the ordinary share capital <strong>of</strong> NV and PLC was divided so that each existing Fl. 4 and 5p ordinary share was split<br />

into four shares <strong>of</strong> Fl. 1 and 1.25p respectively.<br />

The Group applies APB Opinion 25 and related interpretations in accounting for these plans. Accordingly, the Group has recognised<br />

only the following compensation costs, Fl. 29.3 million in 1999, Fl. 1.7 million in 1998 and Fl. 9.5 million in 1997. Had the Group<br />

accounted for options under the requirement <strong>of</strong> SFAS 123 the impact on reported results would have been as follows:<br />

00000000001111011111011111101111101111<br />

Fl. million<br />

01111101111101111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

Actual compensation cost recognised 29.3 1.7 9.5<br />

Pro forma compensation cost under SFAS 123 124.3 74.2 21.8<br />

Actual net pr<strong>of</strong>it 6 106 6 488 10 923<br />

Pro forma net pr<strong>of</strong>it under SFAS 123 6 037 6 433 10 915<br />

00000001111011111011111011111101111101111101111<br />

Guilders per Fl. 1.12 (1997-1998: Fl. 1)<br />

<strong>of</strong> ordinary capital<br />

01111101111101111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

Actual earnings per share 5.80 5.80 9.78<br />

Pro forma earnings per share 5.73 5.75 9.77<br />

Actual diluted earnings per share 5.66 5.66 9.55<br />

Pro forma diluted earnings per share 5.60 5.61 9.54<br />

00000001111011111011111011111101111101111101111<br />

The remaining disclosures required by SFAS 123 are given below for each <strong>of</strong> the plans individually.<br />

The PLC Sharesave Plan<br />

The PLC Sharesave Plan provides for the granting <strong>of</strong> options to purchase shares <strong>of</strong> <strong>Unilever</strong> PLC to eligible employees <strong>of</strong> the Group.<br />

Under the terms <strong>of</strong> the plan, eligible employees, to whom options have been granted, make monthly contributions to a savings plan<br />

approved by the United Kingdom Treasury for this purpose. At the end <strong>of</strong> five years the proceeds from the savings plan may be applied<br />

to purchase ordinary shares <strong>of</strong> PLC at a price which is not less than 90% <strong>of</strong> the market value <strong>of</strong> the shares on a specified date within<br />

a 30 day period ending with the date on which the options were granted. This discount is amortised over the five year vesting period<br />

<strong>of</strong> the PLC Sharesave Plan. In 1999, 1998 and 1997 the total amortisation under the Plan amounted to £2.4 million, £2.1 million and<br />

£1.7 million respectively.<br />

The maximum number <strong>of</strong> shares for which options can be granted are as follows:<br />

PLC Sharesave Plan – 316 000 000<br />

PLC Sharesave Plan and PLC Option Plans – Such number as equals 3% <strong>of</strong> PLC’s issued ordinary share capital, over a three year period.<br />

PLC Sharesave Plan and PLC Option Plans– Such number as equals 10% <strong>of</strong> PLC’s issued ordinary share capital, over a ten year period.<br />

A summary <strong>of</strong> the status <strong>of</strong> the PLC Sharesave Plan as at 31 December 1999, 1998 and 1997 and the changes during these years is<br />

presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

10511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

00000110511 10511 0511 10511 0511 10511<br />

Outstanding at the beginning <strong>of</strong> the year 32 029 021 £3.58 37 439 231 £2.85 43 603 272 £2.30<br />

05111 10511 0511 10511 0511 10511<br />

Granted 6 252 700 £5.14 6 328 960 £5.94 10 200 928 £3.71<br />

Exercised 4 521 318 £2.42 7 192 536 £2.31 14 604 184 £1.89<br />

Forfeited 2 983 085 £4.30 4 546 634 £2.81 1 760 785 £2.43<br />

05111 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 30 777 318 £4.00 32 029 021 £3.58 37 439 231 £2.85<br />

05111 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 127 864 £2.29 250 070 £2.28 772 837 £1.82<br />

10511110511110511110511110511110511


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

Option value informatio n (a)<br />

Fair value per option (b) £1.40 £2.12 £0.57<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 25.04% 17.54% 15.25%<br />

Expected dividend yield 2.84% 1.50% 5.94%<br />

Risk-free interest rate 5.17% 6.02% 6.99%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511005 00511005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

00511 005 005 005 005 005<br />

£2.29 127 864 3 months £2.29 127 864 £2.29<br />

£2.68 5 286 263 1 year £2.68 — —<br />

£2.78 5 883 004 2 years £2.78 — —<br />

£3.71 8 325 975 3 years £3.71 — —<br />

£5.94 5 107 309 4 years £5.94 — —<br />

£5.14 6 046 903 5 years £5.14 — —<br />

00511 005 005 005 005 005<br />

£2.29 to £5.94 30 777 318 £4.00 127 864 £2.29<br />

00000001111011111011111011111101111101111101111<br />

The PLC Option Plans<br />

The PLC Options Plans provide for the granting <strong>of</strong> options to purchase shares in <strong>Unilever</strong> PLC and, from 1997 onwards, also shares <strong>of</strong><br />

<strong>Unilever</strong> NV to key employees <strong>of</strong> the Group. Under the PLC Option Plans, options have been granted on a discretionary basis to<br />

acquire shares at a price which is not less than the market value <strong>of</strong> the shares on a specified date within a 30 day period ending with<br />

the date on which the options were granted. These options become exercisable after a three year period from the date <strong>of</strong> grant and<br />

have a maximum term <strong>of</strong> ten years.<br />

No options to purchase shares may be granted if this would cause the number <strong>of</strong> PLC shares which shall have been or may be issued<br />

in pursuance <strong>of</strong> options to exceed the following numbers:<br />

<strong>Unilever</strong> PLC 1985 Executive Share Option Plan – 79 000 000<br />

<strong>Unilever</strong> PLC 1985 Unapproved Executive Share Option Plan – 79 000 000<br />

PLC Option Plans – Such number as equals 5% <strong>of</strong> PLC’s issued ordinary share capital, over a<br />

ten year period.<br />

PLC Option Plans and PLC Sharesave Plan – Such number as equals 3% <strong>of</strong> PLC’s issued ordinary share capital, over a<br />

three year period.<br />

PLC Option Plans and PLC Sharesave Plan – Such number as equals 10% <strong>of</strong> PLC’s issued ordinary share capital, over<br />

a ten year period.<br />

A summary <strong>of</strong> the status <strong>of</strong> the PLC Option Plans as at 31 December 1999, 1998 and 1997 and <strong>of</strong> the changes during the years ended<br />

on these dates is presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

10511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

00000110511 10511 0511 10511 0511 10511<br />

PLC Options<br />

Outstanding at the beginning <strong>of</strong> the year 10 691 852 £3.80 10 312 216 £3.01 12 633 096 £2.69<br />

10511 10511 0511 10511 0511 10511<br />

Granted 3 577 825 £5.55 2 187 530 £6.68 1 457 400 £4.07<br />

Exercised 1 086 689 £2.56 1 741 396 £2.69 3 600 784 £2.32<br />

Forfeited 54 706 £4.94 66 498 £5.02 177 496 £3.23<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 13 128 282 £4.37 10 691 852 £3.80 10 312 216 £3.01<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 6 039 227 £2.93 4 988 752 £2.73 3 774 648 £2.48<br />

10511110511110511110511110511110511


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

For the years ended 31 December: 1999 1998 1997<br />

10511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

00000110511 10511 0511 10511 0511 10511<br />

NV Options<br />

Outstanding at the beginning <strong>of</strong> the year 546 328 Fl. 129.64 221 712 Fl. 94.40 — —<br />

10511 10511 0511 10511 0511 10511<br />

Granted 547 773 Fl. 139.94 333 926 Fl. 152.83 221 712 Fl. 94.40<br />

Exercised 11 200 Fl. 115.10 2 400 Fl. 94.30 — —<br />

Forfeited 4 900 Fl. 148.79 6 910 Fl. 131.91 — —<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 1 078 001 Fl. 134.94 546 328 Fl. 129.64 221 712 Fl. 94.40<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year — — — — — —<br />

10511110511110511110511110511110511<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

PLC Option value informatio n (a)<br />

Fair value per option (b) £1.16 £1.58 £0.47<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 24.23% 17.62% 15.24%<br />

Expected dividend yield 2.84% 1.50% 5.94%<br />

Risk-free interest rate 4.58% 6.13% 7.12%<br />

NV Option value informatio n (a)<br />

Fair value per option (b) £9.03 £9.92 £3.08<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 23.19% 18.87% 14.92%<br />

Expected dividend yield 1.56% 1.38% 4.36%<br />

Risk-free interest rate 3.32% 4.48% 4.54%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511005 1100511005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

00511 1005 1005 1005 11005 1005<br />

PLC Options<br />

£1.84 29 264 9 months £1.84 29 264 £1.84<br />

£2.07 49 800 2 years £2.07 49 800 £2.07<br />

£2.27 205 040 2 years £2.27 205 040 £2.27<br />

£2.62 60 668 3 years £2.62 60 668 £2.62<br />

£2.54 263 648 3 years £2.54 263 648 £2.54<br />

£2.78 34 520 4 years £2.78 34 520 £2.78<br />

£2.83 128 924 4 years £2.83 128 924 £2.83<br />

£2.54 827 911 4 years £2.54 827 911 £2.54<br />

£2.83 331 444 5 years £2.83 331 444 £2.83<br />

£2.98 1 236 608 5 years £2.98 1 236 608 £2.98<br />

£3.07 893 464 6 years £3.07 893 464 £3.07<br />

£3.08 1 256 136 6 years £3.08 1 256 136 £3.08<br />

£3.43 721 800 7 years £3.43 721 800 £3.43<br />

£4.07 1 375 624 7 years £4.07 — —<br />

£4.53 9 276 7 years £4.53 — —<br />

£6.68 2 108 530 8 years £6.68 — —<br />

£6.79 27 500 8 years £6.79 — —<br />

£5.55 3 568 125 10 years £5.55 — —<br />

00511 1005 1005 1005 11005 1005<br />

£1.84 to £6.79 13 128 282 £4.37 6 039 227 £2.93<br />

00511 1005 1005 1005 11005 1005<br />

NV Options<br />

Fl. 94.30 209 276 7 years Fl. 94.30 — —<br />

Fl. 109.38 1 436 7 years Fl. 109.38 — —<br />

Fl. 152.70 321 666 8 years Fl. 152.70 — —<br />

Fl. 163.00 4 250 8 years Fl. 163.00 — —<br />

Fl. 139.94 541 373 10 years Fl. 139.94 — —<br />

00511 1005 1005 1005 11005 1005<br />

Fl. 94.30 to Fl. 163.00 1 078 001 Fl. 134.94 — —<br />

00511110051100511005111100511005


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

The Ireland Sharesave Plan<br />

The Ireland Sharesave Plan provided for the granting <strong>of</strong> options to purchase shares <strong>of</strong> <strong>Unilever</strong> PLC to eligible employees <strong>of</strong> the Group.<br />

Under the terms <strong>of</strong> the plan, eligible employees, to whom options had been granted, made monthly contributions to a savings plan<br />

approved by the Revenue Commissioners <strong>of</strong> the Republic <strong>of</strong> Ireland for this purpose. At the end <strong>of</strong> five years the proceeds from the<br />

savings plan could be applied to purchase ordinary shares <strong>of</strong> PLC at the market price ruling on the day preceding the date <strong>of</strong> grant.<br />

Following a change in the law, options are no longer granted under this Plan.<br />

A summary <strong>of</strong> the status <strong>of</strong> the Ireland Sharesave Plan as at 31 December 1999, 1998 and 1997 and the changes during these years is<br />

presented below:<br />

00511110051100511005111100511005<br />

For the years ended 31 December: 1999 1998 1997<br />

10511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the beginning <strong>of</strong> the year — — — — 449 544 Ir £2.19<br />

10511 10511 0511 10511 0511 10511<br />

Granted — — — — — —<br />

Exercised — — — — 432 192 Ir £2.19<br />

Forfeited — — — — 17 352 Ir £2.19<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year — — — — — —<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year — — — — — —<br />

10511110511110511110511110511110511<br />

There were no fixed price stock options outstanding at 31 December 1999.<br />

The NV Option Plan<br />

The NV Option Plan provides for the granting <strong>of</strong> options to purchase shares <strong>of</strong> <strong>Unilever</strong> NV and, from 1997 onwards, also shares <strong>of</strong><br />

<strong>Unilever</strong> PLC to key employees <strong>of</strong> the Group. Under the NV Option Plan, options have been granted on a discretionary basis to acquire<br />

shares at market price on the day options were granted. These options become exercisable immediately from the date <strong>of</strong> grant and<br />

have a maximum term <strong>of</strong> five years until 1998 and <strong>of</strong> ten years for subsequent grants.<br />

A summary <strong>of</strong> the status <strong>of</strong> the NV Option Plan as at 31 December 1999, 1998 and 1997 and changes during the years ended on<br />

these dates is presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

10511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

11155555555511110511 10511 0511 10511 0511 10511<br />

NV Options<br />

Outstanding at the beginning <strong>of</strong> the year 1 993 914 Fl. 89.51 1 957 540 Fl. 62.97 2 379 768 Fl. 53.76<br />

10511 10511 0511 10511 0511 10511<br />

Granted 1 133 865 Fl. 139.94 546 156 Fl. 152.51 350 952 Fl. 94.30<br />

Exercised 343 652 Fl. 54.38 490 244 Fl. 51.14 759 268 Fl. 49.14<br />

Forfeited 5 470 Fl. 146.75 19 538 Fl. 125.57 13 912 Fl. 71.96<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 2 778 657 Fl. 114.32 1 993 914 Fl. 89.51 1 957 540 Fl. 62.69<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 2 778 657 Fl. 114.32 1 993 914 Fl. 89.51 1 957 540 Fl. 62.69<br />

10511 10511 0511 10511 0511 10511<br />

PLC Options<br />

Outstanding at the beginning <strong>of</strong> the year 5 791 917 £5.64 2 296 184 £4.07 — —<br />

10511 10511 0511 10511 0511 10511<br />

Granted 7 394 775 £5.55 3 566 477 £6.67 2 320 148 £4.07<br />

Exercised 58 352 £4.07 1 320 £4.07 — —<br />

Forfeited 35 320 £6.15 69 424 £6.23 23 964 £4.07<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 13 093 020 £5.59 5 791 917 £5.64 2 296 184 £4.07<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 13 093 020 £5.59 5 791 917 £5.64 2 296 184 £4.07<br />

10511110511110511110511110511110511


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

NV Option value informatio n (a)<br />

Fair value per option (b) Fl. 26.64 Fl. 28.44 Fl. 9.04<br />

Valuation assumptions<br />

Expected option term 5 years 4 years 4 years<br />

Expected volatility 19.68% 18.93% 14.91%<br />

Expected dividend yield 1.56% 1.38% 4.36%<br />

Risk-free interest rate 3.46% 4.46% 4.54%<br />

PLC Option value informatio n (a)<br />

Fair value per option (b) £3.65 £5.15 £1.48<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 22.82% 17.70% 15.24%<br />

Expected dividend yield 2.84% 1.50% 5.94%<br />

Risk-free interest rate 4.58% 6.11% 7.12%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511005 1100511005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

00111511 1001111 1001111 1001111 11005 1005<br />

NV Options<br />

Fl. 50.29 147 140 6 months Fl. 50.29 147 140 Fl. 50.29<br />

Fl. 56.61 156 012 1 year Fl. 56.61 156 012 Fl. 56.61<br />

Fl. 58.51 278 820 2 years Fl. 58.51 278 820 Fl. 58.51<br />

Fl. 71.60 198 896 2 years Fl. 71.60 198 896 Fl. 71.60<br />

Fl. 94.30 336 448 3 years Fl. 94.30 336 448 Fl. 94.30<br />

Fl. 152.70 519 070 4 years Fl. 152.70 519 070 Fl. 152.70<br />

Fl. 143.20 10 956 4 years Fl. 143.20 10 956 Fl. 143.20<br />

Fl. 139.94 1 131 315 10 years Fl. 139.94 1 131 315 Fl. 139.94<br />

00111511 1001111 1001111 1001111 11005 1005<br />

Fl. 50.29 to Fl. 152.70 2 778 657 Fl. 114.32 2 778 657 Fl. 114.32<br />

00111511 1001111 1001111 1001111 11005 1005<br />

PLC Options<br />

£4.07 2 224 588 3 years £4.07 2 224 588 £4.07<br />

£6.68 3 408 280 4 years £6.68 3 408 280 £6.68<br />

£6.09 81 877 4 years £6.09 81 877 £6.09<br />

£5.55 7 378 275 10 years £5.55 7 378 275 £5.55<br />

00111511 1001111 1001111 1001111 11005 1005<br />

£4.07 to £6.68 13 093 020 £5.59 13 093 020 £5.59<br />

00000001111011111011111011111101111101111101111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

The NV Sharesave Plan<br />

All directors <strong>of</strong> NV and all employees <strong>of</strong> <strong>Unilever</strong> Nederland B.V., may participate in the share option plan for employees in the<br />

Netherlands if they are on the payroll at the date <strong>of</strong> grant and, until 1997, participated in the Save-As-You-Earn Plan.<br />

The grant <strong>of</strong> share options is made after a resolution to such effect has been adopted by the Board <strong>of</strong> <strong>Unilever</strong> Nederland B.V. The<br />

share options are granted at 100% <strong>of</strong> the market price on the date <strong>of</strong> the granting and can be exercised during a period <strong>of</strong> five years.<br />

Options granted since 1998 can generally be exercised after five years. In 1997 each participant was granted an option to acquire<br />

16 shares; in 1998 and 1999 there were grants <strong>of</strong> 50 shares to each participant.<br />

A summary <strong>of</strong> the status <strong>of</strong> the NV Sharesave Plan as at 31 December 1999, 1998 and 1997 and changes during these years is<br />

presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

111151111105111 1051111105111 1051111105111<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

011155555555551 110511 110511 110511 110511 110511<br />

Outstanding at the beginning <strong>of</strong> the year 467 687 Fl. 103.71 236 028 Fl. 72.58 248 808 Fl. 60.24<br />

11111511 110511 110511 110511 110511 110511<br />

Granted 276 751 Fl. 140.27 271 173 Fl. 127.00 90 736 Fl. 94.75<br />

Exercised 53 600 Fl. 84.40 39 195 Fl. 77.23 103 516 Fl. 62.34<br />

Forfeited — — 319 Fl. 127.00 — —<br />

11111511 110511 110511 110511 110511 110511<br />

Outstanding at the end <strong>of</strong> the year 690 838 Fl. 119.85 467 687 Fl. 103.71 236 028 Fl. 72.58<br />

11111511 110511 110511 110511 110511 110511<br />

Options exercisable at the end <strong>of</strong> the year 159 489 Fl. 73.40 198 725 Fl. 72.19 236 028 Fl. 72.58<br />

00000001111011111011111011111101111101111101111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

Option value informatio n (a)<br />

Fair value per option (b) Fl. 29.59 Fl. 28.88 Fl. 12.19<br />

Valuation assumptions<br />

Expected option term 3 years 5 years 5 years<br />

Expected volatility 29.46% 23.32% 15.37%<br />

Expected dividend yield 1.56% 1.38% 4.36%<br />

Risk-free interest rate 3.17% 3.67% 4.35%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511005 1100511005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

00511 1005 1005 1005 11005 005<br />

Fl. 50.87 43 970 10 months Fl. 50.87 43 970 Fl. 50.87<br />

Fl. 68.75 56 753 2 years Fl. 68.75 56 753 Fl. 68.75<br />

Fl. 94.75 58 766 3 years Fl. 94.75 58 766 Fl. 94.75<br />

Fl. 127.00 259 199 4 years Fl. 127.00 — —<br />

Fl. 140.27 272 150 5 years Fl. 140.27 — —<br />

00511 1005 1005 1005 11005 005<br />

Fl. 50.87 to Fl. 140.27 690 838 Fl. 119.85 159 489 Fl. 73.40<br />

00511 1005 1005 1005 11005 005


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

The NA Option Plan<br />

The NA Option Plan provides for the granting <strong>of</strong> options to purchase a maximum <strong>of</strong> 3 200 000 shares in <strong>Unilever</strong> NV <strong>of</strong> the New York<br />

Registry, and amended in 1997 for an additional 4 000 000 shares <strong>of</strong> <strong>Unilever</strong> PLC, to key employees <strong>of</strong> the Group. Under the NA<br />

Option Plan, options are granted on a discretionary basis to acquire shares at market value on the day options are granted.<br />

These options become exercisable over a three-year period from the date <strong>of</strong> grant and have a maximum term <strong>of</strong> ten years.<br />

A summary <strong>of</strong> the status <strong>of</strong> the NA Option Plan as at 31 December 1999, 1998 and 1997 and the changes during the years ended on<br />

these dates is presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

0511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

00000110511 10511 0511 10511 0511 10511<br />

NV Options<br />

Outstanding at the beginning <strong>of</strong> the year 1 702 300 US $ 41.04 1 735 963 US $ 33.64 2 092 448 US $ 29.78<br />

10511 10511 0511 10511 0511 10511<br />

Granted 293 888 US $ 69.19 261 073 US $ 76.69 330 952 US $ 48.50<br />

Exercised 23 933 US $ 29.27 291 802 US $ 29.01 685 433 US $ 28.97<br />

Forfeited 8 784 US $ 38.41 2 934 US $ 33.79 2 004 US $ 54.49<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 1 963 471 US $ 45.41 1 702 300 US $ 41.04 1 735 963 US $ 33.64<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 1 388 599 US $ 36.21 1 073 084 US $ 31.83 952 065 US $ 28.67<br />

10511 10511 0511 10511 0511 10511<br />

PLC Options<br />

Outstanding at the beginning <strong>of</strong> the year 3 878 316 US $ 8.58 2 177 968 US $ 6.72 — —<br />

10511 10511 0511 10511 0511 10511<br />

Granted 1 968 176 US $ 9.30 1 747 196 US $ 10.85 2 177 968 US $ 6.72<br />

Exercised 5 356 US $ 6.72 40 552 US $ 6.72 — —<br />

Forfeited 10 656 US $ 9.46 6 296 US $ 6.72 — —<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 5 830 480 US $ 8.82 3 878 316 US $ 8.58 2 177 968 US $ 6.72<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year 1 982 696 US $ 7.92 688 800 US $ 6.72 — —<br />

10511110511110511110511110511110511<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

NV Option value informatio n (a)<br />

Fair value per option (b) US $ 19.45 US $ 19.67 US $ 13.19<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 24.50% 19.48% 15.67%<br />

Expected dividend yield 1.23% 1.30% 0.82%<br />

Risk-free interest rate 5.21% 5.67% 6.45%<br />

PLC Option value informatio n (a)<br />

Fair value per option (b) US $ 2.23 US $ 2.97 US $ 1.69<br />

Valuation assumptions<br />

Expected option term 5 years 5 years 5 years<br />

Expected volatility 24.26% 20.09% 17.55%<br />

Expected dividend yield 2.48% 1.39% 1.79%<br />

Risk-free interest rate 5.21% 5.64% 6.48%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511111005 00111111005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

0051151 005 005 005 005 005<br />

NV Options<br />

US $ 25.69 43 000 3 years US $ 25.69 43 000 US $ 25.69<br />

US $ 26.81 117 236 4 years US $ 26.81 117 236 US $ 26.81<br />

US $ 25.67 225 398 5 years US $ 25.67 225 398 US $ 25.67<br />

US $ 31.60 5 200 6 years US $ 31.60 5 200 US $ 31.60<br />

US $ 31.95 288 166 6 years US $ 31.95 288 166 US $ 31.95<br />

US $ 33.89 413 140 7 years US $ 33.89 413 140 US $ 33.89<br />

US $ 48.74 317 420 8 years US $ 48.74 209 803 US $ 48.74<br />

US $ 76.69 260 023 9 years US $ 76.69 86 656 US $ 76.69<br />

US $ 69.19 293 888 10 years US $ 69.19 — —<br />

0051151 005 005 005 005 005<br />

US $ 25.67 to US $ 76.69 1 963 471 US $ 45.41 1 388 599 US $ 36.21<br />

0051151 005 005 005 005 005<br />

PLC Options<br />

US $ 6.72 2 122 188 8 years US $ 6.72 1 402 748 US $ 6.72<br />

US $ 10.85 1 740 116 9 years US $ 10.85 579 948 US $ 10.85<br />

US $ 9.30 1 968 176 10 years US $ 9.30 — —<br />

0051151 005 005 005 005 005<br />

US $ 6.72 to US $ 10.85 5 830 480 US $ 8.82 1 982 696 US $ 7.92<br />

0051151100510051005110051005<br />

The NA Purchase Plan<br />

The NA Purchase Plan provides for the granting <strong>of</strong> options to purchase a maximum <strong>of</strong> 10 000 000 shares <strong>of</strong> <strong>Unilever</strong> NV <strong>of</strong> the<br />

New York Registry. The first <strong>of</strong>fering under the purchase plan was held in 1995, and was limited to options covering 2 000 000 shares.<br />

This <strong>of</strong>fering ended in 1997.<br />

The second <strong>of</strong>fering under the NA Purchase Plan was held in 1997, and was limited to 2 000 000 shares. Under the terms <strong>of</strong> the<br />

second <strong>of</strong>fering, eligible employees could elect to accept the option to purchase any number <strong>of</strong> whole shares, being not less than<br />

40 or more than 416, by payroll deductions <strong>of</strong> up to 10% <strong>of</strong> annual base compensation over a two-year period in equal instalments<br />

beginning 1 November 1997 and ending 29 October 1999. At the end <strong>of</strong> the second <strong>of</strong>fering, eligible employees exercised their<br />

options to purchase 631 493 NV shares at an option price <strong>of</strong> US $ 47.83, which represents a 10% discount to the market value on<br />

the grant date. This discount <strong>of</strong> US $ 4.4 million was amortised over the 24 month vesting period <strong>of</strong> the plan.<br />

The third <strong>of</strong>fering, also limited to 2 000 000 shares, was held in 1999. Eligible employees can purchase between 30 and 381 shares<br />

by means <strong>of</strong> a maximum payroll deduction <strong>of</strong> 10% from January 2000 to December 2001. As at 31 December 1999 this represented<br />

557 062 NV shares. The option price <strong>of</strong> US $ 52.43, 10% below the market value on the grant date, leads to a discount <strong>of</strong><br />

US $ 3.2 million being amortised over the 24 month vesting period.<br />

A summary <strong>of</strong> the status <strong>of</strong> the NA Purchase Plan as at 31 December 1999, 1998 and 1997 and the changes during these years is<br />

presented below:<br />

00000001111011111011111011111101111101111101111<br />

For the years ended 31 December: 1999 1998 1997<br />

0511110511 0511110511 0511110511<br />

Weighted Weighted Weighted<br />

Number average Number average Number average<br />

<strong>of</strong> shares price <strong>of</strong> shares price <strong>of</strong> shares price<br />

00000110511 10511 0511 10511 0511 10511<br />

Outstanding at the beginning <strong>of</strong> the year 785 756 US $ 47.83 912 752 US $ 47.83 1 019 636 US $ 28.89<br />

10511 10511 0511 10511 0511 10511<br />

Granted 633 913 US $ 52.43 — — 918 172 US $ 47.83<br />

Exercised 701 897 US $ 47.83 — — 969 724 US $ 28.89<br />

Forfeited 83 859 US $ 47.83 126 996 US $ 47.83 55 332 US $ 30.74<br />

10511 10511 0511 10511 0511 10511<br />

Outstanding at the end <strong>of</strong> the year 633 913 US $ 52.43 785 756 US $ 47.83 912 752 US $ 47.83<br />

10511 10511 0511 10511 0511 10511<br />

Options exercisable at the end <strong>of</strong> the year — — — — — —<br />

00000001111011111011111011111101111101111101111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

33 Equity based compensation plans (continued)<br />

00000000000000001111<br />

1999 1998 1997<br />

00000001111011111011111011111101111 01111 01111<br />

Option value informatio n (a)<br />

Fair value per option (b) US $ 14.80 — US $ 13.67<br />

Valuation assumptions<br />

Expected option term 2 years — 2 years<br />

Expected volatility 34.18% — 21.40%<br />

Expected dividend yield 1.23% — 0.82%<br />

Risk-free interest rate 3.66% — 4.43%<br />

(a) Weighted average <strong>of</strong> options granted during each period.<br />

(b) Estimated using Black Scholes option pricing method.<br />

00000001111011111011111011111101111101111101111<br />

The following table summarises information about fixed price stock options outstanding at 31 December 1999:<br />

00000001111011111011111011111101111101111101111<br />

Options Outstanding Options Exercisable<br />

00511110051100511005 00511005<br />

Number Weighted Number<br />

outstanding at average Weighted exercisable at Weighted<br />

Range <strong>of</strong> 31 December remaining average 31 December average<br />

exercise prices 1999 contractual life exercise price 1999 exercise price<br />

00511 1005 005 1005 005 1005<br />

US $ 52.43 633 913 2 years US $ 52.43 — —<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

34 Summarised accounts <strong>of</strong> the NV and PLC parts <strong>of</strong> the Group<br />

00000000000000001111<br />

The following summarised accounts present the pr<strong>of</strong>it and loss account and balance sheet <strong>of</strong> the <strong>Unilever</strong> Group, analysed between<br />

the NV and PLC parts <strong>of</strong> the Group according to respective ownership.<br />

Pr<strong>of</strong>it and loss account for the year ended 31 December<br />

00000000000000001111<br />

Fl. million NV PLC<br />

01111101111101111 01111101111101111<br />

1999 1998 1997 1999 1998 1997<br />

0000000111101111 01111 01111 01111 01111 01111<br />

Turnover 60 947 61 495 65 239 29 349 27 617 29 358<br />

Continuing operations 60 647 61 495 62 586 29 349 27 617 28 014<br />

Acquisitions 300 —<br />

Discontinued operations 2 653 1 344<br />

Operating pr<strong>of</strong>it 5 841 5 565 4 555 3 641 4 153 3 008<br />

Continuing operations 5 854 5 565 4 217 3 641 4 153 2 832<br />

Acquisitions (13) —<br />

Discontinued operations 338 176<br />

Pr<strong>of</strong>it on sale <strong>of</strong> discontinued speciality chemicals businesses — — 6 463 — — 2 019<br />

Loss on disposal <strong>of</strong> fixed assets in continuing businesses — — (330) — — (154)<br />

Income from fixed investments 83 58 69 31 24 16<br />

Interest (85) 93 (182) 55 251 (48)<br />

01111 01111 01111 01111 01111 01111<br />

Pr<strong>of</strong>it on ordinary activities before taxation 5 839 5 716 10 575 3 727 4 428 4 841<br />

Taxation (1 882) (2 024) (2 857) (1 135) (1 314) (1 328)<br />

01111 01111 01111 01111 01111 01111<br />

Pr<strong>of</strong>it on ordinary activities after taxation 3 957 3 692 7 718 2 592 3 114 3 513<br />

Minority interests (75) (37) (69) (368) (281) (239)<br />

01111 01111 01111 01111 01111 01111<br />

Net pr<strong>of</strong>it 3 882 3 655 7 649 2 224 2 833 3 274<br />

00000000000000001111<br />

Balance sheet as at 31 December<br />

00000000000000001111<br />

Fixed assets 13 943 12 712 7 228 6 283<br />

Current assets<br />

Stocks 7 160 6 831 4 131 3 630<br />

Debtors 13 144 11 142 3 791 3 707<br />

Debtors due within one year 9 703 8 868 2 950 2 429<br />

Debtors due after more than one year 3 441 2 274 841 1 278<br />

Cash and current investments 8 440 16 637 3 621 6 244<br />

01111 01111 01111 01111<br />

28 744 34 610 11 543 13 581<br />

Creditors due within one year (19 156) (26 409) (7 584) (13 205)<br />

Borrowings (5 488) (4 428) (981) (695)<br />

Trade and other creditors (13 668) (21 981) (6 603) (12 510)<br />

Net current assets 9 588 8 201 3 959 376<br />

01111 01111 01111 01111<br />

Total assets less current liabilities 23 531 20 913 11 187 6 659<br />

00000000000000001111<br />

Creditors due after more than one year 5 793 6 218 448 484<br />

Borrowings 4 025 4 771 59 252<br />

Trade and other creditors 1 768 1 447 389 232<br />

Provisions for liabilities and charges 8 094 7 320 2 003 2 187<br />

Intra-group – NV/PLC (4 035) (567) 4 035 567<br />

Minority interests 187 128 1 088 771<br />

Capital and reserves 13 492 7 814 3 613 2 650<br />

01111 01111 01111 01111<br />

Total capital employed 23 531 20 913 11 187 6 659<br />

00000000000000001111


<strong>Unilever</strong> Group Notes to the consolidated accounts<br />

35 Impact <strong>of</strong> discontinued activities (1)(2)<br />

00000000000000001111<br />

Fl. million<br />

000005111<br />

1999 1998 1997<br />

00000000005105111 05111 05111<br />

Turnover (3) Total Group 90 296 89 112 94 597<br />

Continuing businesses 90 296 89 112 90 600<br />

Discontinued operations — — 3 997<br />

Pr<strong>of</strong>it Before Tax Total Group 9 566 10 144 15 416<br />

Continuing businesses 9 566 10 144 6 418<br />

Discontinued operations — — 8 998<br />

Taxation On Pr<strong>of</strong>it (2) Total Group (3 017) (3 338) (4 185)<br />

Continuing businesses (3 017) (3 338) (2 208)<br />

Discontinued operations — — (1 977)<br />

Net Pr<strong>of</strong>it Total Group 6 106 6 488 10 923<br />

Continuing businesses 6 106 6 488 3 962<br />

Discontinued operations — — 6 961<br />

Combined Earnings Per Shar e Guilders per Fl. 1.12 (1997-1998: Fl. 1) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 5.80 5.80 9.78<br />

Continuing businesses 5.80 5.80 3.54<br />

Discontinued operations — — 6.24<br />

Pence per 1.4p (1997-1998: 1.25p) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 26.01 26.45 44.74<br />

Continuing businesses 26.01 26.45 16.66<br />

Discontinued operations — — 28.08<br />

On a SSAP 15 basis the figures would be: Guilders per Fl. 1.12 (1997-1998: Fl. 1) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 5.74 5.67 9.20<br />

Continuing businesses 5.74 5.67 2.94<br />

Discontinued operations — — 6.26<br />

Pence per 1.4p (1997-1998: 1.25p) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 25.73 25.88 41.99<br />

Continuing businesses 25.73 25.88 13.79<br />

Discontinued operations — — 28.20<br />

On a US GAAP basis the figures would be: Guilders per Fl. 1.12 (1997-1998: Fl. 1) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 5.20 5.01 9.47<br />

Continuing businesses 5.20 5.01 3.07<br />

Discontinued operations — — 6.40<br />

Pence per 1.4p (1997-1998: 1.25p) <strong>of</strong> ordinary capital<br />

000005111<br />

Total Group 23.35 22.84 43.25<br />

Continuing businesses 23.35 22.84 14.48<br />

Discontinued operations — — 28.77<br />

(1) The figures shown above for discontinued activities are derived from internal financial information for purposes connected with the<br />

sale <strong>of</strong> the speciality chemicals businesses.<br />

(2) The taxation charge shown above, together with interest and certain other charges, for the activities to be discontinued are based<br />

in some cases on an allocation <strong>of</strong> the charge or credit incurred by the <strong>Unilever</strong> Group in the relevant country, and are not<br />

necessarily representative <strong>of</strong> the results <strong>of</strong> the activities discontinued or the continuing businesses on a stand alone basis.<br />

(3) Turnover excludes sales to <strong>Unilever</strong> group companies.<br />

00000000000000001111


Schedules – <strong>Unilever</strong> Group<br />

Valuation and qualifying accounts<br />

00000000000000001111<br />

Fl. million<br />

Schedule II<br />

00000000000000001111<br />

Additions<br />

051111105111<br />

Charge to Charged to<br />

Balance at pr<strong>of</strong>it and other accounts Balance at<br />

Description 1 January loss account (a) Deductions 31 December<br />

00000011111105111 05111 05111 05111 05111<br />

Year ended 31 December 1999<br />

Provision for doubtful debtors 533 188 37 (143) 615<br />

00000011111105111 05111 05111 05111 05111<br />

Year ended 31 December 1998<br />

Provision for doubtful debtors 540 158 (3) (162) 533<br />

00000011111105111 05111 05111 05111 05111<br />

Year ended 31 December 1997<br />

Provision for doubtful debtors 575 144 (13) (166) 540<br />

00000000000000001111<br />

(a) Includes currency retranslation <strong>of</strong> opening balances.


Key divergence statements from United States GAAP<br />

<strong>Unilever</strong> Group<br />

<strong>Unilever</strong>´s consolidated accounts are prepared in accordance with accounting principles which differ in some respects from those<br />

applicable in the United States. The following is a summary <strong>of</strong> the approximate effect on the Group’s net pr<strong>of</strong>it, combined earnings per<br />

share and capital and reserves <strong>of</strong> the application <strong>of</strong> United States generally accepted accounting principles (US GAAP).<br />

00000000000000001111<br />

Fl. million<br />

0110511150<br />

1999 1998 1997<br />

00000000000511111110 11110 11110<br />

Net pr<strong>of</strong>it as reported in the consolidated pr<strong>of</strong>it and loss account 6 106 6 488 10 923<br />

Attributable to: NV 3 882 3 655 7 649<br />

PLC 2 224 2 833 3 274<br />

US GAAP adjustments:<br />

Pr<strong>of</strong>it on sale <strong>of</strong> speciality chemicals businesses — — 244<br />

Goodwill (470) (437) (325)<br />

Identifiable intangibles (247) (240) (215)<br />

Restructuring costs 99 (412) 89<br />

Interest (19) (54) (22)<br />

Pensions (28) 16 (192)<br />

Taxation effect <strong>of</strong> above adjustments 47 244 79<br />

00000000000511111110 11110 11110<br />

Net increase/(decrease) (618) (883) (342)<br />

1110 11110 11110<br />

Approximate net income under US GAAP 5 488 5 605 10 581<br />

Attributable to: NV 3 472 2 941 7 458<br />

PLC 2 016 2 664 3 123<br />

00000000000000001111<br />

Approximate combined net income per share under US GAAP<br />

Guilders per Fl. 1.12 (1997-98: Fl. 1) <strong>of</strong> ordinary capital 5.20 5.01 9.47<br />

Approximate combined diluted net income per share under US GAAP<br />

Guilders per Fl. 1.12 (1997-98: Fl. 1) <strong>of</strong> ordinary capital 5.08 4.90 9.26<br />

00000000000000001111<br />

Capital and reserves as reported in the consolidated balance sheet 17 105 10 464<br />

Attributable to: NV 13 492 7 814<br />

PLC 3 613 2 650<br />

US GAAP adjustments:<br />

Goodwill 8 629 8 734<br />

Identifiable intangibles 6 584 5 945<br />

Restructuring costs 229 109<br />

Interest 1 223 1 095<br />

Pensions 408 491<br />

Dividends 1 970 17 886<br />

Taxation effect <strong>of</strong> above adjustments (2 265) (2 209)<br />

1110 11110<br />

Net increase 16 778 32 051<br />

1110 11110<br />

Approximate capital and reserves under US GAAP 33 883 42 515<br />

Attributable to: NV 25 165 28 479<br />

PLC 8 718 14 036<br />

00000000000000001111<br />

The aggregate amounts included in capital and reserves in respect <strong>of</strong> cumulative<br />

currency translation adjustments are as follows:<br />

Balance 1 January (8 289) (6 960) (7 661)<br />

Arising during the year 774 (1 329) 701<br />

1110 11110 11110<br />

Balance 31 December (7 515) (8 289) (6 960)<br />

1110 11110 11110<br />

The aggregate amounts <strong>of</strong> foreign currency transaction gains and (losses) charged in the<br />

consolidated pr<strong>of</strong>it and loss account are: (5) (196) (118)<br />

00000000000000001111


Differences from United States GAAP<br />

<strong>Unilever</strong> Group<br />

The consolidated accounts <strong>of</strong> the <strong>Unilever</strong> Group have been<br />

prepared in accordance with accounting principles which differ<br />

in certain respects from those generally accepted in the United<br />

States (US GAAP).<br />

The principal differences are set out below.<br />

Pr<strong>of</strong>it on sale <strong>of</strong> chemicals businesses<br />

<strong>Unilever</strong> calculates pr<strong>of</strong>it on sale <strong>of</strong> businesses after writing back<br />

any goodwill previously charged directly to reserves. Under<br />

US GAAP the pr<strong>of</strong>it on disposal <strong>of</strong> the discontinued speciality<br />

chemicals businesses is stated net <strong>of</strong> the relevant unamortised<br />

goodwill included on the balance sheet and the cumulative<br />

currency retranslation differences recognised through the<br />

statement <strong>of</strong> total recognised gains and losses.<br />

Goodwill and other intangibles<br />

Prior to 1 January 1998 <strong>Unilever</strong> wrote <strong>of</strong>f goodwill and all other<br />

intangible assets arising on the acquisition <strong>of</strong> new interests in<br />

group companies and joint ventures directly to pr<strong>of</strong>it retained in<br />

the year <strong>of</strong> acquisition. Under US GAAP goodwill and identifiable<br />

intangibles, principally trade marks, are capitalised and amortised<br />

against income over their estimated useful lives, not exceeding<br />

40 years.<br />

There is no difference between the accounting policy applied to<br />

goodwill and intangible assets purchased after 1 January 1998<br />

and US GAAP.<br />

Restructuring costs<br />

Under <strong>Unilever</strong>’s accounting policy certain restructuring costs<br />

are recognised when a restructuring plan has been announced.<br />

Under US GAAP certain additional criteria must be met before<br />

such charges are recognised.<br />

Interest<br />

<strong>Unilever</strong> treats all interest costs as a charge to the pr<strong>of</strong>it and loss<br />

account in the current period. Under US GAAP interest incurred<br />

during the construction periods <strong>of</strong> tangible fixed assets is<br />

capitalised and depreciated over the life <strong>of</strong> the assets.<br />

Pensions<br />

Under <strong>Unilever</strong>´s accounting policy the expected costs <strong>of</strong><br />

providing retirement pensions are charged to the pr<strong>of</strong>it and loss<br />

account over the periods benefiting from the employees´ services.<br />

Variations from expected cost are similarly spread. Under US<br />

GAAP pension costs and liabilities are calculated in accordance<br />

with Statement <strong>of</strong> Financial Accounting Standards No. 87 (SFAS<br />

87), which requires the use <strong>of</strong> a prescribed actuarial method and<br />

a set <strong>of</strong> measurement principles.<br />

Investments<br />

<strong>Unilever</strong> accounts for current investments, which are liquid funds<br />

temporarily invested, at their market value.<br />

<strong>Unilever</strong> accounts for changes in the market value <strong>of</strong> current<br />

investments as interest receivable in the pr<strong>of</strong>it and loss account<br />

for the year. Under US GAAP, such current asset investments are<br />

classified as ‘available for sale securities’ and changes in market<br />

rates, which represent unrealised gains or losses, are excluded<br />

from earnings and taken to stockholders’ equity. Unrealised gains<br />

and losses arising from changes in the market values <strong>of</strong> securities<br />

available for sale are not material.<br />

<strong>Unilever</strong> accounts for fixed investments other than in joint<br />

ventures at cost less any amounts written <strong>of</strong>f to reflect a<br />

permanent diminution in value. Under US GAAP such investments<br />

are held at fair value. The difference is not material.<br />

Dividends<br />

The proposed final ordinary dividends are provided for in the<br />

<strong>Unilever</strong> accounts in the financial year in the year to which they<br />

relate. Under US GAAP such dividends are not provided for until<br />

they become irrevocable.<br />

Cash flow statement<br />

Under US GAAP various items would be reclassified within the<br />

consolidated cash flow statement. In particular, interest received,<br />

interest paid and taxation would be part <strong>of</strong> net cash flow from<br />

operating activities, and dividends paid would be included within<br />

net cash flow from financing. In addition, under US GAAP cash<br />

and cash equivalents comprise cash balances and current<br />

investments with an original maturity at the date <strong>of</strong> investment<br />

<strong>of</strong> less than three months. Under <strong>Unilever</strong>’s presentation,<br />

cash includes only cash in hand or available on demand<br />

less bank overdrafts.<br />

Movements in those current investments which are included<br />

under the heading <strong>of</strong> cash and cash equivalents under US GAAP<br />

form part <strong>of</strong> the movement entitled ‘Management <strong>of</strong> liquid<br />

resources’ in the cash flow statements. At the end <strong>of</strong> 1999<br />

the balance <strong>of</strong> such investments was Fl. 62 million (1998:<br />

Fl. 6 622 million, 1997: Fl. 3 954 million).<br />

Exceptional items<br />

In accordance with United Kingdom Financial Reporting Standard<br />

Number 3 (Reporting Financial Performance) certain nonoperating<br />

exceptional items are shown separately in the pr<strong>of</strong>it<br />

and loss account below operating pr<strong>of</strong>it and before interest.<br />

Under US GAAP most non-operating exceptional items would<br />

be included in operating pr<strong>of</strong>it from continuing operations.<br />

The pr<strong>of</strong>it arising on disposal <strong>of</strong> the speciality chemicals<br />

businesses in 1997 would be presented as a separate line<br />

below income from continuing operations.<br />

Discontinued operations<br />

<strong>Unilever</strong> analyses turnover and operating pr<strong>of</strong>it between<br />

continuing and discontinued operations. Under US GAAP the<br />

operating pr<strong>of</strong>it from discontinued operations would be shown<br />

on a separate line below income from continuing operations.


Principal group companies and fixed investments as at 31 December 1999<br />

<strong>Unilever</strong> Group<br />

5000000011111<br />

The companies listed below and on pages 109 and 110 are those<br />

which in the opinion <strong>of</strong> the directors, principally affect the<br />

amount <strong>of</strong> pr<strong>of</strong>it and assets shown in the <strong>Unilever</strong> Group<br />

accounts. The directors consider that those companies not<br />

listed are not significant in relation to <strong>Unilever</strong> as a whole.<br />

Full information as required by Articles 379 and 414 <strong>of</strong> Book 2,<br />

Civil Code, in the Netherlands has been filed by <strong>Unilever</strong> N.V.<br />

with the Commercial Registry in Rotterdam.<br />

Particulars <strong>of</strong> PLC group companies and other significant holdings<br />

as required by the United Kingdom Companies Act 1985 will be<br />

annexed to the next Annual Return <strong>of</strong> <strong>Unilever</strong> PLC.<br />

The main activities <strong>of</strong> the companies listed below are indicated<br />

according to the following key:<br />

5000000011111<br />

Holding companies H<br />

Foods F<br />

Home & Personal Care P<br />

Other Operations O<br />

5000000011111<br />

Unless otherwise indicated the companies are incorporated and<br />

principally operate in the countries under which they are shown.<br />

The letters NV or PLC after the name <strong>of</strong> each country indicate<br />

whether in the country concerned the shares in the companies<br />

listed are held directly or indirectly by NV and/or by PLC.<br />

The percentage <strong>of</strong> equity capital directly or indirectly held by NV<br />

or PLC is shown in the margin, except where it is 100%. All<br />

percentages are rounded down to the nearest whole number.<br />

5000000011111<br />

Principal group companies<br />

% Europe<br />

0000000151111<br />

Austria – NV<br />

Austria Frost Nahrungsmittel Ges.m.b.H. F<br />

Eskimo-Iglo Ges.m.b.H. F<br />

Österreichische <strong>Unilever</strong> Ges.m.b.H. FP<br />

5000000011111<br />

Belgium – NV<br />

<strong>Unilever</strong> Belgium N.V. FPO<br />

5000000011111<br />

Czech Republic – NV<br />

<strong>Unilever</strong> ˘CR s.r.o. FP<br />

5000000011111<br />

Denmark – NV<br />

<strong>Unilever</strong> Danmark A/S FP<br />

5000000011111<br />

Finland – NV<br />

Suomen <strong>Unilever</strong> Oy FP<br />

5000000011111<br />

France – NV<br />

99 Astra-Calvé S.A. F<br />

99 Boursin S.A.S. F<br />

99 Choky S.A. F<br />

99 Cogesal-Miko S.A. F<br />

99 Elida Fabergé S.A. P<br />

99 Fralib S.A. F<br />

99 Frigedoc S.A. F<br />

99 Lever S.A. P<br />

99 Relais d’Or-Miko S.A. F<br />

99 <strong>Unilever</strong> France S.A. H<br />

5000000011111<br />

* See ‘Basis <strong>of</strong> consolidation’ on page 62.<br />

5000000011111<br />

% Europe (continued)<br />

Germany – NV<br />

Deutsche <strong>Unilever</strong> GmbH H<br />

Langnese-Iglo GmbH F<br />

Lever Fabergé Deutschland GmbH P<br />

Meistermarken-Werke GmbH,<br />

Spezialfabrik für Back-und Grossküchenbedarf F<br />

Union Deutsche Lebensmittelwerke GmbH F<br />

5000000011111<br />

Greece – NV<br />

51 ‘Elais’ Oleaginous Products A.E. F<br />

<strong>Unilever</strong> Hellas A.E.B.E. FP<br />

5000000011111<br />

Hungary – NV<br />

<strong>Unilever</strong> Magyarország Beruházási Kft FP<br />

5000000011111<br />

Ireland – PLC<br />

Lever Fabergé Ireland Ltd. P<br />

Lyons Tea Ireland Ltd. F<br />

Van den Bergh Foods Ltd. F<br />

5000000011111<br />

Italy – NV<br />

Sagit SpA F<br />

<strong>Unilever</strong> Italia SpA FP<br />

5000000011111<br />

The Netherlands – NV<br />

DiverseyLever B.V. P<br />

IgloMora Groep B.V. F<br />

Lever Fabergé Nederland B.V. P<br />

Loders Croklaan B.V. F<br />

* <strong>Unilever</strong> N.V. H<br />

<strong>Unilever</strong> Nederland B.V. H<br />

UniMills B.V. F<br />

Van den Bergh Nederland B.V. F<br />

5000000011111<br />

Poland – NV<br />

99 <strong>Unilever</strong> Polska S.A. FP<br />

5000000011111<br />

Portugal – NV<br />

74 IgloOlá-Distribuição de Gelados e de Ultracongelados, Lda. F<br />

60 LeverElida-Distribuição de Produtos de Limpeza e<br />

Higiene Pessoal, Lda. P<br />

5000000011111<br />

Romania – NV<br />

99 <strong>Unilever</strong> Romania FP<br />

5000000011111<br />

Russia – NV<br />

<strong>Unilever</strong> SNG FP<br />

000000011111<br />

Slovakia – NV<br />

<strong>Unilever</strong> Slovensko spol. sr. o. FP<br />

5000000011111<br />

Spain – NV<br />

99 Frigo S.A. F<br />

Frudesa S.A. F<br />

<strong>Unilever</strong> España S.A. HP<br />

<strong>Unilever</strong> Foods España S.A. F<br />

5000000011111


Principal group companies and fixed investments as at 31 December 1999<br />

<strong>Unilever</strong> Group<br />

Principal group companies (continued)<br />

5000000011111<br />

% Europe (continued)<br />

Sweden – NV<br />

GB Glace AB F<br />

Lever Fabergé AB P<br />

Van den Bergh Foods AB F<br />

5000000011111<br />

Switzerland – NV<br />

DiverseyLever A.G. P<br />

Lever Fabergé A.G. P<br />

Lipton-Sais F<br />

Meina Holding A.G. H<br />

Pierrot-Lusso A.G. F<br />

Sunlight A.G. O<br />

<strong>Unilever</strong> Cosmetics International S.A. P<br />

<strong>Unilever</strong> (Schweiz) A.G. O<br />

5000000011111<br />

Turkey – NV<br />

82 Lever Elida Temizlik ve Ki,sisel Bakım Ürünleri<br />

Sanayi ve Ticaret A.‚S. P<br />

Unikom Gida Sanayi ve Ticaret A.‚S. F<br />

<strong>Unilever</strong> Sanayi ve Ticaret Türk A.‚S. F<br />

<strong>Unilever</strong> Tüketim Ürünleri Satı,s Pazarlama ve Ticaret A. ‚S. FP<br />

5000000011111<br />

United Kingdom – PLC<br />

Birds Eye Wall’s Ltd. F<br />

Calvin Klein Cosmetics (UK) Ltd. P<br />

DiverseyLever Ltd. P<br />

Elida Fabergé Ltd. P<br />

Elizabeth Arden Ltd. P<br />

Lever Brothers Ltd. P<br />

Lipton Ltd. F<br />

* <strong>Unilever</strong> PLC H<br />

<strong>Unilever</strong> U.K. Central Resources Ltd. O<br />

<strong>Unilever</strong> U.K. Holdings Ltd. H<br />

Unipath Ltd. P<br />

Van den Bergh Foods Ltd. F<br />

% North America<br />

Canada – PLC<br />

UL Canada Inc. FP<br />

<strong>Unilever</strong> Canada Limited H<br />

United States <strong>of</strong> America – NV (75%); PLC (25%)<br />

† Calvin Klein Cosmetics Company P<br />

DiverseyLever, Inc. P<br />

† Elizabeth Arden Co. P<br />

† Good Humor-Breyers Ice Cream F<br />

† Gorton’s F<br />

† Lipton F<br />

<strong>Unilever</strong> Capital Corporation O<br />

† <strong>Unilever</strong> Home & Personal Care USA P<br />

<strong>Unilever</strong> United States, Inc. H<br />

* See ‘Basis <strong>of</strong> consolidation’ on page 62.<br />

† A division <strong>of</strong> Conopco, Inc., a subsidiary <strong>of</strong> <strong>Unilever</strong> United<br />

States, Inc.<br />

5000000011111<br />

% Africa and Middle East<br />

Côte d’Ivoire – PLC<br />

90 Blohorn S.A. FPO<br />

5000000011111<br />

Democratic Republic <strong>of</strong> Congo – NV<br />

Compagnie des Margarines, Savons et<br />

Cosmétiques au Congo s.a.r.l. FP<br />

76 Plantations et Huileries du Congo O<br />

5000000011111<br />

Dubai – PLC<br />

<strong>Unilever</strong> Gulf Free Zone Establishment O<br />

5000000011111<br />

Egypt – PLC<br />

60 Fine Foods Egypt SAE F<br />

Lever Egypt SAE P<br />

5000000011111<br />

Ghana – PLC<br />

67 <strong>Unilever</strong> Ghana Ltd. FPO<br />

5000000011111<br />

Israel – PLC<br />

50 Glidat Strauss Ltd. F<br />

Lever Israel Ltd. P<br />

5000000011111<br />

Kenya – PLC<br />

88 Brooke Bond Kenya Ltd. O<br />

East Africa Industries Ltd. FP<br />

5000000011111<br />

Malawi – PLC<br />

Lever Brothers (Malawi) Ltd. FP<br />

5000000011111<br />

Morocco – PLC<br />

Lever Maroc S.A. P<br />

5000000011111<br />

Nigeria – PLC<br />

50 Lever Brothers Nigeria PLC FP<br />

5000000011111<br />

Saudi Arabia – PLC<br />

49 Binzagr Lever Ltd. P<br />

49 Binzagr Lipton Ltd. F<br />

49 Binzagr Wall’s Ltd. F<br />

49 Lever Arabia Ltd. P<br />

5000000011111<br />

South Africa – PLC<br />

<strong>Unilever</strong> South Africa (Pty.) Ltd. FP<br />

5000000011111<br />

Tanzania – PLC<br />

Brooke Bond Tanzania Ltd. O<br />

5000000011111<br />

Uganda – PLC<br />

<strong>Unilever</strong> Uganda Ltd. FP<br />

5000000011111<br />

Zambia – PLC<br />

Lever Brothers Zambia Limited FP<br />

5000000011111<br />

Zimbabwe – PLC<br />

Lever Brothers (Private) Ltd. FP


Principal group companies and fixed investments as at 31 December 1999<br />

<strong>Unilever</strong> Group<br />

Principal group companies (continued)<br />

5000000011111<br />

% Asia and Pacific<br />

Australia – PLC<br />

<strong>Unilever</strong> Australia Ltd. FP<br />

5000000011111<br />

Bangladesh – PLC<br />

61 Lever Brothers Bangladesh Ltd. FP<br />

5000000011111<br />

China – NV<br />

<strong>Unilever</strong> (China) Ltd. H<br />

<strong>Unilever</strong> Foods (China) Company Ltd. F<br />

97 Wall’s (China) Company Ltd. F<br />

China S.A.R. – NV<br />

<strong>Unilever</strong> Hong Kong Ltd. FP<br />

5000000011111<br />

India – PLC<br />

51 Hindustan Lever Ltd. (NV 2%) FPO<br />

5000000011111<br />

Indonesia – NV<br />

85 P.T. <strong>Unilever</strong> Indonesia FP<br />

5000000011111<br />

Japan – NV<br />

Nippon Lever B.V. (incorporated in the Netherlands) FP<br />

Japan – PLC<br />

Lever Brothers Ltd. (incorporated in the United Kingdom) P<br />

5000000011111<br />

Malaysia – PLC<br />

Pamol Plantations Sdn. Bhd. O<br />

70 <strong>Unilever</strong> (Malaysia) Holdings Sdn. Bhd. FP<br />

5000000011111<br />

New Zealand – PLC<br />

<strong>Unilever</strong> New Zealand Ltd. FP<br />

5000000011111<br />

Pakistan – PLC<br />

67 Lever Brothers Pakistan Ltd. FP<br />

5000000011111<br />

Philippines – NV<br />

<strong>Unilever</strong> Philippines Inc. FP<br />

5000000011111<br />

Singapore – PLC<br />

<strong>Unilever</strong> Singapore Private Ltd. FP<br />

5000000011111<br />

South Korea – NV<br />

<strong>Unilever</strong> Korea P<br />

5000000011111<br />

Sri Lanka – PLC<br />

<strong>Unilever</strong> Ceylon Ltd. FPO<br />

5000000011111<br />

Taiwan – NV<br />

<strong>Unilever</strong> Taiwan Ltd. P<br />

5000000011111<br />

Thailand – NV<br />

<strong>Unilever</strong> Thai Holdings Ltd. FP<br />

5000000011111<br />

Vietnam – NV<br />

66 Lever HASO P<br />

66 Lever VISO P<br />

% Latin America<br />

Argentina – NV<br />

<strong>Unilever</strong> de Argentina S.A. FP<br />

5000000011111<br />

Bolivia – NV<br />

Quimbol Lever S.A. FP<br />

5000000011111<br />

Brazil – NV<br />

99 Indústrias Gessy Lever Ltda. FP<br />

5000000011111<br />

Chile – NV<br />

Lever Chile S.A. (PLC 25%) FP<br />

5000000011111<br />

Colombia – NV<br />

<strong>Unilever</strong> Andina (Colombia) S.A. FP<br />

60 Varela S.A. P<br />

5000000011111<br />

5000000011111<br />

% Latin America (continued)<br />

Dominican Republic – NV<br />

<strong>Unilever</strong> Dominicana S.A. P<br />

5000000011111<br />

El Salvador – NV<br />

60 Industrias Unisola S.A. FP<br />

5000000011111<br />

Mexico – NV<br />

<strong>Unilever</strong> de Mexico S.A. FP<br />

5000000011111<br />

Netherlands Antilles – NV<br />

<strong>Unilever</strong> Becumij N.V. O<br />

5000000011111<br />

Paraguay – NV<br />

<strong>Unilever</strong> Capsa del Paraguay S.A. FP<br />

5000000011111<br />

Peru – NV<br />

99 Industrias Pacocha S.A. FP<br />

5000000011111<br />

Trinidad & Tobago – PLC<br />

50 Lever Brothers West Indies Ltd. FP<br />

5000000011111<br />

Uruguay – NV<br />

Sudy Lever S.A. FP<br />

5000000011111<br />

Venezuela – NV<br />

<strong>Unilever</strong> Andina S.A. FP<br />

Principal fixed investments<br />

Joint ventures<br />

% Europe<br />

Portugal – NV<br />

40 FIMA–Produtos Alimentares, Lda. F<br />

% North America<br />

United States <strong>of</strong> America – NV (75%); PLC (25%)<br />

50 The Pepsi/Lipton Tea Partnership F


Company accounts<br />

<strong>Unilever</strong> N.V .<br />

Balance sheet as at 31 December<br />

00000000000000001111<br />

Fl. million<br />

0051110<br />

1999 1998<br />

000000000000001111 05111<br />

Fixed assets<br />

Fixed investments 2 197 1 674<br />

Current assets<br />

Debtors 15 589 21 712<br />

Current investments 1 342 587<br />

Cash at bank and in hand 3 632 1 385<br />

1101111 05111<br />

Total current assets 20 563 23 684<br />

Creditors due within one year (10 827) (18 380)<br />

Net current assets 9 736 5 304<br />

111101111 05111<br />

Total assets less current liabilities 11 933 6 978<br />

00000000000000001111<br />

Creditors due after more than one year 3 580 3 780<br />

Provisions for liabilities and charges 376 349<br />

Capital and reserves 7 977 2 849<br />

Called up share capital:<br />

Preferential share capital 20 286 265<br />

Ordinary share capital 20 642 642<br />

1101111 05111<br />

928 907<br />

Share premium account 3 076 52<br />

Pr<strong>of</strong>it retained and other reserves 3 973 1 890<br />

Total capital employed 11 933 6 978<br />

00000000000000001111<br />

Pr<strong>of</strong>it and loss account as at 31 December<br />

00000000000000001111<br />

Income from fixed investments after taxation 3 260 6 984<br />

Other income and expenses 755 190<br />

111101111 05111<br />

Pr<strong>of</strong>it <strong>of</strong> the year 4 015 7 174<br />

00000000000000001111<br />

Pages 62 to 104 and 108 to 112 contain the notes to the NV company accounts. For the information required by Article 392 <strong>of</strong> Book<br />

2, Civil Code, refer to pages 61 and 113.<br />

As the accounts <strong>of</strong> NV have been included in the consolidated accounts, the pr<strong>of</strong>it and loss account mentions only income from fixed<br />

investments after taxation as a separate item. The balance sheet includes the proposed pr<strong>of</strong>it appropriation.<br />

The Board <strong>of</strong> Directors<br />

7 March 2000<br />

References relate to a note on pages 80 to 83.


Notes to the company accounts<br />

<strong>Unilever</strong> N.V .<br />

Fixed investments<br />

00000000<br />

Fl. million<br />

051110<br />

1999 1998<br />

0000005 0111<br />

Shares in group companies 2 173 2 173<br />

Book value <strong>of</strong> PLC shares held in<br />

connection with share options (a) 276 —<br />

Less NV shares held by group<br />

companies (a) (252) (499)<br />

51115 0111<br />

2 197 1 674<br />

51115 0111<br />

(a) During 1999 NV acquired from group companiesNV and PLC shares<br />

held in connection with share options. The PLC shares held by NV are<br />

shown as part <strong>of</strong> the NV fixed investments; NV shares still held by<br />

group companies are deducted from NV fixed investments; NV shares<br />

now held directly by NV are no longer deducted.<br />

00000000<br />

Debtors<br />

00000000<br />

Loans to group companies 8 844 7 935<br />

Other amounts owed by group companies 6 023 13 338<br />

Amounts owed by undertakings in which<br />

the company has a participating interest 156 155<br />

Other 566 284<br />

51115 0111<br />

15 589 21 712<br />

51115 0111<br />

Of which due after more than one year 2 404 2 810<br />

00000000<br />

Current investments<br />

00000000<br />

Listed stocks 1 342 587<br />

Cost <strong>of</strong> current investments 1 338 570<br />

00000000<br />

Cash at bank and in hand<br />

00000000<br />

This includes amounts for which repayment<br />

notice is required <strong>of</strong> 3 376 1 169<br />

00000000<br />

Creditors<br />

00000000<br />

Due within one year:<br />

Bank loans and overdrafts 25 33<br />

Bonds and other loans 1 400 1 253<br />

Loans from group companies 41 26<br />

Other amounts owed to group companies 7 488 6 284<br />

Taxation and social security 128 126<br />

Accruals and deferred income 348 213<br />

Dividends 1 098 10 375<br />

Other 299 70<br />

51115 0111<br />

10 827 18 380<br />

51115 0111<br />

Due after more than one year:<br />

Bonds and other loans 3 580 3 780<br />

Loans from group companies — —<br />

51115 0111<br />

3 580 3 780<br />

51115 0111<br />

These include amounts due<br />

after more than five years:<br />

Bonds and other loans 439 1 698<br />

00000000<br />

Provisions for liabilities and charges<br />

00000000<br />

Fl. million<br />

051110<br />

1999 1998<br />

0000005 0111<br />

Pension provisions 287 275<br />

Deferred taxation and other provisions 89 74<br />

51115 0111<br />

376 349<br />

51115 0111<br />

Of which due within one year 18 41<br />

00000000<br />

Ordinary share capital<br />

00000000<br />

Shares numbered 1 to 2 400 are held by a subsidiary <strong>of</strong> NV and a<br />

subsidiary <strong>of</strong> PLC. Additionally, 7 225 674 Fl. 1.12 ordinary shares<br />

are held by NV and other group companies and trusts. Full details<br />

are given in note 20 on pages 80 to 83.<br />

00000000<br />

Share premium account<br />

00000000<br />

The share premium shown in the balance sheet is not available<br />

for issue <strong>of</strong> tax free bonus shares or for tax free repayment. For<br />

an amount <strong>of</strong> Fl. 3 045 million the premium is for Dutch tax<br />

purposes considered ‘pr<strong>of</strong>it retained’.<br />

00000000<br />

Pr<strong>of</strong>it retained and other reserves<br />

00000000<br />

Pr<strong>of</strong>it retained 31 December 4 782 2 388<br />

Cost <strong>of</strong> NV shares purchased and held<br />

by NV and by group companies (809) (498)<br />

51115 0111<br />

Balance 31 December 3 973 1 890<br />

51115 0111<br />

Pr<strong>of</strong>it retained shown in the company accounts and the notes<br />

thereto is less than the amount shown in the consolidated<br />

balance sheet, mainly because only part <strong>of</strong> the pr<strong>of</strong>its <strong>of</strong> group<br />

companies has been distributed in the form <strong>of</strong> dividends.<br />

00000000<br />

Contingent liabilities<br />

00000000<br />

These are not expected to give rise to any material loss and<br />

include guarantees given for group and other companies, under<br />

which amounts outstanding at 31 December were:<br />

Group companies 4 120 4 303<br />

Other 1 —<br />

51115 0111<br />

4 121 4 303<br />

51115 0111<br />

Of the above, guaranteed also by PLC 990 868<br />

00000000


Further statutory information<br />

<strong>Unilever</strong> N.V .<br />

The rules for pr<strong>of</strong>it appropriation in the Articles <strong>of</strong><br />

Association (summary <strong>of</strong> Article 41)<br />

00000000<br />

The pr<strong>of</strong>it <strong>of</strong> the year is applied firstly to the reserves required by<br />

law or by the Equalisation Agreement, secondly to cover losses<br />

<strong>of</strong> previous years, if any, and thirdly to the reserves deemed<br />

necessary by the Board <strong>of</strong> Directors. Dividends due to the holders<br />

<strong>of</strong> the Cumulative Preference Shares, including any arrears in such<br />

dividends, are then paid; if the pr<strong>of</strong>it is insufficient for this<br />

purpose, the amount available is distributed to them in<br />

proportion to the dividend percentages <strong>of</strong> their shares. Any pr<strong>of</strong>it<br />

remaining thereafter is at the disposal <strong>of</strong> the General <strong>Meeting</strong>.<br />

Distributions from this remaining pr<strong>of</strong>it are made to the holders<br />

<strong>of</strong> the ordinary shares pro rata to the nominal amounts <strong>of</strong> their<br />

holdings. The General <strong>Meeting</strong> can only decide to make<br />

distributions from reserves on the basis <strong>of</strong> a proposal by the<br />

Board and in compliance with the law and the Equalisation<br />

Agreement.<br />

00000000<br />

Fl. million<br />

051110<br />

1999 1998<br />

0000005 0111<br />

Proposed pr<strong>of</strong>it appropriation<br />

Pr<strong>of</strong>it <strong>of</strong> the year 4 015 7 174<br />

Preference dividends (44) (15)<br />

51115 0111<br />

Pr<strong>of</strong>it at disposal <strong>of</strong> the Annual General<br />

<strong>Meeting</strong> <strong>of</strong> shareholders 3 971 7 159<br />

Ordinary dividends (1 577) (10 889)<br />

51115 0111<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 2 394 (3 730)<br />

Pr<strong>of</strong>it retained – 1 January 2 388 6 118<br />

51115 0111<br />

Pr<strong>of</strong>it retained – 31 December 4 782 2 388<br />

00000000<br />

Special controlling rights under the Articles <strong>of</strong> Association<br />

00000000<br />

See note 20 on page 80.<br />

00000000<br />

Auditors<br />

00000000<br />

A resolution will be proposed at the Annual General <strong>Meeting</strong> on<br />

3 May 2000 for the reappointment <strong>of</strong> PricewaterhouseCoopers<br />

N.V. as auditors <strong>of</strong> NV. The present appointment will end at the<br />

conclusion <strong>of</strong> the Annual General <strong>Meeting</strong>.<br />

00000000<br />

J W B Westerburgen<br />

S G Williams<br />

Joint Secretaries <strong>of</strong> <strong>Unilever</strong> N.V.<br />

7 March 2000<br />

Corporate Centr e<br />

<strong>Unilever</strong> N.V.<br />

Weena 455<br />

PO Box 760<br />

3000 DK Rotterdam


Company accounts<br />

<strong>Unilever</strong> PLC<br />

Balance sheet as at 31 December<br />

00000000000000001111<br />

£ million<br />

0051110<br />

1999 1998<br />

000000000000001111 05111<br />

Fixed assets<br />

Fixed investments 1 196 1 421<br />

Current assets<br />

Cash and current investments 5 501<br />

Debtors 1 047 2 248<br />

Debtors due within one year 1 047 2 248<br />

Debtors due after more than one year — —<br />

111101111 05111<br />

Total current assets 1 052 2 749<br />

Creditors due within one year (1 197) (3 406)<br />

Net current liabilities (145) (657)<br />

111101111 05111<br />

Total assets less current liabilities 1 051 764<br />

00000000000000001111<br />

Creditors due after more than one year — —<br />

Capital and reserves 1 051 764<br />

Called up share capital 20 41 41<br />

Share premium account 94 94<br />

Capital redemption reserve 22 11 11<br />

Pr<strong>of</strong>it retained 905 618<br />

Total capital employed 1 051 764<br />

00000000000000001111<br />

All amounts included in capital and reserves are classified as equity as defined under United Kingdom Financial Reporting Standard 4.<br />

As permitted by Section 230 <strong>of</strong> the United Kingdom Companies Act 1985, PLC’s pr<strong>of</strong>it and loss account does not accompany its<br />

balance sheet.<br />

On behalf <strong>of</strong> the Board <strong>of</strong> Directors<br />

N W A FitzGerald Chairman<br />

A Burgmans Vice-Chairman<br />

7 March 2000<br />

References relate to notes on pages 80 to 84.


Notes to the company accounts<br />

<strong>Unilever</strong> PLC<br />

Fixed investments<br />

00000000<br />

£ million<br />

051110<br />

1999 1998<br />

0000005 0111<br />

Shares in group companies 1 016 1 272<br />

Book value <strong>of</strong> PLC shares held in<br />

connection with share options 180 149<br />

0111 0111<br />

1 196 1 421<br />

0111 0111<br />

Shares in group companies<br />

Shares in group companies are stated at cost or valuation, less<br />

amounts written <strong>of</strong>f.<br />

Movements during the year:<br />

1 January 1 272<br />

Additions 218<br />

Disposals (474)<br />

0111<br />

31 December 1 016<br />

0111<br />

Shares held in connection with share options<br />

Movements during the year:<br />

1 January 149<br />

Additions 81<br />

Disposals (50)<br />

0111<br />

31 December 180<br />

00000000<br />

Debtors<br />

00000000<br />

Due within one year:<br />

Amounts owed by group companies 1 034 2 246<br />

Other 13 2<br />

0111 0111<br />

1 047 2 248<br />

0111 0111<br />

Due after more than one year:<br />

Amounts owed by group companies — —<br />

0111 0111<br />

— —<br />

0111 0111<br />

Total debtors 1 047 2 248<br />

00000000<br />

Creditors<br />

00000000<br />

£ million<br />

051110<br />

1999 1998<br />

0000005 0111<br />

Due within one year:<br />

Amounts owed to group companies 940 949<br />

Bonds and other loans — —<br />

Taxation and social security 10 36<br />

Dividends 246 2 406<br />

Other 1 15<br />

0111 0111<br />

1 197 3 406<br />

0111 0111<br />

Due after more than one year:<br />

Bonds and other loans — —<br />

00000000<br />

Pr<strong>of</strong>it retained<br />

00000000<br />

1 January 618 896<br />

Goodwill movements — —<br />

Pr<strong>of</strong>it <strong>of</strong> the year 643 2 222<br />

Dividends on ordinary and deferred shares (356) (2 500)<br />

0111 0111<br />

31 December 905 618<br />

00000000<br />

Contingent liabilities<br />

00000000<br />

These are not expected to give rise to any<br />

material loss and include guarantees<br />

given for group companies, under<br />

which amounts outstanding at<br />

31 December were: 899 1 038<br />

0111 0111<br />

Of the above, guaranteed also by NV 279 278<br />

00000000<br />

Remuneration <strong>of</strong> auditors<br />

00000000<br />

Parent company audit fee 1.3 1.1<br />

Payments by the parent company for<br />

non-audit services provided by<br />

PricewaterhouseCoopers United Kingdom 3.6 0.7<br />

00000000<br />

Pr<strong>of</strong>it appropriation<br />

00000000<br />

The proposed appropriation <strong>of</strong> the pr<strong>of</strong>it <strong>of</strong> PLC is as follows:<br />

Interim and recommended final dividends 356 2 500<br />

0111 0111<br />

Pr<strong>of</strong>it <strong>of</strong> the year retained 287 (278)<br />

00000000


Further statutory information and other information<br />

<strong>Unilever</strong> PLC<br />

Capital and membership<br />

00000000000000001111<br />

At 31 December 1999 PLC had 117 980 ordinary shareholdings.<br />

The following table analyses the registered holdings <strong>of</strong> PLC’s 1.4p ordinary shares at 31 December 1999.<br />

00000000000000001111<br />

Number Total<br />

Number <strong>of</strong> shares <strong>of</strong> holdings % shares held %<br />

511110511 00000511111 0011 0510 0011<br />

1 – 1 000 40 749 34.54 22 855 828 0.78<br />

1 001 – 2 500 34 850 29.54 57 350 097 1.97<br />

2 501 – 5 000 20 302 17.21 72 263 890 2.48<br />

5 001 – 10 000 12 247 10.38 85 908 494 2.95<br />

10 001 – 25 000 6 467 5.48 97 409 085 3.35<br />

25 001 – 50 000 1 498 1.27 51 534 218 1.77<br />

50 001 – 100 000 684 0.58 47 274 912 1.62<br />

100 001 – 1 000 000 870 0.74 273 248 508 9.39<br />

Over 1 000 000 313 0.26 2 203 613 548 75.69<br />

511110511 00000511111 0011 0510 0011<br />

117 980 100.00 2 911 458 580 100.00<br />

00000000000000001111<br />

Substantial interests in the share capital <strong>of</strong> PLC<br />

00000000000000001111<br />

The Register maintained by PLC pursuant to Section 211 <strong>of</strong> the Companies Act 1985 shows that at the date <strong>of</strong> signing the Report and<br />

Accounts 156 815 034 ordinary shares in PLC, representing approximately 5% <strong>of</strong> the issued ordinary capital, were held jointly by Sir<br />

Michael Angus, The Rt Hon The Viscount Leverhulme, Sir Michael Perry, N W A FitzGerald and Dr J I W Anderson as trustees <strong>of</strong> the<br />

Leverhulme Trust and the Leverhulme Trade Charities Trust.<br />

The Register also shows the following interests in PLC’s Ordinary and Deferred capital on that date:<br />

00000000000000001111<br />

Approximate<br />

Holder Class % held<br />

0000000111110000005 0011<br />

Prudential Corporation plc Ordinary 3<br />

N.V. Elma Deferred 50<br />

United Holdings Limited Deferred 50<br />

00000000000000001111<br />

Directors’ interests<br />

00000000000000001111<br />

The Register <strong>of</strong> Directors’ Interests in the share capital <strong>of</strong> PLC and its subsidiaries, which contains full details <strong>of</strong> the directors’ PLC<br />

shareholdings and options, is open to inspection by shareholders and will be open for inspection at the Annual General <strong>Meeting</strong>.<br />

00000000000000001111<br />

Employee involvement and communication<br />

00000000000000001111<br />

<strong>Unilever</strong>’s companies maintain formal processes to inform, consult and involve employees and their representatives. Most <strong>of</strong> the United<br />

Kingdom sites are accredited to the Investors in People standard. The European Foundation for Quality Management’s model for<br />

measuring Business Excellence, with its strong emphasis on maximising the potential <strong>of</strong> employees, is also widely employed.<br />

A European Works Council, embracing employee and management representatives from 15 countries <strong>of</strong> Western Europe, has been in<br />

existence for three years, and provides a forum for discussing issues that extend across national boundaries.<br />

The directors’ report <strong>of</strong> the United Kingdom group companies contain more details about how they have communicated with their<br />

employees during 1999.<br />

00000000000000001111<br />

Equal opportunities and diversity<br />

00000000000000001111<br />

Every <strong>Unilever</strong> company in the United Kingdom has an equal opportunities policy and actively pursues equality <strong>of</strong> opportunity for all<br />

employees.<br />

During 1999, all United Kingdom companies committed to a major UK-wide action programme to accelerate progress in achieving<br />

diversity. They are committed to having an even greater diversity at all levels within the organisation, and will continue to create an<br />

environment in which individuals’ differences are appreciated and in which all employees feel valued and respected.<br />

00000000000000001111<br />

Charitable and other contributions<br />

00000000000000001111<br />

During the year group companies made financial contributions <strong>of</strong> £6 million to United Kingdom charitable organisations and assisted<br />

them with a further £1 million <strong>of</strong> support in other forms. In addition, £100 000 was given to Britain in Europe. No contribution was<br />

made for political purposes.<br />

00000000000000001111


Further statutory information and other information<br />

<strong>Unilever</strong> PLC<br />

Supplier payment policies<br />

00000000000000001111<br />

Individual operating companies are responsible for agreeing the terms and conditions under which business transactions with their<br />

suppliers are conducted. The directors’ reports <strong>of</strong> United Kingdom operating companies give information about their supplier payment<br />

policies as required by the United Kingdom Companies Act 1985. PLC, as a holding company, does not itself make any relevant<br />

payments in this respect.<br />

00000000000000001111<br />

Interests in land<br />

00000000000000001111<br />

The majority <strong>of</strong> <strong>Unilever</strong>’s land and buildings are used for the productive and distributive activities <strong>of</strong> the Group and are not held for<br />

resale. The directors take the view that any difference between their market value and the amount at which they are included in the<br />

balance sheet is not <strong>of</strong> such significance as to require that attention be drawn to it, as would be required by Schedule 7 (Part I) <strong>of</strong> the<br />

United Kingdom Companies Act 1985.<br />

00000000000000001111<br />

Auditors<br />

00000000000000001111<br />

A resolution will be proposed at the Annual General <strong>Meeting</strong> on 3 May 2000 for the reappointment <strong>of</strong> PricewaterhouseCoopers as<br />

auditors <strong>of</strong> PLC. The present appointment will end at the conclusion <strong>of</strong> the Annual General <strong>Meeting</strong>.<br />

00000000000000001111<br />

Corporate Centr e<br />

<strong>Unilever</strong> PLC<br />

PO Box 68 <strong>Unilever</strong> House<br />

Blackfriars<br />

London EC4P 4BQ<br />

<strong>Unilever</strong> PLC Registered Office<br />

Port Sunlight<br />

Wirral<br />

Merseyside CH62 4UJ<br />

By Order <strong>of</strong> the Boar d<br />

J W B Westerburgen<br />

S G Williams<br />

Joint Secretaries <strong>of</strong> <strong>Unilever</strong> PLC<br />

7 March 2000<br />

<strong>Unilever</strong> PLC Registrars<br />

Lloyds TSB Registrars<br />

The Causeway<br />

Worthing<br />

West Sussex BN99 6DA


Control <strong>of</strong> <strong>Unilever</strong><br />

NV’s issued share capital on 31 December 1999 was made<br />

up <strong>of</strong>:<br />

•<br />

•<br />

•<br />

Fl. 640 165 008 split into 571 575 900 ordinary shares<br />

<strong>of</strong> Fl. 1.12 each.<br />

Fl. 2 400 000 split into 2400 ordinary shares<br />

numbered 1 to 2400, known as special shares.<br />

Fl. 286 207 379 split into several classes <strong>of</strong> cumulative<br />

preference shares.<br />

Shareholders <strong>of</strong> NV have one vote for every ten cents<br />

(Fl. 0.10) <strong>of</strong> capital they own, <strong>of</strong> whatever type. An<br />

exception is that half <strong>of</strong> the special shares are owned by<br />

Naamlooze Vennootschap Elma, which is not allowed to<br />

vote at general NV shareholders’ meetings because it is<br />

a subsidiary <strong>of</strong> NV.<br />

PLC’s issued share capital on 31 December 1999 was<br />

made up <strong>of</strong>:<br />

•<br />

•<br />

£40 760 420 split into 2 911 458 580 ordinary shares<br />

<strong>of</strong> 1.4p each.<br />

£100 000 <strong>of</strong> deferred stock.<br />

Shareholders <strong>of</strong> PLC have one vote for every 1.4p <strong>of</strong><br />

capital they own, <strong>of</strong> whichever type. An exception is that<br />

half <strong>of</strong> the deferred stock is owned by United Holdings<br />

Limited, which is not allowed to vote at general PLC<br />

shareholders’ meetings because it is a subsidiary <strong>of</strong> PLC.<br />

Unity <strong>of</strong> management<br />

In order to ensure unity <strong>of</strong> management, NV and PLC<br />

have the same directors. We achieve this through our<br />

nomination procedure. Only the holders <strong>of</strong> NV’s special<br />

shares can nominate anyone for election to the NV board,<br />

and only the holders <strong>of</strong> PLC’s deferred stock can nominate<br />

anyone for election to the PLC board. The current<br />

directors can ensure that both NV and PLC shareholders<br />

are presented with the same candidates for election as<br />

directors, because the joint holders <strong>of</strong> both the special<br />

shares and the deferred stock are NV Elma and United<br />

Holdings Limited, which are subsidiaries <strong>of</strong> NV and PLC.<br />

NV and PLC both act as directors <strong>of</strong> NV Elma and <strong>of</strong><br />

United Holdings Limited. The Chairmen <strong>of</strong> NV and PLC<br />

are additional directors <strong>of</strong> United Holdings Limited.<br />

Equalisation Agreement<br />

In order that NV and PLC operate for all practical purposes<br />

as a single company, we have an Equalisation Agreement.<br />

Under the Equalisation Agreement NV and PLC adopt the<br />

same financial periods and accounting policies. Neither<br />

company can issue or reduce capital without the consent<br />

<strong>of</strong> the other. If one had losses, or was unable to pay its<br />

preference dividends, we would make up the loss or<br />

shortfall out <strong>of</strong>:<br />

•<br />

•<br />

•<br />

the current pr<strong>of</strong>its <strong>of</strong> the other company (after it has<br />

paid its own preference shareholders).<br />

then its own free reserves.<br />

then the free reserves <strong>of</strong> the other company.<br />

If either company could not pay its ordinary dividends we<br />

would follow the same procedure, except that the current<br />

pr<strong>of</strong>its <strong>of</strong> the other company would only be used after it<br />

had paid its own ordinary shareholders and if the directors<br />

thought it appropriate.<br />

So far NV and PLC have always been able to pay their own<br />

dividends, so we have never had to follow this pro c e d u re .<br />

I f we did, the payment from one company to the other<br />

would be subject to any United Kingdom and Dutch tax<br />

and exchange control laws applicable at that time.<br />

The Equalisation Agreement also makes the position <strong>of</strong><br />

the shareholders <strong>of</strong> both companies, as far as possible,<br />

the same as if they held shares in a single company. To<br />

make this possible we compare the ordinary share capital<br />

<strong>of</strong> the two companies in units: a unit made up <strong>of</strong> Fl. 12<br />

nominal <strong>of</strong> NV’s ordinary capital carries the same weight<br />

as a unit made up <strong>of</strong> £1 nominal <strong>of</strong> PLC’s ordinary capital.<br />

For every unit (Fl. 12) you have <strong>of</strong> NV you have the same<br />

rights and benefits as the owner <strong>of</strong> a unit (£1) <strong>of</strong> PLC.<br />

NV’s ordinary shares currently each have a nominal value<br />

<strong>of</strong> Fl. 1.12, and PLC’s share capital is divided into ordinary<br />

shares <strong>of</strong> 1.4p each. This means that a Fl. 12 unit <strong>of</strong> NV is<br />

made up <strong>of</strong> 10.71 NV ordinary shares <strong>of</strong> Fl. 1.12 each and<br />

a £1 unit <strong>of</strong> PLC is made up <strong>of</strong> 71.43 PLC ordinary shares<br />

<strong>of</strong> 1.4p each. Consequently, one NV ordinary share<br />

equates to 6.67 ordinary shares <strong>of</strong> PLC.<br />

When we pay ordinary dividends we use this formula.<br />

On the same day NV and PLC allocate funds for the<br />

dividend from their parts <strong>of</strong> our current pr<strong>of</strong>its and free<br />

reserves. We pay the same amount on each NV share as<br />

on 6.67 PLC shares calculated at the relevant exchange<br />

rate: for interim dividends this exchange rate is the<br />

average rate for the quarter before we declare the<br />

dividend. For final dividends it is the average rate for the<br />

year. In arriving at the equalised amount we include any<br />

tax payable by the company in respect <strong>of</strong> the dividend,<br />

but calculate it before any tax deductible by the company<br />

from the dividend.<br />

In principle, issues <strong>of</strong> bonus shares and rights <strong>of</strong>ferings<br />

can only be made in ordinary shares. Again we would


Control <strong>of</strong> <strong>Unilever</strong><br />

ensure that shareholders <strong>of</strong> NV and PLC received shares<br />

in equal proportions, using the ratio <strong>of</strong> Fl. 12 NV nominal<br />

share capital to £1 PLC nominal share capital. The<br />

subscription price for one new NV share would have to be<br />

the same, at the prevailing exchange rate, as the price for<br />

6.67 new PLC shares.<br />

Under the Equalisation Agreement (as amended in 1981)<br />

the two companies are permitted to pay different<br />

dividends in the following exceptional circumstances:<br />

•<br />

•<br />

if the average annual sterling/guilder exchange rate<br />

changed so substantially from one year to the next<br />

that to pay equal dividends at the current exchange<br />

rates, either NV or PLC would have to pay a dividend<br />

that was unreasonable (i.e. substantially larger or<br />

smaller in its own currency than the dividend it paid<br />

in the previous year).<br />

the government <strong>of</strong> the United Kingdom or the<br />

Netherlands could in some circumstances place<br />

restrictions on the proportion <strong>of</strong> a company’s pr<strong>of</strong>its<br />

which can be paid out as dividends. This could mean<br />

that in order to pay equal dividends one company<br />

would have to pay out an amount which would<br />

breach the limitations in place at the time, or that the<br />

other company would have to pay a smaller dividend.<br />

In either <strong>of</strong> these rare cases, NV and PLC could pay<br />

different amounts <strong>of</strong> dividend if the Boards thought it<br />

appropriate. The company paying less than the equalised<br />

dividend would put the difference between the dividends<br />

into a reserve: an equalisation reserve in the case <strong>of</strong><br />

exchange rate fluctuations, or a dividend reserve in the<br />

case <strong>of</strong> a government restriction. The reserves would be<br />

paid out to its shareholders when it became possible or<br />

reasonable to do so, which would ensure that the<br />

shareholders <strong>of</strong> both companies would ultimately be<br />

treated the same. To date we have never had to use these<br />

measures.<br />

If both companies go into liquidation, NV and PLC will<br />

each use any funds available for shareholders to pay the<br />

prior claims <strong>of</strong> their own preference shareholders. Then<br />

they will use any surplus to pay each other’s preference<br />

shareholders, if necessary. After these claims have been<br />

met, they will pay out any equalisation or dividend reserve<br />

to their own shareholders before pooling the remaining<br />

surplus. This will be distributed to the ordinary<br />

shareholders <strong>of</strong> both companies, once again on the basis<br />

that the owner <strong>of</strong> Fl. 12 nominal NV ordinary share capital<br />

will get the same as the owner <strong>of</strong> £1 nominal PLC<br />

ordinary share capital. If one company goes into<br />

liquidation, we will apply the same principles as if both<br />

had gone into liquidation simultaneously.<br />

More information about our constitutional<br />

documents<br />

Under the Articles <strong>of</strong> Association <strong>of</strong> NV and the<br />

Memorandum and Articles <strong>of</strong> Association <strong>of</strong> PLC both<br />

companies are required to carry out the Equalisation<br />

Agreement with the other. Both documents state that the<br />

agreement cannot be changed or terminated without the<br />

approval <strong>of</strong> both sets <strong>of</strong> shareholders.<br />

For NV the necessary approval is as follows:<br />

•<br />

•<br />

at least one half <strong>of</strong> the total issued ordinary capital<br />

must be represented at an ordinary shareholders<br />

meeting, where the majority must vote in favour; and<br />

(if they would be disadvantaged or the agreement is<br />

to be terminated), at least two thirds <strong>of</strong> the total<br />

issued preference share capital must be represented at<br />

a preference shareholders meeting, where at least<br />

three quarters must vote in favour.<br />

For PLC, the necessary approval must be given by:<br />

•<br />

•<br />

the holders <strong>of</strong> a majority <strong>of</strong> all issued shares voting at<br />

a general meeting; and<br />

the holders <strong>of</strong> the ordinary shares, either by thre e<br />

quarters in writing or by three quarters voting at a<br />

general meeting where the majority <strong>of</strong> the ord i n a r y<br />

s h a res in issue are re p re s e n t e d .<br />

The Articles <strong>of</strong> NV establish that any payment under the<br />

Equalisation Agreement will be credited or debited to the<br />

pr<strong>of</strong>it and loss account for the financial year in question.<br />

The PLC Articles state that the Board must carry out the<br />

Equalisation Agreement and that the provisions <strong>of</strong> the<br />

Articles are subject to it.<br />

We are advised by Counsel that these provisions oblige<br />

the Boards to carry out the Equalisation Agreement,<br />

unless it is amended or terminated with the approval <strong>of</strong><br />

the shareholders <strong>of</strong> both companies. If the Boards fail to<br />

enforce the agreement shareholders can compel them to<br />

do so under Dutch and United Kingdom law.<br />

Mutual guarantee <strong>of</strong> borrowings<br />

There is a contractual arrangement between NV and PLC<br />

under which each will, if asked by the other, guarantee its<br />

borrowings. They can also agree jointly to guarantee the<br />

borrowings <strong>of</strong> their subsidiaries. We use this arrangement,<br />

as a matter <strong>of</strong> financial policy, for certain significant public<br />

borrowings. The arrangements enable lenders to rely<br />

on our combined financial strength.


Control <strong>of</strong> <strong>Unilever</strong><br />

Combined earnings per share<br />

Because <strong>of</strong> the Equalisation Agreement and the other<br />

arrangements between NV and PLC we calculate<br />

combined earnings per share for NV and PLC, and show<br />

the figure in both guilders and sterling. (See note 30 on<br />

pages 90 and 91).<br />

We base the calculation on the average amount <strong>of</strong> NV<br />

and PLC’s ordinary capital in issue during the year. For the<br />

main calculation we exclude shares which have been<br />

purchased to satisfy employee share options. We also<br />

calculate a diluted earnings per share figure, where we<br />

include these shares.<br />

The process by which we calculate earnings per share<br />

is as follows. First we convert the average capital <strong>of</strong> NV<br />

and PLC into units using the formula in the Equalisation<br />

Agreement: one unit equals 10.71 NV shares or 71.43<br />

PLC shares. We add these together to find the total<br />

number <strong>of</strong> units <strong>of</strong> combined share capital.<br />

Then the amount <strong>of</strong> net pr<strong>of</strong>it which is attributable to<br />

ordinary capital, in guilders and in sterling, is divided by<br />

this total number <strong>of</strong> units to find the amount per<br />

combined unit in both currencies.<br />

Finally we convert the combined unit back into NV and<br />

PLC ordinary shares, to show the amount per one share <strong>of</strong><br />

each. The amount per unit is divided by 10.71 to find the<br />

amount per Fl. 1.12 share, and by 71.43 to find the<br />

amount per 1.4p share.<br />

Despite the Equalisation Agreement, NV and PLC are<br />

independent corporations, and are subject to different<br />

laws and regulations on paying dividends in the<br />

Netherlands and the United Kingdom. We assume in<br />

our combined earnings per share calculation that both<br />

companies will be able to pay their dividends out <strong>of</strong> their<br />

part <strong>of</strong> our pr<strong>of</strong>its. This has always been the case in the<br />

past, but if we did have to make a payment from one to<br />

the other it could attract additional tax, and reduce our<br />

combined earnings per share .<br />

Leverhulme Trust<br />

The first Viscount Leverhulme was the founder <strong>of</strong> the<br />

company which became PLC. When he died in 1925,<br />

he left in his will a large number <strong>of</strong> PLC shares in various<br />

trusts. The High Court <strong>of</strong> Justice in England varied these<br />

trusts in 1983 and established two independent<br />

charitable trusts:<br />

•<br />

the Leverhulme Trust, which awards grants for research<br />

and education.<br />

•<br />

the Leverhulme Trade Charities Trust, for the benefit <strong>of</strong><br />

members <strong>of</strong> trades which the first Viscount considered<br />

to have particular associations with the business.<br />

The major assets <strong>of</strong> both these trusts are PLC ord i n a r y<br />

s h a re s .<br />

When the will trusts were varied in 1983 the interests <strong>of</strong><br />

the beneficiaries <strong>of</strong> his will were also preserved. Four<br />

classes <strong>of</strong> special shares were created in Margarine Union<br />

(1930) Limited, a subsidiary <strong>of</strong> PLC. Two <strong>of</strong> these classes<br />

can be converted at the end <strong>of</strong> the year 2038, into a<br />

maximum <strong>of</strong> 207 500 000 PLC ordinary shares <strong>of</strong> 1.4p<br />

each. These convertible shares replicate the rights which<br />

the descendants <strong>of</strong> the Viscount would have had under<br />

his will. Each class <strong>of</strong> these special shares only has a right<br />

to dividends in specified circumstances, and no dividends<br />

have yet been paid. PLC guarantees the dividend and<br />

conversion rights <strong>of</strong> the special shares.<br />

The first Viscount wanted the trustees <strong>of</strong> the trusts<br />

he established to be directors <strong>of</strong> PLC. On 28 April 2000<br />

the trustees <strong>of</strong> both the charitable trusts and the will<br />

trust were:<br />

•<br />

•<br />

•<br />

•<br />

•<br />

Sir Michael Angus – former Chairman<br />

The Viscount Leverhulme (grandson <strong>of</strong> the first<br />

Lord Leverhulme) – honorary advisory director<br />

Sir Michael Perry – former Chairman<br />

Mr N W A FitzGerald – Chairman <strong>of</strong> PLC<br />

Dr J I W Anderson – former director<br />

On 28 April 2000, in their capacity as trustees <strong>of</strong> the two<br />

charitable trusts, they held approximately 5.38% <strong>of</strong> PLC’s<br />

issued ordinary capital.<br />

N.V. Nederlandsch Administratie- en Trustkantoor<br />

(Nedamtrust)<br />

Nedamtrust is an independent trust company under the<br />

Netherlands’ law, which has an agreement with NV to<br />

issue depositary receipts against NV shares. We do not<br />

control Nedamtrust – it is a wholly owned subsidiary <strong>of</strong><br />

N.V. Algemeen Nederlands Trustkantoor ANT (ANT). Five<br />

Dutch financial institutions hold 45% <strong>of</strong> ANT’s shares<br />

between them – they have between 5% and 10% each,<br />

and the rest <strong>of</strong> its shares are owned by a large number<br />

<strong>of</strong> individual shareholders.


Control <strong>of</strong> <strong>Unilever</strong><br />

As part <strong>of</strong> its corporate objects Nedamtrust is able to:<br />

•<br />

•<br />

•<br />

issue depositary receipts;<br />

carry out administration for the shares which underlie<br />

depositary receipts it has issued;<br />

exercise voting rights for these underlying shares.<br />

The depositary receipts issued by Nedamtrust against<br />

NV shares are known as Nedamtrust certificates. They<br />

are in bearer form, and are traded and quoted on the<br />

Amsterdam Stock Exchange and other European stock<br />

exchanges. Nedamtrust has issued certificates for NV’s<br />

ordinary and 7% cumulative preference shares, and<br />

almost all the NV shares traded and quoted in Europe<br />

are in the form <strong>of</strong> these certificates. The exception is<br />

that there are no certificates for NV’s 4%, 6% and<br />

ten cents cumulative preference shares.<br />

If you hold Nedamtrust certificates you can attend or<br />

appoint a proxy at NV shareholders’ meetings, but cannot<br />

vote. By holding a certificate you give Nedamtrust’s Board<br />

the right to vote the underlying share, and to do anything<br />

else they think is necessary in connection with it.<br />

Nedamtrust’s Board decides on the best way to vote<br />

the NV ordinary and preference shares it holds at<br />

shareholders’ meetings. Trust companies in the<br />

Netherlands will not usually vote to influence the<br />

operations <strong>of</strong> companies, and in the past Nedamtrust<br />

has always followed this policy. However, if a change to<br />

shareholders’ rights is proposed Nedamtrust will let<br />

shareholders know if it intends to vote, at least 14 days<br />

in advance if possible. It will do this by advertising in the<br />

press, but it will not necessarily say which way it is<br />

planning to vote.<br />

If you wish to have your full NV shareholder rights,<br />

including the right to vote, you can exchange your<br />

Nedamtrust certificate at any time for the underlying<br />

ordinary or preference share (or vice versa – you will need<br />

to exchange the share for a certificate again in order to<br />

trade it). You will normally have to pay an administration<br />

fee for this. Alternatively, whenever an NV shareholders<br />

meeting is held, if you have:<br />

•<br />

•<br />

Nedamtrust certificates for NV ordinary shares with a<br />

nominal value <strong>of</strong> Fl. 1.12 or a multiple <strong>of</strong> Fl. 1.12; or<br />

Nedamtrust certificates for one or more NV 7%<br />

preference shares<br />

you can request that Nedamtrust issue to you a personal<br />

proxy for those shares. This will be free <strong>of</strong> charge and will<br />

enable you to vote in respect <strong>of</strong> those shares at that<br />

meeting.<br />

Nedamtrust’s NV shareholding fluctuates daily – for<br />

its holdings on 28 April 2000 see below. In the past<br />

the majority <strong>of</strong> votes cast by ordinary and preference<br />

shareholders at NV meetings were cast by Nedamtrust.<br />

457 228 012 ordinary shares <strong>of</strong> Fl. 1.12<br />

9 936 7% Cumulative Preference Shares<br />

<strong>of</strong> Fl. 1 000<br />

6 6% Cumulative Preference Shares<br />

<strong>of</strong> Fl. 1 000<br />

23 4% Cumulative Preference Shares<br />

<strong>of</strong> Fl. 100<br />

Nedamtrust is appointed as a proxyholder for the proxy<br />

voting through the Shareholders Communication Channel<br />

(see page 48).<br />

1999 Special dividend: Preference shar e<br />

alternative<br />

In May 1999 we declared a special dividend. Holders <strong>of</strong><br />

NV’s Fl. 1 ordinary shares could choose to have it in<br />

cumulative preference shares instead <strong>of</strong> cash. If you chose<br />

the preference share alternative you will have received<br />

one preference share for each Fl. 1 ordinary share or<br />

Nedamtrust certificate you had. These preference shares<br />

have a nominal value <strong>of</strong> Fl. 0.10 and had an initial<br />

notional value <strong>of</strong> Fl. 14.50 each. They will be listed on<br />

the Amsterdam Stock Exchange until 31 December 2004.<br />

If you hold these preference shares you are entitled to a<br />

dividend twice a year, which will be paid in guilders at the<br />

rate <strong>of</strong> 65% <strong>of</strong> EURIBOR on the notional value <strong>of</strong> each<br />

preference share. The first period began on 9 June 1999<br />

and ended on 8 December 1999.


Analysis <strong>of</strong> shareholding<br />

Significant shareholders <strong>of</strong> NV<br />

As far as we are aware the only holders <strong>of</strong> more than 10% <strong>of</strong> any class <strong>of</strong> NV shares (apart from Nedamtrust, see<br />

Control <strong>of</strong> <strong>Unilever</strong>, pages 120 and 121) are Nationale Nederlanden N.V. and Aegon Levensverzekering N.V. Details<br />

<strong>of</strong> their holdings on 28 April 2000 are as follows:<br />

Nationale Nederlanden N.V.<br />

2.17% <strong>of</strong> ordinary shares (Fl. 13 901 990)<br />

71.26% <strong>of</strong> 7% Cumulative Preference Shares (Fl. 20 665 500)<br />

74.56% <strong>of</strong> 6% Cumulative Preference Shares (Fl. 120 088 400)<br />

67.23% <strong>of</strong> 4% Cumulative Preference Shares (Fl. 50 423 000)<br />

9.94% 10 cents Cumulative Preference Shares (Fl. 2 101 336)<br />

Aegon Levensverzekering N.V.<br />

0.02% ordinary shares (Fl. 115 220)<br />

17.23% <strong>of</strong> 7% Cumulative Preference Shares (Fl. 4 995 300)<br />

18.34% <strong>of</strong> 6% Cumulative Preference Shares (Fl. 2 954 000)<br />

20.95% <strong>of</strong> 4% Cumulative Preference Shares (Fl. 15 710 600)<br />

Significant shareholders <strong>of</strong> PLC<br />

The following table gives details <strong>of</strong> everyone who held more than 3% <strong>of</strong> PLC’s shares or deferred stock on 28 April<br />

2000. We take this information from the register we hold under section 211 <strong>of</strong> the UK Companies Act 1985.<br />

00000000000000001111<br />

Number <strong>of</strong> shares Approximate<br />

Title <strong>of</strong> Class Name <strong>of</strong> Holder held % held<br />

005111 0000005111 0005111 001111<br />

Deferred Stock Naamlooze Vennootschap Elma £50 000 50<br />

United Holdings Limited £50 000 50<br />

Ordinary shares Prudential Corporation plc 91 776 330 3<br />

Trustees <strong>of</strong> the Leverhulme Trust and the<br />

Leverhulme Trade Charities Trust 156 815 034 5<br />

00000000000000001111<br />

Information about exchange controls affecting security holders<br />

<strong>Unilever</strong> NV<br />

Under the Dutch External Financial Relations Act <strong>of</strong><br />

28 May 1980 the Government, the Minister <strong>of</strong> Finance<br />

and the Central Bank <strong>of</strong> Netherlands are all authorised to<br />

i s s u e regulations relating to financial transactions involving<br />

Dutch residents, if a non-Dutch resident is also involved,<br />

or if the transactions are conducted in a foreign currency.<br />

If regulations are issued in the future, we could be in<br />

need <strong>of</strong> a licence for this type <strong>of</strong> transaction. To date<br />

no regulations <strong>of</strong> this type have been issued.<br />

<strong>Unilever</strong> PLC<br />

None.


Nature <strong>of</strong> the trading market<br />

The main non-US market for NV ordinary shares is the<br />

Amsterdam Stock Exchange, where NV shares trade in the<br />

form <strong>of</strong> Nedamtrust Certificates. Almost all these shares<br />

are in bearer form. In the United States, NV shares are<br />

issued in registered form and transferred by Morgan<br />

Guaranty Trust Company <strong>of</strong> New York, NV’s transfer agent<br />

in the United States, and they are traded on The New<br />

York Stock Exchange.<br />

At 28 April 2000 there were 7 478 registered holders <strong>of</strong><br />

NV ordinary shares in the United States. We estimate that<br />

approximately 30% <strong>of</strong> NV’s ordinary shareholdings were in<br />

the US (34% in 1998), based on the distribution <strong>of</strong> the<br />

1999 final dividend payments.<br />

The London Stock Exchange is the main non-US trading<br />

market for PLC ordinary shares, which are all registered.<br />

American Depositary Receipts, which each represent four<br />

PLC ordinary shares, trade on The New York Stock<br />

Exchange in the form <strong>of</strong> depositary receipts. The receipts<br />

are issued and exchanged in New York by the Morgan<br />

Guaranty Trust Company <strong>of</strong> New York, as Depositary<br />

under a deposit agreement with PLC and receipt holders.<br />

On 28 April 2000 there were 581 registered holders <strong>of</strong><br />

depositary receipts in the United States. Most holders <strong>of</strong><br />

PLC ordinary shares are registered in the United Kingdom<br />

– 99% in both 1999 and 1998.<br />

The high and low trading prices <strong>of</strong> these securities in each<br />

quarter <strong>of</strong> the last two years are shown below.<br />

NV and PLC are both public companies, with separate<br />

stock exchange listings and different shareholders. You<br />

cannot convert or exchange the shares <strong>of</strong> one for shares<br />

<strong>of</strong> the other. There is no fixed relationship between the<br />

trading prices <strong>of</strong> their shares – the relative share prices on<br />

the various markets can, and do, fluctuate from day to<br />

day and hour to hour. This happens for various reasons,<br />

including changes in exchange rates. But over time the<br />

prices <strong>of</strong> PLC and NV shares do stay in close relation to<br />

each other, in particular because <strong>of</strong> our equalisation<br />

arrangements. (See Control <strong>of</strong> <strong>Unilever</strong> – Equalisation<br />

Agreement).<br />

If you are a shareholder <strong>of</strong> NV you have a direct interest<br />

in a Dutch legal entity. Your dividends will be paid in euros<br />

(converted into US dollars if you have shares registered in<br />

the United States) and will be subject to Dutch tax. If you<br />

are a shareholder <strong>of</strong> PLC your interest is in a United<br />

Kingdom legal entity, your dividends will be paid in<br />

sterling (converted into US dollars if you have American<br />

Depositary Receipts) and you will be subject to United<br />

Kingdom tax. Nevertheless the Equalisation Agreement<br />

means that as a shareholder <strong>of</strong> either company you<br />

effectively have an interest in the whole <strong>of</strong> <strong>Unilever</strong>. You<br />

have largely equal rights over our combined net pr<strong>of</strong>it and<br />

capital reserves as shown in the consolidated accounts.<br />

(See Taxation for US Residents on page 124 and Control<br />

<strong>of</strong> <strong>Unilever</strong> on page 118).<br />

00000000000000001111<br />

1999 1st 2nd 3rd 4th<br />

0 0 0 0 0 0 5 1 1 1 1 101111 05111 05111 05111 05111<br />

NV per Fl. 1.12 ordinary share in Amsterdam in € High 74 69 73 64<br />

Low 62 62 64 49<br />

NV per Fl. 1.12 ordinary share in New York in $ High 88 72 74 68<br />

Low 66 65 67 50<br />

PLC per 1.4p ordinary share in London in pence High 695 603 649 580<br />

Low 546 537 572 401<br />

PLC per American Share in New York in $ High 47 39 41 38<br />

Low 36 35 37 27<br />

01111 05111 05111 05111 05111<br />

1998 1st 2nd 3rd 4th<br />

01111 05111 05111 05111 05111<br />

NV per Fl. 1 ordinary share in Amsterdam in Fl. High 143 168 169 161<br />

Low 118 140 107 111<br />

NV per Fl. 1 ordinary share in New York in $ High 69 83 84 86<br />

Low 56 70 59 60<br />

PLC per 1.25p ordinary share in London in pence High 584 707 694 677<br />

Low 480 583 460 476<br />

PLC per American Share in New York in $ High 40 46 46 46<br />

Low 32 40 32 33<br />

00000000000000001111


Taxation for US residents<br />

Netherlands taxation<br />

Income tax<br />

Dividends <strong>of</strong> companies in the Netherlands are subject to<br />

dividend withholding tax <strong>of</strong> 25%. Where one is entitled to<br />

the benefits <strong>of</strong> the current Income Tax Convention (’the<br />

Convention’), concluded on 18 December 1992 between<br />

the United States and the Netherlands, when dividends<br />

are paid by NV to:<br />

•<br />

•<br />

•<br />

a United States resident;<br />

a corporation organised under the laws <strong>of</strong> the United<br />

States (or any territory <strong>of</strong> it) having no permanent<br />

establishment in the Netherlands <strong>of</strong> which such shares<br />

form a part <strong>of</strong> the business property;<br />

or any other legal person subject to United States<br />

Federal income tax with respect to its world-wide<br />

income, having no permanent establishment in the<br />

Netherlands <strong>of</strong> which such shares form a part <strong>of</strong> the<br />

business property;<br />

these dividends qualify for a reduction <strong>of</strong> Netherlands<br />

withholding tax on dividends from 25% to 15% (to 5% if<br />

the beneficial owner is a company which directly holds at<br />

least 10% <strong>of</strong> the voting power <strong>of</strong> NV shares and to 0% if<br />

the beneficial owner is a qualified ‘Exempt Organisation’<br />

as defined in article 36 <strong>of</strong> the Convention).<br />

The entire dividend (including the withheld amount) will<br />

be dividend income to the United States shareholder not<br />

eligible for the dividends received deduction allowed to<br />

corporations. However, the Netherlands withholding tax<br />

will be treated as a foreign income tax that is eligible for<br />

c redit against the share h o l d e r ’s United States income taxes.<br />

Where a United States resident or corporation has a<br />

permanent establishment in the Netherlands, which has<br />

shares in <strong>Unilever</strong> N.V. forming part <strong>of</strong> its business<br />

property, dividends it receives on those shares are included<br />

in that establishment’s pr<strong>of</strong>it. They are subject to the<br />

Netherlands income tax or corporation tax, as appropriate,<br />

and the Netherlands tax on dividends will be applied at<br />

the full rate <strong>of</strong> 25%. This tax will be treated as foreign<br />

income tax eligible for credit against the shareholder’s<br />

United States income taxes.<br />

Under a provision <strong>of</strong> the Netherlands dividend tax act<br />

NV is entitled to a credit (up to a maximum <strong>of</strong> 3% <strong>of</strong><br />

the gross dividend from which dividend tax is withheld)<br />

against the amount <strong>of</strong> dividend tax withheld before<br />

remittance to the Netherlands tax authorities. For<br />

dividends paid on or after 1 January 1995, the United<br />

States tax authority may take the position that the<br />

Netherlands withholding tax eligible for credit should<br />

be limited accordingly.<br />

Under the Convention, qualifying United States<br />

organisations that are generally exempt from United<br />

States taxes and that are constituted and operated<br />

exclusively to administer or provide pension, retirement or<br />

other employee benefits may be exempt at source from<br />

withholding tax on dividends received from a Netherlands<br />

corporation. A recent agreement between the United<br />

States and the Netherlands tax authorities describes the<br />

eligibility <strong>of</strong> these US organisations for benefits under the<br />

Convention and the procedures for them to claim benefits<br />

under the Convention. This agreement was published by<br />

the US Internal Revenue Service on 20 April 2000 in<br />

release IR-INT-2000-9 and these procedures apply to<br />

dividends made payable after 30 June 2000.<br />

A United States trust, company or organisation that is<br />

operated exclusively for religious, charitable, scientific,<br />

educational or public purposes, is now subject to an initial<br />

25% withholding tax rate. Such an exempt organisation<br />

is entitled to reclaim from the Netherlands Tax Authorities<br />

a refund <strong>of</strong> the Netherlands dividend tax, if and to the<br />

extent that it is exempt from United States Federal Income<br />

Tax and it would be exempt from tax in the Netherlands<br />

if it were organised and carried on all its activities there.<br />

If you are a <strong>Unilever</strong> shareholder resident in any<br />

country other than the United States or the Netherlands,<br />

any exemption from, or reduction or refund <strong>of</strong>, the<br />

Netherlands dividend withholding tax may be governed by<br />

the ‘Tax Regulation for the Kingdom <strong>of</strong> the Netherlands’<br />

or by the tax convention, if any, between the Netherlands<br />

and your country <strong>of</strong> residence.<br />

Taxation on capital gains<br />

Under the Convention, if you are a United States resident<br />

or corporation and you have capital gains on the sale <strong>of</strong><br />

shares <strong>of</strong> a Netherlands company, these are generally not<br />

subject to taxation by the Netherlands. The exception<br />

to this is if you have a permanent establishment in the<br />

Netherlands and the capital gain is derived from the<br />

sale <strong>of</strong> shares which form part <strong>of</strong> that permanent<br />

establishment’s business property.<br />

Succession duty and gift taxes<br />

Under the Estate and Inheritance Tax Convention between<br />

the United States and the Netherlands <strong>of</strong> 15 July 1969,<br />

United States individual residents who are not Dutch<br />

citizens, who have shares will generally not be subject to<br />

succession duty in the Netherlands on the individual’s<br />

death unless the shares are part <strong>of</strong> the business property<br />

<strong>of</strong> a permanent establishment situated in the Netherlands.


Taxation for US residents<br />

A gift <strong>of</strong> shares <strong>of</strong> a Netherlands company by a person<br />

who is not a resident or a deemed resident <strong>of</strong> the<br />

Netherlands is generally not subject to Netherlands gift<br />

tax. A non-resident Netherlands citizen, however, is still<br />

treated as a resident <strong>of</strong> the Netherlands for gift tax<br />

purposes for ten years and any other non-resident person<br />

for one year after leaving the Netherlands.<br />

United Kingdom<br />

Income tax<br />

Under United Kingdom law income tax is not withheld<br />

from dividends paid by United Kingdom companies.<br />

Shareholders, whether resident in the United Kingdom or<br />

not, receive the full amount <strong>of</strong> the dividend actually<br />

declared.<br />

If you are a shareholder resident in the United Kingdom<br />

you are entitled to a tax credit against your liability for<br />

United Kingdom income tax, equal to 10% <strong>of</strong> the<br />

aggregate amount <strong>of</strong> the dividend plus tax credit (or oneninth<br />

<strong>of</strong> the dividend). For example, a dividend payment<br />

<strong>of</strong> £9.00 will carry a tax credit <strong>of</strong> £1.00.<br />

If you are a shareholder resident in the US, the dividend<br />

actually declared is taxable in the US as ordinary income<br />

and is not eligible for the dividends received deduction<br />

allowable to corporations. The dividend is foreign source<br />

income for US foreign tax credit purposes.<br />

In addition, under the current income tax Convention<br />

between the US and the UK (the ‘Convention’), a US<br />

shareholder eligible for the benefits <strong>of</strong> the Convention<br />

may elect to be treated for US tax purposes only as having<br />

received an additional taxable dividend. The additional<br />

deemed dividend is equal to one-ninth <strong>of</strong> the actual cash<br />

dividend received (an additional dividend <strong>of</strong> £1 in the<br />

above example). The shareholder will be eligible to claim<br />

a US foreign tax credit in the amount <strong>of</strong> the additional<br />

deemed dividend. The tax credit may, subject to certain<br />

limitations and restrictions, reduce the shareholder’s US<br />

Federal income tax liability. The procedure for making this<br />

election is described in IRS Revenue Procedure 2000-13.<br />

Taxation on capital gains<br />

Under United Kingdom law, when you sell shares you may<br />

be liable to pay capital gains tax. However, if you are<br />

either:<br />

•<br />

•<br />

an individual who is neither resident nor ordinarily<br />

resident in the United Kingdom, or<br />

a company which is not resident in the United<br />

Kingdom<br />

you will not be liable to United Kingdom tax on any<br />

capital gains made on disposal <strong>of</strong> your shares.<br />

The exception is if the shares are held in connection with<br />

a trade or business which is conducted in the United<br />

Kingdom through a branch or an agency.<br />

Inheritance tax<br />

Under the current estate and gift tax convention between<br />

the United States and the United Kingdom, ordinary<br />

shares held by an individual shareholder who is:<br />

•<br />

•<br />

domiciled for the purposes <strong>of</strong> the convention in the<br />

United States; and<br />

is not for the purposes <strong>of</strong> the convention a national <strong>of</strong><br />

the United Kingdom<br />

will not be subject to United Kingdom inheritance tax on:<br />

•<br />

•<br />

the individual’s death; or<br />

on a gift <strong>of</strong> the shares during the individual’s lifetime.<br />

The exception is if the shares are part <strong>of</strong> the business<br />

property <strong>of</strong> a permanent establishment <strong>of</strong> the individual in<br />

the United Kingdom or, in the case <strong>of</strong> a shareholder who<br />

performs independent personal services, pertain to a fixed<br />

base situated in the United Kingdom.


Dividends<br />

Our interim ordinary dividends are normally announced in<br />

November and paid in December. Final ordinary dividends<br />

are normally proposed in February and, if approved by<br />

shareholders at the Annual General <strong>Meeting</strong>, paid in May.<br />

The Annual General <strong>Meeting</strong> <strong>of</strong> 4 May 1999, approved:<br />

•<br />

•<br />

•<br />

the payment <strong>of</strong> a special dividend <strong>of</strong> Fl. 14.50 per<br />

existing ordinary share <strong>of</strong> NV.<br />

the payment <strong>of</strong> a special dividend <strong>of</strong> 66.13p per<br />

existing ordinary share <strong>of</strong> PLC.<br />

the consolidation <strong>of</strong> our ordinary share capital on the<br />

basis <strong>of</strong> 100 new ordinary shares for every 112 existing<br />

ordinary shares on 10 May 1999.<br />

As a result the denomination <strong>of</strong> the ordinary capital was<br />

changed. The nominal value <strong>of</strong> NV ordinary shares is now<br />

Fl. 1.12 per share, and <strong>of</strong> PLC ordinary shares is 1.4p per<br />

share. The amount paid as a special dividend was<br />

equivalent to approximately 10.6% <strong>of</strong> NV and PLC’s<br />

combined market capitalisation prior to the announcement.<br />

Dividends per Fl. 1.12 (1995-1998: Fl. 1) ordinary share<br />

paid for the last five years are shown in the following<br />

table. Dividends have been translated at the exchange<br />

rates prevailing on the dates <strong>of</strong> declaration <strong>of</strong> the<br />

dividends.<br />

The interim dividend is normally 35% <strong>of</strong> the previous<br />

year’s total normal dividend per share, based on the<br />

stronger <strong>of</strong> our two reporting currencies over the first<br />

nine months <strong>of</strong> the year. Equalisation <strong>of</strong> the dividend<br />

in the other currency takes place at the average exchange<br />

rate <strong>of</strong> the third quarter.<br />

00000000000000001111<br />

1995 1996 1997 1998 1999<br />

0000000011111101111 01111 01111 01111 01111<br />

Interim Fl. per Fl. 1.12 (1995-1998: Fl. 1) 0.37 0.56 0.74 0.81 0.88<br />

Exchange rate Fl. to $ 1.5804 1.6928 1.9208 1.8717 2.1173<br />

Interim $ per Fl. 1.12 (1995-1998: Fl. 1) 0.234118 0.329336 0.385256 0.432762 0.415624<br />

Normal final Fl. per Fl. 1.12 (1995-1998: Fl. 1) 1.18 1.19 1.49 1.70 1.91<br />

Special final Fl. per Fl. 1 14.50<br />

Normal final exchange rate Fl. to $ 1.7040 1.9459 1.9951 2.0861 2.4725<br />

Special final exchange rate Fl. to $ 2.0861<br />

Normal final $ per Fl. 1.12 (1995-1998: Fl. 1) 0.691021 0.610257 0.74683 0.814918 0.772497<br />

Special final $ per Fl. 1 6.950769<br />

00000000111111011111101111110111111011110111111<br />

For the purposes <strong>of</strong> illustration, the US dollar dividends shown above are those paid on the Fl. 1.12 (1995-1998: Fl. 1) ordinary shares <strong>of</strong> NV registered in<br />

New York. The above exchange rates were those ruling on the dates <strong>of</strong> declaration <strong>of</strong> the dividend.<br />

SIGNATURE<br />

00000000000000001111<br />

Pursuant to the requirements <strong>of</strong> Section 12 <strong>of</strong> the Securities Exchange Act <strong>of</strong> 1934, the Registrant certifies that it meets<br />

all <strong>of</strong> the requirements for filing on Form 20-F and has duly caused this Annual Report to be signed on its behalf by the<br />

undersigned, thereunto duly authorised.<br />

UNILEVER N.V.<br />

J W B WESTERBURGEN 17 May 2000<br />

SECRETARY


Financial calendar and addresses<br />

Annual General <strong>Meeting</strong>s<br />

00000000 0000000011<br />

NV PLC<br />

00000000 0000000011<br />

10.30 am Wednesday 3 May 2000 11.00 am Wednesday 3 May 2000<br />

Concert- en Congresgebouw de Doelen The Queen Elizabeth II Conference Centre<br />

Entrance Kruisplein Broad Sanctuary, Westminster<br />

Rotterdam London SW1P 3EE<br />

00000000 0000000011<br />

Announcements <strong>of</strong> results<br />

0005111 0005111 0005111 00001111<br />

First quarter 10 May 2000 Nine months 3 November 2000<br />

First half year 4 August 2000 Provisional for year 8 February 2001<br />

0005111 0005111 0005111 00001111<br />

Dividends on ordinary capital<br />

0005111 005111 005111 005111 0001111<br />

Final for 1999 NV PLC NV New York Shares PLC American Shares<br />

0005111 005111 005111 005111 0001111<br />

Proposal announced 22 February 2000 22 February 2000 22 February 2000 22 February 2000<br />

Ex-dividend date 5 May 2000 17 April 2000 8 May 2000 20 April 2000<br />

Record date 4 May 2000 25 April 2000 10 May 2000 25 April 2000<br />

Declaration 3 May 2000 3 May 2000 3 May 2000 3 May 2000<br />

Payment date 22 May 2000 22 May 2000 30 May 2000 30 May 2000<br />

0005111 005111 005111 005111 0001111<br />

Interim for 2000 NV PLC NV New York Shares PLC American Shares<br />

0005111 005111 005111 005111 0001111<br />

Announced 3 November 2000 3 November 2000 3 November 2000 3 November 2000<br />

Ex-dividend date 6 November 2000 13 November 2000 8 November 2000 15 November 2000<br />

Record date 3 November 2000 17 November 2000 10 November 2000 17 November 2000<br />

Payment date 18 December 2000 18 December 2000 18 December 2000 26 December 2000<br />

0005111 005111 005111 005111 0001111<br />

Preferential dividends<br />

0005111 0000000000001111<br />

NV<br />

0005111 0000000000001111<br />

4% Preference Paid 1 January<br />

6% Preference Paid 1 October<br />

7% Preference Paid 1 October<br />

10 cents Preference Paid 9 June and 9 December<br />

0005111 0000000000001111<br />

Contact details<br />

Rotterdam London New York<br />

000005111 000005111 00001111<br />

<strong>Unilever</strong> N.V. <strong>Unilever</strong> PLC <strong>Unilever</strong> United States, Inc.<br />

Corporate Relations Department Corporate Relations Department Corporate Relations Department<br />

Weena 455, P0 Box 760 P0 Box 68, <strong>Unilever</strong> House 390 Park Avenue, New York<br />

3000 DK Rotterdam Blackfriars, London EC4P 4BQ NY 10022-4698<br />

Telephone +31 (0)10 217 4848 Telephone +44 (0)20 7822 5794 Telephone + 1 212 906 4240<br />

Telefax +31 (0)10 217 4587 Telefax +44 (0)20 7822 6907 Telefax + 1 212 906 4666<br />

e-mail: e-mail: e-mail:<br />

corporate.relations-rotterdam corporate.relations-london corporate.relations-newyork<br />

@unilever.com @unilever.com @unilever.com<br />

000005111 000005111 00001111


Publications<br />

Copies <strong>of</strong> the following publications can be obtained<br />

without charge from <strong>Unilever</strong>’s Corporate Relations<br />

Departments.<br />

<strong>Unilever</strong> Annual Review 1999<br />

available in English with guilder or sterling figures, and<br />

Dutch with guilder figures; a supplement is also available<br />

in English with US dollar figures.<br />

<strong>Unilever</strong> Annual Accounts 1999<br />

available in English with guilder or sterling figures, and<br />

Dutch with guilder figures.<br />

Annual Report on Form 20-F<br />

the filings in English, with figures in guilders and sterling,<br />

with the United States Securities and Exchange Commission.<br />

Quarterly Results Announcements<br />

available in English and Dutch with euro figures; with<br />

sterling or US dollar figures available as supplements<br />

in English.<br />

Charts Booklet<br />

available in English with guilder, sterling and US dollar<br />

figures combined in a selection <strong>of</strong> charts and data over<br />

ten years.<br />

Environment Report<br />

available in English. The report charts the objectives and<br />

progress made on environmental management and<br />

product life cycle assessment.<br />

Introducing <strong>Unilever</strong><br />

explains our business activities worldwide – available in<br />

English with guilder, sterling or US dollar figures, and in<br />

Dutch with guilder figures.<br />

Web site<br />

www.unilever.com<br />

Our corporate web site has seven key sections for ease<br />

<strong>of</strong> navigation:<br />

Company<br />

an introduction to <strong>Unilever</strong> – its corporate purpose,<br />

geographic spread, organisation and history.<br />

Brands<br />

details <strong>of</strong> <strong>Unilever</strong>’s best-known brands plus information<br />

on DiverseyLever and interactive marketing.<br />

Environment<br />

our environment commitments and goals are captured<br />

along with case studies <strong>of</strong> our work in sustainable<br />

agriculture and fisheries and the global Living Lakes<br />

project. Our latest environment report is also available.<br />

Society<br />

details <strong>of</strong> our work in society and in the communities in<br />

which we operate – for example in schools, health care<br />

and arts sponsorship.<br />

Finance<br />

<strong>Unilever</strong>’s annual and quarterly results, the Annual Review<br />

and Accounts and the Annual Report on Form 20-F plus<br />

a Shareholder Centre which includes key dates in our<br />

financial year; details <strong>of</strong> shareholder meetings; <strong>Unilever</strong>’s<br />

financial history; share price information; and frequently<br />

asked questions and answers.<br />

Careers<br />

information on careers and opportunities with <strong>Unilever</strong>.<br />

News<br />

up-to-date information, including press releases, keynote<br />

speeches and photographs.<br />

Design: The Partners<br />

Typesetting: Generator Limited<br />

Printed by: Precision Printing Co. Limited

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!